Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - olfactory bulb [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - olfactory bulb [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
LALBA	LYZL7	ENSG00000167531	"Lactalbumin alpha"	P00709	12	48567684-48570066	"Cancer-related genes, Metabolic proteins, Predicted secreted proteins"	"Lactose biosynthesis"	"Milk protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	928	"breast: 2211.1"	"Cell type enriched"	"Detected in some"	160	"Breast glandular cells: 48911.9"	"Cancer enriched"	"Detected in single"	599	"breast cancer: 29.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026343, HPA029855, HPA029856"	Enhanced				"Secreted in female reproductive system"	NA	NA		91000			"CAB026343: , HPA029855: AB_2673222, HPA029856: AB_10671362"															"unprognostic (7.85e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	2211.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	166.6	0.0	0.0	0.0	46.7	0.0	0.0	0.0	0.0	0.0	48911.9	305.6	0.0	0.0	0.0	0.0	0.0	0.0	108.5	0.0	0.0	0.0	0.6	0.0	0.0	15.9	0.0	0.0	0.1	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	58.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.7	0.0	0.0	0.0	32.6	0.0	0.0	0.0
CPB1		ENSG00000153002	"Carboxypeptidase B1"	P15086	3	148791102-148860187	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1969	"pancreas: 228861.2"	"Cell type enriched"	"Detected in some"	12	"Exocrine glandular cells: 7306.0"	"Group enriched"	"Detected in some"	312	"breast cancer: 293.8;pancreatic cancer: 641.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.0;U-2 OS: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026158, HPA038069, HPA046340"	Enhanced				"Secreted to digestive system"	NA	NA		88000000			"CAB026158: , HPA038069: AB_2675816, HPA046340: AB_2679628"	"unprognostic (6.90e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (6.26e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.59e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.50e-8)"	"unprognostic (3.08e-1)"	"unprognostic (1.60e-1)"		"unprognostic (4.93e-2)"	12.1	83.7	0.4	5.1	1.5	2.5	79.2	0.5	1.0	3.6	0.2	2.7	31.5	4.8	0.3	3.5	1.8	0.1	41.1	0.5	0.7	2.0	7.1	1.7	8.2	1.0	1.1	0.2	116.2	228861.2	0.0	2.1	13.8	1.2	4.8	4.5	0.0	36.6	0.0	2.3	2.4	17.3	0.0	0.3	19.4	28.5	2.9	0.9	0.1	1.6	0.0	0.0	1.5	2.1	3.4	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.9	0.2	0.0	0.0	0.0	4.0	0.3	0.5	1.3	0.4	0.9	0.4	0.5	1.1	0.1	0.7	0.3	1.4	1.9	1.4	0.5	0.5	0.3	0.4	0.4	1.5	0.5	1.0	0.5	0.7	1.0	1.1	0.2	1.2	0.3	0.9	3.4	2.2	0.0	0.0	1.0	0.0	0.6	0.5	0.0	0.0	0.0	8.7	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	11.6	11.2	0.0	0.1	1.1	164.9	1.3	0.3	7306.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.2	0.0	0.0	1.0	2.5	0.6	1.5	0.0	0.0	18.1	0.0	0.0	0.0	29.8	590.0	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	4.2	2.5	0.0	1.1	0.1	0.3	0.3	0.3	1.1	0.2	0.2
LACRT	LACRITIN	ENSG00000135413	Lacritin	Q9GZZ8	12	54630811-54634895	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	16	"salivary gland: 13.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	304	"breast cancer: 15.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to digestive system"	NA	NA		230000																					0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP2A7	CYP2A	ENSG00000198077	"Cytochrome P450 family 2 subfamily A member 7"	P20853	19	40875439-40882752	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	101	"liver: 153.7"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 195.3"	"Group enriched"	"Detected in some"	238	"breast cancer: 9.2;liver cancer: 25.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB033510, HPA046713, HPA047262"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB033510: AB_782366, HPA046713: AB_2679767, HPA047262: AB_2680005"	"unprognostic (2.18e-1)"				"unprognostic (3.60e-2)"		"unprognostic (2.65e-3)"	"unprognostic (8.89e-2)"		"unprognostic (1.39e-2)"	"unprognostic (3.95e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.99e-2)"		"unprognostic (1.06e-2)"		0.0	0.0	0.3	0.0	0.3	0.0	0.5	0.0	0.6	1.5	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	153.7	0.1	0.0	0.4	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.6	0.3	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	24.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.2	11.0	195.3	0.0	0.0	0.1	0.8	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.9
CSN2	CASB	ENSG00000135222	"Casein beta"	P05814	4	69955256-69961007	"Predicted secreted proteins"		"Milk protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	94	"breast: 310.5"	"Cell type enriched"	"Detected in some"	97	"Breast glandular cells: 33136.9"	"Cancer enriched"	"Detected in single"	156	"breast cancer: 75.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041036	Supported				"Secreted in female reproductive system"	NA	NA					"HPA041036: AB_10793865"																		0.0	0.0	0.0	0.0	0.0	0.0	310.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	113.1	0.0	0.0	0.0	29.8	0.0	0.0	0.0	0.0	0.0	33136.9	340.4	0.0	0.0	0.0	0.0	0.0	0.0	72.4	0.0	0.0	0.0	0.8	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0
CLEC3A	CLECSF1	ENSG00000166509	"C-type lectin domain family 3 member A"	O75596	16	78022515-78066761	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.1;breast: 9.5;urinary bladder: 5.9"	"Cell type enriched"	"Detected in single"	7	"Prostatic glandular cells: 4.7"	"Cancer enriched"	"Detected in some"	102	"breast cancer: 78.5"	"Region enriched"	"Detected in single"	6	"midbrain: 4.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SK-BR-3: 7.4;T-47d: 21.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051511	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA051511: AB_2681514"	"prognostic unfavorable (1.61e-4)"				"unprognostic (1.60e-1)"							"unprognostic (2.42e-1)"		"unprognostic (1.25e-1)"	"unprognostic (4.95e-2)"		"unprognostic (3.80e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	4.1	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PIP	"GCDFP-15, GCDFP15, GPIP4"	ENSG00000159763	"Prolactin induced protein"	P12273	7	143132077-143139739	"Plasma proteins, Predicted secreted proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"salivary gland: 16928.3"	"Group enriched"	"Detected in many"	4	"Breast glandular cells: 1117.6;Breast myoepithelial cells: 324.2;Melanocytes: 403.8"	"Cancer enriched"	"Detected in many"	70	"breast cancer: 672.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	333	"T-47d: 703.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB002661, HPA009177"	Enhanced				"Secreted in other tissues"	NA	NA		66000000			"CAB002661: , HPA009177: AB_1845459"	"unprognostic (2.80e-1)"	"unprognostic (2.15e-1)"		"unprognostic (1.08e-3)"		"unprognostic (3.01e-2)"		"unprognostic (5.93e-2)"		"unprognostic (2.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (5.96e-5)"	"unprognostic (3.14e-1)"		"unprognostic (3.49e-2)"	"unprognostic (5.55e-1)"	5.2	3.6	2.2	0.2	3.9	0.1	3493.6	1.9	2.3	5.6	0.0	0.5	0.0	0.1	2.7	1.3	4.2	0.1	4.9	0.5	3.1	0.5	2.0	6.5	0.8	6.3	3.7	0.0	3.8	21.3	0.4	1.9	2.3	5.8	33.6	0.0	0.0	16928.3	3170.8	1.7	157.4	0.6	0.0	4.2	0.6	0.6	0.7	3.7	0.3	0.7	0.0	1.8	0.7	1.5	10.9	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.0	1.3	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.2	0.0	0.0	2.1	0.0	0.0	703.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.9	1.9	2.3	0.5	3.1	6.3	3.7	0.0	5.8	4.2	3.7	10.9	6.9	0.0	2.0	0.0	3.6	10.8	6.6	18.8	0.0	0.0	1117.6	324.2	0.1	0.0	48.2	1.8	0.0	0.0	7.0	0.0	0.0	9.3	0.0	0.0	0.0	3.9	0.0	0.0	0.0	2.5	0.0	3.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	24.4	0.0	1.6	0.0	0.0	1.5	403.8	0.0	0.0	0.0	0.0	0.0	0.7	2.1	0.0	0.0	0.0	13.1	0.0	0.1	147.1	0.0	0.0	0.0	9.2	0.0	0.0	0.0	1.7	0.0	2.5	0.0	0.0	13.7
NXPH1		ENSG00000122584	"Neurexophilin 1"	P58417	7	8433609-8752961	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"adrenal gland: 42.4;brain: 24.3"	"Group enriched"	"Detected in some"	40	"Inhibitory neurons: 1486.5;Oligodendrocyte precursor cells: 1500.4"	"Group enriched"	"Detected in some"	62	"breast cancer: 2.3;glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Karpas-707: 10.9;WM-115: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in brain"	NA	NA						"unprognostic (2.84e-2)"		"unprognostic (1.30e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.18e-1)"			"unprognostic (1.39e-2)"			"unprognostic (1.46e-4)"	"unprognostic (1.47e-1)"		"unprognostic (3.01e-2)"	"unprognostic (5.32e-1)"		"unprognostic (9.46e-2)"	0.1	42.4	8.3	0.0	10.5	0.0	0.4	3.5	8.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	13.4	0.0	0.0	0.0	0.0	10.7	24.3	7.6	0.0	0.0	0.0	1.5	0.0	12.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.2	19.1	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.9	0.0	0.0	1.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	10.5	3.5	8.6	8.0	13.4	10.7	24.3	7.6	12.0	5.1	19.1	19.5	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1486.5	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	36.5	0.0	0.6	0.0	1500.4	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.1	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP4Z1	CYP4A20	ENSG00000186160	"Cytochrome P450 family 4 subfamily Z member 1"	Q86W10	1	47067231-47118318	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 6.3"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Breast glandular cells: 8.3;Early spermatids: 2.5;Excitatory neurons: 8.3;Inhibitory neurons: 5.8"	"Cancer enriched"	"Detected in some"	50	"breast cancer: 42.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"HDLM-2: 8.1;SK-BR-3: 3.2"															NA	NA						"unprognostic (4.11e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.33e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.53e-3)"		"unprognostic (7.76e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.53e-1)"	"unprognostic (6.82e-3)"	"unprognostic (5.09e-3)"	"unprognostic (3.88e-2)"	"unprognostic (6.46e-2)"	"unprognostic (3.49e-3)"	1.9	0.2	0.8	0.0	0.8	0.0	6.3	0.2	1.1	0.3	0.0	0.2	0.0	0.3	0.3	0.7	0.6	0.0	0.7	0.7	0.9	0.2	0.7	1.6	0.0	0.3	0.4	0.9	0.0	0.1	0.0	0.6	0.0	0.4	1.2	0.0	0.0	0.8	0.3	0.7	0.9	0.2	0.0	0.1	0.0	0.4	0.4	0.7	0.2	0.5	0.2	0.2	0.5	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.2	1.1	0.7	0.9	0.3	0.4	0.9	0.4	0.1	0.7	1.1	0.3	9.6	1.1	1.0	0.0	0.1	0.5	0.4	0.0	0.0	8.3	0.4	0.4	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.5	0.2	0.1	0.9	0.0	0.0	8.3	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7
ANKRD30A	NY-BR-1	ENSG00000148513	"Ankyrin repeat domain 30A"	Q9BXX3	10	37125725-37384111	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"breast: 38.5"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 295.9;Breast myoepithelial cells: 84.8"	"Cancer enriched"	"Detected in single"	37	"breast cancer: 11.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	32	"A549: 2.7;U-266/70: 10.4"									HPA071849			Uncertain	Nucleoli		NA	NA			Nucleoli		"HPA071849: "	"unprognostic (2.79e-1)"											"unprognostic (2.81e-1)"	"unprognostic (1.01e-7)"	"unprognostic (1.41e-1)"		"unprognostic (5.93e-1)"		1.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	295.9	84.8	0.3	0.0	0.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	16.3	0.0	0.4	1.0	0.0	0.0	1.5	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	8.5	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	45.8	1.7	0.0	0.0	0.3	0.3	0.1	0.0	0.0
CST9	"CLM, CTES7A"	ENSG00000173335	"Cystatin 9"	Q5W186	20	23602410-23605917	"Predicted secreted proteins"		"Antimicrobial, Protease inhibitor, Thiol protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	12	"breast: 1.9"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	37	"breast cancer: 9.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA029190	Uncertain				"Secreted in female reproductive system"	NA	NA					"HPA029190: AB_10602804"	"unprognostic (2.06e-2)"									"unprognostic (2.21e-4)"								0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MUCL1	SBEM	ENSG00000172551	"Mucin like 1"	Q96DR8	12	54830518-54896008	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"breast: 3274.7"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 4494.5;Breast myoepithelial cells: 1273.2;Melanocytes: 1060.1"	"Cancer enriched"	"Detected in many"	30	"breast cancer: 298.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;hTCEpi: 1.3;MCF7: 2.1;SK-BR-3: 4.8;SuSa: 3.3"									HPA039093	Enhanced				"Secreted in other tissues"	NA	NA					"HPA039093: AB_10795577"	"unprognostic (2.26e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.34e-3)"		"unprognostic (5.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.37e-1)"	"unprognostic (4.04e-1)"		"unprognostic (9.90e-2)"	19.9	0.4	0.2	1.1	0.4	0.0	3274.7	0.1	0.6	1.3	0.1	1.8	0.0	0.2	1.5	0.4	2.2	0.2	1.5	0.2	0.2	2.4	1.0	1.1	0.1	0.2	0.2	0.2	0.3	0.3	0.0	0.3	0.4	0.2	1.1	0.0	0.0	209.2	0.0	2.0	710.5	0.3	0.1	0.2	0.2	0.7	1.2	0.2	2.4	0.2	0.0	0.0	1.3	3.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.8	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.6	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	10.4	0.0	1.1	0.0	3.8	188.4	0.4	2.1	0.0	0.0	4494.5	1273.2	0.1	0.0	3.4	0.0	0.0	0.0	12.9	0.0	3.9	0.0	0.0	1.8	0.0	3.4	0.0	0.0	1.4	0.2	0.0	6.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	2.0	0.0	14.1	0.2	0.0	45.5	1060.1	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	5.9	0.0	0.1	2.6	0.0	0.0	0.0	6.1	0.2	0.6	0.0	10.1	0.0	2.5	0.1	0.0	3.8
SLC30A8	"ZnT-8, ZNT8"	ENSG00000164756	"Solute carrier family 30 member 8"	Q8IWU4	8	116950273-117176714	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pancreas: 62.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 4.9;Late spermatids: 7.5;Pancreatic endocrine cells: 5.0;Proximal tubular cells: 3.6;Spermatogonia: 5.0"	"Group enriched"	"Detected in some"	28	"breast cancer: 10.6;pancreatic cancer: 15.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	36	"U-266/70: 48.0;U-266/84: 36.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hippocampal formation: 4.1"	HPA076165	Enhanced					NA	NA					"HPA076165: AB_2732304"	"unprognostic (2.14e-2)"		"unprognostic (1.48e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.38e-2)"		"unprognostic (5.57e-2)"	"unprognostic (4.38e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.66e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.16e-3)"	0.0	0.0	0.2	0.0	0.4	0.3	0.6	0.2	0.3	0.1	0.0	0.3	0.6	0.7	0.0	0.2	0.1	0.2	0.2	0.3	0.1	4.4	0.0	0.1	0.1	0.2	0.1	0.2	0.0	62.4	0.3	0.3	0.3	0.4	0.1	0.2	0.2	13.0	0.0	0.0	0.8	1.0	0.2	0.0	0.0	1.1	2.0	0.1	0.1	0.1	0.0	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	48.0	36.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.3	0.3	0.1	0.2	0.1	0.2	0.4	0.0	0.1	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	4.9	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.0	0.9	5.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	1.8	5.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
GATA3	HDR	ENSG00000107485	"GATA binding protein 3"	P23771	10	8045378-8075198	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 110.7;skin 1: 160.3"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 267.1;Cytotrophoblasts: 323.5;Extravillous trophoblasts: 746.6;Suprabasal keratinocytes: 198.9;Syncytiotrophoblasts: 1134.9"	"Group enriched"	"Detected in many"	24	"breast cancer: 190.0;urothelial cancer: 87.0"	"Group enriched"	"Detected in many"	4	"medulla oblongata: 3.6;midbrain: 9.6;pons: 6.6;thalamus: 4.3;white matter: 3.0"	"Group enriched"	"Detected in many"	41	"gdT-cell: 19.9;MAIT T-cell: 26.9;memory CD4 T-cell: 36.7;memory CD8 T-cell: 28.8;naive CD4 T-cell: 19.9;naive CD8 T-cell: 18.3;NK-cell: 36.1;T-reg: 43.6"	"Group enriched"	"Detected in many"	57	"NK-cells: 36.1;T-cells: 43.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 190.2;MCF7: 473.4;RT4: 194.3;SH-SY5Y: 161.2;T-47d: 605.2"	"Region enriched"	"Detected in single"	6	"midbrain: 6.1"	"Group enriched"	"Detected in some"	11	"medulla oblongata: 5.2;midbrain: 14.0;pons: 11.8;thalamus: 13.1"	"CAB016217, HPA029730"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB016217: AB_2108591, HPA029730: AB_10601907"	"unprognostic (1.70e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.68e-3)"	"unprognostic (4.23e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.82e-3)"	6.8	6.5	1.3	3.9	0.2	4.2	34.6	0.2	1.0	1.9	0.8	0.6	1.0	0.7	8.7	0.6	0.5	1.2	2.0	0.1	0.5	21.0	1.0	3.4	7.9	3.6	9.6	0.0	0.1	0.3	110.7	5.0	32.4	6.6	11.3	0.7	0.0	20.0	25.1	2.1	160.3	2.4	0.3	0.4	7.2	1.5	0.2	4.3	25.2	3.1	1.0	3.8	39.1	10.9	3.0	33.8	8.1	0.0	0.4	0.0	0.0	190.2	0.7	0.0	0.0	0.1	12.4	29.9	0.0	0.1	0.0	0.0	28.9	3.2	0.6	0.1	95.8	10.2	0.2	0.3	0.1	2.1	0.1	0.5	0.0	6.9	0.1	1.8	1.0	15.3	45.8	0.4	0.0	0.1	473.4	54.2	0.5	3.5	6.5	4.5	2.8	2.6	0.8	0.0	194.3	9.8	161.2	0.5	26.8	0.0	34.1	605.2	0.1	0.0	2.4	5.9	1.4	4.3	0.9	0.0	0.0	1.3	0.0	1.7	0.1	0.1	0.0	19.9	0.0	26.9	0.4	36.7	28.8	0.0	0.1	19.9	18.3	0.7	36.1	0.0	0.0	43.6	7.0	1.3	0.2	0.2	1.0	0.1	0.5	3.6	9.6	0.0	6.6	0.4	4.3	3.0	14.6	0.0	6.0	0.0	3.4	94.8	69.6	1.6	0.0	0.0	267.1	167.3	1.3	0.0	1.5	178.4	0.0	323.5	49.2	0.0	0.0	0.2	0.2	0.5	0.4	12.6	0.0	2.1	0.0	0.4	746.6	5.3	2.6	0.7	2.5	0.0	6.8	0.6	30.7	0.0	0.0	0.0	0.0	3.5	9.9	0.1	0.0	3.8	8.8	1.0	1.5	0.0	51.5	0.0	0.0	4.1	1.1	0.0	12.2	45.8	0.0	0.6	0.3	0.0	0.0	1.1	2.8	0.0	1.4	1.0	198.9	1134.9	93.4	0.5	0.0	106.1
SCGB2A2	"MGB1, MGC71974, PSBP1, UGB2"	ENSG00000110484	"Secretoglobin family 2A member 2"	Q13296	11	62270158-62273160	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"breast: 2835.1"	"Group enriched"	"Detected in some"	11	"Breast glandular cells: 2119.6;Breast myoepithelial cells: 1028.8;Melanocytes: 1762.7"	"Cancer enriched"	"Detected in many"	23	"breast cancer: 823.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	124	"SK-BR-3: 18.0"									CAB026270	Enhanced				"Secreted in female reproductive system"	NA	NA					"CAB026270: AB_912980"	"unprognostic (2.38e-1)"	"unprognostic (7.28e-2)"		"prognostic favorable (9.57e-8)"						"unprognostic (4.17e-1)"				"unprognostic (3.75e-1)"				19.3	0.2	0.0	0.0	0.0	0.0	2835.1	0.0	0.0	311.9	0.0	0.4	0.0	4.1	0.0	77.3	0.1	0.0	2.2	0.0	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.6	1.3	0.0	0.2	0.0	0.0	160.6	0.1	1.8	635.0	0.2	0.0	0.0	0.2	0.3	1.1	0.0	2.1	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	6.6	49.6	0.3	0.0	0.0	0.0	2119.6	1028.8	0.1	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	1.4	41.9	21.6	11.3	0.0	0.0	0.0	0.0	0.0	6.7	0.0	141.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	3.2	1762.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	10.9	0.0	9.2	0.0	0.0	0.0
SMR3B	"P-B, PRL3, PROL3"	ENSG00000171201	"Submaxillary gland androgen regulated protein 3B"	P02814	4	70370093-70390244	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	946	"salivary gland: 219074.7"	"Group enriched"	"Detected in some"	55	"Breast glandular cells: 2.3;Early spermatids: 8.4;Late spermatids: 6.0"	"Cancer enriched"	"Detected in some"	22	"breast cancer: 32.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	39	"EFO-21: 4.5"														"Secreted to digestive system"	NA	NA		1900000																			"unprognostic (3.72e-1)"		0.0	9.2	0.0	0.0	0.0	7.7	0.3	0.0	0.4	0.0	0.8	0.0	0.0	0.0	1.1	9.0	0.0	0.0	44.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	47.8	231.4	0.0	1.6	23.4	0.0	1.6	0.0	0.0	219074.7	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	2.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B11		ENSG00000213759	"UDP glucuronosyltransferase family 2 member B11"	O75310	4	69199951-69214748	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"breast: 241.8"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 13.7;Cholangiocytes: 7.2"	"Group enriched"	"Detected in some"	17	"breast cancer: 17.4;liver cancer: 13.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	42	"basophil: 4.7;eosinophil: 3.5"	"Lineage enriched"	"Detected in single"	47	"granulocytes: 4.7"	"Not detected"	"Not detected"											HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.12e-1)"						"unprognostic (1.18e-3)"			"unprognostic (1.49e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-3)"	0.1	0.0	0.0	0.1	0.0	0.1	241.8	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.9	0.0	0.5	11.5	0.0	0.0	0.0	3.6	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.5	0.0	7.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1
BRINP3	"DBCCR1L, DBCCR1L1, FAM5C"	ENSG00000162670	"BMP/retinoic acid inducible neural specific 3"	Q76B58	1	190097658-190478404	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.0;intestine: 18.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 266.7;Excitatory neurons: 333.7;Inhibitory neurons: 129.7;Oligodendrocyte precursor cells: 1079.2"	"Group enriched"	"Detected in some"	14	"breast cancer: 3.4;glioma: 8.6;prostate cancer: 3.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054693	Uncertain				"Secreted in other tissues"	NA	NA					"HPA054693: AB_2682575"	"unprognostic (3.18e-2)"		"unprognostic (1.22e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.40e-1)"			"unprognostic (1.72e-1)"			"unprognostic (8.25e-2)"	"unprognostic (3.65e-1)"		"unprognostic (2.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.58e-3)"	0.3	1.8	16.7	0.6	16.6	0.0	1.4	18.6	17.3	0.2	0.0	6.7	4.6	0.3	3.0	1.7	0.4	1.6	5.3	27.0	22.5	2.3	0.0	1.2	0.0	12.1	15.9	13.8	0.0	0.0	0.0	0.2	0.0	13.3	6.8	6.8	0.7	1.6	5.1	0.1	0.1	18.0	0.6	9.8	0.0	0.2	3.4	20.2	0.1	2.2	0.0	0.1	0.5	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	16.6	18.6	17.3	27.0	22.5	12.1	15.9	13.8	13.3	9.8	20.2	14.9	0.0	0.0	0.0	266.7	0.0	0.0	0.1	0.0	0.0	0.7	0.3	0.4	2.3	0.0	0.0	3.7	0.0	0.0	0.0	2.0	3.9	0.0	63.3	0.0	0.0	0.1	1.2	0.0	333.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	129.7	2.8	0.0	0.0	0.0	10.5	0.0	0.1	0.0	8.4	0.0	0.0	0.0	1079.2	4.3	0.0	10.8	0.0	0.0	1.0	8.1	0.3	0.0	0.1	0.0	0.0	5.8	2.0	0.7	0.1	0.0	0.0	0.0	0.0	5.2	0.1
LMX1B	NPS1	ENSG00000136944	"LIM homeobox transcription factor 1 beta"	O60663	9	126613928-126701032	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.8;salivary gland: 18.7"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 8.3;Breast myoepithelial cells: 7.2;Cardiomyocytes: 1.9;Early spermatids: 1.6;Spermatogonia: 2.1"	"Cancer enriched"	"Detected in some"	14	"breast cancer: 12.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.5;HEK 293: 3.6;MCF7: 11.9;OE19: 10.4;T-47d: 8.1"	"Region enhanced"	"Detected in some"		"pons and medulla: 2.3"	"Region enhanced"	"Detected in many"		"midbrain: 5.0"	"HPA073716, HPA075656"			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA073716: AB_2686630, HPA075656: "	"unprognostic (4.17e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.53e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.63e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-6)"	"unprognostic (1.13e-2)"	0.4	0.0	0.2	0.0	0.5	0.1	4.1	0.3	4.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.0	1.3	3.5	0.0	0.1	0.0	4.0	7.8	0.0	0.0	0.2	1.1	0.2	0.0	2.2	0.0	0.0	0.0	18.7	0.0	0.1	1.9	0.1	0.0	3.8	0.0	0.1	1.4	1.8	0.0	0.4	0.0	0.0	0.0	0.0	2.1	1.2	0.6	0.3	2.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.3	0.0	2.5	0.6	3.5	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	11.9	0.0	0.0	0.0	10.4	0.0	0.0	2.4	0.0	0.0	0.1	0.0	1.1	0.3	0.0	0.2	0.1	8.1	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.3	4.3	1.0	1.3	4.0	7.8	0.0	2.2	3.8	1.8	2.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	8.3	7.2	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	1.6	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
NAT1	AAC1	ENSG00000171428	"N-acetyltransferase 1"	P18440	8	18170477-18223689	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 24.2;Paneth cells: 32.7;Respiratory ciliated cells: 32.0"	"Cancer enriched"	"Detected in all"	14	"breast cancer: 47.9"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB017782, HPA043704"	Approved					NA	NA					"CAB017782: , HPA043704: AB_2678625"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (2.09e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.20e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.51e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.28e-2)"	"unprognostic (8.15e-2)"	3.7	1.5	0.5	5.5	0.6	3.2	5.9	0.8	0.9	6.5	0.9	14.3	11.8	2.4	15.4	2.5	4.4	3.7	1.9	0.5	1.0	5.7	10.4	3.5	6.1	1.1	0.7	0.4	2.9	1.8	1.1	1.0	4.1	0.8	7.4	12.9	0.3	1.9	2.9	0.4	2.5	9.0	3.6	0.8	4.2	5.0	1.8	0.7	4.6	2.1	1.5	6.7	4.5	1.3	0.9	22.6	2.7	2.5	3.3	6.3	6.3	5.3	8.0	8.5	8.8	10.2	4.0	4.7	11.0	6.2	5.2	8.1	3.6	4.5	5.4	8.9	10.3	2.3	7.6	3.0	3.0	6.0	3.3	9.7	5.2	6.5	6.0	0.5	2.2	7.9	9.3	6.6	2.9	10.0	4.0	9.8	10.3	2.4	17.8	3.4	4.9	2.5	4.3	9.3	12.6	1.3	1.7	0.3	9.5	5.5	5.2	7.7	9.7	8.5	5.3	3.1	8.0	1.3	2.0	4.0	9.3	4.6	7.5	2.4	5.4	4.6	9.4	3.3	5.3	2.4	4.4	3.4	3.4	6.1	3.9	3.2	3.9	8.2	6.3	5.4	3.5	6.3	2.7	0.5	0.6	0.8	0.9	0.5	1.0	1.1	0.7	0.4	0.8	0.8	0.7	0.9	4.6	0.0	3.6	0.7	4.7	0.4	0.8	9.1	1.2	0.0	3.5	1.9	1.6	0.0	11.3	5.5	0.0	5.9	2.3	24.2	1.9	5.7	10.8	3.9	3.2	3.0	3.6	0.8	0.8	6.9	7.7	2.1	3.6	2.8	2.5	1.1	2.2	12.7	7.2	0.0	0.2	10.7	8.2	6.3	2.6	2.2	4.1	5.3	3.6	1.9	4.9	2.5	4.1	0.0	0.5	5.8	32.7	5.7	2.6	2.3	12.7	16.6	32.0	0.0	0.0	0.7	3.4	4.2	0.6	2.2	0.6	10.9	4.1	3.2	8.4	2.5
GPR26		ENSG00000154478	"G protein-coupled receptor 26"	Q8NDV2	10	123666355-123697399	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"brain: 7.0"	"Cell type enriched"	"Detected in some"	6	"Excitatory neurons: 11.4"	"Cancer enriched"	"Detected in single"	13	"breast cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"SCLC-21H: 1.0"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 62.7"	HPA062736	Enhanced					NA	NA					"HPA062736: AB_2684855"	"unprognostic (4.15e-2)"				"unprognostic (5.75e-2)"	"unprognostic (3.42e-1)"		"unprognostic (2.12e-1)"			"unprognostic (9.09e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.12e-1)"			0.0	0.0	1.1	0.0	1.5	0.0	0.0	0.0	4.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	2.0	0.0	0.0	0.0	0.0	2.0	7.0	1.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.5	0.0	4.5	5.6	2.0	2.0	7.0	1.3	1.0	0.6	3.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0
INSYN2A	"C10orf141, FAM196A, FLJ45557, INSYN2"	ENSG00000188916	"Inhibitory synaptic factor 2A"	Q6ZSG2	10	127135426-127196591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 7.8"	"Cell type enhanced"	"Detected in single"		"Endothelial cells: 1.4"	"Group enriched"	"Detected in some"	13	"breast cancer: 3.4;glioma: 3.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SCLC-21H: 2.7;U-87 MG: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035898, HPA035899"	Uncertain					NA	NA					"HPA035898: AB_10964352, HPA035899: AB_10961723"	"unprognostic (4.00e-2)"	"unprognostic (9.28e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.18e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.18e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.47e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.45e-1)"	0.0	0.0	4.6	0.1	5.5	0.0	0.6	2.8	4.7	0.0	0.9	0.2	0.1	0.1	0.3	0.0	0.0	0.1	0.1	3.4	5.8	0.2	0.0	0.2	0.0	4.3	5.0	2.9	0.7	0.1	0.0	0.2	0.0	5.6	0.8	0.1	1.6	0.2	0.1	0.0	0.1	0.3	0.1	2.2	0.3	0.2	0.6	7.8	1.1	0.1	0.1	0.1	0.2	0.1	4.7	0.0	0.4	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.6	5.5	2.8	4.7	3.4	5.8	4.3	5.0	2.9	5.6	2.2	7.8	4.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPY1R	NPYR	ENSG00000164128	"Neuropeptide Y receptor Y1"	P25929	4	163323962-163344832	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 120.7"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 32.8;Excitatory neurons: 39.8;Hepatic stellate cells: 160.6;Sertoli cells: 46.0;Smooth muscle cells: 34.1"	"Cancer enriched"	"Detected in many"	13	"breast cancer: 65.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"HEL: 128.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"prognostic favorable (7.68e-5)"	"unprognostic (9.14e-3)"	"unprognostic (1.55e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.29e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.92e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.21e-1)"	30.8	31.3	6.4	2.9	12.3	0.0	32.7	0.0	13.8	7.9	0.4	5.9	1.0	7.4	10.3	1.8	8.4	4.6	2.9	8.5	13.9	32.6	14.8	2.1	17.4	4.4	1.5	12.8	2.9	28.9	3.7	3.0	5.3	4.4	2.6	4.5	4.5	21.6	8.4	2.9	9.1	1.5	5.7	2.7	120.7	1.9	4.1	1.9	1.1	8.0	2.6	0.9	1.8	5.0	9.6	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.0	0.0	7.0	0.0	0.0	0.0	0.0	128.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.9	0.0	0.1	0.4	0.0	0.0	1.2	0.0	4.6	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.0	0.0	0.4	3.0	0.0	0.0	0.1	1.2	0.0	0.6	0.1	0.0	0.0	1.4	0.0	4.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	6.4	12.3	0.0	13.8	8.5	13.9	4.4	1.5	12.8	4.4	2.7	1.9	9.6	2.1	0.0	0.5	1.3	0.7	2.8	0.7	0.0	3.4	11.6	19.2	3.3	0.9	1.5	0.0	0.0	2.1	0.0	0.0	3.4	13.7	12.5	5.0	0.0	0.4	10.8	32.8	0.0	39.8	0.0	0.0	5.1	0.0	0.1	0.0	3.7	160.6	0.9	0.1	0.0	18.8	1.6	0.0	7.2	0.9	2.4	11.5	0.1	5.4	4.7	0.0	1.1	0.0	2.0	1.4	0.1	15.9	0.4	0.0	0.5	0.1	0.1	0.0	2.1	46.0	1.1	34.1	0.5	0.6	0.1	1.7	0.0	0.6	0.5	2.1	0.3
PGR	"NR3C3, PR"	ENSG00000082175	"Progesterone receptor"	P06401	11	101029624-101129813	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 64.4;endometrium 1: 104.4;fallopian tube: 34.6;smooth muscle: 79.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.0;Endometrial ciliated cells: 90.1;Endometrial stromal cells: 177.1;Glandular and luminal cells: 76.3;Late spermatids: 40.9"	"Group enriched"	"Detected in some"	13	"breast cancer: 10.1;endometrial cancer: 11.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	338	"T-47d: 170.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000068, HPA004751, HPA008428, HPA017176, CAB055100"	Enhanced					NA	NA					"CAB000068: AB_442124, CAB055100: AB_2532076, HPA004751: AB_1079681, HPA008428: AB_1079680, HPA017176: AB_1855728"	"unprognostic (2.59e-2)"	"unprognostic (9.80e-3)"	"unprognostic (5.23e-3)"	"prognostic favorable (5.76e-8)"	"unprognostic (2.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (7.71e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.44e-3)"	1.1	1.7	2.0	0.3	1.1	0.0	7.0	1.0	1.0	64.4	1.0	1.8	0.5	104.4	0.8	0.7	34.6	0.9	3.7	0.8	6.4	1.1	0.3	1.4	0.2	1.6	1.5	0.5	16.4	0.6	0.3	1.1	1.8	1.6	3.7	0.7	0.1	3.9	9.1	0.6	0.4	0.7	79.0	1.7	1.8	0.6	3.5	6.2	0.2	1.3	1.8	0.2	1.7	10.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	170.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.1	1.0	1.0	0.8	6.4	1.6	1.5	0.5	1.6	1.7	6.2	1.3	1.3	3.2	0.0	0.3	0.7	0.1	1.1	0.0	0.0	1.3	35.9	19.8	18.7	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	64.0	90.1	177.1	3.5	0.0	0.0	0.1	0.0	0.1	12.5	0.0	76.3	0.0	34.7	2.9	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.3	40.9	14.6	1.9	0.0	22.5	0.0	0.0	0.0	1.0	0.3	0.1	0.0	10.5	0.0	0.3	0.0	0.0	0.0	0.2	6.6	1.4	14.9	3.9	2.3	0.0	0.6	0.0	2.3	15.1	0.0	1.0
AZGP1	"ZA2G, ZAG"	ENSG00000160862	"Alpha-2-glycoprotein 1, zinc-binding"	P25311	7	99966720-99976042	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 2832.6;salivary gland: 3880.0"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 1315.5;Breast myoepithelial cells: 704.8;Hepatocytes: 4270.8;Ionocytes: 901.3;Prostatic glandular cells: 1691.9;Urothelial cells: 674.2"	"Group enriched"	"Detected in many"	12	"breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 56.6;OE19: 158.9;RPMI-8226: 130.4;T-47d: 41.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012582, HPA012876, CAB016087, CAB032276"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	55200000000	74000000000	Vesicles	Nucleoplasm	"CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226, HPA012876: "	"unprognostic (8.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.41e-1)"	"unprognostic (5.42e-3)"	"unprognostic (4.98e-2)"	"unprognostic (5.74e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-3)"	129.8	3.9	17.4	2.8	28.0	0.4	1072.2	23.6	22.9	2.5	16.4	6.8	31.1	1.5	2.5	22.2	3.0	39.1	67.4	15.6	23.4	329.8	2832.6	14.9	0.4	22.9	23.6	14.9	6.1	758.5	0.1	1.3	0.5	29.9	1060.6	4.3	3.6	3880.0	40.6	1.7	188.9	28.9	0.3	14.8	1.4	317.7	26.1	23.1	0.8	1.9	2.3	1.5	5.8	7.6	26.1	0.2	0.0	0.0	0.0	11.3	0.0	5.5	0.0	0.0	0.0	0.0	0.1	4.0	14.2	0.7	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	0.3	0.1	56.6	4.9	1.5	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.3	29.9	0.0	0.0	0.0	5.1	0.2	158.9	0.0	0.0	1.7	130.4	0.0	0.0	0.0	2.0	1.0	25.4	13.0	0.0	41.8	0.0	0.0	0.5	0.1	1.8	0.9	1.9	0.8	0.4	0.0	0.5	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	28.0	23.6	22.9	15.6	23.4	22.9	23.6	14.9	29.9	14.8	23.1	26.1	9.9	22.4	276.8	0.0	14.7	4.2	422.1	25.3	0.0	0.0	1315.5	704.8	115.9	451.8	63.0	5.5	2.1	0.0	10.4	5.5	46.9	11.7	1.9	1.4	1.2	14.2	12.4	85.5	0.1	254.2	0.0	7.7	94.8	5.5	3.8	1.2	65.3	4270.8	0.0	0.0	0.1	13.1	901.3	93.1	0.7	4.2	0.9	14.8	62.2	1.0	2.0	23.7	0.0	7.5	7.3	221.5	6.4	0.0	0.3	1691.9	15.3	596.1	6.3	0.3	0.0	0.0	11.9	7.4	0.4	9.9	9.7	0.0	12.3	0.1	12.6	674.2
GFRA1	"GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1"	ENSG00000151892	"GDNF family receptor alpha 1"	P56159	10	116056925-116273284	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 40.5;Breast glandular cells: 33.1;Fibroblasts: 51.2;Hepatocytes: 42.2;Oligodendrocyte precursor cells: 91.0;Skeletal myocytes: 100.1"	"Cancer enriched"	"Detected in many"	11	"breast cancer: 40.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 44.7;BJ hTERT+ SV40 Large T+ RasG12V: 77.2;EFO-21: 46.5;fHDF/TERT166: 89.3;HBF TERT88: 63.2;MCF7: 59.5;U-251 MG: 53.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043829	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		140000	"Golgi apparatus"	Nucleoplasm	"HPA043829: AB_2678689"	"unprognostic (2.07e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.06e-3)"	"unprognostic (4.10e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.35e-3)"	"unprognostic (1.48e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.64e-2)"	10.8	3.4	7.9	4.3	11.7	0.0	23.4	2.4	9.6	8.4	0.8	14.0	1.7	4.9	20.7	7.0	17.4	5.7	4.0	9.5	13.9	6.0	16.1	2.9	4.0	7.5	25.0	5.0	4.6	6.7	2.8	3.2	0.0	8.0	4.6	4.0	3.3	6.1	5.5	4.3	6.7	8.3	4.8	5.8	3.9	8.2	3.1	7.4	4.2	2.8	14.0	6.5	7.1	9.2	6.1	0.1	3.7	12.2	0.0	0.0	0.1	0.0	7.9	0.4	44.7	77.2	0.0	0.0	0.0	46.5	89.3	0.0	0.0	0.1	0.0	63.2	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	2.5	0.0	11.5	0.0	3.9	0.0	9.1	0.0	0.0	5.6	59.5	7.6	0.0	5.0	0.0	0.0	0.0	1.9	0.0	5.0	0.0	1.6	0.1	0.0	0.0	0.1	2.1	0.4	0.0	0.4	0.0	0.4	0.1	53.5	0.0	0.0	0.1	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	11.7	2.4	9.6	9.5	13.9	7.5	25.0	5.0	8.0	5.8	7.4	6.1	6.1	0.0	0.0	40.5	0.5	5.7	0.0	0.0	1.8	4.1	33.1	11.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	13.2	0.0	0.2	3.2	6.0	0.0	5.1	13.5	0.0	51.2	3.1	0.0	6.3	0.1	0.4	42.2	0.0	0.0	6.6	0.0	0.0	1.0	9.6	12.8	8.1	1.0	5.4	1.9	0.0	12.6	0.0	91.0	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.9	0.0	0.5	0.0	100.1	16.7	0.1	10.4	0.7	4.5	0.0	0.7	0.1	0.0	0.2
CSN1S1	"CASA, CSN1"	ENSG00000126545	"Casein alpha s1"	P47710	4	69931068-69946574	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Milk protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	87	"breast: 1406.5"	"Cell type enriched"	"Detected in some"	47	"Breast glandular cells: 8261.0"	"Cancer enriched"	"Detected in some"	10	"breast cancer: 17.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035659, HPA057031"	Enhanced				"Secreted in female reproductive system"	NA	NA					"HPA035659: AB_10696356, HPA057031: AB_2683315"					"unprognostic (1.52e-2)"										"unprognostic (1.01e-1)"			16.2	0.0	0.1	0.5	0.0	0.0	1406.5	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.4	1.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.3	0.1	28.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	8261.0	172.2	2.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.1	0.3	0.0	2.1	0.0	0.0	0.3	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.6	0.0	0.0	0.0	5.5	0.0	0.0	0.0
GRIA2	"GluA2, GLUR2, GLURB"	ENSG00000120251	"Glutamate ionotropic receptor AMPA type subunit 2"	P42262	4	157204182-157366075	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Autism spectrum disorder, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.4;retina: 29.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 335.0;Bipolar cells: 252.7;Excitatory neurons: 1090.5;Inhibitory neurons: 725.5;Oligodendrocyte precursor cells: 1106.8;Oligodendrocytes: 324.7"	"Group enriched"	"Detected in some"	10	"breast cancer: 2.7;endometrial cancer: 2.6;glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008441	Enhanced					NA	NA					"HPA008441: AB_1078983"	"unprognostic (1.36e-1)"	"unprognostic (9.60e-3)"		"unprognostic (4.15e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"		"unprognostic (8.70e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-3)"	"unprognostic (7.40e-2)"	"unprognostic (2.91e-5)"	"unprognostic (2.42e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.55e-2)"	0.3	7.0	36.7	0.2	68.4	0.0	1.1	16.5	84.4	9.3	0.0	0.2	0.1	17.1	11.6	0.1	11.0	0.0	0.1	83.0	25.9	0.4	0.0	0.2	0.0	5.2	16.0	49.0	0.6	1.4	0.0	21.9	0.1	16.1	0.8	0.1	29.3	4.2	2.3	0.2	1.6	0.1	6.3	1.0	0.2	1.2	1.4	30.4	0.1	0.0	0.6	0.0	0.1	0.4	49.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	2.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.9	0.1	0.0	0.0	0.5	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.7	68.4	16.5	84.4	83.0	25.9	5.2	16.0	49.0	16.1	1.0	30.4	49.4	0.0	0.0	0.0	335.0	0.0	0.0	0.0	0.0	0.0	252.7	2.1	1.0	2.3	0.0	0.0	0.0	43.8	0.0	0.1	0.0	0.0	0.0	0.1	1.7	1.1	0.3	0.0	0.0	1090.5	0.0	0.0	0.2	0.0	2.7	0.0	0.1	0.0	0.0	0.1	138.0	725.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.8	58.1	0.0	4.2	0.0	1106.8	324.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.5	3.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PRR27	C4orf40	ENSG00000187533	"Proline rich 27"	Q6MZM9	4	70133616-70176799	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	959	"salivary gland: 1116.1"	"Group enriched"	"Detected in some"	25	"Early spermatids: 25.5;Late spermatids: 9.8"	"Cancer enriched"	"Detected in single"	10	"breast cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA036150, HPA036151"	Enhanced				"Secreted to digestive system"	NA	NA					"HPA036150: AB_10673001, HPA036151: AB_2674971"														"unprognostic (9.52e-2)"				0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1116.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
SPINK8		ENSG00000229453	"Serine peptidase inhibitor Kazal type 8 (putative)"	P0C7L1	3	48306842-48328341	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	6	"bone marrow: 11.6;breast: 44.6"	"Group enriched"	"Detected in some"	5	"Breast glandular cells: 22.1;Breast myoepithelial cells: 9.9"	"Group enriched"	"Detected in some"	10	"breast cancer: 8.6;glioma: 9.6;prostate cancer: 2.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"eosinophil: 1.3;neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.7"	"Cell line enriched"	"Detected in some"	60	"SK-BR-3: 73.2"	"Region enriched"	"Detected in many"	9	"hippocampal formation: 73.7"	"Low region specificity"	"Detected in all"			HPA053151	Uncertain				"Secreted to blood"	NA	NA					"HPA053151: AB_2682059"	"prognostic unfavorable (8.47e-4)"			"unprognostic (1.98e-1)"	"unprognostic (1.75e-2)"					"unprognostic (1.99e-1)"		"unprognostic (1.15e-1)"					"unprognostic (1.20e-1)"	0.0	0.0	2.0	0.0	2.0	11.6	44.6	2.4	4.6	0.0	0.3	0.0	0.1	0.0	2.5	2.9	0.2	0.0	0.0	2.9	1.7	0.0	0.0	0.1	0.0	2.8	1.7	1.9	0.0	0.4	0.0	0.2	0.2	2.5	0.5	0.0	0.3	2.1	0.3	0.0	0.1	0.0	0.0	1.3	0.6	0.0	0.3	1.9	0.0	0.0	0.0	0.0	0.1	0.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	73.2	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	2.0	2.0	2.4	4.6	2.9	1.7	2.8	1.7	1.9	2.5	1.3	1.9	2.8	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	22.1	9.9	0.0	0.0	0.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.1	0.1	0.0	1.2	0.0	0.0	2.7	1.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	2.0	0.0	0.0	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.0	1.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.6
TFF1	"BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2"	ENSG00000160182	"Trefoil factor 1"	P04155	21	42362282-42366535	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"stomach 1: 8044.5"	"Group enriched"	"Detected in many"	9	"Gastric mucus-secreting cells: 12908.9;Pancreatic endocrine cells: 14603.3"	"Group enriched"	"Detected in many"	10	"breast cancer: 402.1;colorectal cancer: 268.3;pancreatic cancer: 805.7;stomach cancer: 744.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	42	"MCF7: 13512.4;OE19: 5337.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002170, HPA003425"	Enhanced				"Secreted to digestive system"	NA	NA		950000			"CAB002170: AB_563985, HPA003425: AB_1848260"	"prognostic favorable (5.00e-4)"	"unprognostic (8.81e-3)"	"unprognostic (9.82e-2)"	"prognostic favorable (5.67e-4)"		"unprognostic (2.42e-1)"	"unprognostic (1.72e-3)"	"unprognostic (8.14e-2)"		"unprognostic (2.45e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.62e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.07e-1)"	1.1	0.3	0.0	20.5	0.0	0.0	26.9	0.0	0.0	9.8	0.0	115.8	35.1	0.2	0.0	18.5	0.9	168.8	0.4	0.0	0.0	0.9	0.8	1.3	0.2	0.0	0.0	0.0	0.2	10.8	0.0	0.2	1.1	0.0	25.3	109.5	0.0	32.6	0.7	0.2	0.1	69.0	4.8	0.0	3.1	8044.5	0.1	0.0	0.2	5.3	0.0	0.2	30.9	2.2	0.0	0.0	42.7	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	0.0	16.2	5.7	0.0	1.1	0.0	1.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	13512.4	4.6	0.5	5.5	5337.9	223.4	1.7	0.0	0.2	0.0	1.4	0.3	0.2	0.0	5.0	0.0	1.3	5.0	0.1	0.0	0.0	3.5	0.1	0.0	3.6	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	18.7	0.0	6.1	5.9	0.0	0.0	432.7	197.2	0.0	564.7	12.1	35.0	0.0	0.1	3.1	601.9	0.0	245.7	0.0	1.8	0.2	3.5	430.2	0.0	0.0	821.8	3.1	5.1	12908.9	2.9	13.4	0.0	0.0	1.6	0.2	0.0	0.0	1395.6	111.9	0.0	0.0	0.0	0.0	9.2	0.0	0.0	10.3	0.0	0.0	0.0	0.0	14603.3	500.9	0.0	40.6	432.4	78.0	0.0	2.8	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.3	8.9	0.0	80.0	232.6
CARTPT	CART	ENSG00000164326	"CART prepropeptide"	Q16568	5	71719275-71721048	"FDA approved drug targets, Human disease related genes, Predicted secreted proteins"		"Neuropeptide, Neurotransmitter"	"FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"adrenal gland: 119.8;brain: 251.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 47.4;Early spermatids: 25.4;Prostatic glandular cells: 39.5;Spermatocytes: 55.7"	"Cancer enriched"	"Detected in many"	9	"breast cancer: 117.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 209.0"	"CAB025515, HPA046278, CAB079776"	Enhanced	Supported			"Secreted to blood"	NA	NA					"CAB025515: , CAB079776: , HPA046278: AB_10961570"			"unprognostic (1.37e-1)"		"unprognostic (1.43e-1)"					"unprognostic (2.27e-1)"	"unprognostic (3.45e-2)"	"unprognostic (6.67e-2)"		"prognostic unfavorable (4.36e-4)"		"unprognostic (1.14e-1)"		2.4	119.8	87.8	4.4	23.1	0.0	9.4	8.4	59.1	0.0	9.3	11.1	5.5	2.9	0.7	0.3	0.4	0.2	0.1	32.3	71.3	0.0	0.0	0.1	0.0	76.0	116.3	16.1	0.1	0.5	0.0	5.3	0.0	236.6	8.6	4.6	21.6	0.1	0.0	0.0	0.1	3.4	15.3	25.6	0.0	14.7	7.2	122.3	0.3	5.5	0.0	0.0	0.0	0.3	251.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.8	23.1	8.4	59.1	32.3	71.3	76.0	116.3	16.1	236.6	25.6	122.3	251.1	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	47.4	0.2	0.3	0.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	25.4	1.6	0.1	1.0	7.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.6	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	39.5	0.0	0.0	0.0	8.1	0.0	0.0	0.1	55.7	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2
DCD	"AIDD, DCD-1, DSEP, HCAP, PIF"	ENSG00000161634	Dermcidin	P81605	12	54644589-54648493	"Plasma proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 2047.6"	"Cell type enriched"	"Detected in some"	355	"Melanocytes: 8167.8"	"Cancer enriched"	"Detected in some"	9	"breast cancer: 91.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.0"									HPA063967	Enhanced				"Secreted in other tissues"	NA	NA		410000000			"HPA063967: AB_2685163"	"unprognostic (3.55e-2)"													"unprognostic (1.61e-1)"				56.1	0.4	3.3	0.3	3.1	1.1	358.3	3.2	5.4	0.3	3.6	0.7	0.2	0.7	0.9	0.5	0.2	0.8	1.2	3.3	3.0	0.2	1.0	0.6	0.2	3.0	3.3	3.1	0.4	1.1	0.0	0.5	0.1	3.3	0.4	0.2	0.5	0.5	0.1	14.1	2047.6	0.7	0.1	2.9	0.4	0.7	1.1	2.9	0.3	0.5	0.0	0.2	0.2	0.7	3.9	0.2	0.3	0.4	0.4	0.3	0.4	0.4	0.5	0.1	0.0	0.2	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.6	0.4	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.2	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.5	0.2	0.0	0.2	0.1	0.3	0.2	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.1	1.9	0.4	0.5	0.4	0.3	0.6	0.5	0.4	0.3	0.2	0.4	0.5	0.5	1.1	0.9	0.7	0.5	0.6	0.2	3.3	3.1	3.2	5.4	3.3	3.0	3.0	3.3	3.1	3.3	2.9	2.9	3.9	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.1	0.0	0.0	8167.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.4	0.2	0.0	23.0	0.0	1.0	0.0	0.0	0.0
PRLR		ENSG00000113494	"Prolactin receptor"	P16471	5	35048756-35230487	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"choroid plexus: 654.4"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 78.3;Endometrial stromal cells: 113.8;Granulosa cells: 96.4;Proximal tubular cells: 53.0;Syncytiotrophoblasts: 48.3"	"Cancer enriched"	"Detected in many"	9	"breast cancer: 20.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"T-47d: 382.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"	NA	NA						"unprognostic (3.81e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.37e-2)"	"unprognostic (6.04e-2)"	"unprognostic (5.05e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.99e-2)"	"unprognostic (7.94e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.84e-4)"	"unprognostic (2.50e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.84e-5)"	"unprognostic (1.24e-1)"	0.6	12.3	9.4	0.5	13.0	1.1	23.4	5.3	3.2	19.6	654.4	5.5	6.7	20.2	9.4	0.7	2.2	0.8	0.2	30.2	17.5	31.0	11.0	0.6	0.1	3.1	9.1	0.7	2.3	5.5	83.3	4.3	50.7	2.3	1.1	5.8	0.1	1.7	8.2	0.1	3.2	8.2	10.9	2.1	0.2	6.3	0.6	25.6	0.2	0.1	0.7	0.1	0.8	4.8	3.1	0.0	0.0	0.7	3.1	0.0	2.7	0.6	1.7	1.5	3.2	1.2	0.4	0.2	0.0	0.0	1.9	1.2	0.0	4.3	0.0	3.3	0.7	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	4.5	0.2	0.0	0.0	0.0	0.0	0.2	0.7	10.4	0.3	0.0	0.7	0.8	0.0	0.1	0.0	0.1	0.3	0.7	0.1	0.2	0.0	21.1	0.0	0.7	382.8	3.0	0.0	1.9	2.2	0.6	1.4	0.0	0.0	0.0	3.7	0.2	1.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.4	13.0	5.3	3.2	30.2	17.5	3.1	9.1	0.7	2.3	2.1	25.6	3.1	0.2	0.0	2.0	0.7	0.2	2.9	0.3	0.0	3.4	0.0	78.3	31.8	0.8	4.3	0.0	3.7	0.0	32.9	0.5	13.1	7.9	1.3	0.0	7.1	113.8	1.1	8.5	0.0	2.0	5.3	2.4	13.8	11.2	10.5	0.0	96.4	0.7	11.4	8.9	0.0	1.9	16.1	0.0	1.9	0.7	0.2	8.7	3.4	0.0	1.0	7.6	0.0	0.0	0.0	0.6	1.8	15.2	12.8	0.0	1.4	26.4	53.0	0.0	0.0	0.0	0.5	4.6	0.1	0.5	2.2	5.1	48.3	0.7	6.0	23.8	0.1
AARD	"C8orf85, LOC441376"	ENSG00000205002	"Alanine and arginine rich domain containing protein"	Q4LEZ3	8	116938207-116944487	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.7;urinary bladder: 7.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 27.6;Breast glandular cells: 26.0;Breast myoepithelial cells: 29.0;granulocytes: 14.5;Late spermatids: 18.4;Proximal tubular cells: 14.9;Spermatocytes: 57.4"	"Cancer enriched"	"Detected in many"	8	"breast cancer: 27.0"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.7;JURKAT: 7.2;SK-BR-3: 11.8;U-2 OS: 5.5;U-266/84: 4.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in some"	4	"midbrain: 4.4"	HPA068290			Approved	"Lipid droplets"		NA	NA			"Lipid droplets"		"HPA068290: "	"unprognostic (5.81e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.28e-8)"	"unprognostic (3.42e-2)"	"unprognostic (4.32e-3)"	"unprognostic (4.34e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.29e-2)"	"unprognostic (8.57e-3)"	"unprognostic (4.20e-1)"	"unprognostic (2.23e-6)"	"unprognostic (1.67e-1)"	"unprognostic (9.78e-3)"	"unprognostic (3.77e-2)"	"unprognostic (5.27e-4)"	0.3	0.9	0.5	0.4	0.8	0.2	4.3	0.4	0.8	0.2	0.8	3.7	0.1	0.8	0.2	2.4	0.1	0.2	0.0	0.6	0.8	1.0	0.0	2.5	0.8	1.2	1.0	0.6	0.0	0.0	0.0	0.0	0.4	0.9	0.6	0.5	0.1	2.0	0.1	0.1	1.3	1.0	1.0	0.8	0.1	6.9	22.7	0.6	0.0	0.1	0.0	0.4	7.8	0.2	1.4	0.0	0.0	0.5	0.0	0.0	0.0	0.2	1.8	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.5	0.0	0.2	0.1	2.4	0.0	0.2	0.4	0.0	0.1	0.1	0.1	0.0	7.2	0.0	2.4	0.1	0.5	0.9	0.1	1.1	0.0	2.1	0.0	0.0	0.1	0.0	0.0	1.9	0.3	0.0	11.8	0.1	0.2	0.5	0.0	0.0	0.1	5.5	0.2	0.0	1.6	4.5	0.0	3.0	0.0	0.3	1.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.7	0.3	0.1	0.2	0.6	0.0	0.5	0.8	0.4	0.8	0.6	0.8	1.2	1.0	0.6	0.9	0.8	0.6	1.4	0.2	12.8	27.6	0.0	0.1	0.8	0.6	0.2	0.0	0.4	26.0	29.0	0.9	0.0	5.0	7.3	0.0	0.2	0.8	0.1	1.9	0.1	9.3	0.1	1.7	0.9	0.0	0.0	0.8	0.0	0.9	1.4	0.0	0.0	14.5	0.1	0.0	0.1	0.0	1.7	2.1	0.0	0.0	0.0	0.3	18.4	4.1	0.5	0.0	0.0	0.1	0.1	4.1	0.0	0.2	0.1	0.0	0.7	0.0	0.6	0.0	14.9	0.7	0.2	0.0	0.5	1.1	57.4	7.3	0.0	0.6	0.3	0.8	2.0	0.0	0.4
ADIPOQ	"ACDC, ACRP30, adiponectin, apM1, GBP28"	ENSG00000181092	"Adiponectin, C1Q and collagen domain containing"	Q15848	3	186842704-186858463	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hormone	"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	28	"adipose tissue: 906.8;breast: 251.0"	"Cell type enhanced"	"Detected in single"		"Distal tubular cells: 1.9"	"Group enriched"	"Detected in some"	8	"breast cancer: 6.5;pancreatic cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	672	"ASC diff: 312.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB046467, HPA051767"	Uncertain				"Secreted to blood"	NA	NA	8360000000	910000000			"CAB046467: AB_1078104, HPA051767: AB_2681598"	"unprognostic (1.76e-2)"									"unprognostic (1.53e-1)"	"unprognostic (2.20e-2)"			"unprognostic (6.99e-3)"	"unprognostic (1.87e-1)"			906.8	9.0	0.1	2.5	0.1	0.2	251.0	0.2	0.2	0.0	0.0	7.8	0.1	0.1	0.0	1.2	0.1	7.6	6.6	0.0	0.1	0.7	0.1	0.1	1.4	0.1	0.0	0.1	0.0	6.3	0.1	0.1	0.0	0.1	0.3	6.2	0.1	18.9	0.0	2.3	6.3	8.6	1.2	0.0	0.0	4.0	0.1	0.0	2.2	2.9	20.4	0.0	2.4	0.9	0.3	0.0	0.0	0.0	0.1	312.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AGTR1	"AG2S, AGTR1A, AGTR1B, AT1, AT1B, AT2R1, AT2R1A, AT2R1B, HAT1R"	ENSG00000144891	"Angiotensin II receptor type 1"	P30556	3	148697784-148743008	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 97.4;placenta: 142.8"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 53.1;Hepatocytes: 30.9;Leydig cells: 145.1;Sertoli cells: 144.7;Smooth muscle cells: 71.2"	"Group enriched"	"Detected in many"	8	"breast cancer: 9.6;liver cancer: 9.8;prostate cancer: 6.8;renal cancer: 2.8"	"Group enriched"	"Detected in some"	6	"hypothalamus: 6.1;medulla oblongata: 2.2;midbrain: 7.3;pons: 2.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 176.8;ASC TERT1: 24.4;BJ hTERT+ SV40 Large T+: 34.8;HBF TERT88: 53.9;HSkMC: 32.2"					"Low region specificity"	"Detected in all"			HPA003596	Enhanced		Uncertain	Vesicles		NA	NA			Vesicles		"HPA003596: AB_1845163"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.48e-4)"	"unprognostic (5.28e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.08e-2)"	"unprognostic (9.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.41e-3)"	52.7	38.5	0.3	1.8	0.7	0.0	40.2	0.3	0.4	3.4	0.4	15.3	0.9	3.5	2.8	2.8	9.9	6.3	7.7	0.4	6.1	18.6	97.4	10.5	0.7	2.2	7.3	0.2	3.9	3.5	2.9	3.9	142.8	2.6	5.4	4.4	0.9	4.8	4.2	11.7	12.9	4.3	4.6	0.2	9.1	6.5	2.2	0.5	3.0	14.3	13.9	0.2	14.7	6.2	0.3	0.0	1.0	0.8	0.0	176.8	24.4	0.0	0.2	3.9	34.8	20.0	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.0	0.0	53.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	32.2	0.0	3.4	1.8	1.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.3	0.4	0.4	6.1	2.2	7.3	0.2	2.6	0.2	0.5	0.3	20.5	0.0	0.6	0.0	0.0	3.4	0.2	0.0	0.0	0.0	1.3	0.9	6.3	2.8	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.1	0.8	0.0	0.3	3.8	23.5	0.0	0.1	7.6	0.3	53.1	0.5	0.0	0.0	0.0	17.5	30.9	0.7	0.0	0.0	0.2	0.0	0.3	3.5	1.7	145.1	0.5	1.8	2.8	0.0	5.7	0.0	0.0	0.1	0.5	0.0	7.5	0.4	1.1	0.0	0.1	0.0	0.1	144.7	7.6	71.2	0.0	1.8	0.3	1.7	0.3	0.5	0.3	0.0	0.1
ATP1A4	ATP1AL2	ENSG00000132681	"ATPase Na+/K+ transporting subunit alpha 4"	Q13733	1	160151586-160186980	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 6.3;testis: 16.4;urinary bladder: 5.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 26.1;Early spermatids: 87.4;Extravillous trophoblasts: 14.4;Syncytiotrophoblasts: 38.2"	"Group enriched"	"Detected in some"	8	"breast cancer: 0.8;urothelial cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"BEWO: 18.4;HDLM-2: 49.0;RT4: 57.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.33e-1)"	"unprognostic (4.01e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.45e-1)"	"unprognostic (8.77e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.09e-2)"	"prognostic favorable (2.20e-4)"	0.2	0.1	0.1	0.4	0.1	0.0	1.6	0.1	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.7	0.3	0.1	0.2	0.0	0.0	0.1	3.3	0.2	0.1	0.1	0.0	0.0	0.4	0.0	6.3	0.1	0.3	0.1	2.5	0.3	1.3	3.0	0.0	0.2	0.1	0.1	1.1	0.1	16.4	0.1	0.4	0.0	0.0	1.3	5.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.1	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.6	1.6	0.0	0.3	7.3	0.0	0.0	0.0	2.2	1.7	0.9	0.0	0.0	1.8	0.0	26.1	0.1	0.0	0.0	0.0	87.4	0.0	0.0	0.2	0.0	0.0	0.4	0.0	14.4	0.3	0.0	0.0	1.3	0.1	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.0	9.7	0.0	0.2	0.0	0.0	6.5	0.1	0.0	0.5	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.1	0.0	2.2	0.0	1.4	0.3	2.8	0.2	0.0	0.0	38.2	0.7	0.1	0.0	10.4
ELOVL2	Ssc2	ENSG00000197977	"ELOVL fatty acid elongase 2"	Q9NXB9	6	10980759-11044305	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 52.9;placenta: 35.6;retina: 28.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 95.0;Cone photoreceptor cells: 29.2;Extravillous trophoblasts: 19.7;Sertoli cells: 19.7;Spermatocytes: 23.0"	"Group enriched"	"Detected in many"	8	"breast cancer: 11.9;glioma: 25.8;liver cancer: 24.0;melanoma: 14.2;prostate cancer: 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 29.9;GAMG: 31.2;HBF TERT88: 29.0;Hep G2: 23.4;RH-30: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"prognostic favorable (6.73e-5)"	"unprognostic (4.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-5)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.92e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.04e-12)"	"unprognostic (9.98e-4)"	"unprognostic (8.86e-2)"	"unprognostic (3.41e-1)"	"unprognostic (9.47e-2)"	1.2	0.9	9.0	1.5	10.2	0.0	4.9	10.1	14.0	0.1	4.6	0.4	0.2	0.5	2.3	0.4	0.2	0.6	3.2	9.1	22.4	0.2	52.9	0.2	0.5	10.2	9.2	8.6	0.2	2.6	9.8	3.0	35.6	9.5	5.3	0.1	28.1	0.7	0.4	1.0	0.2	0.3	0.7	9.8	0.0	0.1	11.7	9.6	1.1	1.8	1.0	0.9	2.1	0.1	14.5	0.0	5.3	20.1	0.0	0.0	0.0	11.5	0.4	1.0	17.7	29.9	0.0	0.0	0.0	0.0	1.1	31.2	0.0	21.3	0.0	29.0	0.0	18.2	0.1	0.4	23.4	0.9	0.4	4.8	0.2	0.0	13.7	0.0	1.0	0.0	0.9	1.2	0.0	0.4	0.1	12.1	0.2	3.8	0.0	17.4	16.6	31.8	0.0	0.0	0.3	8.0	9.1	0.0	0.0	7.5	16.1	3.7	9.3	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	10.2	10.1	14.0	9.1	22.4	10.2	9.2	8.6	9.5	9.8	9.6	14.5	0.5	0.0	0.0	95.0	0.1	0.1	0.0	0.0	0.0	2.2	7.8	1.3	1.2	8.6	0.0	0.0	29.2	2.3	0.0	0.0	0.0	7.2	10.1	0.0	0.5	1.9	0.0	0.0	2.5	1.0	19.7	8.0	0.0	0.0	0.0	0.3	0.0	17.5	1.2	0.0	5.9	0.0	0.0	0.0	0.0	14.9	0.9	0.1	0.0	6.5	0.0	4.9	0.0	4.5	16.8	1.0	0.0	0.4	0.0	1.9	0.0	0.1	0.0	11.8	19.7	0.1	3.9	23.0	8.9	0.2	0.0	1.6	0.1	0.0	0.0	0.1
FCN2	"EBP-37, FCNL, ficolin-2, P35"	ENSG00000160339	"Ficolin 2"	Q15485	9	134880810-134887523	"Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 100.5"	"Cell type enriched"	"Detected in some"	18	"Hepatic stellate cells: 1192.6"	"Group enriched"	"Detected in some"	8	"breast cancer: 1.0;liver cancer: 2.0;prostate cancer: 1.1;renal cancer: 0.5"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 5.5;intermediate monocyte: 4.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"Region enriched"	"Detected in some"	23	"spinal cord: 38.6"						"Secreted to blood"	NA	NA	8100000000	1400000000				"unprognostic (1.91e-1)"	"unprognostic (1.07e-1)"			"unprognostic (6.96e-4)"		"unprognostic (3.73e-2)"	"unprognostic (2.09e-2)"		"unprognostic (3.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"		"unprognostic (1.05e-1)"	"unprognostic (3.07e-1)"		4.7	24.8	0.3	0.0	0.3	0.1	7.7	0.2	0.5	0.3	0.4	0.0	0.1	0.1	0.2	0.1	0.3	0.1	0.2	0.5	0.3	6.2	100.5	0.1	0.1	0.3	0.5	0.2	0.5	0.5	0.2	3.1	0.0	0.3	3.2	0.0	0.0	3.2	0.4	0.1	0.2	0.1	0.0	0.2	3.1	0.2	0.2	0.3	0.0	2.1	0.1	0.0	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.5	0.0	0.0	4.6	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	1.1	0.0	2.2	0.0	0.0	9.0	0.3	0.3	0.2	0.5	0.5	0.3	0.3	0.5	0.2	0.3	0.2	0.3	0.3	0.1	0.0	0.0	0.7	3.8	0.0	0.1	0.0	0.0	0.0	3.8	0.4	0.1	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	34.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1192.6	12.6	0.0	0.0	0.1	0.0	0.0	64.1	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1
FSIP1	FLJ35989	ENSG00000150667	"Fibrous sheath interacting protein 1"	Q8NA03	15	39588357-39782841	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 11.0;testis: 7.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 67.1;Excitatory neurons: 28.2;Inhibitory neurons: 21.5;Late spermatids: 48.3;Spermatocytes: 35.3"	"Cancer enriched"	"Detected in some"	8	"breast cancer: 6.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 4.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041002	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041002: AB_10796565"	"unprognostic (1.55e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.17e-3)"	"unprognostic (5.37e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.81e-1)"	0.2	0.2	1.8	0.2	1.9	0.6	0.9	0.3	2.0	0.2	1.7	7.4	0.1	0.3	0.3	0.1	1.2	0.2	0.3	1.5	1.8	0.8	0.1	0.3	0.1	1.2	1.5	1.7	0.1	0.1	0.9	1.4	0.3	1.1	0.2	11.0	0.9	0.1	0.2	0.2	0.9	0.1	0.3	0.6	0.2	0.5	7.3	1.3	1.4	0.4	0.1	0.1	0.3	0.1	0.8	0.4	1.3	3.4	0.5	0.6	1.1	0.0	4.1	0.8	0.6	1.2	1.0	0.3	0.2	0.3	1.2	1.7	0.8	0.5	0.7	1.0	1.4	0.3	2.5	0.9	0.0	0.3	0.5	2.7	0.7	2.8	1.5	0.6	0.8	0.7	1.4	0.1	0.3	1.0	0.1	0.3	0.2	0.4	0.2	0.6	0.3	0.7	0.1	1.3	1.5	0.8	2.5	0.8	0.1	0.1	0.3	1.1	0.3	0.6	1.6	0.9	0.9	0.4	0.7	1.6	0.2	3.3	0.9	0.8	0.4	0.3	0.4	0.7	0.2	0.5	0.1	0.3	0.4	0.2	0.2	0.2	0.1	0.2	0.3	0.2	0.0	0.1	0.4	1.8	1.9	0.3	2.0	1.5	1.8	1.2	1.5	1.7	1.1	0.6	1.3	0.8	0.7	0.0	0.5	8.1	1.1	0.6	0.6	3.4	0.0	1.1	14.5	7.9	0.8	2.8	2.9	1.8	12.5	0.9	1.4	17.5	1.9	1.0	67.1	10.0	2.1	1.0	0.0	0.0	28.2	0.4	0.1	1.5	0.5	0.6	15.8	0.4	0.4	0.0	0.1	0.0	21.5	3.5	0.0	0.0	0.3	48.3	1.2	0.6	0.0	7.5	0.1	1.0	3.1	3.0	3.2	0.1	6.6	0.7	0.4	0.7	0.0	3.2	12.6	6.1	0.0	1.2	1.5	35.3	8.3	0.2	0.0	5.6	3.3	0.7	2.9	0.3
KCNC2	Kv3.2	ENSG00000166006	"Potassium voltage-gated channel subfamily C member 2"	Q96PR1	12	75040077-75209839	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 48.5"	"Group enriched"	"Detected in some"	51	"Excitatory neurons: 389.6;Inhibitory neurons: 1425.5"	"Group enriched"	"Detected in some"	8	"breast cancer: 1.5;prostate cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019664, CAB022571"	Uncertain					NA	NA					"CAB022571: , HPA019664: AB_1855578"	"unprognostic (2.01e-1)"				"unprognostic (1.14e-1)"		"unprognostic (2.68e-1)"				"unprognostic (5.58e-3)"	"unprognostic (4.46e-2)"		"unprognostic (3.39e-2)"				0.0	0.0	11.4	0.0	16.2	0.0	1.8	0.0	47.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	6.9	8.5	0.0	0.2	0.0	0.0	22.4	16.2	20.3	0.0	0.0	0.0	7.1	0.0	27.3	2.6	0.0	9.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	48.5	0.0	0.0	0.1	0.0	0.0	0.0	38.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	16.2	0.0	47.3	6.9	8.5	22.4	16.2	20.3	27.3	0.0	48.5	38.6	0.0	0.0	0.0	17.6	0.0	0.0	2.9	0.0	0.0	15.9	16.7	7.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.3	0.0	0.0	389.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1425.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	2.6	0.0	14.1	14.8	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2
OBP2B	"hOBPIIb, LCN14"	ENSG00000171102	"Odorant binding protein 2B"	Q9NPH6	9	133205277-133209250	"Predicted secreted proteins"	"Olfaction, Sensory transduction, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 2.7;testis: 10.1"	"Group enriched"	"Detected in some"	9	"Breast glandular cells: 17.7;Breast myoepithelial cells: 29.1"	"Group enriched"	"Detected in many"	8	"breast cancer: 7.8;endometrial cancer: 16.2;ovarian cancer: 4.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"	NA	NA						"unprognostic (1.40e-1)"		"unprognostic (5.70e-2)"	"unprognostic (9.45e-3)"	"unprognostic (6.65e-2)"					"unprognostic (1.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.03e-2)"	"unprognostic (6.82e-6)"	"unprognostic (2.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.53e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.4	0.3	0.0	0.0	0.0	17.7	29.1	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	2.5	1.2	0.1	1.8	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.2	1.2	0.1	0.1
PYDC1	"ASC2, POP1"	ENSG00000169900	"Pyrin domain containing 1"	Q8WXC3	16	31215962-31217135	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 8.2;skin 1: 13.3"	"Group enriched"	"Detected in some"	5	"Breast glandular cells: 3.2;Breast myoepithelial cells: 2.5;Suprabasal keratinocytes: 6.3"	"Cancer enriched"	"Detected in some"	8	"breast cancer: 8.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA						"unprognostic (9.72e-3)"	"unprognostic (1.00e-2)"		"unprognostic (2.05e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.32e-2)"		"unprognostic (1.49e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.60e-10)"	"unprognostic (3.62e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.47e-2)"	0.0	0.0	5.5	0.0	4.3	0.0	0.5	7.4	8.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	3.4	0.0	0.0	0.0	0.0	2.3	2.0	3.8	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.0	1.1	13.3	0.0	0.0	1.3	0.0	0.1	0.0	3.7	0.4	0.0	0.0	0.2	0.0	0.3	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	5.5	4.3	7.4	8.2	4.9	3.4	2.3	2.0	3.8	3.5	1.3	3.7	2.8	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.7	0.0	0.0	3.2	2.5	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	6.3	0.0	0.1	0.1	0.0	0.1
TFAP2B	AP2-B	ENSG00000008196	"Transcription factor AP-2 beta"	Q92481	6	50818723-50847619	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 33.6;retina: 14.9"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 145.7;Bipolar cells: 76.4;Horizontal cells: 437.4;Melanocytes: 106.7"	"Cancer enriched"	"Detected in some"	8	"breast cancer: 12.1"	"Group enriched"	"Detected in many"	5	"cerebellum: 3.5;medulla oblongata: 3.7;midbrain: 4.6;pons: 5.9;white matter: 2.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 109.6;SH-SY5Y: 208.1"	"Region enhanced"	"Detected in many"		"cerebellum: 10.0"	"Low region specificity"	"Detected in many"			"HPA034683, HPA062942"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA034683: AB_10670966, HPA062942: AB_2684909"	"unprognostic (2.02e-1)"	"unprognostic (2.29e-2)"		"unprognostic (4.27e-2)"	"unprognostic (5.88e-4)"	"unprognostic (9.76e-2)"		"unprognostic (2.10e-1)"	"unprognostic (1.00e-1)"			"unprognostic (4.57e-1)"	"unprognostic (6.58e-6)"	"unprognostic (1.13e-2)"	"unprognostic (1.88e-1)"		"unprognostic (7.17e-3)"	0.1	3.5	0.3	0.0	0.4	0.0	8.3	3.5	0.7	0.1	0.0	0.1	0.0	0.0	33.6	3.9	0.0	0.0	0.0	0.0	0.1	5.3	0.0	0.0	0.0	3.7	4.6	0.0	0.0	0.0	0.0	0.6	0.2	5.9	0.0	0.0	14.9	6.5	0.7	0.0	8.7	0.0	0.0	0.6	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.2	2.4	0.0	0.0	109.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	35.5	0.1	0.2	208.1	0.0	0.8	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	3.5	0.7	0.0	0.1	3.7	4.6	0.0	5.9	0.6	0.8	2.4	0.2	0.0	0.0	0.0	0.0	11.7	0.0	0.0	145.7	76.4	43.0	29.7	0.9	0.0	0.0	51.5	8.4	14.9	0.1	0.0	54.8	0.0	17.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	437.4	0.0	0.0	0.0	0.0	1.5	2.0	0.0	0.5	106.7	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.7	0.0	11.8	0.0	0.0	0.3	1.9	0.6	31.1	4.3	4.9	0.2	0.0	0.0	0.0
TRPS1	"GC79, LGCR"	ENSG00000104447	"Transcriptional repressor GATA binding 1"	Q9UHF7	8	115408496-115809673	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 38.1;breast: 61.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 758.7;Breast glandular cells: 243.2;Oligodendrocyte precursor cells: 280.5;Oligodendrocytes: 294.0"	"Cancer enriched"	"Detected in many"	8	"breast cancer: 49.6"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 47.4;SK-BR-3: 78.1;T-47d: 244.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060380, HPA071767"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060380: AB_2684270, HPA071767: AB_2732185"	"unprognostic (4.34e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.87e-1)"	"prognostic favorable (9.42e-4)"	"unprognostic (2.23e-3)"	"unprognostic (2.08e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (3.16e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.07e-3)"	4.1	3.1	14.7	5.7	16.7	7.6	61.4	12.5	11.0	10.7	6.6	4.3	0.9	10.0	3.5	14.4	5.6	10.0	2.9	14.6	38.1	5.5	2.1	4.7	4.9	31.6	21.5	0.2	5.2	1.1	5.3	2.7	2.8	31.7	9.5	2.8	4.2	12.1	8.4	2.6	10.1	2.1	10.6	14.8	4.2	2.7	12.6	18.4	2.5	5.8	3.4	4.1	5.2	14.2	30.3	3.1	0.6	5.9	0.3	5.4	19.8	0.6	4.9	11.3	3.1	5.2	0.5	4.9	2.4	0.0	12.7	2.6	0.1	22.9	4.3	3.5	0.3	6.9	0.1	10.3	0.2	7.2	0.0	0.3	9.5	4.4	8.6	15.8	8.9	2.7	0.3	1.1	37.7	6.0	47.4	0.2	0.0	1.1	1.1	4.8	0.2	0.2	30.0	4.9	0.3	5.2	3.9	2.5	78.1	3.2	2.8	244.8	2.1	0.2	13.7	6.9	4.0	9.7	10.1	0.3	4.5	14.4	0.0	9.2	0.0	4.5	0.0	0.9	1.9	0.9	0.5	1.0	1.0	1.7	0.8	0.9	0.9	0.8	1.0	1.4	0.6	0.5	0.8	14.7	16.7	12.5	11.0	14.6	38.1	31.6	21.5	0.2	31.7	14.8	18.4	30.3	10.0	6.4	3.0	758.7	13.3	9.4	20.0	10.3	34.1	9.2	243.2	125.1	4.6	2.8	9.2	18.4	43.8	0.1	18.7	0.1	11.7	2.9	95.0	58.5	35.7	7.5	0.0	5.5	128.3	2.9	0.2	26.8	4.6	63.5	12.7	0.3	3.6	1.1	16.5	0.0	148.2	0.0	8.2	55.2	104.1	163.2	25.1	55.5	21.4	171.4	32.5	10.6	5.2	280.5	294.0	2.7	0.0	28.2	10.1	16.9	0.0	23.7	8.9	35.9	6.6	60.2	28.2	1.8	8.3	73.6	12.5	0.3	25.6	19.5	0.0	11.2
UGT2B28		ENSG00000135226	"UDP glucuronosyltransferase family 2 member B28"	Q9BY64	4	69280475-69295050	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"breast: 200.4"	"Cell type enriched"	"Detected in single"	16	"Cholangiocytes: 10.0"	"Cancer enriched"	"Detected in single"	8	"breast cancer: 1.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.3"	"Group enriched"	"Detected in some"	10	"Daudi: 2.9;NB-4: 2.7"									HPA045108	Uncertain				"Intracellular and membrane"	NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.81e-1)"						"unprognostic (1.40e-1)"	"unprognostic (7.20e-3)"				"unprognostic (1.51e-2)"	"unprognostic (4.37e-5)"				"unprognostic (9.79e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	200.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CBLN2		ENSG00000141668	"Cerebellin 2 precursor"	Q8IUK8	18	72536680-72638521	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 36.2"	"Cell type enriched"	"Detected in some"	13	"Excitatory neurons: 508.3"	"Cancer enriched"	"Detected in single"	7	"breast cancer: 3.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 54.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted in brain"	NA	NA		1400000				"unprognostic (2.03e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.13e-3)"	"unprognostic (9.09e-5)"	"unprognostic (7.10e-2)"	"unprognostic (6.27e-3)"		"unprognostic (7.39e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.37e-4)"	"unprognostic (5.01e-4)"	"unprognostic (8.15e-2)"	"unprognostic (6.07e-4)"	"unprognostic (7.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.93e-2)"	0.2	0.2	5.1	0.3	19.4	0.0	0.1	0.0	36.2	0.3	0.0	1.8	1.5	0.0	0.0	0.0	0.1	0.0	0.0	5.4	12.9	0.7	0.4	0.0	0.0	7.9	5.1	15.6	0.1	0.0	0.0	0.2	0.0	12.0	0.9	1.5	5.2	0.0	5.2	0.0	0.5	2.5	0.8	0.0	0.0	0.1	0.2	16.8	0.0	0.0	0.0	0.7	0.1	0.0	15.8	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	54.9	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	19.4	0.0	36.2	5.4	12.9	7.9	5.1	15.6	12.0	0.0	16.8	15.8	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.7	0.3	37.8	0.0	508.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.3	0.6	0.6	0.0	0.0	10.3	0.0	0.5	0.0	9.5	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.3	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CIB3	KIP3	ENSG00000141977	"Calcium and integrin binding family member 3"	Q96Q77	19	16161368-16173525	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"bone marrow: 1.2"	"Group enriched"	"Detected in some"	8	"Cardiomyocytes: 30.2;Late spermatids: 9.5"	"Cancer enriched"	"Detected in single"	7	"breast cancer: 0.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 2.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"HMC-1: 4.5;MCF7: 2.2;NB-4: 1.4;THP-1: 1.3;U-937: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043553, HPA043995"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA043553: AB_10964566, HPA043995: "	"unprognostic (8.43e-2)"	"unprognostic (7.26e-5)"		"unprognostic (3.18e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.25e-1)"		"unprognostic (3.14e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.05e-1)"		"unprognostic (5.68e-2)"	"unprognostic (3.42e-1)"		"unprognostic (1.54e-2)"	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	1.4	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.7	0.0	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.3	30.2	0.0	0.1	0.0	0.0	0.2	0.1	1.8	0.0	0.0	2.3	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLSTN2	"CDHR13, CS2, CSTN2, FLJ39113"	ENSG00000158258	"Calsyntenin 2"	Q9H4D0	3	139935185-140577397	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 18.4;brain: 25.4;ovary: 65.2"	"Cell type enriched"	"Detected in many"	4	"Excitatory neurons: 552.2"	"Cancer enriched"	"Detected in many"	7	"breast cancer: 15.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 32.7;SCLC-21H: 14.5;SuSa: 42.7;THP-1: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031342, HPA061800"	Approved		Uncertain	"Vesicles,Cytokinetic bridge"		Yes	No		130000	Vesicles	"Cytokinetic bridge"	"HPA031342: AB_10602800, HPA061800: AB_2684615"	"unprognostic (7.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.51e-3)"	"unprognostic (5.52e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.58e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.16e-2)"	"unprognostic (7.63e-5)"	"unprognostic (7.22e-5)"	18.4	4.9	10.2	0.3	15.1	0.0	8.9	0.0	25.4	3.6	0.0	1.3	0.5	5.1	0.7	1.0	4.7	2.1	5.5	24.4	3.9	4.4	0.8	1.1	2.7	14.4	3.5	9.3	65.2	1.7	0.8	0.9	0.9	10.7	5.4	0.8	2.8	1.3	1.1	1.6	1.8	1.3	6.9	0.0	0.1	1.0	0.6	2.3	0.7	2.8	2.2	0.3	1.6	3.2	14.5	0.0	0.0	5.1	0.0	2.2	0.6	0.0	0.7	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.1	0.0	32.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	2.1	0.0	0.0	0.0	42.7	2.2	9.4	0.0	1.0	0.5	1.4	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	15.1	0.0	25.4	24.4	3.9	14.4	3.5	9.3	10.7	0.0	2.3	14.5	2.1	0.0	0.0	18.3	0.0	0.5	0.3	0.0	8.6	1.8	10.9	2.2	8.0	0.0	0.6	3.7	0.0	0.2	0.1	0.0	1.9	0.2	39.8	0.5	8.9	0.8	0.0	0.0	552.2	0.2	0.0	9.1	0.0	0.2	0.0	25.0	2.2	0.0	0.1	0.0	111.5	0.0	0.0	0.3	1.5	31.1	28.0	0.8	0.0	5.6	0.0	0.8	0.0	108.6	29.4	0.0	0.0	0.7	0.0	5.0	0.0	32.3	3.0	3.8	0.0	28.3	13.7	0.8	0.8	0.4	0.0	0.0	0.7	0.5	0.0	0.3
CRISP3	"Aeg2, CRISP-3, CRS3, dJ442L6.3, SGP28"	ENSG00000096006	"Cysteine rich secretory protein 3"	P54108	6	49727376-49744437	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"fallopian tube: 1214.1;salivary gland: 2328.9"	"Group enriched"	"Detected in some"	7	"Endometrial ciliated cells: 182.2;Glandular and luminal cells: 551.5"	"Group enriched"	"Detected in many"	7	"breast cancer: 31.9;pancreatic cancer: 59.8;prostate cancer: 85.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"neutrophil: 2.5;non-classical monocyte: 1.2"	"Group enriched"	"Detected in many"	19	"granulocytes: 2.5;monocytes: 1.2"	"Group enriched"	"Detected in some"	20	"HEL: 12.3;RT4: 4.1;SK-BR-3: 9.3;T-47d: 4.4"					"Not detected"	"Not detected"			HPA054392	Supported				"Secreted in other tissues"	NA	NA		420000000			"HPA054392: AB_2682472"	"unprognostic (1.28e-2)"	"unprognostic (7.01e-2)"		"unprognostic (8.93e-2)"		"unprognostic (5.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.22e-4)"	"unprognostic (5.30e-2)"	"unprognostic (6.70e-2)"	"unprognostic (9.16e-2)"	"unprognostic (4.34e-3)"		"unprognostic (1.91e-1)"			"unprognostic (1.93e-1)"	0.2	0.7	0.0	0.0	0.0	385.4	3.9	0.0	0.0	30.1	0.0	0.1	0.4	1.7	0.1	269.2	1214.1	23.3	0.8	0.0	0.0	0.1	0.9	1.3	0.0	0.0	0.0	0.0	0.5	5.6	0.0	0.5	0.6	0.0	2.9	0.0	0.0	2328.9	112.9	0.3	3.5	0.2	0.1	0.0	2.6	0.3	0.2	0.0	0.3	0.2	0.0	4.1	4.7	141.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	9.3	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.0	2.1	5.6	0.0	21.5	13.1	3.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	182.2	47.2	0.8	0.0	0.4	0.0	3.7	0.0	0.2	0.0	551.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	26.8
CYP4F22	FLJ39501	ENSG00000171954	"Cytochrome P450 family 4 subfamily F member 22"	Q6NT55	19	15508525-15552317	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	Ichthyosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 19.0;skin 1: 55.3;vagina: 23.0"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 8.8;Breast myoepithelial cells: 5.5;granulocytes: 7.0;Prostatic glandular cells: 4.0;Suprabasal keratinocytes: 3.0"	"Group enriched"	"Detected in many"	7	"breast cancer: 4.5;head and neck cancer: 5.7;liver cancer: 8.5;melanoma: 4.5;urothelial cancer: 13.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 6.1;MAIT T-cell: 4.3;non-classical monocyte: 14.1"	"Group enriched"	"Detected in many"	8	"monocytes: 14.1;T-cells: 4.3"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.7;T-47d: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058960	Uncertain					NA	NA					"HPA058960: AB_2683862"	"unprognostic (2.32e-3)"	"unprognostic (1.17e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.89e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.21e-5)"	"unprognostic (8.10e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.25e-3)"	"unprognostic (2.03e-2)"	0.9	0.0	0.0	0.0	0.0	0.1	3.7	0.0	0.0	5.1	0.0	0.0	0.2	0.3	0.0	19.0	0.1	0.1	0.0	0.0	0.0	0.0	7.0	0.3	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	8.5	0.0	0.0	3.2	6.4	0.2	55.3	0.1	0.0	0.0	0.3	1.4	1.0	0.0	0.1	0.0	0.0	1.8	6.3	23.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.7	6.1	4.3	0.0	0.5	1.5	0.2	0.0	0.0	0.4	0.0	1.1	14.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	8.8	5.5	0.4	1.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.0	0.0	0.1	0.0	0.0	7.0	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.4	0.0	0.3	0.0	0.0	0.5	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.1	4.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	1.8	0.0	3.0	0.0	1.8	0.0	0.0	0.3
FABP4	"A-FABP, aP2"	ENSG00000170323	"Fatty acid binding protein 4"	P15090	8	81478419-81483236	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adipose tissue: 3821.0;breast: 2214.1"	"Cell type enriched"	"Detected in many"	17	"Adipocytes: 24359.7"	"Group enriched"	"Detected in all"	7	"breast cancer: 42.1;cervical cancer: 141.7;head and neck cancer: 133.8;urothelial cancer: 65.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	171	"ASC diff: 4051.5;RT4: 2107.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA002188, CAB024961"	Enhanced					NA	NA		22000000			"CAB024961: , HPA002188: AB_1078822"	"unprognostic (4.81e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.64e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.70e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.39e-1)"	3821.0	42.6	0.8	47.1	0.9	2.8	2214.1	0.9	1.6	10.0	29.3	53.4	2.8	4.7	0.6	15.3	11.0	68.8	93.4	1.2	0.9	7.0	5.2	114.5	13.7	0.9	0.8	0.7	4.2	16.7	59.6	1.5	188.5	0.9	4.3	33.8	2.6	59.2	5.1	67.2	57.7	45.1	14.3	0.8	6.7	26.7	1.1	3.1	30.1	83.7	168.2	2.0	245.2	19.1	0.9	0.0	0.0	0.0	0.0	4051.5	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	17.9	0.0	0.1	1.3	0.0	0.4	0.0	0.0	2.0	0.7	0.0	0.0	0.0	0.8	1.2	0.1	3.0	0.0	9.4	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	2107.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.2	5.7	0.0	0.2	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.9	1.6	1.2	0.9	0.9	0.8	0.7	0.9	0.8	3.1	0.9	24359.7	35.3	64.3	0.0	19.4	14.4	1.1	0.9	4.6	0.5	71.7	196.2	42.1	0.0	26.7	0.0	0.0	0.5	73.6	0.0	0.0	0.2	1.6	0.4	8.8	1132.7	0.0	0.0	0.0	5.6	0.7	53.1	1.1	0.2	27.8	0.1	23.2	0.4	114.2	0.0	0.0	0.0	0.0	50.4	15.7	10.9	1.5	192.7	16.0	0.0	0.6	0.9	0.0	0.0	0.0	0.2	2.2	1.2	2.7	0.5	0.0	0.3	21.9	2.4	716.6	62.2	1364.8	0.0	0.1	1.2	13.9	0.7	18.7	2.3	0.0	55.3
FOXI1	"FKHL10, FREAC6"	ENSG00000168269	"Forkhead box I1"	Q12951	5	170105897-170109734	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 43.3;salivary gland: 11.5"	"Cell type enriched"	"Detected in some"	4	"Ionocytes: 132.2"	"Group enriched"	"Detected in many"	7	"breast cancer: 5.8;renal cancer: 23.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	16	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 1.5"	"Group enriched"	"Detected in some"	5	"MCF7: 1.4;SuSa: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071469	Enhanced		Supported	Nucleoli,Vesicles		NA	NA			Nucleoli	Vesicles	"HPA071469: AB_2686403"	"unprognostic (3.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.48e-2)"		"unprognostic (8.06e-2)"		"unprognostic (7.47e-2)"		"unprognostic (2.73e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.71e-3)"	"unprognostic (4.88e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.34e-2)"		"unprognostic (2.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	43.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.1	3.0	0.0	0.0	11.5	1.5	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	1.5	0.2	0.0	0.0	7.6	6.5	0.3	0.0	0.3	1.8	0.0	0.0	0.1	0.0	27.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	132.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.0	0.2	0.0	0.0	0.0
GPR12	"GPCR21, PPP1R84"	ENSG00000132975	"G protein-coupled receptor 12"	P47775	13	26755200-26760786	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 10.9;retina: 8.5;salivary gland: 3.0;skin 1: 4.9"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 9.7;Excitatory neurons: 9.5;Hofbauer cells: 17.6;Horizontal cells: 33.7;Inhibitory neurons: 15.7;Skeletal myocytes: 8.1"	"Group enriched"	"Detected in some"	7	"breast cancer: 0.5;glioma: 0.8;ovarian cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050972	Uncertain					NA	NA					"HPA050972: AB_2681295"	"unprognostic (2.37e-2)"				"unprognostic (9.64e-3)"			"unprognostic (3.75e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.42e-1)"		"unprognostic (7.35e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.40e-1)"	0.2	0.0	2.0	0.0	10.9	0.1	1.4	7.8	10.7	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.1	7.3	1.1	0.0	0.0	0.0	0.0	2.5	3.8	1.9	0.0	0.0	0.0	0.7	0.4	2.7	0.0	0.0	8.5	3.0	0.0	0.1	4.9	0.1	0.1	0.0	0.1	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	10.9	7.8	10.7	7.3	1.1	2.5	3.8	1.9	2.7	0.0	5.1	2.8	0.4	0.0	0.0	1.6	0.0	0.1	0.2	0.0	0.0	2.8	2.7	2.8	0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.7	9.7	0.0	9.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	17.6	33.7	15.7	0.0	0.0	0.0	0.0	0.5	0.0	0.2	3.6	0.0	0.0	1.9	0.0	5.0	0.9	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	3.5	0.0	8.1	0.2	0.1	0.3	0.0	0.1	0.3	0.2	0.0	0.0	0.2
KLHL1	"FLJ30047, KIAA1490, MRP2"	ENSG00000150361	"Kelch like family member 1"	Q9NR64	13	69700594-70108493	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"brain: 26.3"	"Cell type enriched"	"Detected in some"	7	"Oligodendrocyte precursor cells: 206.1"	"Cancer enriched"	"Detected in single"	7	"breast cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"HeLa: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA021196	Uncertain					NA	NA					"HPA021196: AB_1852567"					"unprognostic (5.81e-2)"					"unprognostic (7.40e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.41e-1)"						0.0	0.1	3.4	0.0	2.1	0.0	0.0	2.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	8.9	0.0	0.0	0.0	0.0	7.6	26.3	1.5	0.0	0.0	0.0	0.4	0.0	7.3	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.2	18.6	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	2.1	2.7	2.3	1.1	8.9	7.6	26.3	1.5	7.3	3.8	18.6	7.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	206.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MB	PVALB	ENSG00000198125	Myoglobin	P02144	22	35606764-35637951	"Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"	"Muscle protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	37	"heart muscle: 11523.2;skeletal muscle: 41097.5;tongue: 29343.1"	"Cell type enriched"	"Detected in many"	12	"Cardiomyocytes: 5182.1"	"Group enriched"	"Detected in many"	7	"breast cancer: 13.6;head and neck cancer: 31.1;prostate cancer: 30.4"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 1.3"	"Cell line enriched"	"Detected in some"	4	"SK-BR-3: 175.6"	"Low region specificity"	"Detected in many"							"CAB000060, HPA003123"	Enhanced					NA	NA	13500000	140000000			"CAB000060: , HPA003123: AB_1079442"	"unprognostic (7.51e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.07e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.66e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.19e-2)"	6.6	4.6	1.0	1.5	1.0	0.3	43.9	1.0	2.3	2.9	0.7	14.7	1.9	2.3	0.3	742.4	18.8	4.1	11523.2	0.8	1.7	2.7	5.9	15.0	5.4	1.2	1.2	0.7	5.4	27.1	16.3	10.7	3.1	1.1	216.1	13.0	0.2	370.1	0.5	41097.5	16.3	11.2	1.4	0.9	2.1	3.8	4.6	1.3	0.8	8.6	29343.1	1.9	1.3	4.5	1.0	1.9	7.6	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	4.6	0.7	0.1	0.3	1.0	0.8	0.2	0.0	0.0	5.4	0.3	0.1	0.5	0.1	0.0	0.0	0.2	0.1	0.2	0.4	0.0	0.2	0.0	0.0	0.5	0.5	0.0	19.2	0.1	0.6	0.0	1.9	2.3	0.9	0.5	8.0	0.0	6.4	1.5	0.2	19.0	175.6	0.0	0.3	39.4	0.1	0.4	0.5	1.2	2.2	0.2	0.0	0.0	0.2	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.0	1.0	1.0	2.3	0.8	1.7	1.2	1.2	0.7	1.1	0.9	1.3	1.0	0.3	0.0	0.0	0.3	0.1	0.3	4.3	12.5	0.0	0.0	30.7	23.9	5182.1	0.0	30.8	0.0	0.0	0.1	0.5	3.8	0.0	4.7	20.1	20.2	0.1	40.7	11.5	0.0	0.0	0.2	0.0	145.2	0.0	0.2	0.0	0.8	0.0	0.4	0.0	0.0	0.1	114.6	14.2	0.0	0.4	70.0	0.0	2.1	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.7	0.0	21.8	2.6	0.1	19.9	0.0	0.0	420.9	42.0	0.3	0.7	0.6	0.1	0.3	2.8	0.1	2.9	15.1
PI15	P25TI	ENSG00000137558	"Peptidase inhibitor 15"	O43692	8	74824534-74855029	"Predicted secreted proteins"		"Developmental protein, Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 54.9;prostate: 31.3;smooth muscle: 50.3"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 36.8;Breast glandular cells: 73.2;Breast myoepithelial cells: 13.6;Prostatic glandular cells: 19.3;Smooth muscle cells: 36.2;Urothelial cells: 15.7"	"Group enriched"	"Detected in many"	7	"breast cancer: 11.1;melanoma: 8.6;prostate cancer: 18.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AF22: 23.3;SH-SY5Y: 21.3;SK-MEL-30: 30.0;U-266/70: 7.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"spinal cord: 6.3"	"HPA006593, HPA030057"	Uncertain		Approved	Vesicles,Cytosol	"Secreted in other tissues"	NA	NA			Vesicles	Cytosol	"HPA006593: AB_1078568, HPA030057: AB_10602143"	"unprognostic (2.77e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.63e-14)"	"unprognostic (2.54e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.05e-2)"	5.9	1.1	0.7	54.9	0.9	0.0	22.3	0.2	2.0	9.4	0.1	7.0	0.2	20.0	2.1	2.6	21.1	1.5	1.4	0.8	2.3	0.9	0.2	2.2	0.6	1.3	0.5	0.9	6.3	0.3	0.0	0.5	0.3	0.8	31.3	4.7	0.6	2.0	6.8	0.4	0.3	4.7	50.3	1.2	1.3	0.7	0.5	1.9	0.5	0.6	0.2	0.2	8.4	6.6	0.7	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.1	21.3	0.0	0.1	30.0	0.4	0.5	0.5	0.0	0.0	0.5	0.0	0.1	7.9	3.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.2	2.0	0.8	2.3	1.3	0.5	0.9	0.8	1.2	1.9	0.7	0.2	0.0	0.0	2.3	0.1	0.1	36.8	0.0	0.6	0.2	73.2	13.6	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.6	0.2	9.1	2.5	0.0	0.0	4.3	0.0	0.4	3.9	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.6	1.9	0.9	0.2	3.6	1.0	0.0	0.0	0.0	0.5	2.0	0.0	0.0	0.0	0.1	19.3	0.0	0.1	0.0	0.5	0.0	1.7	36.2	0.0	0.0	0.4	0.0	0.1	0.4	0.0	0.0	15.7
PTGER3	"EP3, lnc003875"	ENSG00000050628	"Prostaglandin E receptor 3"	P43115	1	70852353-71047808	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 55.0;endometrium 1: 96.0;kidney: 81.9;smooth muscle: 68.6"	"Group enriched"	"Detected in many"	7	"Distal tubular cells: 225.0;Langerhans cells: 79.8"	"Group enriched"	"Detected in some"	7	"breast cancer: 4.1;renal cancer: 9.4"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	59	"basophil: 43.3"	"Lineage enriched"	"Detected in single"	59	"granulocytes: 43.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 28.6;HAP1: 20.9;HDLM-2: 32.8;HEL: 15.6;T-47d: 72.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010689	Uncertain					NA	NA					"HPA010689: AB_1855883"	"unprognostic (1.53e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (8.83e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.41e-4)"	55.0	6.7	7.4	5.0	4.8	0.2	28.9	0.0	6.1	4.7	8.7	11.1	1.2	96.0	3.7	3.9	10.2	9.0	1.6	4.6	8.1	81.9	0.3	1.1	1.3	6.0	0.7	7.7	1.7	6.7	0.9	0.6	0.6	3.4	3.1	2.4	0.7	12.0	8.0	0.5	12.6	3.8	68.6	1.8	0.3	22.6	1.0	3.3	0.9	1.1	1.4	1.4	6.7	6.1	1.7	0.0	0.0	0.0	0.0	28.6	0.7	0.1	0.7	0.0	0.1	0.7	0.0	0.0	0.0	0.0	3.5	0.0	0.0	20.9	0.0	0.1	32.8	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.9	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.1	0.0	0.3	0.0	0.2	72.5	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.1	7.2	0.0	43.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	7.4	4.8	0.0	6.1	4.6	8.1	6.0	0.7	7.7	3.4	1.8	3.3	1.7	6.9	0.0	0.5	0.0	0.0	5.0	0.2	0.0	0.0	1.6	13.7	6.1	1.8	1.5	0.0	20.2	0.0	0.0	0.2	0.4	225.0	3.0	1.6	0.6	4.6	1.7	2.4	0.0	2.2	0.0	2.4	12.2	1.5	1.2	9.5	0.0	0.7	0.0	0.1	3.3	3.4	1.0	12.2	0.0	79.8	1.0	1.2	3.2	8.8	0.0	0.6	0.2	0.0	0.5	0.3	0.0	0.0	0.0	0.1	1.3	0.1	7.2	0.0	0.2	6.6	0.5	11.7	0.1	0.1	0.1	7.5	0.1	1.2	6.2	0.0	0.2
TBC1D9	"GRAMD9, KIAA0882, MDR1"	ENSG00000109436	"TBC1 domain family member 9"	Q6ZT07	4	140620782-140756385	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 91.6"	"Cancer enriched"	"Detected in all"	7	"breast cancer: 85.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 5.9"	"Group enriched"	"Detected in many"	37	"B-cells: 5.9;dendritic cells: 3.2;monocytes: 1.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000262, HPA006503"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA000262: AB_2665956, HPA006503: AB_2667604"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.77e-2)"	"prognostic favorable (1.61e-6)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.16e-2)"	18.4	9.3	6.2	15.4	8.0	2.0	49.2	23.4	9.3	13.0	29.5	7.3	8.3	8.4	7.9	9.2	10.1	13.9	8.6	8.1	12.7	15.8	12.7	16.5	15.2	7.6	11.9	8.1	16.0	9.2	9.9	6.4	20.7	12.4	14.7	6.7	21.2	8.8	21.5	2.2	3.1	12.9	7.8	5.5	33.9	17.0	3.3	11.2	5.6	5.9	6.9	19.6	15.9	7.2	16.3	0.9	11.9	10.9	9.4	26.0	24.3	22.3	15.3	16.3	10.8	13.7	2.4	10.4	0.1	9.5	19.9	13.4	2.4	13.7	10.8	10.1	0.0	7.7	7.0	8.5	10.4	9.4	0.9	1.1	20.1	17.7	9.4	37.2	31.2	30.3	3.7	0.0	0.0	10.2	12.0	1.6	0.1	1.7	12.7	10.4	7.7	17.9	18.1	12.3	22.0	16.0	11.4	15.8	27.4	10.5	18.4	6.4	0.4	47.7	28.3	8.5	18.6	13.3	0.0	0.0	0.1	17.2	1.3	15.7	0.0	1.7	0.0	0.0	1.3	0.0	5.9	0.0	0.0	2.9	2.9	0.0	0.0	0.0	0.0	0.5	3.2	0.0	0.7	6.2	8.0	23.4	9.3	8.1	12.7	7.6	11.9	8.1	12.4	5.5	11.2	16.3	49.4	54.5	9.3	4.6	42.1	4.6	10.6	21.4	4.0	35.4	91.6	39.4	8.1	17.2	15.1	55.2	4.2	14.1	14.0	8.3	7.9	13.6	0.5	49.4	20.9	32.6	7.7	0.4	54.8	17.2	4.7	15.1	8.2	61.4	0.0	8.0	17.2	23.9	18.3	10.1	66.2	6.6	24.4	39.3	30.3	1.3	13.1	44.8	8.8	78.7	39.5	43.5	1.0	27.6	2.6	12.2	5.8	26.7	25.0	16.3	6.1	5.7	15.9	7.6	0.0	2.8	11.1	0.8	1.7	10.4	3.8	43.2	3.7	16.0	3.1	16.0
TTC36	HBP21	ENSG00000172425	"Tetratricopeptide repeat domain 36"	A6NLP5	11	118527472-118531197	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 172.9"	"Group enriched"	"Detected in many"	13	"Hepatocytes: 492.9;Proximal enterocytes: 185.5;Proximal tubular cells: 172.9"	"Group enriched"	"Detected in some"	7	"breast cancer: 5.0;liver cancer: 12.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SK-BR-3: 9.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA038731	Enhanced		Uncertain	Nucleoplasm		NA	NA		100000	Nucleoplasm		"HPA038731: AB_10672651"	"unprognostic (1.57e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (1.81e-5)"	"unprognostic (6.32e-2)"	"unprognostic (8.80e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.77e-3)"	"unprognostic (3.38e-2)"	"unprognostic (5.77e-7)"	"unprognostic (5.60e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.95e-3)"	8.1	1.3	0.7	0.1	0.6	0.0	11.2	0.8	0.7	0.3	0.5	0.5	5.9	0.4	18.6	0.5	0.5	0.1	1.0	0.3	0.5	8.7	172.9	0.3	0.1	1.2	0.7	0.4	0.6	1.2	0.0	1.6	0.1	1.1	1.0	0.0	0.3	0.9	0.0	1.4	0.5	4.2	0.0	0.6	0.3	0.7	0.8	0.5	0.0	0.7	0.4	0.0	0.5	0.3	1.0	0.0	0.0	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.5	0.2	0.7	0.0	0.0	0.2	0.0	0.0	9.7	0.0	0.0	0.8	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.4	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.6	0.8	0.7	0.3	0.5	1.2	0.7	0.4	1.1	0.6	0.5	1.0	0.3	0.0	0.0	0.3	2.4	0.3	0.6	0.2	0.6	0.1	21.2	11.3	0.3	11.5	0.1	12.9	0.0	1.5	0.1	0.8	17.6	0.2	0.1	1.2	0.6	1.1	2.4	16.4	0.2	0.5	0.2	0.3	2.0	1.7	0.0	0.4	9.7	492.9	0.1	0.0	0.3	9.3	0.0	14.2	0.3	0.2	0.3	0.9	0.0	0.0	0.6	1.1	0.0	0.0	0.1	0.2	7.6	0.0	0.3	1.9	185.5	172.9	0.2	0.8	0.0	0.2	0.2	0.3	0.3	0.3	0.1	2.1	1.1	0.4	11.7	1.3
TTC6	"C14orf25, NCRNA00291"	ENSG00000139865	"Tetratricopeptide repeat domain 6"	Q86TZ1	14	37595847-38041442	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 8.0;prostate: 17.6"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 13.8;Club cells: 11.1;Early spermatids: 39.1;Late spermatids: 18.1;Spermatocytes: 10.7"	"Group enriched"	"Detected in some"	7	"breast cancer: 2.2;prostate cancer: 3.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 8.4;MCF7: 12.2;RT4: 8.4;T-47d: 22.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	7	"midbrain: 9.7"	HPA069293			Approved	Centrosome		NA	NA			Centrosome		"HPA069293: AB_2686110"	"unprognostic (7.92e-2)"	"unprognostic (6.95e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.98e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.60e-4)"	"unprognostic (6.75e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.08e-4)"	"unprognostic (5.60e-2)"	"unprognostic (8.91e-8)"	"unprognostic (1.76e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.07e-3)"	0.0	0.0	2.8	0.2	0.9	0.0	8.0	0.9	0.8	0.0	1.0	1.0	0.6	0.0	0.0	0.4	0.3	0.7	0.0	0.6	2.4	0.0	3.5	1.1	0.0	2.2	6.2	0.6	0.0	0.0	0.0	0.3	0.0	1.2	17.6	0.5	0.0	2.7	0.1	0.0	0.6	0.7	0.0	5.3	0.0	3.6	5.9	3.1	0.0	0.0	0.0	0.1	1.4	0.3	0.9	0.7	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	0.0	0.4	0.0	0.0	2.4	1.3	0.2	0.0	0.0	3.4	0.0	1.2	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	12.2	0.0	0.0	0.0	1.7	4.5	0.0	0.0	0.0	1.0	8.4	2.4	0.0	0.0	4.5	0.0	0.0	22.8	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.9	0.9	0.8	0.6	2.4	2.2	6.2	0.6	1.2	5.3	3.1	0.9	0.2	0.0	8.4	0.3	0.1	0.0	2.8	1.5	6.2	0.0	13.8	6.9	0.8	1.5	11.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	39.1	0.0	0.0	0.4	7.7	0.0	6.4	0.0	0.0	0.4	7.1	0.1	0.0	0.0	0.0	2.5	0.0	0.0	1.0	0.7	0.0	0.0	0.0	18.1	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.8	0.4	0.0	4.9	0.0	0.0	7.5	0.0	0.0	0.2	0.4	10.7	1.9	2.3	0.0	0.0	0.3	0.0	1.1	3.1
CALML5	CLSP	ENSG00000178372	"Calmodulin like 5"	Q9NZT1	10	5498697-5499570	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 2852.4"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 172.1;Breast myoepithelial cells: 156.1;Suprabasal keratinocytes: 390.7"	"Group enriched"	"Detected in many"	6	"breast cancer: 97.6;cervical cancer: 189.1;head and neck cancer: 206.0;melanoma: 222.1;urothelial cancer: 82.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"A-431: 400.3"					"Not detected"	"Not detected"			HPA040725	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		48000000	"Plasma membrane, Cytosol"		"HPA040725: AB_10793863"	"unprognostic (7.68e-3)"	"unprognostic (5.06e-3)"		"unprognostic (5.64e-2)"		"prognostic favorable (2.59e-5)"		"unprognostic (4.82e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.14e-1)"		"unprognostic (2.79e-1)"	"unprognostic (1.71e-1)"		"unprognostic (4.99e-2)"	2.5	0.5	0.0	0.0	0.0	0.1	41.6	0.0	0.0	45.1	0.0	0.7	0.0	0.3	0.7	68.0	0.1	0.0	1.2	0.0	0.0	0.3	1.8	0.8	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.5	0.0	0.0	0.6	0.0	0.0	558.9	0.0	11.8	2852.4	0.6	0.0	0.0	0.4	0.8	1.0	0.0	9.3	0.6	0.0	13.5	0.1	309.1	0.0	400.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	7.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.8	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	27.3	0.3	2.2	0.0	0.0	172.1	156.1	0.2	0.0	1.8	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	11.1	0.0	0.0	0.4	56.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	1.3	0.2	0.3	6.8	390.7	0.0	1.2	0.0	0.0	3.3
CLPSL1	"C6orf127, dJ510O8.6"	ENSG00000204140	"Colipase like 1"	A2RUU4	6	35781019-35793675	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	90	"epididymis: 612.9;pancreas: 179.9"	"Cell type enriched"	"Detected in some"	4	"Exocrine glandular cells: 39.0"	"Group enriched"	"Detected in some"	6	"breast cancer: 3.6;cervical cancer: 1.0;endometrial cancer: 2.8;ovarian cancer: 1.8;pancreatic cancer: 3.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"T-47d: 8.4"									HPA073155	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA073155: AB_2686576"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-1)"		"unprognostic (4.75e-1)"				"unprognostic (2.54e-1)"		"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"			"unprognostic (1.97e-1)"	"unprognostic (6.60e-2)"		"unprognostic (7.06e-3)"	0.1	0.3	0.8	0.0	2.2	0.0	4.3	0.3	2.3	0.0	0.2	0.0	0.0	0.0	612.9	0.0	0.0	0.0	0.0	2.9	0.4	0.0	0.0	0.0	0.0	0.8	0.5	1.2	0.1	179.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.6	2.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	8.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.2	0.3	2.3	2.9	0.4	0.8	0.5	1.2	0.6	0.3	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	39.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0
FGF10		ENSG00000070193	"Fibroblast growth factor 10"	O15520	5	44300247-44389706	"Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Disease variant, Ectodermal dysplasia, Lacrimo-auriculo-dento-digital syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 17.4"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 21.6;Fibroblasts: 14.6;Leydig cells: 8.4;Muller glia cells: 4.3;Peritubular cells: 10.5"	"Cancer enriched"	"Detected in some"	6	"breast cancer: 5.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"AF22: 27.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB010315	Uncertain				"Secreted in other tissues"	NA	NA					"CAB010315: AB_2262731"	"unprognostic (1.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.20e-1)"		"unprognostic (3.54e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.72e-2)"	"unprognostic (6.73e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.23e-4)"	10.2	1.6	0.3	2.6	1.2	0.0	15.3	0.4	0.6	14.2	1.3	5.2	0.4	2.4	4.5	1.4	8.6	2.8	0.6	0.5	2.1	0.4	0.1	2.7	0.6	1.3	1.2	0.4	17.4	4.9	0.0	2.1	5.6	0.5	4.6	1.5	0.3	5.5	3.0	0.7	0.8	2.9	1.3	1.1	0.0	4.3	0.8	1.3	1.1	5.3	3.9	0.2	5.0	12.1	0.8	0.0	0.0	27.9	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.4	0.6	0.5	2.1	1.3	1.2	0.4	0.5	1.1	1.3	0.8	1.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	21.6	0.9	0.0	0.0	3.0	0.5	0.0	14.6	0.0	0.3	0.0	1.6	0.4	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.5	8.4	0.1	0.0	0.0	0.0	4.3	0.0	0.0	0.3	0.3	0.0	10.5	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1
GNAT3	"GDCA, gustducin"	ENSG00000214415	"G protein subunit alpha transducin 3"	A8MTJ3	7	80458635-80512064	"Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"intestine: 1.8"	"Cell type enhanced"	"Detected in single"		"Early spermatids: 2.8"	"Group enriched"	"Detected in some"	6	"breast cancer: 0.8;urothelial cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"SCLC-21H: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071345	Enhanced					NA	NA					"HPA071345: "											"unprognostic (2.01e-1)"							0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
IRX1	IRX-5	ENSG00000170549	"Iroquois homeobox 1"	P78414	5	3595832-3601403	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.0;breast: 16.3;kidney: 12.5;salivary gland: 18.0"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 51.4;Breast myoepithelial cells: 87.6"	"Group enriched"	"Detected in many"	6	"breast cancer: 5.6;glioma: 6.6;testis cancer: 15.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.8;REH: 37.8;U-251 MG: 15.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043160	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA043160: AB_10794771"	"unprognostic (1.52e-2)"				"unprognostic (1.26e-2)"	"unprognostic (2.27e-1)"		"unprognostic (3.73e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.78e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.58e-2)"		4.2	0.0	4.1	0.0	3.9	0.6	16.3	7.7	3.8	0.1	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	1.9	5.1	12.5	0.0	3.1	0.1	12.9	8.3	0.6	0.0	0.2	0.2	1.0	0.0	18.0	0.1	0.0	0.1	18.0	0.5	0.1	7.8	0.0	0.0	7.2	0.0	0.0	0.1	6.8	0.3	0.3	0.0	0.0	0.0	0.5	14.2	0.0	0.0	8.8	0.0	0.5	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	1.8	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	37.8	0.0	0.0	2.8	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	3.9	7.7	3.8	1.9	5.1	12.9	8.3	0.6	18.0	7.2	6.8	14.2	2.5	6.4	3.7	0.0	0.4	3.6	0.0	1.6	1.2	0.8	51.4	87.6	3.5	0.0	1.5	5.5	0.0	0.3	1.0	0.0	15.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.3	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	1.0	0.0	0.5	3.7	0.0	0.2	1.1	3.0	0.3	0.6	0.0	0.0	0.0
LRRN2	"FIGLER7, GAC1, LRANK1, LRRN5"	ENSG00000170382	"Leucine rich repeat neuronal 2"	O75325	1	204617170-204685738	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.2;Distal enterocytes: 18.1;Excitatory neurons: 57.8;Horizontal cells: 52.2;Inhibitory neurons: 40.0;Oligodendrocyte precursor cells: 39.2"	"Group enriched"	"Detected in many"	6	"breast cancer: 6.1;endometrial cancer: 10.6;glioma: 16.8;ovarian cancer: 18.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 9.3;NTERA-2: 18.0;RPMI-8226: 29.0;SuSa: 9.8;T-47d: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029124	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA029124: AB_10601545"	"unprognostic (2.16e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.59e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.59e-3)"	3.3	4.5	17.9	2.8	17.9	1.7	2.5	7.0	17.9	3.0	16.3	7.2	1.2	5.5	0.3	1.8	7.6	4.3	5.4	20.6	13.5	10.9	1.0	2.8	2.1	11.1	14.6	18.6	2.5	1.9	14.8	13.0	0.8	10.4	1.5	5.4	3.9	3.0	2.3	1.6	0.4	4.9	7.2	4.8	7.6	2.1	4.2	18.1	3.1	3.2	3.2	0.7	1.4	2.2	12.5	0.0	4.3	3.5	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.2	9.3	0.6	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.9	1.5	0.0	18.0	0.0	0.1	0.2	0.0	29.0	0.0	0.2	2.4	0.4	5.6	0.1	0.0	9.8	10.1	0.0	0.0	0.0	3.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	17.9	7.0	17.9	20.6	13.5	11.1	14.6	18.6	10.4	4.8	18.1	12.5	3.9	0.0	0.0	22.2	0.3	0.4	0.7	0.1	0.0	7.0	0.6	1.9	1.5	0.0	0.1	1.8	2.1	0.1	0.0	18.1	0.0	3.8	0.0	0.5	0.2	2.3	11.4	2.7	57.8	0.9	0.1	2.9	0.0	0.8	0.0	0.1	3.3	0.0	7.0	52.2	40.0	2.3	2.0	0.3	1.1	0.5	0.0	0.2	0.0	9.4	0.2	4.6	0.0	39.2	1.6	4.9	5.6	0.0	0.1	0.3	0.0	5.5	0.0	1.1	0.0	0.9	0.5	0.1	0.3	0.5	0.1	0.4	0.2	1.4	1.0	0.4
NBPF4	FLJ32833	ENSG00000196427	"NBPF member 4"	Q96M43	1	108223341-108244081	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"intestine: 1.3;testis: 3.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"breast cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.1;K-562: 10.2;Karpas-707: 3.1;MCF7: 12.6;THP-1: 3.8"									"HPA045044, HPA046411, HPA047447, HPA058050"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: "	"unprognostic (6.33e-2)"		"unprognostic (2.08e-1)"						"unprognostic (2.18e-2)"					"unprognostic (8.29e-2)"	"unprognostic (2.90e-1)"		"unprognostic (8.73e-2)"	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.6	0.6	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	10.2	3.1	0.0	12.6	0.0	0.0	0.6	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.2	0.0	0.0	0.1	1.4	0.0	0.1	3.8	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.1	0.1	0.4	0.2	0.0	0.5	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NBPF6		ENSG00000186086	"NBPF member 6"	Q5VWK0	1	108450282-108471002	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"testis: 2.6"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.2;Microglial cells: 1.0"	"Cancer enriched"	"Detected in single"	6	"breast cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.5;HeLa: 1.9;K-562: 11.6;SK-BR-3: 2.4;SK-MEL-30: 1.9"									"HPA045044, HPA046411, HPA047447, HPA058050"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: "	"unprognostic (4.36e-2)"		"unprognostic (5.87e-2)"						"unprognostic (4.62e-2)"					"unprognostic (2.39e-1)"	"unprognostic (2.61e-1)"		"unprognostic (8.02e-2)"	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.5	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	1.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.9	0.0	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAX7	Hup1	ENSG00000009709	"Paired box 7"	P23759	1	18630846-18748866	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Myogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"brain: 5.1;skeletal muscle: 5.8;tongue: 4.4"	"Cell type enriched"	"Detected in some"	284	"Skeletal myocytes: 341.4"	"Group enriched"	"Detected in some"	6	"breast cancer: 0.5;cervical cancer: 1.5;lung cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 1.4;CAPAN-2: 1.4;U-2 OS: 3.0"	"Region enriched"	"Detected in single"	17	"midbrain: 4.6"	"Region enhanced"	"Detected in some"		"thalamus: 4.3"							NA	NA						"unprognostic (8.41e-4)"	"unprognostic (2.07e-1)"			"unprognostic (5.35e-2)"	"unprognostic (3.96e-2)"		"unprognostic (4.21e-1)"						"unprognostic (1.96e-1)"	"unprognostic (1.34e-1)"			0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	3.2	5.1	0.3	0.0	0.0	0.0	0.1	0.0	1.5	0.1	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.6	0.0	0.0	4.4	0.0	0.0	0.0	0.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	1.5	1.4	0.2	0.1	3.2	5.1	0.3	1.5	2.0	0.6	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	341.4	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
SCGB1D2	"LIPB, LPHB"	ENSG00000124935	"Secretoglobin family 1D member 2"	O95969	11	62242239-62244812	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"breast: 1240.5;cervix: 4036.1"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 3242.1;Glandular and luminal cells: 3417.9"	"Group enriched"	"Detected in many"	6	"breast cancer: 625.1;endometrial cancer: 226.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 10.4"									HPA035318	Approved				"Secreted in other tissues"	NA	NA					"HPA035318: AB_10610421"	"unprognostic (8.76e-2)"	"unprognostic (2.14e-1)"		"prognostic favorable (3.46e-6)"	"unprognostic (2.39e-2)"				"unprognostic (5.89e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.43e-2)"	"prognostic favorable (8.03e-6)"		"unprognostic (1.55e-1)"	"unprognostic (1.15e-2)"		7.4	5.0	3.5	0.0	3.4	0.0	1240.5	3.0	5.4	4036.1	11.4	0.3	0.1	89.7	358.9	10.2	111.2	0.1	2.6	3.0	6.5	9.0	0.2	0.1	0.1	4.1	4.5	2.5	1.1	4.5	0.5	5.2	0.2	3.5	8.6	0.2	1.8	69.7	2.9	7.3	305.1	0.5	0.0	2.9	0.0	0.3	0.2	3.9	0.4	0.6	6.0	0.0	0.2	0.3	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.4	0.1	0.0	1.8	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.4	3.0	5.4	3.0	6.5	4.1	4.5	2.5	3.5	2.9	3.9	4.1	2.1	0.0	0.0	0.0	1.6	27.4	4.8	0.0	0.0	0.5	647.8	251.6	10.9	0.0	0.0	7.3	0.0	0.0	5.3	0.0	23.5	0.3	0.0	3242.1	409.9	12.0	0.0	0.0	0.0	0.2	0.0	3.6	0.0	3417.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	15.0	823.6	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.7	0.0	46.1	0.0	0.9	0.0	0.2	8.6	0.0	0.0	0.0	7.0	0.1	20.0	0.0	0.0	1.1
SLC16A6	"MCT6, MCT7"	ENSG00000108932	"Solute carrier family 16 member 6"	O15403	17	68267026-68291267	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 41.7;epididymis: 33.6;retina: 31.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 22.9;Glandular and luminal cells: 27.4;Kupffer cells: 16.7;Macrophages: 21.8;Rod photoreceptor cells: 45.1"	"Group enriched"	"Detected in many"	6	"breast cancer: 10.9;melanoma: 11.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	13	"SK-MEL-30: 481.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054459, HPA066328"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA054459: AB_2682494, HPA066328: AB_2685660"	"unprognostic (2.53e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.41e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.26e-3)"	"unprognostic (5.08e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.44e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.16e-3)"	"unprognostic (2.09e-2)"	"unprognostic (9.46e-2)"	1.5	2.7	3.3	7.3	5.3	9.8	5.9	4.0	4.3	1.6	41.7	0.7	0.5	2.6	33.6	11.0	0.9	1.4	0.8	5.1	4.0	0.7	1.4	3.1	5.3	4.4	3.5	1.8	1.5	0.5	0.1	1.7	2.4	5.3	0.6	0.8	31.2	2.2	4.2	5.1	4.5	1.2	0.8	2.2	5.7	1.0	2.3	6.8	1.6	3.5	0.7	4.8	2.1	2.6	5.2	2.1	1.8	0.6	0.8	0.4	0.6	14.2	0.8	18.0	1.7	1.2	0.7	2.5	17.6	1.4	0.0	0.2	0.6	2.5	0.0	0.7	5.4	1.3	1.4	2.2	22.3	3.2	5.7	1.1	0.8	0.2	1.0	1.0	1.7	0.8	2.5	1.1	3.8	0.0	18.1	8.5	3.6	0.2	0.1	1.0	0.1	0.4	2.4	0.8	1.5	4.2	0.3	0.8	10.7	481.5	3.8	15.0	3.5	2.7	5.9	1.1	0.5	2.0	4.2	17.5	14.6	36.0	4.6	2.6	0.8	3.1	0.2	1.8	2.7	0.8	0.4	0.6	1.4	1.9	0.0	0.4	0.8	5.4	0.4	1.4	0.3	1.5	0.9	3.3	5.3	4.0	4.3	5.1	4.0	4.4	3.5	1.8	5.3	2.2	6.8	5.2	0.6	0.0	2.5	1.6	1.8	0.3	0.2	0.1	1.2	8.2	2.5	0.9	0.8	0.0	4.0	9.2	22.9	0.4	8.4	0.0	0.0	0.0	0.7	4.7	2.5	3.2	0.0	2.7	6.7	0.0	11.5	0.9	0.5	27.4	1.3	0.1	0.7	0.3	5.6	0.0	6.2	0.0	0.0	16.7	7.0	0.3	0.0	21.8	10.6	4.7	11.1	6.2	5.2	0.5	0.8	0.0	0.0	1.9	5.0	0.2	0.0	0.3	1.6	45.1	0.0	0.8	0.3	1.7	0.7	6.7	0.4	0.4	5.3	0.4	0.1	0.2
SLC4A8	NBC3	ENSG00000050438	"Solute carrier family 4 member 8"	Q2Y0W8	12	51391317-51515763	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 27.6;pituitary gland: 18.0;retina: 11.2;testis: 11.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 92.6;Cone photoreceptor cells: 179.3;Excitatory neurons: 115.0;Horizontal cells: 116.1;Inhibitory neurons: 127.8;Oligodendrocytes: 248.9;Spermatocytes: 91.9"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.7;glioma: 2.7;testis cancer: 4.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 21.0;HMC-1: 14.8;SCLC-21H: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077895			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA077895: "	"unprognostic (4.01e-1)"	"unprognostic (8.15e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.72e-4)"	"unprognostic (3.13e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.07e-4)"	"unprognostic (1.70e-1)"	"unprognostic (9.60e-6)"	"unprognostic (1.35e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.47e-1)"	0.2	3.1	4.4	0.9	6.5	0.6	1.3	8.8	16.7	1.1	0.0	0.3	0.4	0.3	2.5	0.1	1.7	0.3	0.3	9.9	8.9	1.3	0.1	1.2	1.4	20.4	9.7	4.2	3.3	1.0	2.3	18.0	0.2	23.5	0.4	0.4	11.2	0.9	0.6	0.1	0.2	0.8	0.3	2.3	1.0	1.3	11.7	12.2	0.6	0.2	0.0	1.2	0.2	0.1	27.6	0.2	1.0	11.9	0.1	0.5	0.6	21.0	3.3	5.5	5.2	3.3	7.2	0.2	4.5	0.5	4.5	2.9	0.1	4.7	0.2	4.8	0.9	0.6	2.3	0.3	0.0	0.0	0.7	14.8	0.2	0.2	2.7	0.5	3.1	6.2	1.9	0.1	7.6	2.7	2.6	6.6	1.4	5.1	1.4	3.6	0.1	0.0	0.0	0.6	0.1	15.7	10.7	1.3	1.6	0.0	3.6	2.0	0.5	5.7	3.3	1.7	0.2	4.3	3.8	1.3	0.2	4.6	0.6	0.4	0.4	0.5	0.9	0.4	0.3	0.0	0.1	0.1	0.4	0.7	0.2	0.1	0.2	0.5	0.5	0.8	0.2	0.0	0.2	4.4	6.5	8.8	16.7	9.9	8.9	20.4	9.7	4.2	23.5	2.3	12.2	27.6	1.2	0.0	8.7	33.6	3.1	0.0	0.8	0.2	0.0	92.6	5.0	1.5	1.9	0.0	5.4	1.8	179.3	1.4	4.9	0.5	7.9	0.1	61.9	1.7	0.6	2.4	6.0	0.8	115.0	1.3	5.2	2.1	13.3	0.7	7.6	11.5	1.1	0.2	2.2	116.1	127.8	0.4	0.0	4.7	2.2	32.8	2.8	4.5	1.8	18.7	3.4	11.5	7.2	20.1	248.9	0.1	5.4	3.8	3.5	1.0	1.9	1.0	25.0	19.9	0.0	0.7	1.0	91.9	8.2	0.1	0.1	0.4	4.3	0.9	0.2	1.1
STC2	STC-2	ENSG00000113739	"Stanniocalcin 2"	O76061	5	173314723-173328447	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"breast: 145.1"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 278.3;Breast myoepithelial cells: 119.6;Extravillous trophoblasts: 59.5"	"Cancer enriched"	"Detected in all"	6	"breast cancer: 91.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 1019.9;T-47d: 940.0;U-138 MG: 382.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA045372	Approved		Approved	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		19000000	"Endoplasmic reticulum"		"HPA045372: AB_10961040"	"prognostic favorable (7.40e-5)"	"unprognostic (2.40e-2)"	"unprognostic (9.03e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.89e-3)"	"prognostic unfavorable (1.76e-6)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (5.28e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (4.17e-8)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (8.56e-2)"	"unprognostic (5.06e-2)"	"unprognostic (7.93e-3)"	6.4	1.8	1.9	2.4	1.1	0.0	145.1	2.0	3.0	13.3	1.5	4.0	0.6	3.1	0.3	2.0	2.0	6.4	7.7	2.7	1.9	3.6	0.8	11.4	1.1	4.9	2.0	0.4	0.7	32.8	3.4	1.7	28.2	3.7	4.9	0.6	7.7	1.1	6.8	4.4	9.5	2.7	21.4	1.8	11.6	3.4	0.7	4.4	0.2	9.1	4.9	0.3	4.8	3.0	2.8	52.5	15.3	2.7	13.0	47.9	20.5	133.8	234.5	239.4	59.1	115.0	74.4	36.7	0.0	33.4	139.8	298.2	21.5	33.8	72.0	102.5	0.1	18.9	0.0	26.7	50.2	311.3	15.8	4.3	43.6	117.9	133.3	7.9	274.4	16.7	42.4	2.4	0.1	1019.9	41.6	0.7	0.7	7.9	23.4	73.2	0.3	36.5	27.4	0.0	3.9	35.6	9.6	10.3	1.1	42.5	10.4	940.0	15.9	151.5	382.8	1.3	229.1	49.2	42.0	24.3	10.5	74.6	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.1	2.0	3.0	2.7	1.9	4.9	2.0	0.4	3.7	1.8	4.4	2.8	6.9	0.0	0.0	0.0	0.4	5.0	0.2	4.9	0.6	11.1	278.3	119.6	27.1	0.0	0.6	0.0	0.0	37.0	2.4	0.4	0.0	31.6	0.6	9.5	1.0	25.3	7.2	0.0	0.2	13.1	59.5	16.7	0.0	16.1	0.0	0.0	3.6	0.0	5.2	0.0	0.2	0.2	0.0	0.0	4.8	1.0	23.0	0.5	10.6	1.0	0.0	0.9	0.0	0.0	0.1	7.8	0.0	0.4	0.0	0.8	0.0	4.5	0.2	2.4	0.0	2.3	24.6	0.7	0.8	0.5	6.3	21.9	1.0	0.9	0.4	0.5
STMND1	FLJ23152	ENSG00000230873	"Stathmin domain containing 1"	H3BQB6	6	17102050-17131378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 18.0;gallbladder: 5.3;testis: 5.7"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 93.8;Respiratory ciliated cells: 72.8;Spermatocytes: 18.7;Spermatogonia: 23.8"	"Group enriched"	"Detected in some"	6	"breast cancer: 4.1;endometrial cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEK 293: 2.4;SCLC-21H: 6.0;T-47d: 7.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA067970	Enhanced		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA067970: AB_2685934"	"unprognostic (7.70e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.09e-3)"	"unprognostic (6.88e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.29e-2)"	"unprognostic (4.22e-2)"		"unprognostic (3.13e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.72e-2)"	"unprognostic (5.29e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-2)"		0.0	0.0	0.6	0.1	0.3	0.0	3.1	0.3	0.4	0.4	1.8	0.9	0.1	0.5	0.3	0.0	18.0	5.3	0.0	0.4	0.5	0.0	0.1	2.4	0.0	0.5	0.6	0.3	0.0	3.5	0.0	0.5	0.1	0.3	0.0	0.9	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.0	0.0	5.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.2	0.5	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0	0.0	0.0	0.0	0.5	7.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.2	0.0	0.0	0.6	0.3	0.3	0.4	0.4	0.5	0.5	0.6	0.3	0.3	0.5	0.3	0.6	0.0	0.0	1.3	0.0	0.0	0.0	1.7	2.9	0.0	0.1	5.0	1.4	0.7	2.8	8.3	0.0	0.0	0.0	0.0	1.2	0.0	0.6	1.3	93.8	0.9	0.5	1.8	0.0	0.5	0.2	0.0	0.4	0.0	2.3	0.0	0.7	0.0	0.3	0.0	0.0	0.2	0.7	2.0	0.0	0.4	2.8	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.6	0.3	0.4	0.0	0.7	0.0	0.0	72.8	0.0	6.6	1.3	2.7	18.7	23.8	0.0	0.9	0.0	0.3	0.0	1.8	0.6
SYCP2	SCP2	ENSG00000196074	"Synaptonemal complex protein 2"	Q9BX26	20	59863564-59933655	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 43.5"	"Cell type enriched"	"Detected in many"	5	"Spermatocytes: 468.5"	"Group enriched"	"Detected in many"	6	"breast cancer: 6.7;cervical cancer: 11.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 25.9;JURKAT: 47.2;MOLT-4: 54.4;SiHa: 92.2;T-47d: 82.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA062401, HPA065613"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA062401: AB_2684752, HPA065613: AB_2685519"	"unprognostic (8.10e-3)"	"unprognostic (8.28e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.74e-1)"	"unprognostic (7.02e-3)"	"unprognostic (4.84e-3)"	"unprognostic (8.48e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.21e-1)"	3.3	0.8	2.5	1.5	3.2	2.4	14.1	10.2	4.7	2.1	0.2	1.3	1.7	1.6	1.2	1.0	1.3	2.4	2.0	2.6	2.0	4.4	1.1	2.2	2.6	3.3	3.1	1.8	0.7	6.7	0.7	1.9	4.0	5.3	3.8	1.1	1.5	4.4	1.0	1.3	2.8	2.4	0.7	1.6	3.1	6.2	43.5	2.2	1.3	2.4	1.0	1.7	1.8	1.5	4.2	0.3	1.3	0.2	1.4	0.6	0.8	1.4	4.1	1.1	1.8	0.2	25.9	2.6	0.1	4.0	1.8	0.8	0.6	0.5	0.1	1.0	8.5	0.6	0.2	6.1	0.4	0.2	0.4	19.0	0.4	0.4	0.4	0.0	0.9	0.0	47.2	0.2	0.0	0.9	12.5	54.4	2.9	0.4	1.5	0.3	0.0	0.1	0.2	2.1	6.1	0.2	4.5	92.2	13.3	3.3	1.6	82.6	4.7	0.5	0.1	2.8	11.2	0.0	0.0	0.0	0.0	0.0	1.7	5.2	0.7	0.1	0.7	0.8	0.0	0.8	0.2	0.4	0.5	0.0	0.2	0.2	0.4	0.7	0.0	0.0	0.0	0.3	0.2	2.5	3.2	10.2	4.7	2.6	2.0	3.3	3.1	1.8	5.3	1.6	2.2	4.2	11.5	0.0	1.1	24.5	1.4	1.0	1.1	1.0	0.0	1.9	12.7	9.4	3.6	2.8	6.3	1.8	2.1	0.8	3.0	0.1	1.9	0.9	82.3	0.4	5.0	6.5	0.0	0.0	27.5	3.6	0.4	2.1	2.6	0.5	2.5	1.2	2.9	0.0	0.5	0.0	14.6	0.1	0.0	1.2	0.8	21.8	4.7	1.6	5.4	13.1	1.4	2.3	5.2	28.6	11.1	1.2	1.2	1.9	0.4	1.8	0.3	5.4	8.6	1.1	52.6	1.7	3.8	468.5	92.4	0.6	0.0	0.4	4.1	0.2	0.3	1.2
SYNPO2L	FLJ12921	ENSG00000166317	"Synaptopodin 2 like"	Q9H987	10	73644881-73663803	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"heart muscle: 264.8;skeletal muscle: 281.9;tongue: 88.0"	"Cell type enriched"	"Detected in some"	52	"Cardiomyocytes: 665.1"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 4.1;HSkMC: 3.2;RH-30: 3.0;SK-BR-3: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA055192, HPA057142"	Enhanced		Supported	"Nuclear speckles,Cell Junctions,Cytosol"		NA	NA			"Nuclear speckles"	"Cell Junctions, Cytosol"	"HPA055192: AB_2682732, HPA057142: AB_2683348"	"unprognostic (2.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.34e-1)"	0.1	0.5	0.6	0.1	0.8	0.3	3.6	0.8	0.8	0.2	0.1	0.0	0.1	0.1	0.1	11.9	0.1	0.1	264.8	0.7	0.4	0.1	0.1	1.3	0.2	0.8	0.6	0.4	0.2	0.4	0.0	0.1	0.6	0.7	3.1	0.0	0.4	4.8	0.0	281.9	0.3	0.0	0.0	0.5	0.2	0.1	0.3	0.5	0.1	0.2	88.0	0.2	0.1	1.1	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.5	0.6	0.1	0.0	4.1	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.3	0.1	0.0	3.2	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.1	0.1	0.1	0.0	3.2	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.2	0.0	0.0	0.6	0.8	0.8	0.8	0.7	0.4	0.8	0.6	0.4	0.7	0.5	0.5	0.7	0.5	3.2	0.0	0.3	0.9	1.5	1.4	0.0	2.2	1.9	1.0	0.8	665.1	0.0	0.7	0.0	2.1	0.2	0.5	0.0	0.0	0.0	2.6	0.1	0.4	5.0	0.0	0.0	0.3	0.0	0.2	12.6	0.0	0.3	1.3	0.3	0.0	0.4	0.2	0.0	0.9	0.0	0.0	0.6	2.1	1.1	0.9	0.8	1.8	1.0	0.3	0.4	0.0	1.5	1.1	0.0	0.0	0.4	0.3	0.9	0.0	0.2	0.7	1.2	0.0	12.0	5.2	0.8	1.3	0.4	0.4	0.0	0.7	0.2	0.0	1.0
VTCN1	"B7-H4, B7H4, B7S1, B7x, FLJ22418"	ENSG00000134258	"V-set domain containing T cell activation inhibitor 1"	Q7Z7D3	1	117143587-117210960	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 101.9;fallopian tube: 32.9;pancreas: 30.3"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 62.3;Collecting duct cells: 55.2;Ductal cells: 83.6;Endometrial ciliated cells: 42.7;Exocrine glandular cells: 34.2;Glandular and luminal cells: 79.1"	"Group enriched"	"Detected in many"	6	"breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 244.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054200	Approved		Approved	"Plasma membrane,Cell Junctions,Focal adhesion sites"		No	NA			"Plasma membrane"	"Cell Junctions, Focal adhesion sites"	"HPA054200: AB_2682415"	"unprognostic (4.13e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.45e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	101.9	0.0	0.0	15.4	0.0	0.0	0.4	4.6	5.1	0.4	32.9	5.1	0.2	0.0	0.1	17.5	1.1	0.7	0.0	0.0	0.0	0.0	0.1	30.3	0.0	0.1	0.9	0.0	3.0	0.0	0.0	22.2	7.9	0.2	2.6	0.0	0.1	0.0	0.0	3.7	1.1	0.1	0.1	0.0	0.0	0.0	3.2	0.1	0.0	1.0	0.1	1.7	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	7.5	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.9	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.1	4.2	0.1	1.2	0.0	0.0	244.8	0.1	29.9	14.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	2.5	6.9	0.0	0.0	62.3	18.4	1.1	0.0	22.6	55.2	0.0	3.4	1.1	0.0	0.0	83.6	2.5	42.7	4.4	0.6	0.0	0.0	0.8	34.2	1.4	0.4	0.0	79.1	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	6.1	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.3	11.3	0.0	0.0	0.0	1.6	0.0	0.3	8.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	3.0	0.5	0.0	0.0	4.8
AFF3	"LAF4, MLLT2-like"	ENSG00000144218	"AF4/FMR2 family member 3"	P51826	2	99545419-100192428	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 154.9;Excitatory neurons: 491.3;Inhibitory neurons: 300.7;Oligodendrocyte precursor cells: 211.6"	"Group enriched"	"Detected in many"	5	"breast cancer: 11.4;prostate cancer: 7.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"memory B-cell: 31.0;naive B-cell: 44.2;plasmacytoid DC: 23.9"	"Group enriched"	"Detected in many"	17	"B-cells: 44.2;dendritic cells: 23.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 51.1;U-698: 56.5"	"Low region specificity"	"Detected in all"							"HPA044512, HPA053379"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044512: AB_10795984, HPA053379: AB_2682133"	"unprognostic (1.05e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.98e-5)"	"unprognostic (1.11e-3)"	"unprognostic (3.04e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.95e-3)"	"unprognostic (7.57e-2)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (6.40e-3)"	"unprognostic (6.79e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.87e-3)"	3.4	1.6	2.0	6.2	4.2	11.3	11.7	18.0	13.9	3.3	0.0	4.4	1.1	7.8	0.8	3.5	4.5	2.2	4.3	10.5	5.2	1.4	1.7	6.6	14.3	2.8	0.9	2.8	6.4	0.4	0.1	4.4	6.2	6.2	16.3	2.2	4.3	1.9	2.5	0.7	0.8	6.0	6.0	0.0	7.4	4.6	5.5	0.7	7.8	1.2	0.7	12.3	6.8	2.3	10.3	0.2	0.0	18.0	6.4	0.0	0.6	0.0	2.8	0.7	5.6	1.9	0.0	0.0	51.1	0.1	3.8	12.4	0.2	0.5	0.0	4.0	14.3	6.3	0.0	0.0	0.0	0.4	0.2	12.4	0.8	0.0	12.8	0.2	13.8	0.0	2.2	0.3	0.1	0.0	0.1	4.3	0.3	1.8	0.0	3.2	7.5	0.0	0.3	0.0	0.0	17.4	6.5	0.0	0.3	11.0	1.5	17.9	16.5	6.7	19.1	3.4	0.5	2.9	0.8	0.1	56.5	15.9	1.5	2.0	0.6	0.5	0.1	0.0	0.5	0.3	31.0	0.2	0.0	5.1	44.2	1.9	0.0	0.0	1.0	0.4	23.9	0.0	0.8	2.0	4.2	18.0	13.9	10.5	5.2	2.8	0.9	2.8	6.2	0.0	0.7	10.3	1.2	6.4	40.9	41.8	154.9	1.8	0.4	0.0	1.8	21.8	78.9	37.7	11.1	0.0	3.7	0.0	12.5	0.4	32.8	0.1	0.0	0.0	33.9	0.9	19.8	6.0	22.9	3.4	491.3	0.0	0.2	13.5	1.1	1.1	0.0	31.6	0.7	1.2	1.8	47.1	300.7	0.5	0.0	9.2	18.2	38.5	10.8	16.5	14.2	66.5	5.2	6.8	0.0	211.6	46.7	0.0	0.1	21.1	0.8	14.3	0.1	1.9	0.0	1.7	0.0	1.1	8.5	10.5	9.8	0.0	1.3	0.1	6.1	5.7	0.6	0.3
ANKRD30B	NY-BR-1.1	ENSG00000180777	"Ankyrin repeat domain 30B"	Q9BXX2	18	14728272-14854038	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"testis: 8.3"	"Group enriched"	"Detected in some"	8	"Early spermatids: 13.1;Excitatory neurons: 32.6;Inhibitory neurons: 39.3;Late spermatids: 13.9;Spermatocytes: 23.7"	"Cancer enriched"	"Detected in single"	5	"breast cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-2197: 63.1"									"HPA060455, HPA071849"	Uncertain		Uncertain	Nucleoli		NA	NA			Nucleoli		"HPA060455: AB_2684282, HPA071849: "	"unprognostic (1.53e-1)"		"unprognostic (1.50e-1)"		"unprognostic (1.01e-2)"				"unprognostic (1.65e-1)"	"unprognostic (1.86e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.55e-9)"	"unprognostic (1.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.98e-2)"		0.1	0.1	0.2	0.0	0.4	0.0	1.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	8.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	13.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.7	0.0	1.1	4.4	0.3	63.1	0.0	6.7	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.6	0.4	0.3	0.4	0.1	0.4	0.1	0.1	0.1	0.6	0.0	0.0	0.0	1.6	0.1	0.0	0.4	0.0	0.0	0.0	2.8	1.0	1.9	0.0	0.0	0.0	0.0	0.5	0.0	0.5	1.9	0.0	13.1	0.7	0.1	0.2	1.8	0.0	32.6	0.0	0.4	0.1	0.0	1.8	0.0	0.1	0.0	0.1	0.1	0.0	39.3	1.6	0.0	0.3	0.0	13.9	0.9	0.2	0.0	1.0	0.0	0.0	0.0	2.5	1.1	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	23.7	1.7	0.0	0.3	0.5	0.1	0.0	1.1	0.3
CACNG4	"MGC11138, MGC24983"	ENSG00000075461	"Calcium voltage-gated channel auxiliary subunit gamma 4"	Q9UBN1	17	66964707-67033398	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 33.4;prostate: 11.8"	"Cell type enriched"	"Detected in some"	6	"Oligodendrocyte precursor cells: 145.3"	"Group enriched"	"Detected in many"	5	"breast cancer: 30.3;glioma: 35.8;ovarian cancer: 14.8;prostate cancer: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	6	"SH-SY5Y: 387.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 118.1"	"HPA005803, HPA065370"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA005803: AB_2667439, HPA065370: AB_2685480"	"unprognostic (1.27e-1)"	"unprognostic (3.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.91e-1)"	"unprognostic (7.08e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.85e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.38e-10)"	"unprognostic (8.57e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.71e-2)"	"unprognostic (4.28e-1)"	0.2	0.8	26.4	0.1	33.4	0.0	5.4	6.0	22.6	0.4	3.3	0.5	0.2	0.5	0.1	0.2	4.2	0.4	0.1	13.0	15.4	0.1	0.0	5.8	0.0	15.7	15.1	15.8	0.1	0.4	1.2	0.3	0.7	21.4	11.8	0.1	0.8	1.7	1.3	0.1	0.4	0.1	1.1	10.0	0.0	1.5	0.2	21.1	0.0	0.1	0.0	0.0	0.4	0.7	10.6	6.4	4.1	15.6	0.0	0.0	0.0	4.4	0.0	0.0	1.4	0.0	4.6	0.2	0.0	0.2	0.0	41.2	64.1	0.1	0.0	0.0	0.0	0.3	0.0	1.8	3.7	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	34.5	0.1	0.3	15.7	7.3	0.0	0.0	0.4	8.7	0.0	11.1	15.8	387.4	3.6	10.4	0.0	38.1	38.5	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	33.4	6.0	22.6	13.0	15.4	15.7	15.1	15.8	21.4	10.0	21.1	10.6	0.0	3.2	1.3	0.0	0.0	0.0	1.1	0.3	0.0	0.2	6.4	3.4	1.3	0.0	1.4	0.0	0.0	0.3	0.1	0.6	0.0	0.1	2.6	1.0	0.2	0.1	7.7	0.0	1.8	0.2	0.2	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.7	0.0	3.4	0.0	145.3	0.3	0.7	0.2	0.0	0.0	2.6	0.0	0.0	1.9	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.7
CHAD	SLRR4A	ENSG00000136457	Chondroadherin	O15335	17	50464496-50468906	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 36.5;pancreas: 32.8"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 4.6;Breast myoepithelial cells: 2.4;Distal enterocytes: 3.3;Gastric mucus-secreting cells: 4.6;Hepatocytes: 2.4;Intestinal goblet cells: 4.3;Oligodendrocyte precursor cells: 5.5;Paneth cells: 2.5;Proximal enterocytes: 2.6"	"Group enriched"	"Detected in many"	5	"breast cancer: 23.7;liver cancer: 10.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	53	"memory B-cell: 21.5;naive B-cell: 8.0"	"Lineage enriched"	"Detected in single"	76	"B-cells: 21.5"	"Cell line enhanced"	"Detected in some"		"RT4: 4.0;SCLC-21H: 8.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA018241	Enhanced				"Secreted to extracellular matrix"	NA	NA		22000000			"HPA018241: AB_1846612"	"prognostic favorable (7.68e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.92e-1)"	"unprognostic (3.06e-3)"	"prognostic favorable (1.59e-4)"	"unprognostic (1.51e-2)"	"unprognostic (4.75e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.41e-3)"	1.5	14.2	7.2	0.7	8.0	0.3	9.7	16.9	7.4	21.9	5.1	4.1	7.7	0.5	0.1	1.8	0.8	1.5	1.2	6.6	6.8	2.3	36.5	1.7	0.6	7.5	6.7	6.4	3.2	32.8	0.0	1.3	0.5	9.6	1.9	4.0	0.5	21.5	0.2	14.7	8.6	10.4	0.1	6.1	1.2	10.8	1.2	6.7	0.2	4.2	0.9	0.2	1.3	1.6	6.8	1.0	0.8	0.7	0.6	0.0	0.0	2.1	0.1	0.0	0.0	0.0	1.5	0.8	0.1	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.6	0.7	1.2	0.7	1.5	0.0	0.4	1.1	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.1	0.3	0.0	0.5	0.0	0.7	0.1	0.1	0.7	0.9	0.1	1.5	0.0	4.0	8.5	0.2	0.1	0.3	0.0	0.3	0.3	0.2	0.9	2.1	0.4	0.1	0.0	1.4	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.2	0.0	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	7.2	8.0	16.9	7.4	6.6	6.8	7.5	6.7	6.4	9.6	6.1	6.7	6.8	0.0	0.0	0.0	1.3	1.0	0.3	0.2	0.3	0.0	0.0	4.6	2.4	0.2	1.5	0.2	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	4.6	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.2	4.3	0.0	0.3	0.4	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	5.5	0.1	0.0	2.5	0.0	1.1	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.4
CHRNA9	NACHRA9	ENSG00000174343	"Cholinergic receptor nicotinic alpha 9 subunit"	Q9UGM1	4	40335333-40355217	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"breast cancer: 2.5;glioma: 3.5;lung cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"U-87 MG: 15.9"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.0"	"Not detected"	"Not detected"									NA	NA						"unprognostic (6.20e-3)"	"unprognostic (9.18e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.48e-1)"		"unprognostic (1.58e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.94e-1)"		"unprognostic (8.96e-6)"	"unprognostic (9.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.01e-2)"	"unprognostic (9.18e-3)"	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.1	0.1	0.1	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CIDEC	"CIDE-3, FLJ20871, Fsp27"	ENSG00000187288	"Cell death inducing DFFA like effector c"	Q96AQ7	3	9866711-9880255	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 738.8;breast: 497.0"	"Cell type enriched"	"Detected in some"	7	"Proximal enterocytes: 219.4"	"Group enriched"	"Detected in many"	5	"breast cancer: 4.5;colorectal cancer: 1.4;liver cancer: 2.4;pancreatic cancer: 4.6;stomach cancer: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC diff: 1683.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018837, HPA020553"	Uncertain					NA	NA					"HPA018837: AB_1846767, HPA020553: AB_1846769"	"unprognostic (1.83e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.26e-5)"	"unprognostic (9.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.48e-3)"	"unprognostic (8.14e-2)"	"unprognostic (5.37e-5)"	"unprognostic (9.47e-3)"	"unprognostic (2.02e-1)"	"unprognostic (7.46e-3)"	"unprognostic (2.94e-2)"	738.8	5.6	0.2	1.1	0.3	0.0	497.0	0.1	0.4	0.9	0.0	11.6	69.6	4.7	0.3	0.7	2.2	5.0	7.0	0.1	0.2	2.1	10.1	0.2	1.2	0.2	0.1	0.0	0.4	7.4	0.1	0.2	0.0	0.1	2.3	3.9	0.0	16.3	3.8	6.2	15.5	90.6	1.6	0.1	0.2	7.5	0.9	0.1	1.5	3.9	11.7	0.0	13.4	4.9	0.3	0.0	0.2	0.0	0.0	1683.2	376.0	1.2	0.1	0.0	0.0	0.0	7.5	9.1	0.0	0.2	0.6	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	19.1	2.8	0.0	0.0	228.9	0.4	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.3	0.0	0.6	1.6	0.0	0.0	1.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.1	0.4	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.3	2.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	2.0	0.2	0.0	0.0	0.0	0.0	0.0	1.5	30.0	1.9	0.0	0.5	0.2	0.1	0.1	3.5	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.1	8.4	0.0	0.0	0.4	1.0	2.5	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	14.5	0.4	0.0	0.4	219.4	1.1	0.0	0.0	0.0	0.5	0.6	0.6	0.4	0.0	0.0	0.0	0.2	0.1	3.8	0.3
CREB3L4	"AIbZIP, ATCE1, CREB3, CREB4, hJAL"	ENSG00000143578	"CAMP responsive element binding protein 3 like 4"	Q8TEY5	1	153967534-153974361	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 107.2"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 49.9;Breast myoepithelial cells: 40.1;Intestinal goblet cells: 56.9;Prostatic glandular cells: 49.3"	"Group enriched"	"Detected in all"	5	"breast cancer: 47.8;endometrial cancer: 28.7;prostate cancer: 109.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 81.8;OE19: 82.7;SK-BR-3: 174.6;T-47d: 139.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA038122	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		No	No			"Nucleoplasm, Nuclear membrane"	Mitochondria	"HPA038122: AB_10669516"	"unprognostic (1.35e-1)"	"unprognostic (4.71e-2)"	"unprognostic (8.13e-3)"	"prognostic favorable (7.21e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.51e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.12e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.34e-3)"	6.3	8.6	4.2	4.5	3.6	7.6	48.7	4.2	4.7	30.8	4.1	11.6	11.5	13.1	13.1	8.3	19.4	6.8	4.8	3.4	3.6	7.5	14.1	5.8	6.0	3.7	3.8	2.7	17.6	13.3	6.8	6.2	6.4	3.7	107.2	15.3	5.0	44.2	7.7	5.7	10.2	9.1	5.8	4.0	7.6	29.6	5.3	3.4	12.1	11.4	5.4	7.5	6.8	7.0	4.6	7.5	10.6	9.8	10.9	6.9	10.0	24.7	6.2	7.2	8.3	7.3	5.1	31.0	13.9	31.7	2.6	6.1	12.0	14.5	9.7	4.5	11.4	5.9	10.3	11.7	8.9	5.6	4.9	8.5	10.9	9.2	7.9	17.9	7.5	7.4	16.5	8.1	16.9	3.8	81.8	9.3	3.8	6.7	82.7	12.7	20.9	10.3	26.1	9.0	5.3	18.5	20.1	6.6	174.6	16.8	12.8	139.9	14.9	4.5	2.5	7.3	5.2	4.9	31.4	17.3	10.6	5.3	8.5	8.2	1.5	2.9	2.2	3.4	1.2	4.5	4.5	1.9	2.4	5.0	4.8	1.8	3.5	0.1	9.4	1.7	5.7	1.8	2.5	4.2	3.6	4.2	4.7	3.4	3.6	3.7	3.8	2.7	3.7	4.0	3.4	4.6	7.2	6.4	13.1	3.6	6.2	2.9	13.1	10.1	6.8	5.3	49.9	40.1	2.0	7.2	20.3	1.8	2.1	12.9	5.6	3.6	9.8	14.0	0.4	10.6	5.2	6.9	9.0	8.6	0.4	13.3	17.0	4.8	10.7	13.5	5.7	8.7	4.2	14.2	5.4	0.0	0.4	56.9	6.1	7.5	2.0	0.6	7.2	5.1	5.4	0.0	2.8	6.6	8.2	1.5	2.2	7.9	4.3	2.2	5.3	49.3	4.0	4.1	16.6	8.8	19.7	3.1	5.0	7.4	10.6	6.3	3.0	4.2	4.5	7.6	10.9	7.0
CSN3	CSN10	ENSG00000171209	"Casein kappa"	P07498	4	70242588-70251428	"Predicted secreted proteins"		"Milk protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"breast: 382.2"	"Cell type enriched"	"Detected in some"	48	"Breast glandular cells: 2554.0"	"Cancer enriched"	"Detected in some"	5	"breast cancer: 35.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035953, HPA035954"	Enhanced				"Secreted in female reproductive system"	NA	NA					"HPA035953: AB_10673226, HPA035954: AB_2674884"																		0.0	0.0	0.0	0.0	0.0	0.0	382.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	10.3	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	2554.0	52.2	0.1	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.1	3.7	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0
CST5		ENSG00000170367	"Cystatin D"	P28325	20	23875934-23879748	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	960	"salivary gland: 2175.7"	"Group enriched"	"Detected in some"	8	"Alveolar cells type 1: 9.6;Langerhans cells: 3.4"	"Cancer enriched"	"Detected in many"	5	"breast cancer: 17.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB024944, HPA061449"	Enhanced				"Secreted to digestive system"	NA	NA					"CAB024944: , HPA061449: AB_2684523"	"unprognostic (2.43e-1)"		"unprognostic (8.83e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.19e-1)"			"unprognostic (1.51e-2)"	"unprognostic (4.73e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.83e-3)"		"unprognostic (5.14e-2)"	"unprognostic (2.31e-1)"	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.1	0.3	0.4	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	2175.7	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
EFHD1	FLJ13612	ENSG00000115468	"EF-hand domain family member D1"	Q9BUP0	2	232606057-232682780	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 427.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 241.8;Breast myoepithelial cells: 129.0;Distal tubular cells: 393.2;Oligodendrocytes: 173.4;Sertoli cells: 197.2;Smooth muscle cells: 130.9;Syncytiotrophoblasts: 263.9"	"Cancer enriched"	"Detected in all"	5	"breast cancer: 100.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 125.8;RPTEC TERT1: 68.6;SK-BR-3: 301.8;T-47d: 236.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049331, HPA056959"	Enhanced		Supported	"Nucleoli fibrillar center,Golgi apparatus"		No	NA		14000	"Golgi apparatus"	"Nucleoli fibrillar center"	"HPA049331: AB_2680716, HPA056959: AB_2683288"	"unprognostic (9.51e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.78e-3)"	"unprognostic (3.25e-1)"	"unprognostic (3.40e-1)"	"unprognostic (9.70e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.57e-2)"	"unprognostic (9.99e-2)"	"prognostic favorable (2.93e-7)"	"unprognostic (2.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.29e-3)"	77.1	7.1	206.3	3.7	306.5	0.8	182.6	255.8	248.9	85.2	155.1	16.3	4.5	73.0	34.0	9.6	74.4	12.1	35.4	205.9	235.6	167.4	55.0	15.4	3.9	264.6	271.4	177.3	77.1	87.3	10.6	16.6	78.5	296.9	25.8	5.8	9.6	22.4	28.0	35.8	27.1	16.3	20.8	236.3	52.9	17.7	20.3	256.6	3.1	32.9	43.1	2.5	22.2	44.9	427.5	0.0	3.4	5.7	1.4	2.2	0.1	125.8	26.8	2.1	2.3	1.9	0.9	0.6	0.1	2.0	11.6	2.9	0.2	19.0	0.0	0.3	0.5	9.2	0.0	2.4	1.9	0.0	0.1	0.3	1.0	0.4	0.2	0.0	0.4	0.0	5.5	3.9	0.5	0.5	2.3	0.6	0.2	8.4	0.0	0.2	0.6	7.2	0.4	68.6	0.7	0.3	3.2	9.1	301.8	18.3	42.3	236.9	2.6	0.0	0.0	1.8	0.4	0.8	0.2	0.1	0.1	0.3	0.1	13.4	1.0	0.2	0.1	0.2	0.1	0.4	0.3	0.3	0.4	0.1	0.1	0.6	0.6	2.2	0.1	0.1	0.2	0.1	0.1	206.3	306.5	255.8	248.9	205.9	235.6	264.6	271.4	177.3	296.9	236.3	256.6	427.5	15.6	0.0	0.0	37.5	1.5	3.6	2.8	1.3	1.2	0.5	241.8	129.0	7.4	1.5	4.6	35.0	0.0	112.0	3.0	0.3	393.2	0.0	9.0	1.1	37.8	16.8	0.0	2.7	2.6	0.0	19.7	41.1	0.0	1.7	0.0	3.2	6.4	89.4	8.7	0.0	5.3	0.1	59.0	1.3	3.0	7.0	44.4	2.1	8.8	18.7	0.0	48.0	0.0	1.5	173.4	0.0	0.0	57.2	0.1	4.6	0.0	116.5	1.9	1.4	197.2	8.7	130.9	17.3	13.6	0.4	3.1	263.9	2.5	1.5	0.3	2.0
FOXA1	HNF3A	ENSG00000129514	"Forkhead box A1"	P55317	14	37589552-37596059	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 75.4;stomach 1: 28.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 113.8;Basal squamous epithelial cells: 76.8;Breast glandular cells: 87.9;Enteroendocrine cells: 84.6;Prostatic glandular cells: 89.8;Respiratory ciliated cells: 66.7;Urothelial cells: 154.5"	"Group enriched"	"Detected in many"	5	"breast cancer: 80.0;prostate cancer: 127.0"	"Region enhanced"	"Detected in single"		"midbrain: 3.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 48.9;MCF7: 105.3;PC-3: 69.5;RT4: 96.7;SK-BR-3: 97.0;T-47d: 135.9"	"Region enhanced"	"Detected in some"		"midbrain: 1.1"	"Region enriched"	"Detected in single"	6	"midbrain: 5.4"	"CAB011595, HPA050505"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"CAB011595: AB_2104842, HPA050505: AB_2681148"	"unprognostic (1.61e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.30e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.67e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.69e-2)"	"prognostic favorable (1.00e-4)"	0.2	0.1	0.0	1.6	0.0	0.0	22.6	0.0	0.0	0.8	0.0	12.5	8.4	0.1	0.6	12.0	2.4	2.3	0.0	0.0	0.7	0.1	27.1	7.6	0.0	0.1	3.0	0.0	0.0	0.5	0.0	0.7	0.0	0.1	75.4	10.5	0.0	19.4	0.3	0.0	1.2	4.9	0.2	0.3	0.0	28.3	0.4	0.5	0.0	0.0	0.0	2.3	20.7	4.5	0.0	4.9	4.4	0.0	2.8	0.0	0.0	0.5	0.0	0.4	0.0	0.0	21.3	2.7	0.0	1.4	0.0	0.1	23.4	13.2	3.3	0.1	0.0	23.4	0.0	4.1	48.9	0.0	0.0	0.2	0.0	0.7	0.0	0.4	1.9	0.0	0.4	0.9	0.0	0.0	105.3	0.1	0.3	0.0	32.0	69.5	0.0	1.1	0.4	9.9	96.7	11.8	0.0	4.8	97.0	0.0	0.0	135.9	0.4	0.0	0.9	0.1	0.4	3.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	3.0	0.0	0.1	0.3	0.5	0.0	0.3	28.9	43.5	0.0	0.1	1.0	113.8	47.8	76.8	0.0	87.9	34.8	1.3	30.0	52.3	3.7	0.0	0.0	0.5	27.5	0.0	1.5	0.4	2.7	0.2	1.2	84.6	0.0	0.0	2.4	0.0	1.0	35.7	4.4	2.5	0.0	1.1	31.7	0.0	0.0	0.0	34.9	42.7	0.9	0.3	0.9	0.0	0.7	3.6	0.0	1.0	0.0	0.0	0.0	0.0	4.3	27.2	0.0	1.2	89.8	4.9	0.0	66.7	0.0	0.0	0.0	2.3	0.9	1.2	62.9	0.1	0.0	1.4	0.1	27.9	154.5
GDF9		ENSG00000164404	"Growth differentiation factor 9"	O60383	5	132861181-132866884	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 9.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 19.9;Late spermatids: 5.2;Spermatocytes: 15.2"	"Cancer enriched"	"Detected in some"	5	"breast cancer: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069146	Supported		Approved	"Golgi apparatus,Cytosol"	"Secreted in female reproductive system"	NA	NA			"Golgi apparatus"	Cytosol	"HPA069146: AB_2686094"	"unprognostic (4.64e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.70e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.75e-3)"	"unprognostic (3.10e-2)"	0.3	0.6	1.5	0.2	1.5	0.3	0.8	1.4	2.0	0.4	0.9	0.3	0.4	0.3	4.1	0.3	0.8	0.2	0.3	1.4	1.4	1.0	0.7	0.3	0.5	1.4	1.5	1.3	0.5	1.0	0.7	1.7	0.2	1.4	0.6	0.3	1.3	0.8	0.5	0.7	1.1	0.4	0.2	1.4	0.4	1.0	9.0	1.3	0.7	1.0	0.7	0.4	0.6	0.3	1.5	0.2	0.1	0.5	1.1	0.7	0.3	0.1	0.0	0.1	0.1	0.1	0.3	0.8	0.2	0.6	0.1	0.9	0.2	0.4	0.4	0.1	0.4	0.7	0.5	0.5	0.1	0.1	0.1	0.0	0.3	0.6	0.0	0.3	0.1	0.0	3.9	0.0	1.2	0.2	0.2	0.7	0.8	0.2	0.1	0.0	0.6	0.0	0.2	0.3	0.2	1.0	0.9	0.2	0.1	0.5	0.7	0.5	0.1	0.1	0.9	0.4	0.2	0.1	1.3	1.7	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	1.5	1.4	2.0	1.4	1.4	1.4	1.5	1.3	1.4	1.4	1.3	1.5	0.9	0.0	0.0	1.6	0.1	0.1	0.4	0.1	0.0	0.4	1.9	2.2	0.6	0.0	0.1	0.0	4.2	0.4	0.3	0.7	3.9	0.1	19.9	1.4	0.9	0.5	0.0	0.0	0.5	0.2	0.3	0.4	0.0	1.9	0.0	0.5	0.4	0.2	0.1	0.0	0.8	0.9	0.0	0.3	0.0	5.2	0.6	0.5	0.0	0.0	0.0	1.0	0.0	2.0	0.9	0.1	0.1	0.4	0.1	0.6	0.3	0.4	0.6	1.0	0.0	1.6	0.8	15.2	2.5	1.1	0.1	0.7	0.2	0.2	0.5	0.2
GJC3	"CX30.2, GJE1"	ENSG00000176402	"Gap junction protein gamma 3"	Q8NFK1	7	99923266-99929620	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 8.7;pancreas: 11.1;salivary gland: 11.8"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 36.3;Breast myoepithelial cells: 26.9;Exocrine glandular cells: 24.0;Pancreatic endocrine cells: 12.8;Prostatic glandular cells: 13.0"	"Group enriched"	"Detected in many"	5	"breast cancer: 3.8;melanoma: 3.0;prostate cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 1.3;SK-MEL-30: 2.3;U-2197: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015024	Uncertain					NA	NA					"HPA015024: AB_1847132"	"unprognostic (9.31e-2)"	"unprognostic (6.43e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.68e-2)"	"unprognostic (9.14e-2)"	"unprognostic (6.71e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.81e-3)"	1.3	0.5	0.9	0.1	1.0	0.1	8.7	0.2	1.5	0.3	0.0	0.4	0.4	0.2	0.0	0.2	0.3	0.3	0.4	1.2	0.4	1.0	2.8	0.2	0.2	0.4	0.5	1.0	0.4	11.1	0.0	0.4	1.0	0.6	4.7	0.0	1.0	11.8	0.1	0.2	2.2	0.3	0.2	0.0	0.3	1.4	1.8	0.7	0.1	0.3	0.2	0.0	0.3	0.3	1.5	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.0	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.0	0.1	0.3	0.1	0.9	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.4	0.7	0.5	0.6	0.1	0.5	0.2	0.4	1.1	1.3	0.0	0.0	0.4	0.3	0.0	0.4	0.1	0.2	0.1	0.3	2.3	0.5	0.7	0.0	0.3	0.1	0.4	1.8	0.1	0.1	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.9	1.0	0.2	1.5	1.2	0.4	0.4	0.5	1.0	0.6	0.0	0.7	1.5	1.1	3.2	3.7	0.0	0.4	0.3	4.9	1.4	0.0	0.0	36.3	26.9	0.0	4.3	2.1	1.8	0.0	0.0	0.6	0.0	1.9	0.4	0.4	0.0	0.0	1.5	1.2	0.0	0.7	24.0	0.0	0.2	0.0	0.0	4.5	0.2	1.1	5.0	0.1	0.0	0.4	0.1	8.2	0.0	0.3	1.1	0.3	0.1	0.0	0.0	0.6	4.0	0.0	0.0	0.6	12.8	0.0	0.0	0.0	13.0	0.0	9.7	0.3	0.0	0.0	0.0	0.3	1.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	9.4
IGSF21	"MGC15730, RP11-121A23.1"	ENSG00000117154	"Immunoglobin superfamily member 21"	Q96ID5	1	18107798-18378483	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.1"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 177.8;Excitatory neurons: 82.2;Microglial cells: 74.9;Oligodendrocyte precursor cells: 141.3"	"Group enriched"	"Detected in many"	5	"breast cancer: 4.1;glioma: 8.6;prostate cancer: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		23000				"unprognostic (1.87e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-3)"	"unprognostic (7.06e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.85e-4)"	"unprognostic (3.76e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.63e-2)"	1.8	4.9	23.2	0.4	33.7	0.4	3.1	39.9	52.1	1.4	7.9	0.8	0.0	1.0	0.5	1.0	1.0	0.9	0.8	35.9	16.6	1.1	0.4	1.5	0.2	24.0	22.3	29.1	0.6	1.9	10.5	1.6	1.4	25.4	3.8	0.3	9.5	1.2	1.1	0.3	0.8	0.4	0.3	17.3	13.1	0.6	0.8	22.8	0.8	0.6	0.4	0.7	3.9	1.1	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.2	33.7	39.9	52.1	35.9	16.6	24.0	22.3	29.1	25.4	17.3	22.8	31.4	0.1	0.0	0.0	3.6	0.6	0.3	0.2	0.0	0.0	177.8	9.2	2.7	0.6	1.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	5.9	0.0	0.0	1.8	3.0	0.0	82.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.7	28.9	0.1	0.0	23.6	4.0	12.8	0.6	12.8	0.0	74.9	0.0	6.3	0.0	141.3	2.4	0.1	1.3	0.0	0.0	0.9	0.0	0.0	0.0	13.0	6.6	4.5	0.2	0.4	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.2
KCNJ3	"GIRK1, KGA, Kir3.1"	ENSG00000162989	"Potassium inwardly rectifying channel subfamily J member 3"	P48549	2	154697855-154858354	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.6;heart muscle: 15.2"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 309.6;Horizontal cells: 124.5;Inhibitory neurons: 431.3"	"Group enriched"	"Detected in many"	5	"breast cancer: 12.2;renal cancer: 4.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.5;SH-SY5Y: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024231, HPA064138"	Uncertain		Approved	"Plasma membrane,Mitochondria"		NA	NA			Mitochondria	"Plasma membrane"	"HPA024231: AB_1855558, HPA064138: "	"unprognostic (1.45e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.49e-4)"	"unprognostic (8.89e-2)"		"unprognostic (6.81e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.25e-3)"	"unprognostic (3.72e-3)"	"unprognostic (3.33e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.75e-2)"	"unprognostic (5.59e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.17e-1)"	0.5	1.4	5.2	0.1	9.1	0.1	0.3	33.6	17.7	1.6	3.9	0.8	10.8	0.1	1.1	0.1	0.4	1.3	15.2	15.6	6.4	10.6	3.2	0.2	0.0	2.7	7.2	9.0	0.1	2.1	10.4	6.9	0.0	10.3	6.6	0.8	5.1	0.0	11.4	5.3	0.1	9.6	0.2	0.6	0.4	0.7	0.4	4.6	0.0	0.1	0.2	0.0	0.4	0.6	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.4	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.3	0.2	0.1	0.1	0.1	5.2	9.1	33.6	17.7	15.6	6.4	2.7	7.2	9.0	10.3	0.6	4.6	8.6	0.3	0.0	0.0	38.8	0.0	0.8	5.3	0.0	0.0	10.9	3.7	1.7	49.0	5.7	0.0	20.2	14.6	0.0	0.0	0.1	5.9	0.1	0.3	0.0	0.0	1.3	31.1	0.0	309.6	3.2	0.0	5.4	0.0	0.0	0.0	0.0	0.0	1.3	0.1	124.5	431.3	7.0	0.0	0.0	2.1	0.0	6.2	0.6	1.8	5.6	0.0	0.7	0.0	32.6	6.8	0.0	1.2	4.1	0.0	6.1	16.2	8.7	0.0	3.9	0.0	8.0	1.6	0.4	0.3	0.0	1.8	0.0	0.8	1.9	8.4	4.7
KLHL38	C8ORFK36	ENSG00000175946	"Kelch like family member 38"	Q2WGJ6	8	123645527-123652950	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 57.2;skeletal muscle: 270.9;tongue: 77.6"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.3;melanoma: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.7;SK-BR-3: 2.8;U-2197: 4.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA024770, HPA027115"	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	NA			Nucleoplasm	Cytosol	"HPA024770: AB_10599286, HPA027115: AB_10599950"	"unprognostic (8.62e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.02e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.09e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-2)"	"unprognostic (5.73e-6)"	"unprognostic (8.46e-3)"	"unprognostic (3.82e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.84e-2)"	0.1	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.5	0.2	0.1	0.7	0.1	1.3	0.0	2.5	0.7	0.7	57.2	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.5	0.1	1.3	0.0	1.5	0.2	0.8	0.1	0.0	0.7	0.1	270.9	0.2	0.2	2.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	77.6	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.9	0.0	0.5	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT79	"K6L, KRT6L"	ENSG00000185640	"Keratin 79"	Q5XKE5	12	52821408-52834311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"skin 1: 43.8"	"Cell type enhanced"	"Detected in some"		"granulocytes: 4.5;Late spermatids: 1.1;Melanocytes: 3.6"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.4;cervical cancer: 2.6;head and neck cancer: 2.7;melanoma: 1.6;urothelial cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"HMC-1: 425.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059347	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA		1900000000	"Nucleoplasm, Nuclear membrane, Cytosol"		"HPA059347: AB_2683986"	"unprognostic (5.19e-3)"	"unprognostic (1.56e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-2)"		"unprognostic (6.85e-2)"		"unprognostic (6.36e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.88e-2)"			"unprognostic (1.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.99e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	43.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	425.5	0.0	0.0	5.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	21.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0
LTF	HLF2	ENSG00000012223	Lactotransferrin	P02788	3	46435645-46485234	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Ion transport, Iron transport, Osteogenesis, Transcription, Transcription regulation, Transport"	"Antibiotic, Antimicrobial, DNA-binding, Heparin-binding, Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 4295.9;salivary gland: 1172.0"	"Cell type enriched"	"Detected in many"	5	"Breast glandular cells: 1519.6"	"Group enriched"	"Detected in all"	5	"breast cancer: 239.0;endometrial cancer: 170.3;glioma: 152.6;prostate cancer: 195.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	23	"neutrophil: 5.4;non-classical monocyte: 17.0"	"Group enriched"	"Detected in many"	23	"granulocytes: 5.4;monocytes: 17.0"	"Group enriched"	"Detected in some"	11	"RPMI-8226: 43.2;TIME: 14.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB008646, CAB016201, HPA057177, HPA059976"	Enhanced				"Secreted to blood"	NA	NA		350000000			"CAB008646: AB_1618695, CAB016201: AB_629860, HPA057177: AB_2683361, HPA059976: AB_2684185"	"unprognostic (7.24e-3)"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.45e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (6.30e-5)"	"unprognostic (1.66e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.09e-3)"	4.9	1.2	2.3	36.4	3.2	4295.9	336.8	6.5	4.2	663.9	2.5	2.8	1.2	4.2	158.8	23.2	4.4	7.6	4.2	3.0	6.8	102.3	3.3	29.7	8.7	4.6	20.2	0.7	0.5	18.8	6.2	7.0	3.1	10.5	155.5	2.2	0.9	1172.0	382.4	1.7	11.9	5.2	1.9	7.2	71.0	334.6	0.4	16.1	30.0	10.2	1.7	348.4	2.4	1.2	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	1.9	0.5	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.7	0.1	0.1	0.0	0.1	0.6	43.2	0.2	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	14.3	0.0	0.3	1.2	0.1	0.6	0.0	0.1	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	17.0	0.4	0.0	29.5	2.3	3.2	6.5	4.2	3.0	6.8	4.6	20.2	0.7	10.5	7.2	16.1	9.6	15.5	0.0	2.8	0.7	4.3	1.1	8.6	82.8	0.0	0.0	1519.6	198.4	1.0	2.8	298.0	71.7	0.0	0.0	6.2	0.1	0.0	1.4	1.2	0.3	0.2	8.8	0.0	3.0	0.1	0.9	0.2	2.5	56.1	2.3	1.3	0.1	5.0	0.0	0.0	0.0	0.0	0.2	14.2	0.0	0.7	1.5	5.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.1	78.6	0.0	18.6	14.9	0.0	0.0	0.3	9.9	0.2	0.1	15.4	0.1	0.1	4.0	0.1	0.1	101.7
MCCD1		ENSG00000204511	"Mitochondrial coiled-coil domain 1"	P59942	6	31528962-31530232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	71	"kidney: 80.3"	"Group enriched"	"Detected in some"	44	"Distal tubular cells: 401.1;Proximal tubular cells: 414.8"	"Group enriched"	"Detected in some"	5	"breast cancer: 0.7;endometrial cancer: 0.8;liver cancer: 2.4;renal cancer: 2.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (1.34e-1)"			"unprognostic (2.39e-2)"			"unprognostic (2.71e-1)"			"unprognostic (3.22e-2)"			"prognostic favorable (1.73e-4)"					0.0	0.0	0.1	0.0	0.2	0.1	1.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	80.3	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.5	0.1	0.2	0.4	0.2	0.1	0.4	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	401.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	414.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1
MGP		ENSG00000111341	"Matrix Gla protein"	P08493	12	14880864-14885857	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Developmental protein"	Deafness	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 9375.3;Breast myoepithelial cells: 4639.0;Fibroblasts: 4233.6;Hepatic stellate cells: 1826.5;Leydig cells: 2016.2"	"Cancer enriched"	"Detected in all"	5	"breast cancer: 845.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 1.6"	"Cell line enriched"	"Detected in many"	5	"AN3-CA: 9874.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013949	Approved				"Secreted to blood"	NA	NA		29000000			"HPA013949: AB_1853599"	"unprognostic (5.71e-3)"	"unprognostic (5.85e-3)"	"unprognostic (1.20e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.01e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (4.15e-6)"	"unprognostic (1.55e-2)"	"unprognostic (4.69e-2)"	"unprognostic (7.50e-2)"	"unprognostic (8.97e-3)"	1242.2	1522.6	48.2	189.2	48.9	1.6	3774.0	42.0	213.4	1468.1	350.3	1412.1	70.4	2060.9	759.5	220.3	2300.1	1093.0	1944.9	41.1	76.4	1325.6	58.6	1280.7	107.9	59.4	44.2	41.9	845.7	220.7	110.7	930.2	205.9	49.1	1972.2	280.0	7.6	2131.3	1151.6	178.5	340.4	826.0	1321.5	46.9	143.3	913.6	143.4	47.5	100.4	1513.2	277.5	66.4	996.2	1277.1	43.3	0.9	0.0	0.1	9874.6	1624.2	2.4	3.7	31.8	1.0	0.0	0.0	0.0	12.7	0.2	0.5	3.1	0.4	0.1	0.2	0.2	0.0	0.3	0.3	0.0	1.3	0.0	55.0	0.2	0.2	33.6	0.0	0.0	1.5	3.2	105.4	0.0	0.0	0.3	0.0	0.9	1.2	4.8	7.0	2.2	0.0	0.4	0.2	2.6	0.0	10.5	4.8	31.1	2.0	8.9	0.6	2.8	1810.9	0.1	21.7	11.1	1.2	3.6	28.7	0.5	0.1	1.1	9.0	0.6	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	48.2	48.9	42.0	213.4	41.1	76.4	59.4	44.2	41.9	49.1	46.9	47.5	43.3	451.0	19.2	72.8	1.3	29.9	149.3	220.4	0.3	19.9	0.5	9375.3	4639.0	70.2	8.6	187.5	115.8	4.2	19.0	85.7	0.1	1.9	2.3	16.9	14.7	355.8	856.1	0.0	18.7	0.2	83.4	13.5	4233.6	86.2	10.9	13.9	0.3	1826.5	6.0	30.8	0.0	0.1	0.0	0.0	9.4	219.9	67.9	2016.2	36.1	225.9	23.4	2.6	28.8	0.0	0.0	0.2	1.8	1.1	1301.8	17.0	164.3	0.0	0.7	25.8	6.8	841.5	558.8	847.0	8.2	6.1	25.8	118.5	39.5	54.5	140.6	0.0	74.6
MYB	c-myb	ENSG00000118513	"MYB proto-oncogene, transcription factor"	P10242	6	135181308-135219173	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 35.5;breast: 20.3;intestine: 26.8;lymphoid tissue: 66.7"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 47.8;Erythroid cells: 83.2;granulocytes: 26.0;Intestinal goblet cells: 32.7;Ionocytes: 26.4;Respiratory ciliated cells: 37.2;Undifferentiated cells: 52.0"	"Group enriched"	"Detected in many"	5	"breast cancer: 17.7;colorectal cancer: 16.4;stomach cancer: 5.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basophil: 4.6;eosinophil: 5.4;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 219.8;MOLT-4: 403.1;NB-4: 208.5;REH: 244.9;THP-1: 343.8;U-937: 186.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB017704, HPA071605"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB017704: , HPA071605: "	"unprognostic (1.69e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (2.41e-11)"	"prognostic favorable (9.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.40e-2)"	0.2	0.5	1.7	5.3	1.6	35.5	20.3	0.1	0.6	1.6	0.4	25.5	11.0	1.0	0.1	3.1	8.5	1.0	0.1	0.3	0.4	0.1	0.4	2.0	6.3	0.8	0.8	0.3	0.0	0.3	3.7	0.0	0.4	0.7	1.5	26.8	0.3	0.6	0.9	0.1	3.0	9.5	1.4	0.3	1.2	2.1	0.7	0.4	66.7	0.1	0.0	7.1	1.2	1.3	0.2	1.8	0.3	1.9	3.0	0.0	0.1	0.3	1.0	0.6	1.1	1.1	0.3	1.4	10.9	0.4	0.3	0.4	0.9	5.6	0.0	0.7	18.0	2.5	138.8	1.0	0.5	0.1	219.8	105.1	0.0	0.1	0.6	0.0	0.5	0.3	133.4	114.6	20.1	1.1	11.6	403.1	208.5	1.5	19.2	1.7	244.9	5.9	33.2	0.3	1.5	10.5	6.9	0.5	10.4	0.6	0.5	7.9	343.8	0.4	0.3	1.6	7.9	2.4	27.7	7.7	66.0	0.1	186.1	2.3	4.6	0.7	5.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.5	0.4	0.2	1.7	1.6	0.1	0.6	0.3	0.4	0.8	0.8	0.3	0.7	0.3	0.4	0.2	0.2	0.0	1.3	0.0	2.3	2.7	1.3	1.3	0.6	0.9	47.8	12.6	0.4	2.8	7.1	0.0	0.0	1.4	9.1	18.1	0.0	0.0	0.1	24.3	0.3	0.3	17.6	83.2	0.6	0.8	0.4	0.5	4.6	2.2	26.0	0.4	0.0	0.0	1.1	0.0	2.7	32.7	26.4	1.2	1.7	0.2	0.0	2.1	8.8	0.0	2.8	0.9	0.0	0.0	0.2	0.1	10.2	0.0	4.6	2.1	2.3	0.0	37.2	0.0	0.0	0.6	0.9	0.0	1.8	10.2	7.0	0.3	3.6	0.1	52.0	2.2
NEK10	FLJ32685	ENSG00000163491	"NIMA related kinase 10"	Q6ZWH5	3	27110085-27369460	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 36.9;tongue: 20.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 87.6;Early spermatids: 123.5;Endometrial ciliated cells: 59.3;Excitatory neurons: 131.4;Inhibitory neurons: 130.2;Late spermatids: 61.7;Respiratory ciliated cells: 104.2"	"Cancer enriched"	"Detected in single"	5	"breast cancer: 1.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 6.0;LHCN-M2: 8.2;U-2 OS: 6.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038941	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA038941: AB_10673600"	"prognostic favorable (4.20e-4)"	"unprognostic (2.17e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.14e-1)"	0.2	0.3	7.0	0.3	6.1	0.3	14.2	1.2	10.4	1.4	3.3	1.4	2.5	0.8	8.4	1.9	11.1	1.4	3.3	10.6	4.4	1.1	2.6	2.4	0.5	3.6	4.4	3.8	0.7	0.7	0.4	3.4	0.1	2.4	1.7	0.5	6.2	0.3	1.2	12.5	0.3	0.8	0.3	3.1	0.4	1.0	36.9	4.0	0.5	0.7	20.2	0.6	1.2	0.2	1.3	0.8	1.6	0.8	0.9	0.6	1.5	0.3	6.0	0.9	1.6	1.4	0.0	0.4	0.5	1.4	2.5	1.1	0.1	0.4	0.4	1.7	1.1	0.6	0.1	3.4	2.9	0.1	0.3	0.8	1.8	0.4	2.5	0.1	2.0	1.1	3.4	0.1	0.6	8.2	0.1	0.6	0.4	0.5	0.2	0.2	0.8	0.3	0.2	3.0	0.5	0.1	0.2	0.9	0.3	0.4	0.5	4.8	0.3	0.7	4.3	6.8	0.2	0.6	0.2	0.2	0.4	3.6	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.0	6.1	1.2	10.4	10.6	4.4	3.6	4.4	3.8	2.4	3.1	4.0	1.3	1.5	6.4	0.0	11.4	0.3	0.3	0.3	3.2	0.0	14.5	25.8	7.4	12.9	4.3	9.3	1.8	87.6	0.0	0.8	0.2	0.0	0.4	123.5	59.3	1.3	2.4	0.0	0.0	131.4	0.0	0.3	3.1	0.0	7.7	0.0	1.1	0.7	1.3	0.2	0.0	130.2	0.4	12.2	1.0	0.8	61.7	1.8	1.1	0.0	32.8	0.1	1.0	1.0	20.6	12.9	0.2	2.7	1.2	0.1	1.9	2.1	0.3	104.2	19.1	0.0	14.9	2.4	32.2	2.2	0.1	0.4	0.0	1.1	3.7	0.6	0.4
NKAIN1	"FAM77C, FLJ12650"	ENSG00000084628	"Sodium/potassium transporting ATPase interacting 1"	Q4KMZ8	1	31179745-31239887	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 24.4;brain: 18.6;skeletal muscle: 19.6;tongue: 12.0"	"Cell type enriched"	"Detected in some"	12	"Oligodendrocytes: 43.9"	"Group enriched"	"Detected in many"	5	"breast cancer: 17.2;glioma: 4.6;prostate cancer: 10.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 21.2;AN3-CA: 35.8;NTERA-2: 92.7;SCLC-21H: 27.3;SH-SY5Y: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006873	Uncertain					NA	NA					"HPA006873: AB_1848410"	"unprognostic (1.58e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.54e-2)"	"unprognostic (6.11e-5)"	"unprognostic (6.59e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.30e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.07e-2)"	"unprognostic (6.31e-9)"	"unprognostic (1.00e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.62e-4)"	"unprognostic (5.50e-2)"	0.1	24.4	8.6	0.2	14.2	0.0	0.4	16.5	10.8	0.2	3.2	0.2	0.1	0.6	3.5	0.6	0.1	0.0	0.0	11.7	11.5	0.2	0.0	0.0	0.0	17.7	16.4	7.4	0.1	0.2	0.6	2.2	0.3	18.6	1.0	0.1	1.5	0.4	0.3	19.6	1.7	0.1	0.2	5.8	0.0	0.1	0.3	12.1	0.2	0.0	12.0	0.0	0.0	0.5	13.7	0.0	0.4	21.2	35.8	0.2	0.0	0.3	0.1	0.0	0.4	0.1	0.4	0.2	0.0	0.7	0.4	0.4	0.0	5.3	0.0	0.1	0.0	1.5	0.0	0.3	0.3	0.2	0.4	0.1	0.1	0.1	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.3	0.8	92.7	0.0	0.9	0.0	0.3	0.1	0.1	3.6	27.3	43.9	1.0	0.3	2.5	2.4	9.6	0.4	0.0	0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	14.2	16.5	10.8	11.7	11.5	17.7	16.4	7.4	18.6	5.8	12.1	13.7	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.2	0.0	0.5	0.5	0.1	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	1.9	0.2	0.0	0.1	1.1	0.0	0.0	0.0	3.6	0.0	0.3	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	3.3	0.0	2.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.5	43.9	0.1	0.0	0.0	0.0	0.3	0.0	0.8	0.1	0.5	0.0	0.3	0.3	0.8	1.2	0.3	1.4	0.4	0.0	0.1	0.0	0.2
OPRPN	"BPLP, PRL1, PROL1"	ENSG00000171199	"Opiorphin prepropeptide"	Q99935	4	70397931-70410195	"Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"salivary gland: 147.7"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 12.5;Breast myoepithelial cells: 3.3;Glandular and luminal cells: 2.1"	"Group enriched"	"Detected in some"	5	"breast cancer: 7.4;liver cancer: 4.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA065711	Approved				"Secreted in other tissues"	NA	NA		63000			"HPA065711: AB_2685541"	"unprognostic (3.11e-3)"						"unprognostic (2.22e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	147.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
PLIN1	PLIN	ENSG00000166819	"Perilipin 1"	O60240	15	89664367-89679427	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	17	"adipose tissue: 964.8;breast: 466.9"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 59.0"	"Group enriched"	"Detected in many"	5	"breast cancer: 8.4;liver cancer: 2.3;pancreatic cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	171	"ASC diff: 208.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024299, CAB033821, CAB037333"	Enhanced		Uncertain	Peroxisomes		NA	NA		22000	Peroxisomes		"CAB033821: AB_2252681, CAB037333: , HPA024299: AB_1855467"	"unprognostic (4.62e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.51e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.54e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.28e-3)"	"unprognostic (2.62e-6)"	"unprognostic (5.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.85e-2)"	964.8	11.4	12.4	3.5	12.2	0.3	466.9	7.7	10.7	1.3	5.2	9.3	0.5	0.7	0.4	1.3	1.4	6.6	8.3	10.3	10.1	2.7	41.2	0.7	1.7	9.4	10.5	7.3	2.1	6.2	0.2	1.3	0.2	11.8	2.6	3.8	0.6	21.0	0.6	9.6	13.7	14.0	1.5	6.3	1.1	5.5	13.3	9.3	2.3	5.3	17.5	0.1	8.0	3.1	8.4	0.0	0.2	0.2	0.0	208.2	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.7	0.5	0.1	0.7	0.2	0.0	0.2	0.6	0.7	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.1	0.3	0.2	0.1	0.3	1.2	0.1	0.5	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.4	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	12.2	7.7	10.7	10.3	10.1	9.4	10.5	7.3	11.8	6.3	9.3	8.4	2.6	0.0	0.0	4.2	0.2	0.1	0.3	0.1	0.0	0.3	0.7	3.0	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	7.5	0.1	0.2	0.2	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.2	0.0	0.1	1.1	59.0	0.0	0.0	0.3	0.3	0.0	1.0	0.3	7.5	0.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.2	1.3	0.0	0.0	0.6	0.3	0.1	0.1	0.1	0.0	1.3	1.3	4.8	0.2	0.0	0.4	0.0	0.1	0.1	0.5	0.9
PNMT	PENT	ENSG00000141744	"Phenylethanolamine N-methyltransferase"	P11086	17	39667981-39670475	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"adrenal gland: 159.8"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 20.1;Breast myoepithelial cells: 15.1;Cardiomyocytes: 13.4;Endometrial ciliated cells: 24.0;Erythroid cells: 16.6;Hepatic stellate cells: 27.5;Skeletal myocytes: 48.0"	"Group enriched"	"Detected in many"	5	"breast cancer: 7.7;cervical cancer: 27.0;urothelial cancer: 9.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 5.3;K-562: 12.8;NB-4: 24.1;NTERA-2: 4.5;SCLC-21H: 6.4;SH-SY5Y: 5.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.4"	"Not detected"	"Not detected"			"CAB017029, HPA043412, HPA051005"	Enhanced					NA	NA					"CAB017029: , HPA043412: AB_2630373, HPA051005: AB_2681306"	"unprognostic (1.50e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (3.95e-5)"	"unprognostic (4.27e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.75e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.52e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.87e-2)"	4.5	159.8	15.1	0.2	23.1	2.1	8.5	17.5	13.8	5.9	6.1	4.0	0.5	4.4	1.4	3.0	9.1	0.3	18.3	8.7	14.9	2.4	0.5	9.0	0.3	25.7	20.2	9.6	3.0	1.8	7.5	30.9	3.3	20.0	8.6	0.0	0.1	3.2	21.5	21.3	3.0	7.3	0.2	9.2	2.2	7.0	4.5	19.8	0.1	1.8	17.7	0.0	6.6	5.9	10.6	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.9	5.3	0.2	0.4	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	24.1	4.5	0.5	0.1	0.1	0.0	0.3	0.0	0.0	6.4	5.8	0.1	2.3	0.2	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.1	23.1	17.5	13.8	8.7	14.9	25.7	20.2	9.6	20.0	9.2	19.8	10.6	3.1	0.0	0.0	1.0	0.5	0.5	0.7	0.0	0.0	0.3	20.1	15.1	13.4	1.5	0.0	5.5	0.0	0.1	1.1	0.1	1.9	0.0	0.7	24.0	2.6	5.0	3.0	16.6	0.5	0.0	0.9	1.1	0.0	9.0	0.0	0.7	27.5	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	1.5	2.1	0.2	0.0	1.0	0.0	3.5	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.2	0.1	0.1	0.0	0.5	0.0	48.0	0.8	1.0	2.3	0.0	0.4	0.0	11.0	0.0	0.3	1.8
PTPRT	"KIAA0283, RPTPrho"	ENSG00000196090	"Protein tyrosine phosphatase receptor type T"	O14522	20	42072752-43189970	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 22.9;fallopian tube: 10.9"	"Group enriched"	"Detected in some"	14	"Excitatory neurons: 500.7;Inhibitory neurons: 700.2;Oligodendrocyte precursor cells: 418.7"	"Group enriched"	"Detected in many"	5	"breast cancer: 5.1;prostate cancer: 1.9"	"Region enhanced"	"Detected in many"		"cerebral cortex: 22.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017336, CAB069423"	Approved					NA	NA					"CAB069423: AB_1622602, HPA017336: AB_1855943"	"unprognostic (7.17e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.37e-6)"	"unprognostic (3.16e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-1)"	0.1	0.2	5.1	0.1	9.4	0.0	2.7	0.0	22.9	0.7	0.0	0.1	0.5	0.0	0.2	0.0	10.9	0.1	0.2	5.7	4.8	0.1	0.2	1.1	0.4	0.3	0.5	7.3	0.0	0.4	0.0	3.0	2.8	3.2	0.2	0.0	3.7	1.0	2.6	0.0	0.3	0.3	0.0	0.0	0.1	0.8	1.6	0.5	6.4	0.0	0.1	0.4	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	9.4	0.0	22.9	5.7	4.8	0.3	0.5	7.3	3.2	0.0	0.5	4.9	0.4	0.0	1.1	13.1	0.0	0.9	0.0	0.0	0.0	36.2	2.6	6.9	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	3.2	0.1	0.2	0.0	0.0	500.7	0.0	0.0	1.2	0.0	0.2	0.0	3.3	6.4	0.2	0.2	5.0	700.2	0.0	0.0	0.3	0.3	12.6	0.0	0.1	0.0	8.4	0.0	10.3	0.0	418.7	8.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	18.5	2.1	0.0	0.5	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1
RAB6C	WTH3	ENSG00000222014	"RAB6C, member RAS oncogene family"	Q9H0N0	2	129979666-129982738	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.8;breast: 2.5;parathyroid gland: 3.6"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 10.3;Oligodendrocytes: 3.3"	"Group enriched"	"Detected in some"	5	"breast cancer: 0.7;prostate cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 2.5;HMC-1: 2.2;REH: 5.4;T-47d: 3.2;U-266/70: 2.1"									HPA059131	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA059131: AB_2683916"	"unprognostic (3.84e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.48e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.78e-1)"	0.1	0.6	1.1	0.1	1.9	0.0	2.5	0.6	2.2	1.9	0.6	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.1	1.5	1.5	0.1	0.0	0.0	0.0	1.3	1.8	1.0	0.1	0.0	3.6	0.2	0.3	1.8	1.7	0.0	0.3	0.0	0.4	0.1	0.0	0.1	0.0	0.5	0.5	0.0	0.9	1.3	0.0	0.1	0.0	0.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.4	0.1	0.5	3.2	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	0.6	2.2	1.5	1.5	1.3	1.8	1.0	1.8	0.5	1.3	3.8	0.1	0.0	0.0	0.3	0.1	0.8	0.3	0.3	0.0	0.0	0.9	0.1	10.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.1	1.7	1.0	0.0	0.0	0.7	0.0	1.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.4	0.0	0.3	0.4	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.7	0.0	0.6	0.7	0.0	0.1	0.0	0.0	0.6	1.4	1.4	1.3	0.0	1.1	0.5	0.1	0.1	0.1	0.3
RANBP3L	FLJ25422	ENSG00000164188	"RAN binding protein 3 like"	Q86VV4	5	36246913-36302114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.3;kidney: 24.8"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 355.9"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.4;glioma: 3.7;prostate cancer: 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"ASC diff: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA037471, HPA037472, HPA061526"	Approved		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037471: AB_10671756, HPA037472: AB_2675489, HPA061526: AB_2684552"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-3)"	"unprognostic (5.52e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.08e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.76e-4)"	"unprognostic (1.68e-2)"	"unprognostic (9.13e-2)"	"unprognostic (8.87e-3)"	"unprognostic (5.71e-2)"	3.8	1.7	26.6	0.3	25.6	0.0	7.6	6.3	32.3	1.2	7.8	0.6	0.2	0.7	1.8	0.5	1.2	1.9	1.5	26.8	13.2	24.8	9.9	2.0	0.2	13.5	15.7	17.4	2.1	0.4	0.2	2.9	5.1	15.1	13.6	0.4	5.3	0.6	3.0	0.4	0.3	0.4	0.6	12.0	0.2	1.8	4.8	18.5	0.1	2.2	3.0	0.6	6.9	0.8	16.8	0.0	0.0	0.1	0.2	12.1	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	25.6	6.3	32.3	26.8	13.2	13.5	15.7	17.4	15.1	12.0	18.5	16.8	0.3	0.0	0.0	355.9	0.0	0.0	0.1	0.0	0.6	0.4	4.1	2.3	0.3	0.0	0.0	9.2	0.0	0.0	1.3	0.0	46.9	0.0	0.1	0.1	0.7	0.4	0.0	0.0	5.1	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.4	1.3	1.9	0.0	4.5	0.0	0.0	0.0	0.3	0.8	2.1	0.2	1.8	23.4	0.0	16.1	0.0	5.5	2.8	0.0	0.0	2.2	0.0	1.3	0.0	0.2	0.0	0.6	13.1	0.6	8.3	0.0	0.1	0.0	0.0	0.1	0.0	3.0	0.0	0.1
RLN2	"bA12D24.1.1, bA12D24.1.2, H2, RLXH2"	ENSG00000107014	"Relaxin 2"	P04090	9	5299864-5304716	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 5.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 13.0;Muller glia cells: 9.6;Spermatocytes: 17.3;Syncytiotrophoblasts: 13.5"	"Group enriched"	"Detected in some"	5	"breast cancer: 2.0;prostate cancer: 6.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	26	"gdT-cell: 1.4;MAIT T-cell: 4.2;memory B-cell: 1.9;memory CD4 T-cell: 2.8;memory CD8 T-cell: 2.3;naive B-cell: 1.4;naive CD4 T-cell: 4.0;naive CD8 T-cell: 3.0;NK-cell: 3.5;T-reg: 1.3"	"Group enriched"	"Detected in many"	33	"B-cells: 1.9;NK-cells: 3.5;T-cells: 4.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.6;HEL: 21.9;T-47d: 6.1;U-266/84: 10.2"														"Secreted to blood"	NA	NA	24400	10000				"unprognostic (1.63e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.03e-2)"	"unprognostic (9.99e-2)"		"unprognostic (1.48e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.50e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.74e-6)"	"unprognostic (2.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.88e-2)"	"unprognostic (8.41e-4)"	0.4	0.0	0.4	1.4	0.4	0.3	2.3	0.5	0.7	0.4	0.4	0.5	0.0	0.5	0.3	0.3	5.2	0.2	0.5	0.4	0.5	1.5	0.0	0.7	2.8	0.5	0.4	0.3	0.1	0.5	4.2	3.0	0.6	0.6	4.0	0.4	3.0	0.3	0.6	0.0	0.4	0.5	0.2	0.4	0.9	0.5	2.8	0.5	2.8	0.8	0.2	2.3	0.2	0.1	0.4	3.0	0.4	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.5	1.0	0.3	1.6	5.6	0.4	0.0	0.0	0.9	0.0	2.8	0.7	4.4	2.0	21.9	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.5	0.0	0.0	0.2	0.1	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.0	0.6	2.7	3.0	0.0	0.6	0.1	0.2	6.1	0.1	0.2	0.0	0.5	0.0	0.1	1.3	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.2	1.9	2.8	2.3	0.0	1.4	4.0	3.0	0.0	3.5	0.0	0.0	1.3	0.8	0.4	0.4	0.5	0.7	0.4	0.5	0.5	0.4	0.3	0.6	0.4	0.5	0.4	0.8	3.2	0.6	0.3	2.6	0.5	2.3	1.5	1.2	1.5	3.8	3.0	1.9	1.5	1.2	1.8	0.0	6.3	1.3	0.1	7.9	2.8	13.0	3.3	0.3	0.8	3.6	1.7	0.4	1.5	2.3	0.4	0.5	0.3	0.0	0.6	0.0	0.0	0.6	3.3	0.9	1.7	2.0	0.0	0.0	5.3	0.6	0.1	0.0	1.0	0.8	9.6	4.1	0.0	0.9	0.8	0.2	0.4	0.5	1.0	0.1	1.4	5.0	1.7	0.0	0.6	0.4	17.3	5.1	1.4	1.3	13.5	3.4	0.0	1.5	0.5
ROPN1B		ENSG00000114547	"Rhophilin associated tail protein 1B"	Q9BZX4	3	125969160-125983454	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 215.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 2012.7;Late spermatids: 1967.9"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.3;melanoma: 4.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SK-MEL-30: 54.6;WM-115: 18.5"									HPA052530	Supported					NA	NA					"HPA052530: AB_2681861"	"unprognostic (7.73e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.22e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.19e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.91e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.89e-3)"	"unprognostic (3.78e-2)"	0.2	0.5	1.2	0.2	1.5	0.1	38.5	1.9	1.8	0.2	0.0	0.1	0.1	0.3	22.3	0.1	0.5	0.0	2.7	1.2	1.0	0.1	1.2	0.3	0.6	0.9	1.1	0.9	0.3	0.3	0.0	3.0	0.2	1.0	0.7	0.0	1.8	14.7	0.2	0.5	6.7	0.1	0.0	0.3	0.1	0.1	215.9	0.6	0.0	0.7	0.8	0.3	0.4	0.1	1.9	0.0	0.0	0.3	0.2	0.0	0.0	2.9	0.0	0.3	0.2	0.2	0.2	2.4	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	1.4	0.0	0.1	1.1	0.2	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.3	0.9	0.3	0.1	0.0	54.6	0.1	0.7	0.7	0.0	0.0	0.5	0.2	0.2	5.4	1.1	0.3	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	1.5	1.9	1.8	1.2	1.0	0.9	1.1	0.9	1.0	0.3	0.6	1.9	0.6	0.0	0.0	1.3	0.3	3.7	0.1	1.4	0.0	0.2	60.1	86.2	18.8	0.0	3.9	0.0	0.0	0.3	2.0	0.0	0.0	0.2	2012.7	3.1	0.1	1.6	0.0	0.0	0.5	0.2	2.5	1.3	0.0	0.1	0.0	0.2	0.0	0.5	0.1	3.3	0.4	0.0	2.0	0.0	2.0	1967.9	19.0	1.5	149.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	9.8	0.0	0.6	0.0	0.1	17.8	0.2	19.7	0.0	1.0	493.4	11.8	0.0	0.6	0.1	0.5	0.0	0.0	1.2
S100G	"CABP1, CABP9K, CALB3"	ENSG00000169906	"S100 calcium binding protein G"	P29377	X	16650158-16654670	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	201	"intestine: 240.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	5	"breast cancer: 4.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPMI-8226: 2.5"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.1"	"Not detected"	"Not detected"			"CAB017688, HPA028920, HPA055873"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"CAB017688: AB_1119899, HPA028920: , HPA055873: AB_2682952"	"unprognostic (2.68e-2)"									"unprognostic (2.78e-1)"				"unprognostic (9.88e-3)"				0.0	0.0	0.1	0.1	0.4	0.1	1.1	0.7	0.3	0.0	0.1	0.2	240.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	2.5	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.7	0.3	0.2	0.6	0.5	0.1	0.1	0.4	0.3	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERHL2		ENSG00000183569	"Serine hydrolase like 2"	Q9H4I8	22	42553617-42574382	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"breast: 424.7"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 18.1;Hepatic stellate cells: 21.8;Sertoli cells: 19.7"	"Group enriched"	"Detected in all"	5	"breast cancer: 8.0;prostate cancer: 5.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"memory B-cell: 3.5;naive B-cell: 8.4;plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	12	"B-cells: 8.4;dendritic cells: 3.9"	"Cell line enriched"	"Detected in many"	10	"SK-BR-3: 276.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.14e-1)"	"unprognostic (1.56e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.27e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.04e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.42e-1)"	1.9	2.6	4.2	1.0	4.9	2.1	424.7	5.2	7.4	3.4	3.0	1.9	0.7	3.1	36.7	2.4	3.4	1.6	3.9	4.4	4.2	2.0	1.7	1.6	4.0	3.8	3.8	4.3	13.8	0.6	5.4	1.1	0.8	4.6	10.3	1.2	1.1	6.4	5.5	1.4	13.5	2.1	2.0	3.5	1.9	3.0	2.9	4.3	0.7	2.9	1.3	1.4	2.6	2.9	4.5	0.7	0.0	1.6	3.0	3.7	8.7	0.5	2.2	2.0	2.0	2.6	0.1	0.5	1.3	1.2	5.4	1.2	1.4	1.5	0.9	1.1	0.5	0.9	1.2	0.1	2.9	1.9	1.8	2.5	8.7	1.5	1.3	0.2	1.7	0.6	0.2	11.7	0.2	2.1	5.8	29.0	1.8	0.3	0.7	0.7	15.6	0.0	0.5	0.9	0.7	0.5	0.8	0.5	276.7	0.3	2.9	1.2	1.9	2.0	1.0	0.3	1.5	0.0	1.2	0.1	13.5	1.8	0.2	1.2	0.0	0.0	0.4	0.1	0.0	0.2	3.5	0.1	0.3	0.1	8.4	0.0	0.1	0.0	0.2	0.1	3.9	0.0	0.3	4.2	4.9	5.2	7.4	4.4	4.2	3.8	3.8	4.3	4.6	3.5	4.3	4.5	2.6	3.2	0.0	3.6	3.2	1.3	6.1	1.5	1.8	1.4	18.1	6.3	0.5	1.5	2.4	12.9	0.0	5.4	3.2	0.5	3.9	1.3	3.5	2.4	2.2	8.5	0.0	2.7	5.0	0.2	3.7	4.0	0.5	5.0	0.0	0.7	21.8	1.2	1.2	1.7	4.4	1.7	0.0	1.6	1.9	3.1	5.3	2.4	5.4	4.7	0.0	4.1	1.0	3.0	9.9	0.5	0.6	6.8	0.1	13.2	0.4	1.0	2.5	1.5	19.7	3.1	3.3	5.3	8.3	2.6	1.6	8.1	1.3	3.3	1.2	4.5
SYT13	KIAA1427	ENSG00000019505	"Synaptotagmin 13"	Q7L8C5	11	45240302-45286341	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.2;gallbladder: 21.0;pituitary gland: 16.9"	"Cell type enriched"	"Detected in many"	7	"Enteroendocrine cells: 336.8"	"Group enriched"	"Detected in many"	5	"breast cancer: 13.5;colorectal cancer: 7.4;pancreatic cancer: 19.9;renal cancer: 16.9;stomach cancer: 11.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 19.1;NTERA-2: 8.8;RPTEC TERT1: 56.8;SCLC-21H: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046224, HPA056602"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA046224: AB_10961288, HPA056602: AB_2683185"	"unprognostic (4.96e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.92e-2)"	"prognostic unfavorable (7.79e-5)"	"unprognostic (1.00e-2)"	"unprognostic (4.17e-2)"	"unprognostic (3.75e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.19e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.70e-2)"	"unprognostic (5.13e-2)"	0.1	4.7	4.9	1.5	12.5	0.0	0.2	1.5	30.7	0.0	0.0	12.4	12.7	0.2	0.0	0.0	0.2	21.0	5.2	15.7	14.0	9.0	0.3	0.5	0.0	6.8	8.3	17.3	0.0	7.1	0.4	16.9	0.0	12.2	1.9	12.7	11.4	1.9	0.0	0.1	0.2	12.9	0.8	0.0	0.1	11.1	1.7	9.0	0.3	1.6	0.1	0.0	0.0	0.0	31.2	0.0	19.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.2	0.0	1.1	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	8.8	0.0	0.2	0.0	0.0	0.0	56.8	0.0	15.0	0.7	0.0	0.0	0.1	0.7	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	12.5	1.5	30.7	15.7	14.0	6.8	8.3	17.3	12.2	0.0	9.0	31.2	0.0	0.0	0.0	4.6	0.1	0.0	0.2	0.0	0.0	3.3	0.1	0.3	15.3	17.2	0.0	3.7	25.0	0.0	0.0	10.2	5.9	1.2	3.1	0.4	0.2	0.1	336.8	0.0	41.6	0.6	0.0	1.7	3.6	2.0	0.0	2.5	0.0	0.0	0.0	1.7	43.8	37.3	4.1	0.0	0.0	9.7	0.3	0.0	0.0	5.6	0.0	0.7	0.0	1.5	3.5	8.2	14.3	0.0	0.0	2.3	13.9	0.5	0.0	2.7	0.0	0.0	0.2	2.0	0.2	0.0	0.0	0.0	0.0	0.0	32.8	0.2
TRH		ENSG00000170893	"Thyrotropin releasing hormone"	P20396	3	129974688-129977935	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 110.9;cervix: 26.2;retina: 35.5"	"Cell type enriched"	"Detected in some"	10	"Muller glia cells: 234.5"	"Group enriched"	"Detected in some"	5	"breast cancer: 13.3;endometrial cancer: 10.2;glioma: 4.3"	"Group enriched"	"Detected in many"	5	"hypothalamus: 28.6;medulla oblongata: 110.9;pons: 41.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.0"	"Group enriched"	"Detected in many"	5	"hypothalamus: 175.6;olfactory bulb: 148.0"	"Low region specificity"	"Detected in many"			HPA035596	Enhanced				"Secreted in other tissues"	NA	NA					"HPA035596: AB_2674695"	"unprognostic (1.22e-1)"	"unprognostic (8.94e-2)"		"unprognostic (5.82e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.82e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.82e-2)"	0.2	0.0	11.2	0.1	3.1	3.8	1.9	1.9	0.9	26.2	0.2	0.0	0.1	18.9	0.0	0.0	2.5	0.0	0.3	2.2	28.6	0.1	0.0	0.6	0.0	110.9	4.5	0.6	3.9	0.0	0.0	0.2	0.2	41.3	0.1	0.0	35.5	0.5	0.1	0.1	0.5	0.0	0.3	1.7	0.1	0.0	1.3	10.1	0.4	0.0	0.0	0.0	0.0	0.4	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.2	3.1	1.9	0.9	2.2	28.6	110.9	4.5	0.6	41.3	1.7	10.1	2.7	0.3	0.0	0.0	0.3	0.2	0.8	0.7	0.0	0.0	10.4	1.6	1.4	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	7.1	9.0	0.8	0.7	0.0	0.0	0.2	0.0	0.1	0.2	0.0	22.5	0.0	0.1	0.0	0.0	0.1	5.0	0.3	0.0	0.0	0.0	11.5	2.7	0.0	2.0	0.0	0.0	0.0	234.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	9.2	0.0	0.0	0.2	0.7	1.6	0.0	0.1	0.1	0.2	0.1	0.0	4.3
ABCC11	MRP8	ENSG00000121270	"ATP binding cassette subfamily C member 11"	Q96J66	16	48165773-48247568	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"breast: 46.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 3.3;Breast glandular cells: 4.4;Early spermatids: 3.3;Hepatocytes: 2.5;Late spermatids: 1.9;Spermatocytes: 4.0"	"Cancer enriched"	"Detected in some"	4	"breast cancer: 8.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"T-47d: 67.1"					"Not detected"	"Not detected"									NA	NA						"unprognostic (1.35e-1)"	"unprognostic (3.47e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.54e-4)"	0.1	0.0	0.2	0.0	0.2	0.1	46.9	0.3	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.5	0.1	0.0	0.2	0.2	0.0	1.6	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	3.6	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.6	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	16.0	0.1	0.0	67.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.3	0.2	0.2	0.2	0.1	0.1	0.2	0.0	0.1	0.3	0.1	0.0	0.5	3.3	0.2	0.0	0.0	0.0	0.0	0.4	4.4	0.9	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	3.3	0.3	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	2.5	0.0	0.0	0.6	0.0	0.0	0.3	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.5	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	4.0	0.4	0.5	0.0	0.3	0.2	0.1	0.0	0.1
CHST8	GALNAC-4-ST1	ENSG00000124302	"Carbohydrate sulfotransferase 8"	Q9H2A9	19	33621953-33773509	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	25	"brain: 29.8;pituitary gland: 64.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 15.4;Excitatory neurons: 11.8;Granulosa cells: 7.9;Late spermatids: 56.5;Oligodendrocyte precursor cells: 12.1"	"Group enriched"	"Detected in many"	4	"breast cancer: 4.1;glioma: 4.9;testis cancer: 3.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"RPMI-8226: 24.7;SCLC-21H: 13.5;SH-SY5Y: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA016004	Enhanced				"Intracellular and membrane"	NA	NA					"HPA016004: AB_1846731"	"unprognostic (1.00e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.98e-8)"	"unprognostic (9.37e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.87e-2)"	0.6	0.7	6.4	0.3	6.4	0.0	1.9	9.3	10.0	0.8	0.0	0.3	0.0	0.6	0.0	0.3	1.2	0.9	0.4	10.4	8.6	0.1	0.1	0.2	0.4	24.9	9.6	3.6	1.0	0.7	0.0	64.4	0.0	29.8	0.7	0.0	0.7	0.2	0.0	0.1	0.3	0.3	0.1	3.5	1.3	0.3	1.4	11.5	0.0	0.6	0.0	0.2	0.3	0.6	21.3	0.0	0.0	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	4.7	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	3.6	0.0	0.0	0.0	0.1	24.7	0.0	0.4	13.5	23.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	6.4	9.3	10.0	10.4	8.6	24.9	9.6	3.6	29.8	3.5	11.5	21.3	0.2	0.0	0.0	0.7	0.0	0.8	0.4	0.0	0.0	3.1	3.8	0.6	5.1	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.3	0.2	0.4	0.0	0.0	11.8	0.0	1.3	0.2	0.0	0.1	0.0	7.9	0.4	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	56.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	12.1	3.6	0.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	4.7	0.0	0.3	3.2	0.5	0.7	0.3	0.1	0.0	0.0	0.0	0.0	1.1
EPYC	"DSPG3, Pg-Lb, SLRR3B"	ENSG00000083782	Epiphycan	Q99645	12	90963682-91005026	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"placenta: 6.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"breast cancer: 2.4;ovarian cancer: 7.7;pancreatic cancer: 4.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTERT-RPE1: 3.0"	"Region enhanced"	"Detected in single"		"midbrain: 1.4"	"Group enriched"	"Detected in some"	5	"amygdala: 1.7;basal ganglia: 2.9;cerebral cortex: 2.7;hippocampal formation: 2.2"	"HPA038212, HPA045455"	Approved				"Secreted to extracellular matrix"	NA	NA					"HPA038212: AB_10672739, HPA045455: AB_2679330"	"unprognostic (2.25e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.28e-2)"		"unprognostic (1.81e-2)"		"unprognostic (4.07e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (2.77e-2)"	"unprognostic (6.44e-9)"	"unprognostic (2.83e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.20e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ERBB4	"ALS19, HER4"	ENSG00000178568	"Erb-b2 receptor tyrosine kinase 4"	Q15303	2	211375717-212538841	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Lactation, Transcription, Transcription regulation"	"Activator, Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.6;fallopian tube: 11.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 2020.2;Inhibitory neurons: 6091.7;Oligodendrocyte precursor cells: 2369.0;Oligodendrocytes: 1049.9"	"Group enriched"	"Detected in many"	4	"breast cancer: 4.1;endometrial cancer: 2.1;glioma: 1.2;ovarian cancer: 2.8;testis cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.9;EFO-21: 5.1;HEK 293: 3.8;RPTEC TERT1: 5.6;SCLC-21H: 3.1;T-47d: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000276, HPA012016, CAB025522"	Enhanced					NA	NA		220000			"CAB000276: , CAB025522: , HPA012016: AB_1846541"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.31e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.49e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.11e-2)"	0.2	0.4	10.3	0.0	13.4	0.0	5.6	10.5	11.3	3.0	0.0	0.0	0.0	0.2	0.0	0.1	11.3	0.0	3.0	9.6	28.6	5.2	0.0	0.9	0.0	6.8	15.4	9.9	0.1	0.6	3.1	2.4	0.1	7.6	0.3	0.0	2.0	4.8	1.2	1.5	0.3	0.0	0.0	2.2	0.0	0.4	3.3	7.1	0.0	1.6	1.7	0.0	0.1	0.1	9.0	0.0	0.0	6.9	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	5.1	0.7	0.0	0.3	0.2	0.0	0.0	0.1	3.8	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.0	5.6	0.3	3.1	0.2	0.0	0.1	0.1	0.1	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	13.4	10.5	11.3	9.6	28.6	6.8	15.4	9.9	7.6	2.2	7.1	9.0	0.4	0.0	12.6	2020.2	0.0	0.6	0.9	1.1	0.6	15.9	45.6	17.0	27.2	0.0	10.2	12.9	0.0	0.0	0.2	0.0	5.9	0.5	6.7	25.4	1.0	1.0	0.0	0.0	62.0	0.5	0.2	1.8	0.0	25.8	0.0	5.4	0.0	0.0	0.1	0.0	6091.7	0.0	2.0	0.0	0.3	2.2	1.8	0.3	3.6	96.5	0.0	9.1	0.0	2369.0	1049.9	0.0	0.0	0.4	0.0	1.6	0.0	0.2	28.1	1.9	6.6	4.1	3.0	1.8	2.6	0.2	1.3	0.0	0.2	0.0	0.0	1.2
GABRP		ENSG00000094755	"Gamma-aminobutyric acid type A receptor subunit pi"	O00591	5	170763350-170814047	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 153.9;esophagus: 173.1"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 169.0;Breast myoepithelial cells: 113.2;Club cells: 83.1;Endometrial ciliated cells: 146.0;Glandular and luminal cells: 464.0;Urothelial cells: 146.6"	"Group enriched"	"Detected in many"	4	"breast cancer: 35.4;cervical cancer: 49.3;endometrial cancer: 16.8;pancreatic cancer: 41.9;stomach cancer: 25.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 11.8"	"Group enriched"	"Detected in many"	8	"granulocytes: 11.8;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"A-431: 215.1;EFO-21: 236.8;HeLa: 166.8;PC-3: 331.3;SuSa: 418.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB014883	Uncertain					NA	NA					"CAB014883: "	"unprognostic (3.98e-3)"	"prognostic favorable (3.37e-4)"	"unprognostic (8.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.89e-2)"	"unprognostic (4.97e-3)"	"unprognostic (3.72e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.92e-3)"	"unprognostic (6.52e-3)"	4.5	3.6	13.5	7.3	13.5	10.0	153.9	21.1	19.6	8.7	5.4	4.3	15.5	49.1	19.2	173.1	13.0	27.5	5.4	12.5	12.4	6.1	7.2	14.8	5.7	13.2	9.6	5.5	3.9	24.0	2.0	2.0	9.1	15.5	12.8	5.0	42.5	36.0	16.8	13.8	19.1	16.3	2.7	3.3	7.4	27.6	8.3	14.1	4.7	6.2	2.7	42.6	5.4	29.7	22.3	215.1	9.9	10.1	7.0	0.7	4.3	23.8	3.8	1.5	0.5	0.6	38.1	23.6	3.3	236.8	1.1	2.3	75.7	6.4	0.5	0.6	3.5	7.6	14.1	166.8	5.7	0.8	5.1	11.2	1.6	3.0	2.8	1.8	8.0	1.4	13.4	57.6	26.5	0.4	6.7	9.5	4.7	84.5	3.7	331.3	13.7	6.6	8.2	13.8	11.6	8.2	4.0	76.5	3.9	2.2	418.8	4.2	2.4	8.8	19.1	69.3	15.7	15.7	10.0	6.7	6.3	2.6	13.9	2.9	11.8	1.9	6.1	0.4	1.5	1.1	0.3	0.4	0.3	0.6	0.7	0.5	0.5	4.5	0.2	5.7	0.9	0.6	2.3	13.5	13.5	21.1	19.6	12.5	12.4	13.2	9.6	5.5	15.5	3.3	14.1	22.3	1.1	3.2	0.6	0.0	0.9	0.0	14.9	44.4	0.0	0.0	169.0	113.2	0.7	51.5	83.1	1.8	0.0	5.2	2.3	0.0	0.0	10.4	0.0	146.0	48.8	3.8	0.0	0.0	0.3	13.8	0.6	2.4	2.0	464.0	0.0	0.0	0.0	0.1	2.3	0.0	0.2	0.3	12.2	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	56.6	0.1	0.0	0.0	24.2	0.1	0.1	34.0	0.0	0.0	0.2	5.9	0.0	0.0	4.5	0.0	5.7	2.7	0.0	0.6	146.6
GHR	GHBP	ENSG00000112964	"Growth hormone receptor"	P10912	5	42423439-42721878	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor	"Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 85.5;liver: 215.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 53.3;Hepatocytes: 141.3;Inhibitory neurons: 115.7;Oligodendrocyte precursor cells: 181.0"	"Group enriched"	"Detected in many"	4	"breast cancer: 2.8;liver cancer: 7.6;prostate cancer: 8.1;renal cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HSkMC: 21.2;T-47d: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045339, HPA057705"	Enhanced		Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"	"Secreted to blood"	NA	NA	2200000	24000000	"Plasma membrane, Cytosol, Cytoplasmic bodies"		"HPA045339: AB_2679294, HPA057705: AB_2683507"	"unprognostic (2.18e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.73e-6)"	"unprognostic (1.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.73e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.29e-4)"	"unprognostic (7.82e-2)"	"unprognostic (7.33e-4)"	"unprognostic (8.35e-6)"	85.5	5.6	1.6	1.7	2.3	0.2	30.3	1.9	1.7	5.1	2.4	5.3	1.1	4.5	4.6	3.9	5.4	5.2	9.0	1.8	4.2	11.9	215.0	4.0	1.3	1.1	1.9	1.5	7.6	2.2	5.5	1.2	4.9	1.4	11.2	5.7	0.4	3.8	4.7	46.1	5.6	4.3	4.0	1.1	4.1	6.1	1.7	2.6	2.3	4.7	11.7	0.9	5.0	5.9	1.5	0.0	0.0	0.6	5.0	3.3	0.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.3	4.3	0.0	0.0	2.6	0.0	0.1	0.0	0.6	0.0	0.0	21.2	7.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	1.8	0.2	0.0	0.0	0.3	0.0	0.7	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.3	0.1	3.5	0.6	56.0	0.1	3.0	4.8	2.1	2.6	0.5	0.5	0.0	0.0	0.5	0.0	2.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	2.3	1.9	1.7	1.8	4.2	1.1	1.9	1.5	1.4	1.1	2.6	1.5	17.2	0.0	0.5	14.7	0.4	4.7	4.5	17.8	10.2	0.6	9.7	16.0	18.6	1.5	1.9	1.8	0.0	17.4	0.5	2.8	1.9	0.0	5.1	0.5	9.4	4.8	3.0	5.3	53.3	0.2	2.2	23.8	0.5	0.3	0.0	1.1	6.1	141.3	1.9	0.0	115.7	1.9	0.0	3.0	1.8	2.8	18.6	0.7	1.8	36.5	0.0	0.7	0.0	181.0	3.6	0.2	1.7	12.0	0.0	5.2	0.0	9.6	0.6	0.4	13.1	18.7	15.1	0.7	0.3	2.9	3.7	40.2	0.5	49.4	2.2	0.9
GLYATL2	"BXMAS2-10, MGC24009"	ENSG00000156689	"Glycine-N-acyltransferase like 2"	Q8WU03	11	58834065-58904215	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 12.1;cervix: 20.1;salivary gland: 33.7"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 14.8;Oligodendrocyte precursor cells: 3.0;Prostatic glandular cells: 3.6;Sertoli cells: 6.6"	"Group enriched"	"Detected in many"	4	"breast cancer: 16.7;endometrial cancer: 15.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.3;BJ hTERT+ SV40 Large T+ RasG12V: 3.7;HAP1: 6.0;SK-BR-3: 14.1;U-2197: 6.6"					"Low region specificity"	"Detected in many"			"HPA060292, HPA065454"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA060292: AB_2684245, HPA065454: "	"unprognostic (1.02e-2)"	"unprognostic (3.79e-3)"	"unprognostic (8.11e-4)"	"prognostic favorable (9.05e-7)"	"unprognostic (1.05e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.42e-5)"	"unprognostic (7.79e-3)"	"unprognostic (8.28e-2)"	"unprognostic (9.11e-3)"	"unprognostic (2.31e-2)"	0.1	0.1	0.3	0.1	0.3	0.1	12.1	0.3	0.5	20.1	0.1	0.1	0.3	0.4	0.3	0.9	0.1	7.6	0.3	0.2	0.4	0.2	0.1	0.0	0.3	0.6	0.4	0.2	0.0	0.1	0.0	0.1	0.0	0.6	0.9	0.2	0.3	33.7	0.1	0.0	1.1	0.1	0.3	0.9	0.3	0.1	0.0	0.3	0.1	0.1	0.5	0.4	0.1	0.3	1.1	0.0	0.0	0.4	0.0	0.7	2.6	0.0	1.7	5.3	2.3	3.7	0.0	0.0	0.1	0.0	1.4	1.0	0.4	6.0	0.0	1.9	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.5	0.2	2.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.1	14.1	0.0	0.0	0.0	0.0	0.0	1.8	0.1	6.6	2.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.5	0.2	0.4	0.6	0.4	0.2	0.6	0.9	0.3	1.1	0.2	0.0	0.0	0.0	0.0	1.0	2.3	1.4	0.0	0.5	14.8	2.2	0.1	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	1.1	0.0	0.0	1.5	1.4	0.0	0.5	0.0	1.2	0.0	0.4	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.4	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	3.0	0.4	0.1	0.0	0.0	0.0	3.6	0.0	0.2	0.1	0.1	6.6	0.2	0.6	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	1.9
GRPR	"BB2, BB2R"	ENSG00000126010	"Gastrin releasing peptide receptor"	P30550	X	16123565-16153518	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"pancreas: 20.4"	"Cell type enriched"	"Detected in single"	15	"Inhibitory neurons: 6.3"	"Cancer enriched"	"Detected in some"	4	"breast cancer: 6.6"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"PC-3: 29.2;T-47d: 38.2;U-138 MG: 51.5"	"Region enhanced"	"Detected in single"		"hypothalamus: 2.0"	"Low region specificity"	"Detected in all"			HPA069604			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA069604: AB_2686158"	"unprognostic (3.32e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.68e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.86e-2)"	0.1	0.1	0.1	0.2	0.2	0.1	1.9	0.0	0.2	0.4	0.1	0.3	0.1	0.5	1.9	0.0	0.1	0.1	0.2	0.2	1.6	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	20.4	0.2	0.0	0.1	0.2	0.5	0.3	0.1	0.0	0.1	0.2	0.0	0.1	0.8	0.6	0.1	1.2	0.0	0.2	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.3	0.0	0.9	0.1	4.0	1.6	0.4	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.5	0.0	0.0	0.0	0.5	0.0	29.2	0.0	0.1	0.1	0.1	0.0	0.8	0.1	0.0	0.1	0.1	1.5	38.2	0.1	0.2	51.5	1.9	0.0	1.6	0.3	0.2	0.2	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.2	1.6	0.2	0.1	0.1	0.2	0.6	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IBSP	"BSP, BSP-II, SP-II"	ENSG00000029559	"Integrin binding sialoprotein"	P21815	4	87799554-87812435	"Cancer-related genes, Predicted secreted proteins"	"Biomineralization, Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.4;pituitary gland: 2.0"	"Cell type enriched"	"Detected in some"	4	"Hofbauer cells: 5.8"	"Group enriched"	"Detected in many"	4	"breast cancer: 3.8;glioma: 12.2"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-138 MG: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA						"unprognostic (2.53e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.75e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.03e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.02e-3)"		"unprognostic (5.81e-11)"	"unprognostic (6.20e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.11e-1)"	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.3	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.1	2.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.2	0.0	0.2	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.1	3.4	0.3	0.6	0.0	0.3	0.2	1.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
KMO		ENSG00000117009	"Kynurenine 3-monooxygenase"	O15229	1	241532134-241595642	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Pyridine nucleotide biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 31.8;liver: 92.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 33.8;Hepatocytes: 46.9;Langerhans cells: 49.4;Macrophages: 33.0;Proximal tubular cells: 63.2;Syncytiotrophoblasts: 180.1"	"Group enriched"	"Detected in many"	4	"breast cancer: 1.6;liver cancer: 3.3;renal cancer: 3.3"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.8"	"Group enriched"	"Detected in many"	79	"classical monocyte: 11.0;intermediate monocyte: 32.3;memory B-cell: 36.1;myeloid DC: 11.3;naive B-cell: 42.0;non-classical monocyte: 33.8;plasmacytoid DC: 24.3"	"Group enriched"	"Detected in many"	97	"B-cells: 42.0;dendritic cells: 24.3;monocytes: 33.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.2;RPMI-8226: 9.1;RPTEC TERT1: 21.9;SK-BR-3: 10.9;U-698: 9.4"	"Region enriched"	"Detected in single"	4	"thalamus: 1.1"	"Low region specificity"	"Detected in many"			"HPA031115, HPA056942"	Enhanced					NA	NA					"HPA031115: AB_10601924, HPA056942: AB_2683281"	"unprognostic (4.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.95e-2)"	"unprognostic (7.48e-3)"	"unprognostic (8.37e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.75e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (6.49e-8)"	"unprognostic (1.60e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.81e-2)"	1.4	0.8	0.1	5.2	0.4	1.4	5.3	0.1	1.8	0.6	2.1	0.9	0.6	5.4	0.2	0.2	0.2	1.6	0.4	0.4	0.2	31.8	92.4	5.1	8.9	0.1	0.1	0.2	0.2	0.1	0.1	0.2	6.9	0.2	0.3	1.1	0.2	0.3	0.2	0.1	0.2	1.2	0.8	0.0	8.4	1.2	1.3	0.7	1.6	0.2	0.0	11.3	5.6	0.1	0.4	0.2	1.8	0.1	0.0	0.0	0.3	0.3	0.1	0.1	0.2	0.4	0.0	0.2	6.2	0.4	0.0	0.2	2.5	0.0	0.2	0.0	1.1	0.0	0.0	0.1	0.1	0.0	0.6	0.2	0.2	0.7	0.1	0.2	0.5	0.0	0.4	0.1	0.9	0.0	0.2	0.0	2.4	1.0	0.9	0.4	1.6	0.1	9.1	21.9	4.5	0.3	0.1	0.0	10.9	0.1	2.1	4.3	2.1	0.0	0.0	0.1	0.1	1.6	0.4	0.6	9.4	0.2	2.7	1.8	0.1	11.0	0.2	0.0	32.3	0.0	36.1	0.0	0.0	11.3	42.0	0.0	0.1	0.3	0.0	33.8	24.3	0.0	6.1	0.1	0.4	0.1	1.8	0.4	0.2	0.1	0.1	0.2	0.2	0.0	0.7	0.4	0.1	0.0	0.5	0.0	33.8	1.0	0.1	13.3	2.2	0.0	1.8	0.8	0.4	2.8	11.1	0.0	0.0	3.6	5.5	0.1	5.9	4.8	4.9	9.5	1.5	0.3	0.0	5.2	6.6	0.2	2.3	0.4	2.0	26.6	0.0	0.1	0.7	46.9	7.0	0.0	30.0	0.0	4.1	22.7	49.4	1.8	0.0	33.0	0.0	0.0	5.5	0.0	1.0	1.0	0.6	1.5	0.0	0.0	11.7	0.2	0.2	63.2	2.3	0.0	0.0	0.1	1.3	1.6	0.3	3.1	1.4	180.1	1.6	0.1	0.0	0.1
NCAM2	"MGC51008, NCAM21"	ENSG00000154654	"Neural cell adhesion molecule 2"	O15394	21	20998409-21543329	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 12.1;brain: 22.3;liver: 6.8;testis: 6.4"	"Group enriched"	"Detected in some"	19	"Astrocytes: 713.0;Excitatory neurons: 866.5;Inhibitory neurons: 909.2;Oligodendrocyte precursor cells: 1729.1;Oligodendrocytes: 1526.6"	"Group enriched"	"Detected in some"	4	"breast cancer: 2.6;glioma: 5.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"T-47d: 92.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030900, HPA030901"	Enhanced	Supported	Supported	"Nuclear bodies,Plasma membrane"		No	No		120000000	"Nuclear bodies, Plasma membrane"		"HPA030900: AB_10602037, HPA030901: AB_2673650"	"unprognostic (9.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.61e-1)"	"unprognostic (3.07e-4)"	"unprognostic (2.47e-4)"	"unprognostic (1.62e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.35e-3)"	0.8	12.1	14.5	0.9	19.7	0.0	1.6	8.8	17.7	1.7	0.0	1.5	0.2	1.0	0.5	0.5	0.6	1.2	1.7	21.0	17.4	0.2	6.8	2.8	0.1	10.0	14.1	15.5	0.3	0.2	0.6	0.8	0.5	9.8	0.9	1.1	1.2	0.7	1.0	0.4	0.8	0.7	1.4	6.1	0.9	0.6	6.4	21.7	0.1	0.3	0.9	0.2	0.6	1.2	22.3	0.0	0.0	0.5	0.0	4.6	4.7	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.5	1.3	0.0	0.5	1.3	0.0	2.2	0.0	0.1	11.3	0.0	3.5	0.0	0.4	0.0	0.0	11.4	2.4	0.2	15.4	0.2	0.0	0.4	0.0	0.0	1.0	0.0	4.7	0.0	0.0	0.0	5.3	0.0	0.8	0.6	0.1	92.1	7.2	0.0	1.3	0.9	0.1	0.0	0.6	0.0	0.0	2.5	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	19.7	8.8	17.7	21.0	17.4	10.0	14.1	15.5	9.8	6.1	21.7	22.3	0.4	3.2	1.3	713.0	0.1	0.5	0.3	0.0	0.0	1.0	2.0	1.4	1.8	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	57.6	0.3	6.1	0.4	0.0	0.0	866.5	0.0	0.4	4.8	0.0	0.2	0.0	0.2	2.2	0.0	0.3	0.0	909.2	0.0	0.0	0.0	0.3	24.7	0.9	0.1	1.8	30.9	0.0	1.0	0.0	1729.1	1526.6	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0	0.1	0.0	2.4	1.6	3.7	9.6	0.1	0.1	0.3	0.2	1.9	0.0	0.2
PXDNL	"FLJ25471, PMR1"	ENSG00000147485	"Peroxidasin like"	A1KZ92	8	51319577-51809445	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Hydrogen peroxide"	"Endonuclease, Hydrolase, Nuclease, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"heart muscle: 38.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 42.2;Early spermatids: 43.8;Excitatory neurons: 25.2;Inhibitory neurons: 68.8;Microglial cells: 16.9;Muller glia cells: 18.6;Spermatocytes: 24.2"	"Group enriched"	"Detected in some"	4	"breast cancer: 1.7;glioma: 0.7;renal cancer: 0.8;testis cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AF22: 7.7;Daudi: 5.9;SH-SY5Y: 6.1"									HPA007919			Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"		"HPA007919: AB_1855966"	"prognostic unfavorable (3.27e-5)"	"unprognostic (4.59e-4)"	"unprognostic (5.57e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.71e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.60e-4)"	"unprognostic (2.28e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.97e-4)"	1.6	0.1	0.1	0.2	0.1	0.0	0.2	0.2	0.6	0.1	0.0	0.1	0.0	0.1	9.5	0.2	0.0	0.1	38.9	0.2	0.3	1.4	0.0	0.2	0.3	0.5	0.3	0.1	0.1	0.0	0.2	0.0	0.0	0.8	0.2	0.1	2.9	0.4	0.0	1.4	0.2	0.2	0.0	0.1	0.4	0.0	5.1	0.2	0.5	0.3	2.1	0.5	0.0	0.0	0.4	0.5	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.6	0.2	0.3	0.5	0.3	0.1	0.8	0.1	0.2	0.4	0.3	0.0	0.0	10.7	0.0	0.1	0.1	0.0	0.0	1.2	3.7	0.1	42.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.9	0.0	43.8	0.0	0.0	0.3	0.0	0.0	25.2	0.0	0.0	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	68.8	0.0	0.0	0.0	0.0	6.3	0.0	0.1	0.0	16.9	0.0	18.6	0.0	14.1	14.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.2	0.8	24.2	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
SLC24A2	NCKX2	ENSG00000155886	"Solute carrier family 24 member 2"	Q9UI40	9	19507452-19786928	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport, Vision"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 108.6"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocytes: 2710.1"	"Group enriched"	"Detected in some"	4	"breast cancer: 0.5;glioma: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 2.6;SCLC-21H: 2.2;U-87 MG: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA079359			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA079359: "	"unprognostic (1.30e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.48e-2)"		"unprognostic (8.46e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.08e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.51e-2)"	0.1	6.0	21.1	0.0	49.8	0.1	0.0	29.1	62.5	0.1	0.0	0.1	0.0	2.1	0.0	0.0	0.5	0.1	0.0	19.6	28.7	0.1	0.0	0.0	0.0	69.7	37.7	4.5	0.0	0.0	0.0	0.8	0.1	77.8	0.1	0.0	18.9	0.0	0.0	0.1	0.1	0.0	0.0	14.7	0.1	0.1	0.2	59.0	0.0	0.0	0.3	0.0	0.0	0.0	108.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.1	0.0	21.1	49.8	29.1	62.5	19.6	28.7	69.7	37.7	4.5	77.8	14.7	59.0	108.6	0.0	0.0	0.0	18.9	0.1	0.0	0.0	0.0	0.0	58.7	0.0	0.0	2.3	0.0	0.0	0.0	273.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.0	668.6	0.0	0.1	0.9	0.0	0.1	0.0	0.0	1.4	0.0	0.1	97.6	637.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	25.3	0.0	4.1	0.0	217.6	2710.1	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	10.4	0.0	3.2	0.2	0.2	0.7	0.0	0.1	0.3	0.0	0.0	0.1	0.0
SLC39A6	LIV-1	ENSG00000141424	"Solute carrier family 39 member 6"	Q13433	18	36108531-36129385	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Breast glandular cells: 307.0;Prostatic glandular cells: 197.9"	"Group enriched"	"Detected in all"	4	"breast cancer: 361.9;prostate cancer: 127.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042377	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA042377: AB_2677968"	"unprognostic (7.60e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.87e-3)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.50e-2)"	"unprognostic (7.63e-3)"	"unprognostic (2.16e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	27.5	26.1	23.0	21.8	27.1	11.7	148.7	27.7	26.3	34.8	43.1	12.7	9.7	57.5	56.7	17.1	64.1	24.4	14.1	20.8	27.1	28.5	16.6	19.1	17.5	28.5	26.8	19.6	43.5	38.0	87.2	24.1	31.9	30.1	130.2	13.5	50.6	31.2	115.4	12.8	51.8	8.9	30.4	28.7	15.6	16.6	19.5	28.4	18.7	37.6	16.7	28.6	53.1	16.2	34.2	43.7	54.0	127.1	75.1	131.4	96.6	33.0	116.2	137.3	76.5	88.7	30.3	47.5	47.1	57.3	113.1	53.1	104.1	112.4	109.2	115.5	105.4	40.7	20.6	69.5	44.4	83.2	69.8	49.6	88.7	236.1	116.2	100.5	69.9	11.7	38.6	10.7	92.1	108.9	67.0	69.0	15.6	30.6	24.0	30.4	70.6	72.8	61.4	84.4	145.2	132.8	116.8	143.5	41.5	200.6	52.1	56.7	32.4	18.9	184.9	30.5	35.5	59.2	85.9	90.0	35.7	64.0	48.3	99.8	29.2	13.3	31.2	16.3	19.7	19.7	16.7	13.8	14.7	16.4	17.3	12.0	17.7	10.2	18.1	19.4	33.6	17.0	14.2	23.0	27.1	27.7	26.3	20.8	27.1	28.5	26.8	19.6	30.1	28.7	28.4	34.2	13.3	38.5	18.7	8.8	22.5	45.9	58.2	79.6	59.2	41.5	307.0	132.2	19.6	10.0	66.4	42.3	33.3	6.6	36.7	4.0	1.9	53.1	21.3	37.1	76.1	12.9	25.6	4.6	13.0	37.8	56.7	45.6	9.2	73.8	23.5	18.9	8.9	11.0	20.4	23.5	23.9	7.4	38.7	20.1	30.0	18.1	37.3	26.0	67.6	1.9	25.7	38.2	10.3	34.2	36.5	39.5	1.9	47.8	24.4	197.9	2.7	13.6	44.3	41.3	39.5	40.4	38.6	43.9	27.8	32.6	74.4	23.8	23.2	23.0	5.7	69.3
SLC5A8	AIT	ENSG00000256870	"Solute carrier family 5 member 8"	Q8N695	12	101155493-101210238	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Ion transport, Sodium transport, Symport, Transport"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"cervix: 20.4;kidney: 5.6;thyroid gland: 15.7"	"Cell type enhanced"	"Detected in some"		"Club cells: 9.1;Early spermatids: 7.9;Enteroendocrine cells: 31.5;Excitatory neurons: 14.6;Horizontal cells: 10.1;Inhibitory neurons: 17.3;Proximal tubular cells: 21.4"	"Group enriched"	"Detected in many"	4	"breast cancer: 2.7;renal cancer: 7.6;thyroid cancer: 5.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"SK-BR-3: 5.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"prognostic favorable (9.04e-6)"	"unprognostic (1.84e-1)"		"unprognostic (1.17e-2)"		"unprognostic (1.27e-3)"		"unprognostic (1.24e-1)"			"unprognostic (5.20e-1)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.97e-4)"	"unprognostic (6.16e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.87e-2)"		0.0	2.5	0.4	0.0	0.4	0.0	0.0	0.2	1.1	20.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	5.6	0.0	0.9	0.0	0.8	0.2	0.3	1.1	0.0	0.0	0.1	0.0	0.5	0.8	0.0	0.1	0.9	0.0	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.2	1.0	0.2	15.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	1.1	0.4	0.4	0.8	0.2	0.3	0.5	0.3	1.0	0.7	0.0	0.0	5.3	1.3	0.0	0.0	0.0	4.6	0.0	3.9	0.1	0.1	0.6	0.0	9.1	1.8	0.0	0.0	0.0	0.3	1.9	0.0	7.9	0.0	0.1	0.0	31.5	0.0	14.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	17.3	0.2	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.6	0.2	21.4	2.1	0.1	0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.9
SPANXB1	"CT11.2, SPANXB2, SPANXF1, SPANXF2"	ENSG00000227234	"SPANX family member B1"	Q9NS25	X	141002594-141003706	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"testis: 89.5"	"Group enriched"	"Detected in some"	160	"Early spermatids: 686.8;Late spermatids: 2015.4"	"Group enriched"	"Detected in some"	4	"breast cancer: 2.1;cervical cancer: 1.1;head and neck cancer: 2.1;lung cancer: 1.8;urothelial cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 81.9;GAMG: 16.6;U-2 OS: 27.4"									"HPA046423, HPA073647"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"															"unprognostic (8.55e-2)"			0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.5	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.3	81.9	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	16.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.2	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	27.4	1.9	0.7	0.4	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	686.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2015.4	6.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.2	0.0	0.0	6.6	0.0	0.1	8.4	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SRARP	"C1orf64, ERRF, MGC24047"	ENSG00000183888	"Steroid receptor associated and regulated protein"	Q8NEQ6	1	16004236-16008807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.4;breast: 5.2;choroid plexus: 5.5"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 25.0;Distal tubular cells: 90.1"	"Group enriched"	"Detected in some"	4	"breast cancer: 7.7;endometrial cancer: 2.2;prostate cancer: 6.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.8"	"Group enriched"	"Detected in some"	13	"Hep G2: 7.9;SK-BR-3: 13.6;T-47d: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026676	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA026676: AB_1853866"	"unprognostic (8.55e-2)"	"unprognostic (1.01e-1)"		"prognostic favorable (1.68e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.41e-2)"		"unprognostic (3.49e-1)"		"unprognostic (8.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.65e-3)"	"unprognostic (6.32e-2)"	0.1	0.2	10.3	0.2	8.2	0.7	5.2	7.9	11.4	2.3	5.5	0.1	0.2	1.2	0.1	0.2	0.1	0.2	0.5	7.8	8.2	1.5	0.1	0.1	0.3	8.8	8.5	6.5	0.2	0.2	0.0	0.0	0.1	8.9	0.7	0.0	0.8	3.1	0.0	0.2	0.6	0.1	0.0	7.5	0.2	0.3	0.2	9.5	0.0	1.2	0.0	0.0	0.1	0.0	9.5	0.3	0.1	0.3	0.4	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.1	0.4	0.6	7.9	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.6	0.5	0.0	0.4	0.3	0.3	0.1	0.1	0.2	0.2	0.3	0.2	0.0	0.1	0.4	0.6	0.3	13.6	0.2	0.4	4.3	0.4	0.2	0.4	0.3	0.3	0.1	0.2	0.5	0.2	0.2	0.2	0.6	0.8	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.2	1.8	0.3	0.1	0.1	0.0	0.0	10.3	8.2	7.9	11.4	7.8	8.2	8.8	8.5	6.5	8.9	7.5	9.5	9.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	25.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.1	0.0	0.0	1.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SULT1C3		ENSG00000196228	"Sulfotransferase family 1C member 3"	Q6IMI6	2	108239971-108265351	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	83	"breast: 372.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	4	"breast cancer: 2.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"spinal cord: 36.7"	HPA060368			Approved	Cytosol		NA	NA			Cytosol		"HPA060368: "			"unprognostic (1.14e-3)"								"unprognostic (1.78e-1)"	"unprognostic (4.13e-1)"		"unprognostic (6.64e-2)"				0.1	0.0	0.2	0.0	0.1	0.0	372.0	0.0	0.2	0.1	1.4	0.4	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.2	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
TMEM26	"Em:AC068892.1, MGC35010"	ENSG00000196932	"Transmembrane protein 26"	Q6ZUK4	10	61406642-61453381	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.9"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 8.2;Endometrial stromal cells: 5.4;Excitatory neurons: 5.3;Hepatic stellate cells: 4.6;Inhibitory neurons: 4.8;Kupffer cells: 12.2;Late spermatids: 5.6;Theca cells: 15.0"	"Group enriched"	"Detected in some"	4	"breast cancer: 2.5;endometrial cancer: 1.0;prostate cancer: 1.8;renal cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.7;fHDF/TERT166: 1.1;HSkMC: 2.0;HUVEC TERT2: 1.5;MOLT-4: 2.3"	"Region enhanced"	"Detected in some"		"hypothalamus: 2.3"	"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.21e-3)"	"unprognostic (2.84e-1)"	"unprognostic (7.34e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.56e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.13e-1)"	"unprognostic (9.41e-2)"	"unprognostic (5.38e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.29e-5)"	"unprognostic (2.55e-2)"	"unprognostic (1.51e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.95e-1)"	0.4	0.5	1.3	0.9	1.6	0.1	5.3	0.3	1.0	2.3	0.2	0.7	1.4	4.0	0.1	0.6	0.4	1.0	0.1	1.1	0.7	2.2	2.5	1.4	0.7	1.8	1.0	0.9	0.5	0.0	1.4	0.2	1.5	0.6	2.6	0.9	0.0	0.0	2.4	0.8	0.0	0.8	2.0	0.3	8.9	0.2	3.7	1.2	2.1	0.4	0.2	0.2	0.7	0.5	0.8	0.0	0.0	0.1	0.0	0.1	0.8	0.1	0.0	4.7	0.4	0.6	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.0	0.0	0.5	0.0	0.5	1.5	0.5	0.0	0.0	0.1	0.0	2.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.6	0.3	1.0	1.1	0.7	1.8	1.0	0.9	0.6	0.3	1.2	0.8	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.2	2.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.7	5.4	1.7	0.0	0.0	5.3	0.0	0.0	1.4	0.0	1.6	0.0	0.1	4.6	0.2	0.3	0.0	4.8	0.0	0.0	12.2	0.0	5.6	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.1	1.2	0.5	0.2	0.0	0.1	0.0	0.1	15.0	0.0	0.0
TPRG1	"FAM79B, FLJ41238, FLJ43694"	ENSG00000188001	"Tumor protein p63 regulated 1"	Q6ZUI0	3	188947214-189325304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.0;vagina: 32.5"	"Cell type enriched"	"Detected in many"	5	"Early spermatids: 199.7"	"Cancer enriched"	"Detected in many"	4	"breast cancer: 7.0"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.6;Karpas-707: 4.7;OE19: 23.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA044751, HPA060187"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044751: AB_2679073, HPA060187: AB_2684217"	"prognostic favorable (5.43e-4)"	"unprognostic (8.71e-3)"	"unprognostic (2.10e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.52e-8)"	"unprognostic (8.50e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.73e-2)"	10.3	2.0	0.3	1.8	1.1	0.0	23.5	0.5	2.2	13.7	3.0	0.5	0.3	3.1	2.8	51.0	8.5	2.9	1.4	0.4	1.5	0.4	9.0	4.4	0.9	1.3	0.5	0.3	2.2	0.6	0.1	0.2	1.2	1.4	1.3	0.3	0.4	6.2	1.4	9.2	24.1	0.7	3.0	0.8	0.7	0.5	4.8	2.7	1.5	1.4	0.4	9.1	1.0	32.5	1.4	0.9	0.2	0.3	0.0	2.0	1.7	0.0	0.0	0.0	0.1	0.1	1.1	2.2	1.3	3.4	0.1	0.6	0.2	0.0	0.0	0.0	9.6	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.5	0.4	0.0	0.0	0.5	0.0	0.0	0.0	4.7	0.2	0.4	0.0	0.0	0.6	23.4	0.3	0.0	0.0	1.7	0.0	1.8	0.0	0.0	0.2	0.5	0.0	0.7	4.1	0.6	0.0	0.1	0.3	0.0	0.3	4.3	3.7	0.4	0.1	0.0	0.1	0.0	1.5	0.0	3.8	1.2	0.5	0.1	3.0	4.0	0.4	0.0	0.6	1.5	0.7	0.0	1.1	0.0	3.8	0.9	0.3	1.1	0.5	2.2	0.4	1.5	1.3	0.5	0.3	1.4	0.8	2.7	1.4	0.9	38.5	1.7	3.6	0.9	5.6	19.9	10.5	13.6	1.3	9.8	31.1	0.8	0.0	6.4	0.0	0.0	0.4	5.3	0.2	0.0	0.3	199.7	1.2	1.1	1.0	0.0	2.7	2.8	0.6	0.2	5.5	0.5	0.2	1.3	0.3	0.0	8.4	4.8	0.0	7.9	0.3	2.0	3.5	2.7	24.4	7.2	2.5	0.0	3.7	0.6	0.2	2.1	9.5	2.1	4.5	0.1	3.0	5.6	1.7	0.2	0.2	1.0	0.2	0.0	30.7	5.3	5.1	1.1	4.3	5.8	0.3	14.4	1.2	0.2	5.7
ADAMTS15		ENSG00000166106	"ADAM metallopeptidase with thrombospondin type 1 motif 15"	Q8TE58	11	130448974-130476641	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 26.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 8.6;Cardiomyocytes: 11.0;Endometrial stromal cells: 15.6;Fibroblasts: 9.6;Gastric mucus-secreting cells: 8.2;Glandular and luminal cells: 7.5;Granulosa cells: 6.8;Skeletal myocytes: 6.9"	"Cancer enhanced"	"Detected in many"		"breast cancer: 13.2"	"Region enhanced"	"Detected in many"		"medulla oblongata: 4.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 72.0;ASC TERT1: 43.0;EFO-21: 36.6;hTERT-RPE1: 19.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA042867	Uncertain		Approved	Cytosol	"Secreted to extracellular matrix"	NA	NA			Cytosol		"HPA042867: AB_10794535"	"unprognostic (7.64e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.07e-3)"	"unprognostic (7.07e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (9.72e-4)"	"unprognostic (6.18e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.95e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.63e-5)"	26.7	1.2	0.6	1.7	0.5	0.0	15.4	0.4	0.9	3.4	1.9	3.2	0.5	4.3	1.3	3.7	9.9	2.3	13.7	0.4	1.0	3.6	0.4	7.3	1.2	4.6	0.6	0.4	2.7	1.5	0.4	1.3	17.1	1.3	1.9	1.9	0.3	1.3	1.1	1.8	4.2	3.6	4.7	0.9	2.3	5.5	0.9	1.1	1.1	7.1	1.0	0.3	8.9	2.6	1.2	0.0	2.6	1.6	0.8	72.0	43.0	0.0	2.7	5.2	1.0	0.2	0.5	1.2	0.0	36.6	0.2	2.6	7.0	0.6	0.7	0.2	0.0	1.7	0.0	3.3	0.0	0.7	0.0	0.0	14.1	0.0	0.6	0.1	19.5	0.0	0.3	0.0	0.0	0.0	0.1	0.1	8.1	1.3	0.0	5.7	0.0	4.1	0.0	0.1	0.1	0.6	0.0	12.1	0.0	0.0	5.2	3.9	0.0	0.0	0.6	8.5	7.0	3.5	0.0	0.0	0.1	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.4	0.9	0.4	1.0	4.6	0.6	0.4	1.3	0.9	1.1	1.2	8.6	0.0	0.0	0.3	0.2	0.5	0.1	3.5	0.0	1.3	5.6	2.7	11.0	0.0	0.5	1.8	0.0	0.6	0.0	1.0	0.0	0.0	0.0	4.4	15.6	1.7	0.0	0.0	0.4	0.8	0.6	9.6	8.2	7.5	0.0	6.8	0.4	0.1	0.9	0.0	1.6	0.5	2.0	0.0	0.3	0.0	5.0	0.3	3.6	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.9	0.7	0.0	0.0	0.1	1.0	0.5	0.0	0.0	6.9	3.6	0.2	0.3	0.0	0.3	0.8	0.1	0.0	1.8	0.1
AGR3	"BCMP11, hAG-3, HAG3, PDIA18"	ENSG00000173467	"Anterior gradient 3, protein disulphide isomerase family member"	Q8TD06	7	16859412-16881987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 227.1;intestine: 239.5;lung: 154.1"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 861.1;Intestinal goblet cells: 701.9;Paneth cells: 744.5;Proximal enterocytes: 1051.2;Respiratory ciliated cells: 1771.2;Undifferentiated cells: 495.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 104.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	28	"OE19: 109.8;T-47d: 339.3"	"Region enriched"	"Detected in some"	5	"olfactory bulb: 4.6"					HPA053942	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		67000	"Endoplasmic reticulum"	Vesicles	"HPA053942: AB_2682317"	"unprognostic (2.18e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.59e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.08e-2)"		"unprognostic (1.49e-1)"		"unprognostic (1.46e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.96e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.57e-1)"	0.6	0.1	0.1	11.1	0.4	0.0	70.3	0.4	0.2	25.2	0.0	222.0	168.7	8.7	0.0	1.5	227.1	48.7	0.0	0.1	0.8	2.5	0.3	154.1	0.2	2.0	0.9	0.0	0.3	10.7	0.0	21.4	0.8	1.0	4.8	217.0	0.0	31.1	0.9	0.0	1.5	239.5	8.7	0.9	0.3	100.8	0.2	0.4	0.0	7.4	0.0	0.8	27.9	0.2	0.4	0.0	0.6	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	109.8	0.0	0.0	0.0	2.3	8.1	0.0	1.3	0.4	0.0	0.6	0.0	0.0	339.3	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.2	0.1	0.8	2.0	0.9	0.0	1.0	0.9	0.4	0.4	0.7	333.3	408.1	0.3	1.4	2.7	12.5	108.5	0.0	0.0	105.1	51.9	0.1	31.5	319.9	29.5	0.0	3.4	0.7	380.0	1.9	30.4	0.0	861.1	7.4	1.9	112.7	0.0	0.2	71.4	3.3	5.3	71.4	39.2	20.8	0.0	0.0	0.0	0.5	0.0	0.2	701.9	134.3	0.0	0.3	0.0	0.3	2.3	0.0	0.0	0.6	0.0	0.0	0.0	0.1	16.6	744.5	0.0	0.4	7.1	1051.2	0.0	1771.2	0.0	0.0	0.0	27.9	0.0	0.1	0.0	9.8	2.2	4.1	0.0	495.4	117.9
AR	"AIS, DHTR, HUMARA, NR3C4, SBMA, SMAX1"	ENSG00000169083	"Androgen receptor"	P10275	X	67544021-67730619	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 38.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 93.7;Granulosa cells: 104.8;Hepatocytes: 269.2;Leydig cells: 77.9;Peritubular cells: 86.5;Skeletal myocytes: 75.0"	"Cancer enhanced"	"Detected in many"		"breast cancer: 15.6;prostate cancer: 16.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 13.3;BJ hTERT+: 10.3;HAP1: 14.9;LHCN-M2: 16.1;RH-30: 23.6;T-47d: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000001, HPA004733, CAB065764"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"CAB000001: AB_2060174, CAB065764: AB_10620739, HPA004733: "	"unprognostic (1.34e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.49e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.35e-2)"	"prognostic favorable (8.77e-4)"	"unprognostic (4.99e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.29e-1)"	"prognostic favorable (1.03e-8)"	"unprognostic (8.23e-3)"	"unprognostic (8.90e-2)"	"unprognostic (4.23e-2)"	"unprognostic (7.97e-2)"	6.8	1.0	1.6	0.5	1.1	0.0	8.8	1.7	1.1	23.8	0.4	1.5	0.2	18.8	16.3	1.2	20.9	2.0	5.9	0.7	5.3	3.6	38.6	1.5	0.3	3.4	2.5	0.1	14.8	0.8	0.1	1.9	0.1	2.6	16.6	0.6	0.2	1.4	18.4	14.1	5.3	0.9	9.5	2.2	1.3	1.5	3.9	3.6	2.7	2.1	6.2	0.5	3.5	13.0	2.8	0.0	4.8	13.3	0.0	0.0	0.0	0.0	7.3	10.3	0.3	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.0	14.9	0.0	0.0	0.0	2.4	0.0	1.5	0.0	0.8	0.0	0.0	5.5	0.0	1.8	0.0	0.0	3.9	0.1	4.6	2.2	16.1	1.5	0.0	0.0	5.4	0.0	0.0	0.0	23.6	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	3.6	10.9	7.6	0.3	0.3	2.2	0.0	3.5	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.1	1.7	1.1	0.7	5.3	3.4	2.5	0.1	2.6	2.2	3.6	2.8	3.1	0.0	5.0	28.4	0.4	9.7	17.8	0.2	15.9	0.7	93.7	33.7	37.4	14.3	10.7	3.7	0.0	3.5	14.0	0.0	1.9	11.3	1.1	2.9	49.1	10.5	0.0	5.3	7.7	0.0	0.2	39.4	0.0	5.8	1.3	104.8	36.0	269.2	0.8	0.0	17.8	0.3	0.0	2.2	4.2	4.4	77.9	3.3	10.6	1.0	1.7	0.2	0.0	26.7	0.2	0.6	0.0	86.5	0.0	36.5	0.6	27.7	3.6	0.3	65.7	75.0	20.8	0.8	3.3	12.7	16.1	1.0	1.7	37.8	0.2	22.0
ART3	ARTC3	ENSG00000156219	"ADP-ribosyltransferase 3 (inactive)"	Q13508	4	76011184-76112802	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 61.5;skeletal muscle: 222.2;testis: 97.3;tongue: 102.5"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 76.2;Spermatocytes: 262.8"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"NB-4: 5.5;NTERA-2: 14.1;SK-MEL-30: 6.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA011268	Enhanced				"Intracellular and membrane"	NA	NA		48000000			"HPA011268: AB_1845059"	"unprognostic (2.45e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.85e-4)"	"unprognostic (2.35e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.61e-3)"	0.8	0.4	4.0	1.1	4.7	0.0	0.9	7.6	7.9	2.0	4.3	2.8	0.3	0.3	0.5	4.8	0.9	0.2	61.5	5.0	5.5	0.2	0.2	0.4	0.3	3.5	3.3	4.2	0.4	7.9	0.1	2.5	0.1	5.2	2.0	2.3	0.2	3.1	1.3	222.2	0.8	2.3	0.4	3.9	2.7	1.9	97.3	3.6	0.6	0.3	102.5	0.1	0.7	1.7	10.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.5	14.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.7	7.6	7.9	5.0	5.5	3.5	3.3	4.2	5.2	3.9	3.6	10.3	0.4	0.0	0.0	0.7	0.1	0.5	0.5	1.1	0.0	0.5	0.2	0.3	76.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.3	2.1	0.4	0.8	0.0	0.0	37.9	0.0	0.1	2.6	0.0	5.9	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.4	13.5	1.8	0.2	1.8	0.0	0.0	0.3	0.0	5.0	7.3	0.0	0.0	1.2	0.0	1.0	0.0	0.0	0.1	0.3	0.0	21.7	2.7	262.8	24.2	0.0	0.3	0.0	0.2	0.1	0.8	0.4
ASPN	"FLJ20129, PLAP-1, SLRR1C"	ENSG00000106819	Asporin	Q9BXN1	9	92456205-92482506	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 96.2;smooth muscle: 111.5"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 67.2;Fibroblasts: 94.6;Microglial cells: 24.4;Sertoli cells: 39.5;Smooth muscle cells: 73.5;Suprabasal keratinocytes: 27.0"	"Cancer enhanced"	"Detected in all"		"breast cancer: 51.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 16.0;BJ hTERT+: 5.7;HHSteC: 23.2;HSkMC: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007894, HPA008435, HPA024230"	Approved		Uncertain	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		2100000	Nucleoplasm	Cytosol	"HPA007894: , HPA008435: AB_1845112, HPA024230: AB_1845113"	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.13e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.70e-2)"	"prognostic unfavorable (1.64e-7)"	"unprognostic (1.42e-3)"	"unprognostic (3.04e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.48e-2)"	29.8	7.6	1.2	5.7	1.4	0.1	12.0	2.2	3.3	41.2	3.5	18.9	9.6	70.3	9.8	10.2	17.0	66.5	96.2	1.1	1.0	11.3	41.4	14.4	3.0	1.3	1.4	0.9	7.1	13.5	3.9	2.6	4.3	1.6	4.8	11.4	0.2	3.3	11.8	7.8	12.2	17.8	111.5	0.8	2.3	12.1	1.2	1.3	2.5	11.2	20.0	5.6	13.5	5.1	1.3	0.1	0.0	0.0	0.0	1.4	16.0	0.2	2.6	5.7	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	23.2	0.2	0.0	4.5	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	1.2	1.4	2.2	3.3	1.1	1.0	1.3	1.4	0.9	1.6	0.8	1.3	1.3	12.9	0.0	1.1	0.3	0.1	67.2	0.1	0.0	0.0	0.4	0.4	0.1	8.5	0.0	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.1	4.2	6.8	0.0	0.0	2.0	0.0	0.1	94.6	0.5	0.2	1.3	0.1	13.9	0.4	0.2	0.0	1.7	0.0	0.0	0.0	13.5	0.6	5.9	0.8	14.2	24.4	0.0	0.1	0.0	1.5	1.1	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.7	0.6	39.5	4.3	73.5	0.0	0.1	0.3	27.0	0.0	1.7	0.3	0.0	0.0
BMPR1B	"ALK6, CDw293"	ENSG00000138696	"Bone morphogenetic protein receptor type 1B"	O00238	4	94757955-95158448	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Chondrogenesis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.0;cervix: 24.9;prostate: 22.6"	"Cell type enriched"	"Detected in many"	7	"Astrocytes: 480.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 32.4;prostate cancer: 24.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 22.0;MCF7: 11.1;SH-SY5Y: 18.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.25e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.40e-3)"	"prognostic favorable (2.84e-4)"	"unprognostic (1.57e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-3)"	"unprognostic (7.89e-4)"	"unprognostic (6.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.63e-2)"	0.6	4.6	16.6	0.3	14.0	0.1	1.0	15.1	15.1	24.9	2.8	0.8	0.1	4.4	2.4	0.2	12.6	2.7	0.7	13.4	22.0	7.8	0.8	1.7	0.0	20.2	17.5	10.2	6.2	1.1	0.1	1.9	0.7	16.8	22.6	0.2	8.2	1.0	14.3	3.0	0.8	0.1	0.6	14.8	0.9	2.4	3.7	15.1	6.5	0.5	1.1	0.0	0.2	0.5	12.9	0.0	22.0	5.6	0.0	2.3	4.8	0.2	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.2	1.0	0.0	1.3	3.6	8.4	0.1	0.0	4.9	0.0	1.4	0.0	0.6	0.5	0.1	2.7	9.0	2.8	6.2	0.4	0.1	0.0	0.0	0.0	7.1	11.1	0.6	0.1	2.1	0.1	3.2	0.2	3.4	0.1	4.3	0.1	0.2	18.8	0.3	3.2	3.2	0.8	1.7	0.0	0.0	4.0	3.8	0.2	4.3	0.0	0.0	0.0	1.5	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	16.6	14.0	15.1	15.1	13.4	22.0	20.2	17.5	10.2	16.8	14.8	15.1	12.9	0.0	6.4	0.0	480.6	0.0	2.7	1.3	13.1	1.2	0.4	3.8	1.0	3.4	2.8	33.4	60.7	0.0	0.0	0.0	0.0	1.9	3.0	1.4	28.5	1.4	1.1	18.4	0.0	51.0	0.4	0.3	1.5	0.0	20.8	0.0	38.6	2.9	0.0	0.1	0.0	2.5	0.0	8.2	0.0	1.2	1.4	3.1	0.4	28.4	22.5	0.0	38.5	0.0	10.1	2.8	0.7	0.0	3.8	0.0	28.5	0.0	0.2	15.7	1.6	0.0	1.7	2.9	1.2	10.6	0.4	2.3	0.0	0.5	4.4	0.0	1.6
BTN1A1	"BT, BTN, BTN1"	ENSG00000124557	"Butyrophilin subfamily 1 member A1"	Q13410	6	26501221-26510422	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	39	"breast: 32.8"	"Cell type enriched"	"Detected in some"	43	"Breast glandular cells: 111.9"	"Cancer enhanced"	"Detected in single"		"breast cancer: 0.6"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.1;naive B-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011126, CAB037340"	Supported				"Intracellular and membrane"	NA	NA					"CAB037340: , HPA011126: AB_1845491"	"unprognostic (4.07e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.77e-2)"		"unprognostic (5.50e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.35e-10)"	"unprognostic (4.62e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.31e-4)"	0.0	0.0	0.0	0.3	0.0	0.0	32.8	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	2.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	111.9	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0
C10orf82	"Em:AC016825.4, MGC33547"	ENSG00000165863	"Chromosome 10 open reading frame 82"	Q8WW14	10	116663696-116670264	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"testis: 85.2"	"Group enriched"	"Detected in some"	113	"Early spermatids: 1053.9;Late spermatids: 1926.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 2.4"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	103	"basophil: 10.2"	"Lineage enriched"	"Detected in single"	103	"granulocytes: 10.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;Hep G2: 2.8;NTERA-2: 1.4;SuSa: 2.5;T-47d: 3.5"	"Not detected"	"Not detected"							HPA043022			Approved	Mitochondria		Yes	NA			Mitochondria		"HPA043022: "	"unprognostic (9.98e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.52e-2)"		"unprognostic (3.46e-3)"	"unprognostic (3.48e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.50e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.07e-1)"	0.2	1.8	0.2	0.2	0.2	0.0	0.9	0.1	0.4	0.3	0.0	0.7	0.1	0.0	0.2	0.3	0.2	0.1	0.3	0.2	0.5	0.5	0.0	0.0	0.0	0.4	0.4	0.2	3.6	1.1	0.0	1.0	0.0	0.3	0.9	0.2	0.1	0.2	0.7	0.0	0.2	0.4	0.0	0.2	0.1	0.4	85.2	0.7	0.0	1.6	0.1	0.0	0.3	0.6	0.4	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.4	0.2	0.5	0.4	0.4	0.2	0.3	0.2	0.7	0.4	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	1.1	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1053.9	0.3	0.2	0.5	1.2	0.0	0.5	0.2	0.1	0.1	0.0	0.7	0.0	5.6	0.0	0.0	0.1	0.0	1.8	1.1	0.0	0.0	0.0	1926.7	9.0	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	5.3	0.0	0.7	0.1	0.1	0.0	0.0	13.1	0.4	0.2	10.5	8.0	0.0	0.0	0.0	0.1	8.0	1.2	0.3
C5AR2	"C5L2, GPR77"	ENSG00000134830	"Complement component 5a receptor 2"	Q9P296	19	47332175-47347329	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 14.4;Hepatic stellate cells: 23.9;Kupffer cells: 48.6;Macrophages: 34.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 3.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 17.8;eosinophil: 11.9;neutrophil: 33.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 33.0"	"Group enriched"	"Detected in some"	4	"MCF7: 20.7;T-47d: 24.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA016629	Uncertain					NA	NA					"HPA016629: AB_1849312"	"unprognostic (5.00e-2)"	"unprognostic (2.31e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.00e-6)"	"unprognostic (2.88e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.73e-5)"	"unprognostic (1.16e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.88e-3)"	3.9	1.2	1.1	4.2	0.8	5.9	2.2	1.0	2.6	1.0	1.5	1.2	0.4	0.7	0.4	0.6	2.4	0.7	1.4	2.1	0.9	1.2	1.9	6.6	0.9	1.2	0.4	0.7	0.6	0.8	0.1	0.9	2.2	0.9	0.4	0.4	0.4	1.2	0.3	0.3	1.3	1.5	1.0	0.4	14.3	1.1	3.2	0.6	0.3	0.9	0.4	3.2	1.2	1.4	1.2	0.1	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.7	0.4	0.3	0.2	0.0	0.0	0.0	0.1	0.1	0.1	5.2	0.1	0.0	0.8	1.5	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.4	0.0	20.7	0.1	2.4	0.2	0.0	0.1	0.3	0.1	2.7	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.1	24.8	0.3	0.2	0.8	0.2	0.5	0.1	0.3	0.3	0.9	0.8	1.4	0.1	17.8	2.7	11.9	0.3	2.3	0.4	0.3	0.2	0.2	0.6	0.4	0.2	0.2	33.0	0.3	4.4	0.3	0.6	0.7	1.1	0.8	1.0	2.6	2.1	0.9	1.2	0.4	0.7	0.9	0.4	0.6	1.2	0.6	3.2	1.9	0.3	1.1	0.4	2.8	0.1	0.0	1.3	4.7	2.8	1.6	2.8	2.6	1.8	2.1	0.1	1.7	0.0	0.0	0.0	14.4	0.5	0.5	1.7	0.0	3.2	0.6	0.0	0.2	2.1	0.0	1.1	1.3	6.1	23.9	1.2	8.3	0.0	0.1	0.0	0.0	48.6	4.6	3.0	0.0	34.5	0.0	1.0	8.3	0.3	1.0	0.0	0.1	0.0	0.0	0.4	1.3	2.0	0.0	0.3	0.8	4.2	0.0	4.0	1.0	0.2	0.4	0.1	0.9	0.1	1.3	4.1	0.0	1.9
CACNG1	CACNLG	ENSG00000108878	"Calcium voltage-gated channel auxiliary subunit gamma 1"	Q06432	17	67044554-67056797	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	55	"skeletal muscle: 330.4;tongue: 122.9"	"Cell type enriched"	"Detected in single"	27	"Skeletal myocytes: 8.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.6;head and neck cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HSkMC: 2.9"	"Region enriched"	"Detected in single"	6	"basal ganglia: 3.4"	"Not detected"	"Not detected"									NA	NA						"unprognostic (1.76e-1)"	"unprognostic (9.83e-3)"		"unprognostic (1.75e-5)"	"unprognostic (2.60e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-2)"		"unprognostic (4.84e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-2)"		"unprognostic (1.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.94e-1)"	0.0	1.7	0.5	0.0	0.6	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	3.3	0.0	330.4	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.6	0.0	122.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.1	0.6	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC196	"C14orf53, LINC00238, NCRNA00238"	ENSG00000196553	"Coiled-coil domain containing 196"	A0A1B0GTZ2	14	66411704-66498677	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	12	"testis: 5.4"	"Cell type enhanced"	"Detected in some"		"Exocrine glandular cells: 1.0;Proximal tubular cells: 2.0"	"Cancer enhanced"	"Detected in single"		"breast cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.96e-2)"		"unprognostic (6.53e-2)"		"unprognostic (6.56e-2)"		"unprognostic (2.57e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.47e-1)"		"unprognostic (7.20e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.60e-6)"	"unprognostic (5.72e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.03e-2)"		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.2	0.1	0.1	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CGA	"FSHA, GPA1, GPHa, GPHA1, HCG, LHA, TSHA"	ENSG00000135346	"Glycoprotein hormones, alpha polypeptide"	P01215	6	87085498-87095106	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pituitary gland: 4423.7"	"Cell type enriched"	"Detected in some"	15	"Syncytiotrophoblasts: 85317.2"	"Cancer enhanced"	"Detected in many"		"breast cancer: 10.9;testis cancer: 13.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	28	"BEWO: 776.1;SuSa: 1437.9"	"Region enriched"	"Detected in many"	6	"hypothalamus: 22.2"	"Region enriched"	"Detected in many"	40	"hypothalamus: 82.2"	"CAB023350, HPA029698"	Enhanced				"Secreted to blood"	NA	NA					"CAB023350: AB_617281, HPA029698: AB_2673153"	"unprognostic (1.66e-1)"	"unprognostic (2.10e-1)"		"unprognostic (3.22e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.17e-1)"			"unprognostic (7.04e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.85e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.32e-2)"	"unprognostic (9.15e-3)"	0.5	4.1	0.2	0.1	0.5	2.0	0.1	0.5	0.6	0.0	0.3	0.3	0.5	1.0	1.2	1.2	0.1	0.2	1.2	0.2	0.6	2.7	2.0	0.7	0.3	1.6	1.0	0.3	0.5	1.3	19.0	4423.7	732.2	1.0	2.7	0.3	0.3	0.5	1.1	3.3	1.9	0.3	3.4	0.2	1.1	38.4	0.5	0.6	0.8	0.5	0.0	0.3	0.4	0.2	1.3	0.0	1.0	0.0	0.1	0.0	0.0	776.1	0.7	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.9	4.2	1.8	0.3	40.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.2	0.1	0.0	0.3	0.0	0.1	1.0	0.6	0.1	22.6	0.0	1437.9	0.1	0.0	0.0	0.9	0.2	0.4	0.3	3.1	0.4	0.5	0.2	0.0	0.1	0.7	0.2	0.1	0.3	0.0	0.1	0.2	0.1	0.3	0.1	0.4	0.2	0.4	0.6	0.2	0.3	0.4	0.1	0.0	0.2	0.5	0.5	0.6	0.2	0.6	1.6	1.0	0.3	1.0	0.2	0.6	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.9	1.9	0.0	0.0	7.3	0.0	1414.2	0.1	0.0	0.0	0.0	0.2	20.2	1.1	22.9	1.8	0.0	0.2	0.0	5400.7	65.5	0.0	28.4	0.0	0.0	0.0	0.0	625.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.0	85317.2	6.0	0.0	0.2	9.9
CIDEA	CIDE-A	ENSG00000176194	"Cell death inducing DFFA like effector a"	O60543	18	12254361-12277595	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	23	"adipose tissue: 223.3;breast: 108.9"	"Cell type enriched"	"Detected in some"	78	"Breast glandular cells: 330.6"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"hTEC/SVTERT24-B: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.96e-2)"	"unprognostic (2.43e-2)"			"unprognostic (1.74e-1)"	"unprognostic (1.49e-1)"		"unprognostic (8.93e-3)"	"unprognostic (3.20e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.72e-2)"			"unprognostic (1.91e-3)"	"unprognostic (3.17e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.96e-1)"	223.3	3.8	2.7	0.2	3.5	0.0	108.9	3.5	4.6	1.7	2.4	1.2	0.0	0.0	0.0	4.9	0.0	1.2	1.9	3.3	2.5	0.2	0.2	0.0	0.3	3.0	2.8	3.0	0.0	0.9	0.0	0.0	0.0	3.5	0.1	0.9	0.1	4.3	0.0	1.1	7.3	2.1	0.2	2.8	0.0	1.0	0.1	2.6	0.2	0.5	4.7	0.2	1.1	5.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.5	3.5	4.6	3.3	2.5	3.0	2.8	3.0	3.5	2.8	2.6	3.7	1.9	0.0	0.0	0.7	0.5	0.1	0.1	0.3	0.0	0.2	330.6	3.8	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.3	1.0	0.0	0.2	0.3	0.0	0.0	3.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	4.2	0.6	0.6	1.8	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.4	0.3	0.7	1.0	0.0	0.3	0.5	0.0	0.8
CILP	HsT18872	ENSG00000138615	"Cartilage intermediate layer protein"	O75339	15	65194760-65211473	"Disease related genes, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 42.9;Fibroblasts: 138.1;Leydig cells: 231.5;Peritubular cells: 57.6;Theca cells: 83.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 30.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.2;ASC TERT1: 2.5;EFO-21: 1.1;HSkMC: 6.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA003195	Uncertain				"Secreted to extracellular matrix"	NA	NA		13000000			"HPA003195: AB_1078524"	"unprognostic (2.21e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.18e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-13)"	"unprognostic (5.10e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (4.68e-3)"	40.7	0.8	0.2	9.5	0.2	0.1	22.1	0.3	0.3	45.3	0.1	18.4	2.4	14.0	3.6	11.1	15.9	37.1	27.6	0.1	0.2	0.7	1.6	3.0	1.6	0.2	0.2	0.1	7.6	3.0	0.3	0.7	2.6	0.2	3.2	7.0	0.5	9.4	4.8	15.6	12.5	22.8	51.4	0.2	0.6	8.4	12.2	0.2	1.8	2.4	33.2	0.8	27.2	28.3	0.2	0.0	0.0	0.0	0.0	4.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.3	0.1	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	8.1	0.0	0.0	0.0	0.0	5.2	0.1	0.2	0.0	0.9	0.4	0.5	2.1	0.0	0.4	1.8	0.0	0.0	0.2	0.1	0.0	0.1	1.7	1.2	42.9	1.5	0.0	0.0	0.3	0.0	0.0	138.1	4.1	1.7	0.0	0.1	2.2	0.1	0.1	0.0	0.6	0.1	2.0	0.0	11.9	7.1	231.5	1.7	1.8	1.9	0.0	0.2	0.0	1.0	0.3	0.0	0.0	57.6	0.3	0.1	0.0	0.0	0.0	0.1	0.0	14.7	6.6	0.6	0.3	0.1	6.1	0.0	1.6	83.5	0.2	0.0
CLPSL2	"C6orf126, dJ510O8.5, UNQ3045"	ENSG00000196748	"Colipase like 2"	Q6UWE3	6	35776594-35779552	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	102	"epididymis: 536.8"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 3.4;Breast myoepithelial cells: 2.2;Enteroendocrine cells: 1.8;Exocrine glandular cells: 4.0;Pancreatic endocrine cells: 2.1;Spermatogonia: 2.2"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"T-47d: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051655	Approved				"Secreted in male reproductive system"	NA	NA					"HPA051655: "	"unprognostic (2.38e-1)"	"unprognostic (3.65e-1)"	"unprognostic (6.39e-3)"	"unprognostic (9.38e-2)"	"unprognostic (4.03e-2)"			"unprognostic (2.47e-1)"		"unprognostic (4.85e-3)"	"unprognostic (8.69e-2)"	"unprognostic (3.17e-2)"		"unprognostic (3.95e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.37e-1)"	0.0	0.0	0.2	0.0	0.4	0.1	0.4	0.2	0.8	0.0	0.2	0.0	0.0	0.0	536.8	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.0	5.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.7	0.7	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.2	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.7	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.3	0.0	0.1	6.3	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.2	0.4	0.2	0.8	0.5	0.3	0.2	0.3	0.3	0.2	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	2.2	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.0	1.8	0.0	0.2	4.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1
COL10A1		ENSG00000123500	"Collagen type X alpha 1 chain"	Q03692	6	116118909-116158747	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 15.1;choroid plexus: 32.6;gallbladder: 9.0"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 26.6;Inhibitory neurons: 6.3;Microglial cells: 8.4;Oligodendrocytes: 27.9"	"Cancer enhanced"	"Detected in many"		"breast cancer: 42.8;pancreatic cancer: 51.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"hTEC/SVTERT24-B: 39.7"					"Low region specificity"	"Detected in many"			HPA053268			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		160000	"Endoplasmic reticulum"		"HPA053268: "	"unprognostic (3.83e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.20e-2)"	"unprognostic (7.45e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.37e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.38e-11)"	"unprognostic (2.16e-3)"	"unprognostic (7.22e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.06e-3)"	0.3	0.0	2.1	0.2	7.7	0.3	0.3	3.8	5.2	1.2	32.6	0.2	0.0	0.3	0.0	0.0	0.0	9.0	0.3	1.0	3.2	0.4	0.2	2.9	0.6	7.0	5.0	0.4	3.9	3.3	2.5	0.4	0.1	6.6	2.0	0.1	0.9	2.7	0.8	0.1	0.4	0.1	0.5	4.8	2.5	0.1	0.2	5.6	0.1	0.8	0.0	1.9	0.2	0.1	15.1	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.2	2.9	0.4	6.0	0.1	0.0	0.1	0.0	1.0	0.0	0.7	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.8	0.0	39.7	0.0	0.2	0.0	0.1	0.2	0.0	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.2	0.3	0.1	0.1	0.0	0.0	0.2	0.0	0.0	6.3	0.1	0.4	0.5	0.0	0.0	0.1	0.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	7.7	3.8	5.2	1.0	3.2	7.0	5.0	0.4	6.6	4.8	5.6	15.1	2.6	0.0	0.6	3.9	0.1	0.1	0.1	0.0	0.0	0.6	0.0	0.1	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.3	0.0	0.4	26.6	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	6.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.4	0.0	2.2	0.0	2.5	27.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.2	0.0	0.2	5.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1
COL11A1	"CO11A1, COLL6, DFNA37, STL2"	ENSG00000060718	"Collagen type XI alpha 1 chain"	P12107	1	102876467-103108872	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Cataract, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 20.3;retina: 9.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 83.9;Excitatory neurons: 99.5;Oligodendrocyte precursor cells: 557.4;Theca cells: 139.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 27.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 116.9;BJ: 43.2;BJ hTERT+ SV40 Large T+ RasG12V: 85.3;HBF TERT88: 48.7;HSkMC: 142.5;SuSa: 60.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA058335			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	No	No		640000	"Endoplasmic reticulum"		"HPA058335: AB_2683682"	"unprognostic (2.60e-3)"	"unprognostic (6.61e-4)"	"unprognostic (9.58e-2)"	"unprognostic (5.06e-5)"	"unprognostic (2.83e-1)"	"unprognostic (2.85e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.23e-3)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.01e-12)"	"unprognostic (1.27e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.32e-2)"	0.3	0.6	4.8	0.3	3.4	0.0	0.4	1.8	4.5	0.9	4.2	0.3	0.1	0.5	0.1	0.0	0.0	3.1	0.0	2.7	2.1	0.1	0.0	0.3	0.1	2.9	3.4	2.6	0.6	0.7	0.2	3.3	20.3	2.9	0.2	0.3	9.7	1.5	0.8	0.1	1.0	0.1	0.3	1.5	0.5	0.1	1.4	2.8	0.0	0.1	0.1	0.0	0.2	0.1	2.3	0.0	0.8	116.9	0.0	4.6	5.9	0.0	43.2	16.1	23.3	85.3	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	48.7	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	142.5	0.0	1.1	0.0	17.7	0.0	0.0	0.0	0.0	31.6	0.0	0.0	0.0	8.1	0.0	0.1	0.0	7.4	0.0	15.2	0.0	0.1	0.0	0.0	0.1	0.0	60.5	0.0	0.1	0.0	0.6	27.0	0.0	4.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	3.4	1.8	4.5	2.7	2.1	2.9	3.4	2.6	2.9	1.5	2.8	2.3	0.0	0.0	2.2	83.9	0.0	1.8	0.0	0.0	0.0	9.4	0.1	4.2	0.5	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	21.0	0.1	0.9	2.2	0.0	0.0	99.5	0.0	0.8	18.7	0.0	0.0	2.5	8.3	0.0	0.0	0.3	0.0	32.9	0.0	0.0	0.0	1.3	4.0	1.2	0.2	10.6	29.0	0.0	29.8	0.0	557.4	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.9	2.6	0.5	0.8	0.0	1.1	0.3	0.2	139.6	0.0	0.0
CYP4X1	MGC40051	ENSG00000186377	"Cytochrome P450 family 4 subfamily X member 1"	Q8N118	1	47023669-47050751	"Metabolic proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 37.4;salivary gland: 31.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 37.5;Club cells: 59.0;Excitatory neurons: 37.4;Respiratory ciliated cells: 104.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 24.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.6;CACO-2: 4.6;NTERA-2: 2.1;SCLC-21H: 2.7;T-47d: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017661	Approved					NA	NA					"HPA017661: AB_2669633"	"unprognostic (1.19e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.56e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.03e-2)"	9.8	3.2	7.4	0.7	9.4	0.1	15.0	5.9	11.2	37.4	4.6	1.6	1.7	2.1	2.8	14.9	9.4	1.6	6.3	8.8	11.0	5.9	10.6	8.9	1.9	5.5	5.8	8.8	1.2	1.7	1.7	3.8	1.1	6.3	8.1	1.9	2.3	31.3	2.9	4.7	6.4	1.4	1.9	3.8	0.7	22.5	4.0	8.5	1.1	5.0	4.1	9.2	3.4	7.2	7.6	0.0	0.0	0.0	0.0	2.6	0.2	0.1	0.0	0.1	0.0	0.0	4.6	0.0	0.0	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.6	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	2.1	0.7	0.0	0.0	0.3	0.0	0.4	0.2	2.7	0.0	0.0	0.2	0.0	0.1	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	9.4	5.9	11.2	8.8	11.0	5.5	5.8	8.8	6.3	3.8	8.5	7.6	4.4	22.4	17.0	2.3	0.0	2.5	26.9	37.5	25.0	2.4	31.0	0.9	0.8	1.5	59.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	8.4	7.6	0.8	4.0	0.0	0.0	37.4	0.7	0.0	7.1	4.1	1.4	0.0	0.0	1.1	2.8	3.9	0.0	29.3	0.2	18.3	0.6	0.7	8.6	10.5	0.5	5.4	4.7	0.0	0.1	0.0	1.0	2.0	0.1	0.0	20.7	0.0	8.4	0.5	1.7	104.6	0.8	0.0	2.0	19.1	0.5	3.6	21.4	1.4	0.1	0.5	0.1	1.9	31.8
DNAJC12	JDP1	ENSG00000108176	"DnaJ heat shock protein family (Hsp40) member C12"	Q9UKB3	10	67796669-67838188	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 70.9;liver: 68.1"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 75.9;Enteroendocrine cells: 166.2;Hepatocytes: 74.5;Intestinal goblet cells: 98.0;Proximal tubular cells: 163.2"	"Cancer enhanced"	"Detected in many"		"breast cancer: 22.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"plasmacytoid DC: 7.7"	"Lineage enriched"	"Detected in single"	24	"dendritic cells: 7.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 91.5;NB-4: 76.0;SCLC-21H: 72.0;U-698: 68.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036289	Enhanced					NA	NA					"HPA036289: AB_10670794"	"unprognostic (1.52e-2)"	"unprognostic (3.65e-3)"	"unprognostic (4.12e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (6.59e-3)"	"unprognostic (6.35e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.14e-2)"	"unprognostic (5.05e-2)"	"unprognostic (3.97e-2)"	"unprognostic (7.31e-3)"	"prognostic unfavorable (1.97e-10)"	"unprognostic (7.35e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.81e-3)"	"unprognostic (7.99e-2)"	1.3	70.9	24.5	2.3	28.9	1.5	30.5	39.0	28.8	6.0	16.0	9.2	3.2	7.3	6.0	1.2	3.5	5.4	5.5	27.6	29.9	29.8	68.1	1.7	0.6	25.1	31.8	27.0	15.1	37.3	6.6	41.5	0.1	26.9	7.7	14.3	13.8	5.4	4.9	11.0	0.3	4.8	6.1	22.3	1.2	6.6	7.1	27.9	2.1	1.5	10.0	0.7	4.5	3.4	29.2	0.0	32.9	5.3	0.9	7.5	6.1	0.1	0.1	2.0	1.1	6.8	0.5	0.0	91.5	13.4	0.1	0.4	0.0	0.9	1.2	0.3	4.4	36.9	21.9	26.9	8.5	7.9	41.7	0.5	19.3	7.6	3.2	1.9	0.1	11.4	2.6	40.5	1.2	3.2	1.8	2.0	76.0	1.5	0.4	36.4	1.2	3.0	48.2	0.8	0.0	72.0	41.1	0.5	14.4	1.3	0.3	0.7	0.4	0.0	3.5	1.0	0.8	1.0	8.6	1.0	68.2	6.6	49.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.1	0.1	0.3	0.0	0.0	0.0	7.7	0.0	0.0	24.5	28.9	39.0	28.8	27.6	29.9	25.1	31.8	27.0	26.9	22.3	27.9	29.2	1.5	0.0	1.1	2.9	2.1	0.3	2.2	1.4	0.6	31.9	75.9	35.6	9.3	1.5	13.0	5.5	6.2	0.1	0.6	7.2	9.8	1.5	5.6	2.2	24.8	2.3	166.2	9.1	12.3	55.9	0.1	8.7	6.1	1.6	0.0	2.0	1.4	74.5	0.6	38.7	14.8	98.0	8.2	2.6	0.4	4.2	16.1	3.1	0.0	1.0	3.7	13.5	0.0	11.6	13.6	43.4	4.1	21.4	0.4	26.3	1.1	163.2	20.3	5.5	0.0	4.6	5.3	2.8	0.7	0.2	0.1	0.0	0.9	21.6	4.4	1.3
ELF5		ENSG00000135374	"E74 like ETS transcription factor 5"	Q9UKW6	11	34478791-34525193	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 152.8;salivary gland: 148.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 40.3;Breast glandular cells: 143.2;Breast myoepithelial cells: 57.1;Collecting duct cells: 101.2;Cytotrophoblasts: 26.9"	"Cancer enhanced"	"Detected in many"		"breast cancer: 8.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"RT4: 30.2;T-47d: 56.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA062706			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062706: AB_2684841"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.55e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.41e-4)"	"unprognostic (6.90e-2)"	"unprognostic (3.93e-1)"	"prognostic favorable (3.64e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.86e-1)"	0.2	0.0	0.2	0.0	0.1	0.2	152.8	0.2	0.2	0.4	0.4	0.0	2.1	0.0	0.0	1.3	0.1	0.2	0.0	0.1	0.0	17.2	0.2	7.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.4	0.0	2.6	0.0	0.0	148.9	30.6	0.0	6.3	0.0	0.0	0.0	1.1	0.6	0.2	0.0	0.6	0.0	0.0	2.5	5.8	2.3	0.2	0.1	0.0	0.0	0.1	0.0	0.5	3.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	30.2	0.0	0.0	0.0	5.1	0.0	0.1	56.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	3.2	40.3	0.0	1.1	0.3	1.9	0.9	0.0	0.0	143.2	57.1	0.4	0.0	9.7	101.2	0.0	26.9	1.4	0.0	0.0	0.0	0.2	0.1	0.1	0.8	0.0	0.0	0.0	0.0	1.2	0.7	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.0	1.9	0.4	0.1	0.0	0.5	17.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.4	4.8	0.0	0.0	0.2	0.9	2.5	0.2	0.0	0.1	11.5	0.6	0.0	0.0	6.5
EN1		ENSG00000163064	"Engrailed homeobox 1"	Q05925	2	118842171-118847648	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 15.0;skeletal muscle: 14.1;skin 1: 9.0"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 5.6;Fibroblasts: 4.8;Melanocytes: 12.4;Skeletal myocytes: 12.0;Smooth muscle cells: 5.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.6"	"Region enriched"	"Detected in many"	5	"midbrain: 15.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.1;ASC TERT1: 7.2;fHDF/TERT166: 13.3;HSkMC: 13.5;PC-3: 7.8;U-138 MG: 9.9;U-2197: 11.2"	"Region enriched"	"Detected in single"	5	"midbrain: 4.9"	"Region enriched"	"Detected in some"	6	"midbrain: 23.6"	"CAB014884, HPA073141"	Enhanced		Approved	"Nucleoplasm,Nucleoli rim"		NA	NA			"Nucleoli rim"	Nucleoplasm	"CAB014884: , HPA073141: AB_2686573"	"unprognostic (5.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.84e-7)"	"unprognostic (1.87e-3)"	"unprognostic (1.90e-1)"		"unprognostic (1.95e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.38e-9)"	"unprognostic (2.15e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.30e-3)"	2.2	0.2	0.2	0.0	0.1	0.0	1.7	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.8	1.4	15.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	14.1	9.0	0.0	0.0	0.6	0.0	0.0	0.1	2.8	0.0	0.0	0.6	0.0	0.0	0.0	0.8	4.0	0.2	0.6	0.2	16.1	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	4.7	0.5	0.6	0.0	0.0	0.0	1.3	0.0	0.7	0.0	0.1	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	2.3	0.0	0.0	0.0	9.9	1.0	11.2	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.4	0.2	0.0	0.4	1.4	15.0	0.0	2.1	0.6	2.8	0.8	1.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	5.6	2.8	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	12.4	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	5.4	0.1	0.4	0.0	2.6	0.0	0.2	0.0	0.0	0.0
ESR1	"ER-alpha, Era, ESR, NR3A1"	ENSG00000091831	"Estrogen receptor 1"	P03372	6	151656691-152129619	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 84.5;endometrium 1: 111.9;fallopian tube: 65.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 86.6;Endometrial ciliated cells: 77.9;Endometrial stromal cells: 79.9;Glandular and luminal cells: 98.9;Hepatocytes: 52.1;Horizontal cells: 62.2;Skeletal myocytes: 56.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 40.2;endometrial cancer: 24.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"MCF7: 46.0;T-47d: 57.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000037, HPA000449, HPA000450, CAB055099, CAB072858"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"CAB000037: AB_563706, CAB055099: AB_2101946, CAB072858: AB_2665701, HPA000449: AB_1078753, HPA000450: AB_1078754"	"unprognostic (8.28e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.43e-2)"	"prognostic favorable (5.47e-7)"	"unprognostic (4.79e-1)"	"unprognostic (2.43e-3)"	"unprognostic (4.10e-5)"	"unprognostic (9.92e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.91e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.52e-1)"	4.3	1.9	3.3	1.5	0.9	0.8	29.4	3.1	1.3	84.5	3.3	0.9	0.4	111.9	1.2	0.5	65.5	1.2	1.6	0.7	5.4	2.8	17.0	2.0	1.6	0.5	0.5	0.6	9.1	1.0	0.2	6.7	0.4	0.9	6.2	0.5	3.5	0.9	9.9	5.9	1.0	0.8	50.8	0.4	1.7	0.6	2.3	3.9	1.1	3.4	2.6	2.3	2.2	47.3	0.6	0.6	0.0	0.1	0.1	0.1	1.9	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.6	0.0	0.0	0.0	1.2	0.1	46.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.7	0.0	3.3	0.1	0.0	0.0	0.6	0.0	0.2	57.4	0.0	0.1	0.2	0.2	0.5	0.0	5.2	1.1	0.1	0.2	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.9	3.1	1.3	0.7	5.4	0.5	0.5	0.6	0.9	0.4	3.9	0.6	0.6	0.0	1.1	1.3	2.3	1.0	1.7	0.0	0.0	3.9	86.6	16.4	4.4	0.0	1.0	0.0	8.4	0.1	0.4	0.1	1.9	0.0	40.1	77.9	79.9	2.7	1.8	0.0	4.5	0.2	0.1	11.3	0.0	98.9	2.5	36.9	5.0	52.1	0.9	62.2	5.4	0.0	0.0	4.0	3.1	10.3	4.1	2.5	1.8	1.0	0.2	2.4	0.0	25.1	0.6	0.1	0.0	2.2	8.5	0.6	0.0	3.7	1.3	4.6	0.0	56.7	11.7	1.8	1.3	0.4	1.7	0.1	2.2	4.8	0.1	6.8
F2RL2	PAR3	ENSG00000164220	"Coagulation factor II thrombin receptor like 2"	O00254	5	76615482-76623413	"G-protein coupled receptors, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 6.9"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 2.3;Fibroblasts: 3.9;Hepatic stellate cells: 10.0;Rod photoreceptor cells: 5.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 9.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	9	"basophil: 10.4"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 10.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 53.5;HBF TERT88: 33.8;HEL: 78.4;hTEC/SVTERT24-B: 34.8;hTERT-RPE1: 73.2;U-138 MG: 54.0;WM-115: 69.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.35e-3)"	"unprognostic (5.71e-3)"	"prognostic favorable (4.69e-4)"	"unprognostic (6.71e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.56e-2)"	"unprognostic (9.71e-2)"	"unprognostic (8.49e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.24e-8)"	"unprognostic (7.64e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	0.3	0.4	1.4	1.8	1.3	0.3	3.8	5.0	0.7	1.3	0.2	2.7	1.6	2.3	0.1	0.8	0.3	6.9	1.8	0.3	3.9	0.3	2.0	0.6	0.1	3.3	4.1	0.1	0.1	1.0	0.3	0.4	0.2	2.7	0.3	1.7	5.0	3.7	0.1	0.0	2.3	2.3	3.8	2.0	0.3	1.3	0.0	4.9	0.8	0.2	0.5	0.3	1.0	0.3	0.6	0.0	2.0	0.2	0.2	2.3	12.1	0.0	31.3	53.5	8.3	30.0	0.0	0.1	0.0	1.8	0.2	24.8	0.1	0.0	0.2	33.8	0.0	0.1	78.4	0.7	0.2	4.7	0.1	0.1	6.7	0.2	34.8	0.1	73.2	2.9	0.2	0.0	0.1	3.0	0.0	0.0	0.0	2.8	0.0	0.3	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	54.0	16.2	2.4	0.4	2.7	0.0	0.0	6.4	0.0	69.8	10.4	0.4	0.1	0.7	0.2	0.6	0.1	0.7	0.4	0.1	0.1	0.3	0.7	0.9	1.1	0.1	1.1	0.9	0.0	1.4	1.3	5.0	0.7	0.3	3.9	3.3	4.1	0.1	2.7	2.0	4.9	0.6	0.0	0.0	0.0	0.3	0.3	0.9	0.1	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.0	1.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	2.3	1.0	0.0	0.0	0.2	0.0	0.0	3.9	1.1	0.3	0.0	0.0	10.0	0.3	0.1	0.0	0.3	0.0	0.0	1.2	1.1	0.0	0.0	0.3	0.0	0.0	0.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.5	0.0	0.0	0.1	0.6	0.0	0.9	0.0	0.0	0.1
FAM234B	KIAA1467	ENSG00000084444	"Family with sequence similarity 234 member B"	A2RU67	12	13044381-13142521	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 23.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 29.8;Breast glandular cells: 16.8;Collecting duct cells: 18.4;Erythroid cells: 13.2;Spermatogonia: 13.7"	"Cancer enhanced"	"Detected in all"		"breast cancer: 16.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010803, HPA010850"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA010803: AB_1079200, HPA010850: AB_2732402"	"unprognostic (1.85e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.03e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.85e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.06e-3)"	"unprognostic (7.62e-2)"	3.4	2.6	11.3	1.6	15.7	3.0	16.6	10.3	23.9	2.3	4.4	1.3	1.8	2.5	3.2	2.0	2.9	1.6	1.7	16.6	17.0	5.5	2.2	2.7	1.6	10.5	13.0	14.3	2.5	2.7	3.3	5.2	5.7	15.1	6.3	1.2	17.8	2.7	2.4	2.3	12.8	1.8	2.4	6.9	2.2	1.6	5.7	12.6	2.3	8.7	1.7	1.6	2.5	2.7	15.8	3.6	3.6	10.9	7.7	8.3	8.0	8.4	2.4	2.8	5.3	10.4	3.8	5.3	14.7	2.9	2.9	9.4	5.4	13.9	2.6	11.0	1.7	7.7	8.7	4.1	3.0	4.4	7.6	4.7	6.3	5.5	7.8	5.9	8.0	7.2	10.2	2.2	5.1	5.8	12.2	6.5	4.8	14.3	2.8	2.0	8.5	14.0	1.6	3.3	8.9	15.0	4.9	5.3	3.5	4.3	18.5	4.4	4.2	3.5	3.5	5.8	6.5	2.6	2.8	3.9	9.4	11.1	3.4	4.4	0.2	1.4	1.1	1.3	2.6	1.8	2.4	1.5	1.3	1.2	3.4	2.1	2.3	0.3	1.5	4.2	2.3	1.2	0.7	11.3	15.7	10.3	23.9	16.6	17.0	10.5	13.0	14.3	15.1	6.9	12.6	15.8	5.4	3.2	3.3	0.0	2.2	0.0	2.1	0.0	1.2	29.8	16.8	3.6	0.0	2.8	0.0	18.4	2.1	9.6	1.0	0.0	1.9	2.0	9.3	1.1	1.0	3.2	12.2	13.2	0.0	1.3	3.4	1.9	0.5	1.5	0.0	2.0	5.0	2.3	3.6	3.3	0.0	0.8	0.0	1.6	0.0	3.6	5.6	1.5	0.0	0.0	2.3	4.2	1.0	0.0	0.0	1.1	1.2	5.3	1.9	3.3	2.6	1.2	0.0	3.3	0.0	1.6	1.3	9.2	13.7	2.2	0.0	3.6	1.3	1.2	0.9	1.5
FLT3	"CD135, FLK2, STK1"	ENSG00000122025	"Fms related receptor tyrosine kinase 3"	P36888	13	28003274-28100592	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.3;brain: 4.9;lymphoid tissue: 6.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 24.4;Inhibitory neurons: 59.9;Kupffer cells: 29.1;Langerhans cells: 21.4;Macrophages: 16.9;monocytes: 39.5"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.8"	"Region enhanced"	"Detected in some"		"cerebellum: 4.9"	"Group enriched"	"Detected in many"	13	"myeloid DC: 68.7;plasmacytoid DC: 26.2"	"Lineage enriched"	"Detected in many"	19	"dendritic cells: 68.7"	"Group enriched"	"Detected in some"	11	"REH: 42.5;THP-1: 26.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047539			Approved	"Endoplasmic reticulum"		NA	NA		210000	"Endoplasmic reticulum"		"HPA047539: AB_2680080"	"unprognostic (2.19e-3)"	"unprognostic (3.16e-3)"	"unprognostic (6.54e-3)"	"unprognostic (9.96e-2)"	"unprognostic (3.88e-1)"	"unprognostic (3.96e-7)"	"unprognostic (7.99e-3)"	"unprognostic (1.65e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.22e-1)"	0.5	0.1	0.4	3.0	0.3	5.3	1.5	4.9	0.8	0.5	0.2	0.7	0.3	0.2	0.1	0.6	0.4	1.6	0.1	0.2	0.5	1.5	0.5	0.7	6.5	1.2	0.9	0.2	0.1	2.8	0.0	0.0	0.0	1.7	0.1	0.8	0.1	0.4	0.2	0.0	0.7	1.6	0.8	0.8	5.7	0.6	0.6	0.8	4.7	0.1	0.3	3.6	1.3	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.2	0.6	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	3.6	3.4	0.0	0.8	0.0	0.2	0.0	0.0	68.7	0.0	0.0	0.0	0.1	2.0	0.0	26.2	0.0	2.7	0.4	0.3	4.9	0.8	0.2	0.5	1.2	0.9	0.2	1.7	0.8	0.8	1.2	0.0	0.0	0.0	2.3	1.5	0.3	0.0	0.0	0.0	0.0	1.5	1.0	0.4	1.5	0.0	0.0	0.0	0.0	24.4	0.0	0.0	2.7	3.7	0.3	0.1	0.2	0.0	8.2	7.4	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.7	0.1	0.5	0.0	59.9	0.0	0.0	29.1	21.4	2.3	0.0	16.9	1.8	1.9	39.5	0.0	0.0	1.5	4.2	0.1	0.0	0.0	2.2	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.2	0.6	0.0	0.6	0.0	1.7	0.0	0.0	0.0
GALNT6	GalNAc-T6	ENSG00000139629	"Polypeptide N-acetylgalactosaminyltransferase 6"	Q8NCL4	12	51351247-51392867	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 63.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 49.2;Gastric mucus-secreting cells: 130.5;granulocytes: 164.5;Oligodendrocytes: 57.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 31.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 29.1"	"Group enriched"	"Detected in all"	4	"granulocytes: 29.1;monocytes: 9.7;NK-cells: 15.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 107.0;CACO-2: 104.1;OE19: 97.6;SK-BR-3: 110.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA011762, HPA017086"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		4800000	"Nucleoplasm, Golgi apparatus"		"HPA011762: AB_1849450, HPA017086: AB_1849452"	"unprognostic (2.03e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.26e-2)"	"prognostic favorable (9.85e-4)"	"unprognostic (1.35e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.27e-2)"	"prognostic favorable (5.40e-4)"	"unprognostic (1.88e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.13e-4)"	"unprognostic (5.65e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.18e-2)"	1.7	3.1	2.6	8.1	10.5	9.7	18.3	6.4	10.5	32.4	0.6	6.8	21.4	1.3	24.9	2.4	6.6	2.4	0.4	3.6	7.1	2.0	1.2	5.8	7.3	11.2	11.1	2.0	0.9	8.3	1.4	1.1	9.7	13.8	0.9	7.0	0.1	31.3	3.2	0.4	5.6	21.8	1.6	5.0	8.3	63.1	0.6	9.6	6.9	2.5	0.1	6.0	3.7	1.8	17.8	39.0	4.1	0.7	0.1	0.0	0.6	59.8	63.0	107.0	25.4	17.0	104.1	19.0	0.5	5.8	34.4	0.0	35.9	1.5	27.3	17.1	8.3	4.1	24.6	0.7	0.8	1.0	13.6	82.2	2.3	25.2	23.1	23.0	0.2	65.7	14.2	5.4	1.0	0.1	73.7	43.2	10.1	5.3	97.6	66.6	0.2	0.1	10.3	21.3	2.2	0.5	23.5	0.4	110.5	0.1	12.2	59.3	5.9	75.7	0.2	12.9	0.2	0.3	2.1	0.5	3.6	7.2	29.5	0.2	7.1	5.8	29.1	3.8	5.2	1.6	1.2	2.2	3.1	4.5	3.3	3.4	2.9	1.1	15.5	9.7	4.1	1.7	3.2	2.6	10.5	6.4	10.5	3.6	7.1	11.2	11.1	2.0	13.8	5.0	9.6	17.8	0.8	3.2	2.4	0.3	11.8	2.9	3.8	5.8	5.7	0.4	38.9	18.4	1.3	1.5	15.6	1.8	0.0	14.1	11.3	12.4	3.9	2.6	2.0	3.5	0.3	4.1	0.0	15.3	1.0	10.9	49.2	1.6	130.5	5.8	164.5	3.8	1.4	0.3	14.4	0.0	0.5	17.4	2.0	16.3	10.3	1.5	0.0	15.1	1.8	1.0	7.2	0.2	9.2	0.0	57.6	24.3	33.9	0.4	5.5	7.6	39.6	2.0	12.4	0.0	0.0	1.5	1.5	0.4	1.6	2.6	9.2	4.8	14.9	1.8	11.8	5.8
GLRA3		ENSG00000145451	"Glycine receptor alpha 3"	O75311	4	174636920-174829247	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 6.7;breast: 2.0"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 25.3;Early spermatids: 24.7;Excitatory neurons: 52.4;Inhibitory neurons: 11.2;Late spermatids: 22.8"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.75e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-2)"		"unprognostic (1.36e-1)"	"unprognostic (9.02e-2)"		"unprognostic (3.82e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.64e-5)"	"unprognostic (4.61e-4)"	"unprognostic (2.24e-1)"		"unprognostic (1.15e-2)"	0.0	0.8	3.0	0.0	4.0	0.0	2.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	4.0	0.0	0.0	0.0	0.2	1.0	3.2	2.8	0.0	0.4	0.0	0.6	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.5	6.7	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.0	4.0	0.0	2.8	2.5	4.0	1.0	3.2	2.8	0.6	0.5	6.7	1.2	0.0	0.0	0.6	1.3	1.6	0.0	1.3	0.0	0.0	5.0	25.3	0.3	2.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.1	0.4	0.0	0.0	52.4	0.0	0.0	1.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	22.8	0.0	0.1	0.0	2.8	0.0	0.2	0.0	1.0	1.0	0.2	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.6	0.0	1.0	0.3	0.7	1.6	0.1	0.1	0.0	0.3	0.0	0.0	0.4
GREB1L	"C18orf6, FLJ13687, KIAA1772"	ENSG00000141449	"GREB1 like retinoic acid receptor coactivator"	Q9C091	18	21242242-21525417	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 9.2"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 95.2;Inhibitory neurons: 39.2;Leydig cells: 46.0;Oligodendrocytes: 252.5"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 50.7;BEWO: 100.9;CACO-2: 45.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA041647, HPA044218"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA041647: AB_2677597, HPA044218: AB_2678859"	"unprognostic (1.88e-3)"	"unprognostic (9.01e-4)"	"unprognostic (2.92e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.32e-3)"	"unprognostic (2.87e-2)"	"unprognostic (3.30e-8)"	"unprognostic (4.72e-3)"	"unprognostic (1.89e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.35e-1)"	2.6	1.4	5.4	0.1	4.0	0.2	3.3	3.6	2.5	0.9	0.0	0.4	0.1	2.7	2.8	0.2	4.5	0.1	4.7	2.1	5.9	0.3	1.8	0.2	0.1	3.8	4.0	1.3	3.8	0.1	0.3	1.3	2.1	5.1	1.6	0.1	3.1	0.5	2.9	9.2	1.2	0.5	0.8	1.0	0.0	0.6	6.2	5.2	0.0	3.8	6.8	0.0	0.1	0.7	4.2	0.0	0.9	50.7	0.0	11.4	0.0	100.9	2.4	2.4	4.3	3.8	45.7	3.7	0.1	5.1	7.6	0.1	9.7	19.4	2.4	7.5	0.7	9.3	0.0	13.4	0.4	0.3	0.0	0.0	0.0	0.7	0.1	9.3	0.5	0.0	1.4	0.0	0.3	10.5	3.5	0.2	0.2	4.9	0.4	6.0	0.2	0.0	2.0	4.8	8.7	3.2	0.0	0.1	1.6	0.2	13.2	2.7	0.2	20.9	0.5	2.9	4.9	0.0	0.1	0.7	0.0	2.2	0.0	0.4	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.4	4.0	3.6	2.5	2.1	5.9	3.8	4.0	1.3	5.1	1.0	5.2	4.2	0.4	0.0	0.5	0.7	0.4	0.1	0.1	1.0	0.0	32.3	3.1	1.1	13.4	0.0	1.1	3.7	2.1	3.2	1.8	0.1	0.0	0.2	8.3	2.2	3.4	0.5	0.0	0.0	23.1	0.4	13.2	6.2	0.0	7.0	0.0	95.2	0.0	3.1	0.5	0.0	39.2	0.2	0.0	0.0	1.1	17.9	46.0	0.3	1.8	2.8	0.1	0.8	2.1	8.0	252.5	2.8	0.0	35.7	0.0	0.6	0.3	0.0	2.3	1.6	6.6	2.8	2.3	4.3	5.6	0.0	0.9	1.5	0.3	10.5	1.5	0.2
HCAR1	"FKSG80, GPR104, GPR81, HCA1, LACR1, TA-GPCR"	ENSG00000196917	"Hydroxycarboxylic acid receptor 1"	Q9BXC0	12	122726076-122730844	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 11.6;parathyroid gland: 40.7"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 8.7;Breast myoepithelial cells: 5.2;Club cells: 3.2;Early spermatids: 9.6;Extravillous trophoblasts: 3.7;Late spermatids: 6.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 7.9"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.1;MCF7: 8.1;RT4: 35.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"									NA	NA						"prognostic unfavorable (3.61e-5)"	"unprognostic (8.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.80e-4)"	"unprognostic (5.43e-4)"	"unprognostic (1.41e-1)"	"unprognostic (7.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.87e-2)"	5.6	0.3	0.5	0.2	0.5	1.0	11.6	1.6	0.8	0.6	0.5	0.1	0.3	0.4	1.2	0.2	1.7	0.2	0.2	0.6	0.2	0.8	0.1	0.4	0.4	0.4	0.2	0.6	0.4	0.1	40.7	0.3	1.0	0.6	1.1	0.1	0.6	5.0	5.1	1.2	0.7	0.3	0.2	0.1	2.3	2.0	0.8	0.3	0.4	1.3	0.1	0.1	1.2	0.3	1.3	0.1	0.3	0.2	0.3	0.0	0.0	1.9	0.1	0.0	0.0	0.1	2.5	12.1	0.3	0.4	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.6	1.8	0.2	0.3	0.2	0.6	0.0	0.6	0.0	0.1	0.0	0.2	0.2	0.6	0.1	8.1	0.2	0.4	0.3	3.0	0.6	0.3	0.2	0.3	0.1	35.3	2.6	0.2	0.1	4.2	0.0	0.3	3.4	0.1	0.3	0.4	0.2	0.2	0.2	0.4	0.1	0.4	0.2	0.2	0.3	2.0	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	1.2	0.4	0.1	0.3	0.1	0.1	0.5	0.5	1.6	0.8	0.6	0.2	0.4	0.2	0.6	0.6	0.1	0.3	1.3	1.3	0.0	0.5	0.0	0.0	0.1	1.4	0.2	0.0	0.3	8.7	5.2	0.4	0.0	3.2	0.0	0.0	0.4	0.3	0.0	0.0	0.0	9.6	0.2	0.2	0.3	0.0	0.0	0.0	0.0	3.7	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	6.5	0.3	0.3	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.1	1.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	1.0
HDC		ENSG00000140287	"Histidine decarboxylase"	P19113	15	50241947-50265965	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 87.6;epididymis: 46.5"	"Cell type enriched"	"Detected in some"	12	"granulocytes: 596.0"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.9;testis cancer: 2.7"	"Group enriched"	"Detected in many"	5	"hypothalamus: 87.6;pons: 36.0"	"Immune cell enriched"	"Detected in single"	2140	"basophil: 686.2"	"Lineage enriched"	"Detected in single"	2140	"granulocytes: 686.2"	"Group enriched"	"Detected in some"	4	"HEL: 460.8;HMC-1: 1051.3"	"Region enriched"	"Detected in many"	5	"hypothalamus: 43.9"	"Group enriched"	"Detected in some"	10	"hypothalamus: 16.5;midbrain: 4.2"	HPA038891	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA038891: AB_10673231"	"unprognostic (4.97e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.93e-7)"	"unprognostic (4.18e-5)"	"unprognostic (8.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	2.0	0.4	0.2	3.5	3.6	4.7	1.4	0.0	0.2	2.3	0.6	3.8	4.1	2.6	46.5	4.9	0.8	11.3	0.7	0.2	87.6	0.4	0.5	7.0	0.9	0.0	8.1	0.0	0.1	1.2	0.5	0.4	0.4	36.0	1.8	3.6	0.8	1.3	1.0	0.3	2.0	4.6	2.5	0.0	0.5	13.0	1.3	12.9	0.9	0.1	0.8	1.0	3.8	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	460.8	0.2	0.0	0.0	1.2	1051.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.5	181.8	0.3	0.0	0.0	0.2	0.4	0.4	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.5	0.2	0.4	686.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	1.6	0.2	3.6	0.0	0.2	0.2	87.6	0.0	8.1	0.0	36.0	0.0	12.9	0.1	0.0	12.8	47.5	0.3	0.0	0.8	0.0	0.0	0.0	2.6	0.0	0.0	0.5	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	10.9	0.3	0.0	0.0	2.3	9.2	0.0	596.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.8	0.4	0.0	1.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	3.5	0.0	0.1	0.1
HOXC12	"HOC3F, HOX3, HOX3F"	ENSG00000123407	"Homeobox C12"	P31275	12	53954903-53958956	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"skin 1: 2.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 1.8;stomach cancer: 2.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 23.4;OE19: 35.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055632	Uncertain					NA	NA					"HPA055632: AB_2682867"	"unprognostic (6.95e-2)"	"unprognostic (2.34e-2)"				"unprognostic (1.10e-1)"		"unprognostic (4.37e-2)"	"unprognostic (5.98e-2)"			"unprognostic (1.45e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.84e-2)"	"unprognostic (2.55e-1)"			0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.6	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	1.1	0.2	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HS6ST3		ENSG00000185352	"Heparan sulfate 6-O-sulfotransferase 3"	Q8IZP7	13	96090107-96839562	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.6"	"Group enriched"	"Detected in some"	27	"Excitatory neurons: 1308.8;Inhibitory neurons: 893.1;Oligodendrocyte precursor cells: 968.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RT4: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA078257			Approved	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments"	"Intracellular and membrane"	NA	NA		24000	"Nucleoplasm, Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA078257: AB_2732374"	"unprognostic (2.34e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.78e-2)"		"unprognostic (1.55e-1)"		"unprognostic (3.67e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (6.12e-5)"	"unprognostic (1.54e-4)"	"unprognostic (2.24e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.89e-2)"	0.8	4.3	2.5	0.2	4.0	0.0	0.3	0.0	9.7	1.8	0.0	0.2	0.4	2.1	2.1	0.4	0.5	0.2	0.7	11.6	6.7	0.8	0.0	0.0	0.0	0.7	2.7	6.8	0.1	2.2	2.1	2.0	0.0	1.1	0.2	0.1	2.2	0.0	0.3	1.1	0.3	0.4	1.6	0.0	0.0	0.9	0.3	6.0	0.0	2.4	0.0	0.0	2.7	0.2	3.7	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	1.1	0.0	1.2	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	17.3	0.9	0.7	0.1	0.1	0.0	0.2	0.5	0.0	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	4.0	0.0	9.7	11.6	6.7	0.7	2.7	6.8	1.1	0.0	6.0	3.7	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.3	0.6	0.1	0.0	0.0	1308.8	0.6	0.1	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	3.3	893.1	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	38.4	0.0	0.9	0.0	968.6	16.5	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.2	0.0	0.1	1.8	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8
IL20	"IL-20, IL10D, ZCYTO10"	ENSG00000162891	"Interleukin 20"	Q9NYY1	1	206865623-206869223	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"Basal keratinocytes: 69.6"	"Cancer enhanced"	"Detected in some"		"breast cancer: 3.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SiHa: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025802	Uncertain				"Secreted to blood"	NA	NA	109000				"CAB025802: "	"unprognostic (3.08e-2)"	"unprognostic (1.91e-1)"		"unprognostic (1.82e-1)"		"unprognostic (1.16e-2)"		"unprognostic (6.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.60e-1)"		"unprognostic (3.38e-2)"	"unprognostic (1.67e-1)"		"unprognostic (1.71e-1)"	0.8	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.9	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.6	6.6	15.1	0.0	0.0	9.4	3.7	0.1	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.3	0.1	0.3	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.1	0.0	2.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.5	0.3	0.0	9.9	0.0	0.1	0.0	0.1	7.3
IRS4	"IRS-4, PY160"	ENSG00000133124	"Insulin receptor substrate 4"	O14654	X	108719946-108736563	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		Transducer	"Cancer-related genes, Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.3;choroid plexus: 6.6;ovary: 4.7;pituitary gland: 5.3"	"Cell type enhanced"	"Detected in some"		"Inhibitory neurons: 2.9;Oligodendrocytes: 1.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 9.4;NTERA-2: 1.3;RT4: 3.1;WM-115: 2.2"	"Group enriched"	"Detected in many"	5	"basal ganglia: 11.7;hypothalamus: 45.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 14.5;hypothalamus: 36.7"	HPA017372	Uncertain					NA	NA					"HPA017372: AB_2669600"	"unprognostic (3.74e-3)"				"unprognostic (3.27e-2)"			"unprognostic (1.32e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.65e-1)"		"unprognostic (1.05e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.28e-4)"	"unprognostic (8.71e-2)"	0.0	0.0	3.6	0.0	1.3	0.0	0.0	0.0	0.6	1.0	6.6	0.0	0.0	1.4	0.5	0.0	0.2	0.0	0.0	1.4	10.3	0.0	0.0	0.0	0.0	2.1	2.3	0.5	4.7	0.0	0.0	5.3	0.0	2.2	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.5	0.9	0.0	0.2	0.0	7.6	3.8	1.8	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	1.3	0.0	0.6	1.4	10.3	2.1	2.3	0.5	2.2	0.9	7.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IRX2		ENSG00000170561	"Iroquois homeobox 2"	Q9BZI1	5	2745845-2751677	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.9;breast: 24.3;salivary gland: 30.9;skin 1: 25.6"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 109.0;Alveolar cells type 2: 74.2;Basal keratinocytes: 202.1;Breast glandular cells: 147.4;Breast myoepithelial cells: 159.8;Suprabasal keratinocytes: 131.3"	"Cancer enhanced"	"Detected in many"		"breast cancer: 14.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 93.2;BEWO: 56.4;HaCaT: 32.0;hTCEpi: 68.9;SK-BR-3: 39.1"	"Group enriched"	"Detected in many"	5	"midbrain: 26.5;pons and medulla: 20.9;thalamus: 11.2"	"Region enhanced"	"Detected in some"		"pons: 5.1"	"HPA050895, HPA054669"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA050895: AB_2616458, HPA054669: AB_2682566"	"unprognostic (9.79e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.50e-3)"	"unprognostic (8.12e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (8.84e-4)"	"unprognostic (2.62e-2)"	"unprognostic (3.98e-7)"	"unprognostic (4.40e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.97e-2)"	2.5	0.1	2.8	0.0	2.5	0.0	24.3	5.3	5.3	0.3	0.4	0.7	0.0	0.0	3.1	4.5	0.2	0.0	1.6	0.8	3.3	8.6	0.0	18.2	0.2	16.0	7.7	0.3	0.0	2.0	3.0	1.6	5.6	22.9	3.6	0.3	1.1	30.9	0.9	0.3	25.6	0.0	0.0	3.6	0.0	15.8	2.1	5.7	0.5	1.9	0.7	0.2	0.2	2.0	18.2	10.7	0.0	93.2	0.0	5.4	3.9	56.4	5.4	3.4	5.0	4.0	11.8	0.0	0.0	0.0	11.5	0.0	32.0	0.1	24.6	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	68.9	2.4	20.1	0.0	0.0	0.0	0.0	0.0	3.6	19.1	0.0	0.1	10.2	25.7	0.0	0.0	5.7	0.0	22.7	0.0	3.5	0.0	18.6	39.1	0.0	14.3	4.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	2.5	5.3	5.3	0.8	3.3	16.0	7.7	0.3	22.9	3.6	5.7	18.2	5.5	109.0	74.2	0.0	0.2	202.1	17.6	33.1	31.9	1.4	147.4	159.8	2.7	0.0	23.9	7.3	0.0	27.8	1.2	3.0	27.4	0.1	5.0	0.1	0.4	2.9	0.0	0.0	0.0	0.0	18.6	15.0	15.3	0.0	1.3	0.1	0.0	0.0	3.3	0.0	0.0	2.5	14.2	0.0	15.4	10.4	0.0	0.7	19.6	0.0	0.0	0.3	0.0	1.5	0.0	0.3	2.9	0.0	0.1	23.5	0.2	0.6	13.0	2.5	0.0	3.6	14.6	9.4	9.4	20.1	131.3	15.2	0.9	0.0	2.8	8.3
IRX5	IRX-2a	ENSG00000176842	"Iroquois homeobox 5"	P78411	16	54930865-54934485	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Vision"	DNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 14.2;salivary gland: 10.2;skin 1: 15.4"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 40.3;Breast myoepithelial cells: 55.5;Granulosa cells: 43.8;Muller glia cells: 43.1;Squamous epithelial cells: 33.9"	"Cancer enhanced"	"Detected in many"		"breast cancer: 20.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 27.1;T-47d: 36.6;THP-1: 20.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA047130			Approved	"Nuclear speckles,Microtubules,Cytosol"		No	NA			"Nuclear speckles"	"Microtubules, Cytosol"	"HPA047130: AB_10962983"	"unprognostic (2.63e-1)"	"unprognostic (4.49e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.38e-3)"	"prognostic favorable (4.59e-4)"	"unprognostic (8.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.34e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.77e-3)"	"unprognostic (4.28e-2)"	1.0	0.6	1.4	0.0	1.3	0.0	14.2	4.5	0.5	1.0	0.2	0.2	0.0	0.1	0.0	7.3	0.2	0.1	5.3	0.2	1.9	3.2	0.0	6.4	0.0	3.3	3.8	0.0	0.3	0.1	0.3	0.4	0.0	3.0	3.5	0.0	1.3	10.2	0.2	1.4	15.4	0.0	0.0	3.5	0.0	2.6	0.8	4.5	0.3	0.1	1.1	0.0	0.6	5.9	3.8	0.8	0.5	8.6	3.2	3.1	0.6	0.4	3.3	8.2	1.1	0.8	1.9	0.8	0.0	0.7	4.5	0.3	8.4	3.0	3.6	0.6	6.0	4.1	0.9	3.4	0.0	0.1	2.0	3.3	0.8	15.1	5.4	2.3	1.5	0.0	4.8	0.5	0.0	6.2	3.3	9.6	12.3	0.1	1.3	2.4	5.0	4.4	0.5	27.1	0.2	2.9	3.0	1.4	7.3	3.9	0.0	36.6	20.2	0.5	5.9	0.2	4.2	1.3	3.6	2.3	2.9	9.6	3.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.3	4.5	0.5	0.2	1.9	3.3	3.8	0.0	3.0	3.5	4.5	3.8	2.4	9.6	21.9	0.0	0.1	8.3	9.7	6.7	15.9	8.6	40.3	55.5	11.1	0.0	15.4	0.0	0.0	0.2	1.0	0.2	0.0	0.3	1.0	9.6	1.2	1.6	0.0	0.0	0.0	0.6	0.0	5.3	7.7	12.2	0.0	43.8	0.0	0.0	0.2	1.7	0.0	0.8	4.1	0.0	2.7	2.4	0.0	0.6	5.4	0.0	0.0	43.1	0.0	0.0	0.0	2.9	0.3	0.0	0.3	4.8	0.0	1.5	13.0	1.9	0.0	8.3	5.2	0.7	2.8	33.9	8.0	0.0	0.4	0.0	0.5	8.5
KCNE4	MiRP3	ENSG00000152049	"Potassium voltage-gated channel subfamily E regulatory subunit 4"	Q8WWG9	2	223051814-223198399	"Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 37.8"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 32.3;Melanocytes: 32.0;Sertoli cells: 118.3;Smooth muscle cells: 128.3"	"Cancer enhanced"	"Detected in all"		"breast cancer: 20.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AN3-CA: 164.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA011420	Approved		Approved	"Nuclear bodies,Microtubules"		NA	NA			Microtubules	"Nuclear bodies"	"HPA011420: AB_1079170"	"unprognostic (1.23e-1)"	"unprognostic (2.02e-3)"	"prognostic unfavorable (9.42e-5)"	"unprognostic (2.17e-2)"	"unprognostic (7.56e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.89e-2)"	"prognostic unfavorable (2.02e-7)"	"unprognostic (4.70e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.24e-3)"	"unprognostic (9.08e-3)"	12.9	3.4	10.3	11.1	8.2	0.5	7.0	7.3	10.2	5.0	7.6	6.4	1.3	31.0	2.3	5.1	8.0	20.5	10.4	9.2	9.4	4.2	5.2	3.1	5.7	11.2	7.8	7.6	12.4	10.4	1.8	10.4	6.8	10.1	4.5	2.0	3.4	2.7	5.6	5.4	2.8	3.6	37.8	8.7	4.5	12.6	1.1	8.7	0.7	9.5	3.2	1.1	10.8	3.8	11.7	0.0	0.8	0.0	164.3	36.6	3.7	0.2	4.0	3.8	0.8	1.8	0.0	0.2	0.0	0.0	2.5	5.8	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.3	0.0	4.5	0.0	0.1	6.3	0.0	5.5	0.0	0.0	0.0	0.1	0.0	0.2	6.7	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.4	0.1	0.1	0.4	6.4	0.1	12.1	0.7	0.1	0.0	0.0	3.8	0.1	3.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.3	8.2	7.3	10.2	9.2	9.4	11.2	7.8	7.6	10.1	8.7	8.7	11.7	8.2	0.0	2.2	4.2	0.0	3.8	0.4	0.2	0.0	0.1	1.8	0.4	4.9	0.0	1.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.8	16.3	19.8	4.8	0.0	0.0	0.0	0.2	32.3	9.2	0.6	3.8	0.4	3.9	0.2	0.1	3.3	0.3	0.0	2.0	0.0	5.8	0.3	21.1	1.0	32.0	5.6	0.0	6.1	0.0	1.0	0.0	0.4	0.1	17.0	0.4	1.4	0.0	0.0	3.7	0.7	118.3	1.7	128.3	0.1	0.2	0.4	3.1	0.3	0.6	0.1	0.2	1.8
KRT81	"Hb-1, KRTHB1"	ENSG00000205426	"Keratin 81"	Q14533	12	52285913-52291534	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"skin 1: 86.9"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 41.0;Club cells: 20.4;Ductal cells: 67.3;Pancreatic endocrine cells: 27.2"	"Cancer enhanced"	"Detected in many"		"breast cancer: 46.1;cervical cancer: 49.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	49	"basophil: 170.8"	"Lineage enriched"	"Detected in many"	49	"granulocytes: 170.8"	"Cell line enhanced"	"Detected in many"		"A-431: 3086.0;A549: 2296.0;MCF7: 700.1;PC-3: 1088.7;U-251 MG: 2151.1"									HPA049778	Supported					NA	NA		130000000			"HPA049778: AB_2680877"	"unprognostic (1.69e-2)"	"unprognostic (5.61e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.64e-4)"	"unprognostic (5.98e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.31e-2)"	0.8	0.0	0.3	0.2	0.4	0.3	3.1	0.3	0.6	0.1	0.1	0.2	0.3	0.3	0.2	0.1	0.1	0.0	0.0	0.4	0.5	0.0	0.1	0.2	0.0	0.4	0.3	0.3	0.0	0.2	0.0	0.1	1.0	0.4	0.3	0.0	0.0	2.1	0.2	0.2	86.9	0.2	0.0	0.3	0.2	0.1	0.4	0.4	0.2	0.9	0.0	0.0	0.1	0.1	0.4	3086.0	2296.0	0.0	0.0	0.0	0.0	0.3	18.6	3.2	23.9	2.2	6.7	0.7	0.0	3.0	0.3	1.6	43.2	0.0	0.0	4.2	4.6	0.0	0.0	1.3	0.2	1.4	0.0	0.2	0.0	0.0	0.4	1.1	32.9	0.0	0.0	0.0	1.6	0.2	700.1	0.3	6.4	0.2	0.1	1088.7	0.5	0.0	10.4	0.6	0.2	0.7	0.0	1.0	179.1	11.1	0.1	0.5	12.9	0.2	0.4	564.4	0.2	2151.1	0.3	4.4	3.1	0.4	7.2	0.2	170.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.3	0.3	0.4	0.3	0.6	0.4	0.5	0.4	0.3	0.3	0.4	0.3	0.4	0.4	0.1	0.0	0.0	0.3	0.0	0.0	3.3	4.4	0.0	0.0	41.0	4.6	0.3	0.0	20.4	0.0	0.0	0.1	12.8	0.1	0.0	67.3	0.9	1.9	0.3	0.4	0.0	0.0	3.9	1.3	2.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.2	4.1	0.0	0.4	2.5	0.0	0.1	0.0	1.0	0.0	0.0	6.2	0.0	3.3	27.2	0.0	0.0	0.1	2.6	0.0	0.0	2.0	0.0	0.0	1.2	6.8	0.0	0.1	0.0	0.3	2.9	10.5	0.0	0.0	6.0
LEP	"OB, OBS"	ENSG00000174697	Leptin	P41159	7	128241278-128257629	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	39	"adipose tissue: 310.3;breast: 90.9"	"Group enriched"	"Detected in some"	44	"Extravillous trophoblasts: 124.2;Syncytiotrophoblasts: 432.2"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;SuSa: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010490	Approved				"Secreted to blood"	NA	NA	17000000	19000000			"CAB010490: AB_2296951"	"unprognostic (8.19e-3)"	"unprognostic (5.33e-1)"	"unprognostic (1.60e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.99e-3)"	"unprognostic (1.83e-1)"		"unprognostic (6.56e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.84e-2)"	310.3	0.9	0.2	5.1	0.1	0.1	90.9	0.5	0.3	0.1	0.2	2.0	0.1	0.0	0.0	0.2	0.1	1.3	0.7	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.1	2.4	0.0	0.0	4.6	0.2	0.0	0.4	0.0	1.1	0.0	0.7	2.9	1.2	0.1	0.0	0.2	0.5	0.2	0.1	0.3	0.2	1.2	0.0	1.0	0.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.3	0.2	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.2	0.9	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.8	0.1	0.6	0.3	0.0	0.2	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	124.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	6.2	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.1	432.2	0.1	0.1	0.0	0.1
LRP1B	"LRP-DIT, LRPDIT"	ENSG00000168702	"LDL receptor related protein 1B"	Q9NZR2	2	140231423-142131016	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 23.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2119.8;Excitatory neurons: 3755.5;Inhibitory neurons: 2917.8;Oligodendrocyte precursor cells: 5568.9;Oligodendrocytes: 1203.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 0.8;glioma: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.5;HEK 293: 1.7;U-138 MG: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069094, HPA074788"	Approved		Approved	Vesicles		NA	NA		370000	Vesicles		"HPA069094: AB_2686082, HPA074788: AB_2797273"	"unprognostic (5.31e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.36e-4)"	"unprognostic (5.19e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.75e-1)"	"unprognostic (7.02e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.94e-3)"	"unprognostic (4.85e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.36e-1)"	2.4	1.4	13.4	0.0	23.0	0.0	1.7	7.2	19.3	0.2	0.0	0.3	0.0	0.0	2.2	0.0	0.3	0.1	0.2	22.2	8.6	0.4	0.2	0.1	0.0	8.2	10.1	18.0	0.6	0.1	0.1	1.9	0.0	8.4	0.9	0.0	2.6	0.6	1.0	4.5	0.3	0.1	0.0	2.9	0.0	0.4	0.3	11.5	0.2	5.7	3.5	0.0	0.1	0.9	20.5	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.1	0.2	1.7	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.4	23.0	7.2	19.3	22.2	8.6	8.2	10.1	18.0	8.4	2.9	11.5	20.5	1.4	0.0	0.0	2119.8	0.0	0.3	0.5	0.0	3.4	14.9	0.2	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.9	0.1	1.7	0.2	0.0	0.0	3755.5	0.0	0.0	9.1	0.0	0.5	0.0	0.1	0.0	0.5	0.0	0.0	2917.8	0.0	0.0	0.0	0.5	5.4	1.2	0.1	0.0	142.4	0.0	2.4	0.0	5568.9	1203.1	0.0	0.0	0.7	0.0	0.3	0.0	0.2	0.0	0.8	0.0	1.1	0.4	0.2	0.3	0.2	0.3	0.0	0.1	0.2	0.0	0.8
LRRC15	LIB	ENSG00000172061	"Leucine rich repeat containing 15"	Q8TF66	3	194355249-194369743	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 5.0;skin 1: 5.3"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 1.9;Endothelial cells: 1.0;Fibroblasts: 2.3;Hepatic stellate cells: 1.8;Langerhans cells: 3.0;Suprabasal keratinocytes: 1.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 25.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"fHDF/TERT166: 120.6;U-87 MG: 62.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035503	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA		1700000	Vesicles	"Plasma membrane"	"HPA035503: AB_10961253"	"unprognostic (3.20e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-8)"	"unprognostic (5.81e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.62e-3)"	"unprognostic (7.54e-3)"	1.1	0.1	0.0	1.4	0.0	0.0	3.7	0.0	0.1	2.9	0.1	1.7	0.5	1.9	0.0	0.5	1.1	1.6	0.1	0.0	0.0	0.0	0.1	2.0	0.8	0.0	0.1	0.0	0.2	0.1	0.1	0.0	2.3	0.0	0.1	3.1	0.0	1.0	0.0	0.1	5.3	0.4	0.6	0.0	1.3	1.5	0.0	0.0	0.2	1.3	0.2	5.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.7	0.1	0.1	0.4	0.0	0.0	1.0	120.6	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	7.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	22.5	3.7	3.0	0.0	0.0	0.0	0.0	62.7	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0
MALRD1	"bA265G8.2, C10orf112, Diet1"	ENSG00000204740	"MAM and LDL receptor class A domain containing 1"	Q5VYJ5	10	19048801-19790401	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 31.4"	"Group enriched"	"Detected in some"	4	"Astrocytes: 37.9;Oligodendrocyte precursor cells: 76.4;Proximal enterocytes: 69.3"	"Cancer enhanced"	"Detected in some"		"breast cancer: 0.9;stomach cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"Karpas-707: 44.2"	"Not detected"	"Not detected"							"HPA035732, HPA038106, HPA046848"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA035732: AB_2674756, HPA038106: AB_2675836, HPA046848: AB_2679837"	"unprognostic (9.03e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.40e-2)"	"unprognostic (4.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.69e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.80e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.78e-4)"	0.5	0.7	1.8	0.2	1.8	0.4	0.6	1.1	1.3	0.6	1.2	0.4	30.9	0.6	2.2	0.2	0.2	0.4	0.9	1.7	3.6	1.5	0.1	0.9	0.1	1.4	1.1	1.2	1.2	0.1	0.0	1.5	0.4	1.4	0.6	0.1	0.3	0.1	0.3	0.6	0.2	31.4	0.4	1.5	0.2	0.3	2.1	1.4	1.9	0.5	0.1	0.0	0.6	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.8	0.0	2.6	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	44.2	0.0	4.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.8	1.8	1.1	1.3	1.7	3.6	1.4	1.1	1.2	1.4	1.5	1.4	1.6	0.0	0.0	1.8	37.9	0.0	0.4	0.2	0.0	0.0	0.1	0.1	0.6	1.6	0.0	0.0	0.0	0.0	0.8	1.3	0.0	1.9	0.1	7.9	0.1	0.3	0.1	0.0	4.2	11.6	0.0	0.8	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	11.0	9.5	0.0	0.0	0.3	1.8	0.0	0.0	0.0	5.6	0.0	1.4	0.0	76.4	4.9	0.0	13.8	0.7	0.0	0.2	69.3	0.2	0.0	0.0	0.0	0.1	0.2	9.0	4.1	0.1	0.1	0.3	0.0	1.9	9.7	0.0
MAPT	"DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau"	ENSG00000186868	"Microtubule associated protein tau"	P10636	17	45894527-46028334	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Alzheimer disease, Disease variant, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 68.5;skeletal muscle: 79.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 142.4;Bipolar cells: 314.4;Early spermatids: 199.9;Excitatory neurons: 189.2;Horizontal cells: 361.7;Inhibitory neurons: 153.7;Late spermatids: 416.6;Muller glia cells: 145.7;Oligodendrocytes: 163.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 9.5;glioma: 13.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"HDLM-2: 69.0;SCLC-21H: 21.1;T-47d: 34.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000151, HPA048895, HPA069524, HPA069570, CAB072344"	Enhanced		Supported	"Nuclear speckles,Plasma membrane"	"Secreted to blood"	NA	NA		7100	"Plasma membrane"	"Nuclear speckles"	"CAB000151: , CAB072344: , HPA048895: AB_2680550, HPA069524: AB_2686145, HPA069570: AB_2686155"	"unprognostic (1.78e-3)"	"unprognostic (7.51e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.40e-5)"	"unprognostic (1.40e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.06e-5)"	"unprognostic (6.04e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.47e-2)"	4.5	4.4	16.5	0.3	28.0	0.0	9.2	7.8	68.5	1.8	0.0	6.0	0.5	1.0	0.2	8.4	1.0	0.8	6.7	26.5	31.1	14.6	0.6	0.8	0.3	13.7	7.4	31.9	0.6	1.5	2.9	29.7	3.4	24.3	5.4	0.3	17.8	8.5	3.4	79.7	5.9	1.9	0.3	1.7	0.4	1.8	20.4	18.9	0.4	0.9	27.6	0.2	10.3	2.4	62.0	2.9	0.5	0.3	6.4	0.3	0.9	1.8	0.1	0.3	0.1	0.0	0.2	0.0	0.0	0.6	0.4	0.5	0.1	2.3	0.3	0.0	69.0	3.4	0.0	0.3	4.2	0.0	0.1	0.1	0.0	0.5	0.1	0.3	0.1	0.0	4.4	0.7	3.6	0.0	7.7	1.0	0.2	0.2	0.7	2.0	0.0	4.0	8.5	0.0	9.1	21.1	9.1	2.5	0.0	1.8	1.0	34.7	0.1	0.1	0.3	0.8	1.7	0.3	0.9	0.3	0.0	0.6	2.0	0.5	0.1	0.0	0.0	0.2	0.7	0.2	0.0	0.1	0.5	0.0	0.0	0.2	0.3	0.2	0.1	1.7	0.0	0.7	0.0	16.5	28.0	7.8	68.5	26.5	31.1	13.7	7.4	31.9	24.3	1.7	18.9	62.0	1.9	0.0	9.8	142.4	1.0	1.0	1.4	0.2	1.2	314.4	26.7	21.2	35.2	0.0	0.1	1.8	64.6	0.2	0.4	0.1	7.9	0.5	199.9	0.4	1.7	1.8	0.0	0.0	189.2	0.4	9.1	3.7	0.5	1.3	4.5	1.6	1.1	0.5	0.3	361.7	153.7	0.0	2.0	0.6	1.7	416.6	2.8	0.8	5.4	8.4	0.7	145.7	0.0	129.7	163.8	0.6	0.0	2.6	0.1	2.5	0.1	76.1	0.0	28.3	0.0	28.2	6.0	18.4	8.1	22.7	3.3	0.3	1.5	0.8	0.3	0.6
NPY5R	NPYR5	ENSG00000164129	"Neuropeptide Y receptor Y5"	Q15761	4	163343892-163351934	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 7.2;lymphoid tissue: 8.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 4.6;Granulosa cells: 1.4;Inhibitory neurons: 3.5;Smooth muscle cells: 3.1;Spermatocytes: 3.0"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (4.63e-6)"		"unprognostic (3.00e-1)"		"unprognostic (2.79e-1)"		"unprognostic (2.13e-1)"	"unprognostic (1.24e-1)"			"unprognostic (3.74e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.94e-1)"	7.2	3.3	0.8	0.3	2.3	0.0	1.7	0.0	1.4	0.7	0.0	0.3	0.0	0.7	1.0	0.2	0.8	0.5	0.6	1.2	2.3	4.6	1.0	0.3	2.4	0.8	0.5	1.5	0.2	1.0	0.7	0.3	2.9	0.6	0.2	0.3	0.2	3.7	0.9	0.1	0.8	0.1	0.7	0.6	8.9	0.2	5.2	0.8	0.1	0.7	0.4	0.1	0.3	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.3	0.0	1.4	1.2	2.3	0.8	0.5	1.5	0.6	0.6	0.8	1.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.5	0.0	0.0	4.6	0.0	0.0	0.7	0.0	0.0	0.0	1.4	0.7	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.1	3.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PCSK1	"NEC1, PC1, PC3, SPC3"	ENSG00000175426	"Proprotein convertase subtilisin/kexin type 1"	P29120	5	96390333-96434143	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.8"	"Cell type enriched"	"Detected in some"	4	"Enteroendocrine cells: 224.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 12.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 22.6;U-138 MG: 19.0;U-87 MG: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA048564, HPA079656"	Approved				"Secreted in other tissues"	NA	NA					"HPA048564: AB_2680444, HPA079656: "	"unprognostic (1.86e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.20e-5)"	"prognostic unfavorable (9.13e-5)"	"unprognostic (8.47e-4)"	"unprognostic (1.46e-1)"	"unprognostic (5.84e-3)"	"unprognostic (4.71e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.89e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.90e-6)"	"unprognostic (5.25e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.37e-3)"	1.6	6.3	8.8	4.7	4.1	0.1	1.5	1.0	36.9	0.8	0.0	2.4	5.3	0.1	0.0	0.1	0.2	0.2	0.5	4.7	44.8	0.2	0.0	0.4	0.1	4.8	6.6	2.9	0.4	7.7	0.0	12.2	0.0	20.0	0.4	2.4	8.8	2.7	0.1	0.3	1.1	3.6	0.6	1.6	0.1	5.8	0.1	8.9	0.2	1.9	0.0	0.0	2.1	0.5	16.0	0.0	0.0	0.3	0.0	2.3	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	1.0	3.8	0.0	0.0	0.1	0.0	0.1	0.1	0.8	2.4	0.0	0.0	0.0	0.0	2.0	1.0	0.4	0.1	0.2	0.9	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	3.3	0.0	0.0	0.4	0.0	0.0	1.2	19.0	0.6	0.3	0.2	0.0	0.0	0.1	15.8	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	4.1	1.0	36.9	4.7	44.8	4.8	6.6	2.9	20.0	1.6	8.9	16.0	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	1.8	13.2	0.0	0.0	0.7	0.0	0.0	0.0	2.1	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.2	0.2	224.6	0.0	54.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	4.0	10.7	2.0	0.0	0.4	1.6	0.0	0.0	0.0	4.7	0.0	0.5	0.0	3.5	4.9	1.5	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.9	0.0	1.7	1.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.7	0.0
PKIB	PRKACN2	ENSG00000135549	"CAMP-dependent protein kinase inhibitor beta"	Q9C010	6	122471917-122726373	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.4;intestine: 91.6;parathyroid gland: 64.2;placenta: 61.0"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 542.7;Distal enterocytes: 750.2;Extravillous trophoblasts: 420.5;Langerhans cells: 251.9;Late spermatids: 251.1;Paneth cells: 355.4;Proximal enterocytes: 255.0;Syncytiotrophoblasts: 959.8"	"Cancer enhanced"	"Detected in all"		"breast cancer: 16.3"	"Region enriched"	"Detected in all"	4	"cerebellum: 69.4"	"Immune cell enriched"	"Detected in some"	11	"myeloid DC: 34.8"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 34.8"	"Cell line enhanced"	"Detected in many"		"AF22: 71.8;MCF7: 84.9;OE19: 91.2;PC-3: 112.5;RPTEC TERT1: 187.1;SCLC-21H: 157.7"	"Region enhanced"	"Detected in all"		"cerebellum: 63.0"	"Region enhanced"	"Detected in all"		"cerebellum: 45.0"	HPA030156	Approved					NA	NA					"HPA030156: AB_10602816"	"unprognostic (1.59e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.39e-1)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (4.72e-7)"	"unprognostic (1.94e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.58e-2)"	"prognostic favorable (2.47e-7)"	"unprognostic (1.82e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.48e-1)"	2.2	5.9	5.2	9.1	4.7	0.2	23.5	69.4	6.5	4.9	4.4	91.6	15.7	3.4	3.4	5.3	5.5	5.8	0.5	6.3	6.3	2.8	8.3	4.2	2.2	12.3	8.6	4.2	0.8	6.3	64.2	22.3	61.0	16.9	6.2	63.0	56.5	8.5	2.4	0.7	9.2	28.6	3.9	4.3	3.3	34.7	4.2	8.0	3.8	1.1	0.6	4.2	5.5	1.3	12.3	0.1	2.8	71.8	0.3	0.6	0.3	62.4	0.0	0.8	0.3	1.2	0.4	3.0	0.0	0.4	0.0	3.8	0.3	0.0	1.5	0.8	0.4	3.7	1.2	3.9	1.7	0.2	0.0	12.3	0.3	1.2	1.2	15.3	34.0	0.3	0.5	22.3	0.4	0.2	84.9	0.3	0.4	29.6	91.2	112.5	0.6	10.8	0.4	187.1	10.6	157.7	0.2	0.0	17.1	2.0	39.4	12.0	1.8	5.7	0.2	47.3	0.2	6.2	0.2	0.3	0.2	46.7	1.5	0.4	0.0	0.6	0.0	0.0	3.2	0.7	0.0	0.0	0.0	34.8	0.1	0.4	0.1	0.1	1.9	0.3	0.5	0.4	0.7	5.2	4.7	69.4	6.5	6.3	6.3	12.3	8.6	4.2	16.9	4.3	8.0	12.3	3.0	3.2	3.9	17.0	4.6	19.8	2.3	2.5	2.8	23.6	94.8	53.3	0.3	2.8	10.2	1.8	4.2	542.7	0.9	750.2	19.6	22.6	106.0	5.3	1.6	3.9	98.0	4.0	5.5	35.8	420.5	6.9	52.0	5.5	38.7	0.3	1.1	3.8	53.1	6.7	15.5	94.9	14.2	75.5	251.9	251.1	1.2	51.2	44.4	9.4	25.5	15.2	0.0	6.0	8.5	50.4	355.4	0.4	1.2	13.8	255.0	26.9	58.3	54.8	6.6	0.3	2.7	3.3	5.8	12.4	17.0	959.8	3.5	0.2	92.9	8.3
PLAAT5	"HRASLS5, HRLP5, iNAT, PLAAT-5"	ENSG00000168004	"Phospholipase A and acyltransferase 5"	Q96KN8	11	63461404-63491194	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"adipose tissue: 16.6;pancreas: 13.7;testis: 53.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;Syncytiotrophoblasts: 1.0"	"Cancer enhanced"	"Detected in many"		"breast cancer: 3.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	64	"basophil: 5.4;eosinophil: 16.4"	"Lineage enriched"	"Detected in single"	97	"granulocytes: 16.4"	"Group enriched"	"Detected in some"	5	"HAP1: 11.4;NB-4: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042493			Uncertain	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA042493: AB_10797499"	"unprognostic (3.16e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.83e-3)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (7.11e-3)"	"unprognostic (2.14e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.46e-2)"	"unprognostic (8.89e-3)"	"unprognostic (3.15e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.04e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.57e-3)"	"unprognostic (4.50e-4)"	16.6	0.2	1.1	0.3	0.9	0.1	3.4	0.9	0.8	0.1	0.0	0.6	0.2	0.5	0.2	0.8	0.9	0.6	0.6	0.9	2.3	0.1	0.0	0.6	0.1	1.4	0.5	0.6	0.6	13.7	0.0	0.0	0.0	0.9	0.4	0.2	0.5	0.8	1.4	0.1	0.2	0.3	1.4	1.3	0.1	0.5	53.9	0.7	0.0	0.1	0.1	0.0	0.5	0.1	3.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.4	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.9	0.8	0.9	2.3	1.4	0.5	0.6	0.9	1.3	0.7	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0
POSTN	"OSF-2, periostin, PN"	ENSG00000133110	Periostin	Q15063	13	37562583-37598844	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 208.9;stomach 1: 176.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 295.7;Breast myoepithelial cells: 158.1;Endothelial cells: 134.6;Fibroblasts: 191.5;Smooth muscle cells: 151.5"	"Cancer enhanced"	"Detected in all"		"breast cancer: 231.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTEC/SVTERT24-B: 490.2;SuSa: 440.5;U-138 MG: 619.3;U-2197: 427.2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"spinal cord: 87.9"	HPA012306	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		660000000	"Golgi apparatus"	Nucleoplasm	"HPA012306: AB_1854827"	"unprognostic (7.73e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.19e-3)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (3.05e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (1.83e-7)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.32e-3)"	67.3	5.3	4.7	24.0	0.2	0.3	84.8	0.0	4.5	20.5	4.7	61.8	5.1	53.7	13.1	20.7	84.3	64.9	84.0	3.3	0.2	27.3	13.1	45.6	13.0	1.0	0.7	0.0	3.6	2.3	21.7	2.4	61.5	2.1	16.2	85.8	0.0	17.9	45.2	10.7	208.9	15.1	67.2	0.0	1.1	176.2	3.4	2.3	5.8	19.2	30.1	3.9	92.2	10.8	1.2	0.0	0.0	71.0	1.6	85.0	51.0	0.2	23.1	0.0	5.5	0.7	0.0	1.4	0.1	0.0	18.7	0.1	0.0	0.7	0.0	2.6	0.0	0.0	0.0	0.0	0.0	14.2	0.2	0.1	90.8	0.0	490.2	1.9	15.9	0.7	0.0	0.0	0.0	11.8	0.0	0.3	0.4	4.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.4	0.2	0.1	0.6	0.0	440.5	0.9	0.0	0.0	619.3	0.3	427.2	3.4	0.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.2	0.0	4.5	3.3	0.2	1.0	0.7	0.0	2.1	0.0	2.3	1.2	46.7	6.4	10.6	0.7	0.3	295.7	1.3	51.5	0.0	0.0	2.9	158.1	22.8	0.0	18.7	0.0	0.0	2.5	1.0	0.0	0.0	0.0	0.5	0.5	9.8	134.6	0.0	0.0	1.5	0.0	0.2	191.5	0.0	0.3	3.8	0.0	22.5	0.6	3.7	0.0	36.8	0.0	24.4	0.0	27.0	1.1	6.5	0.8	30.2	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.7	0.4	0.4	0.0	0.0	5.6	0.0	0.0	0.7	151.5	1.3	0.9	0.2	48.4	3.4	2.3	49.3	0.0	0.3
RAB30		ENSG00000137502	"RAB30, member RAS oncogene family"	Q15771	11	82973133-83071923	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 87.8;Oligodendrocytes: 243.1;Plasma cells: 260.9"	"Cancer enhanced"	"Detected in all"		"breast cancer: 6.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 54.4;naive B-cell: 55.0"	"Lineage enriched"	"Detected in many"	5	"B-cells: 55.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 55.7;HDLM-2: 57.6;U-698: 164.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054514, HPA060565"	Approved		Enhanced	Vesicles		NA	NA			Vesicles		"HPA054514: AB_2682512, HPA060565: AB_2684320"	"unprognostic (3.21e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.18e-2)"	"unprognostic (7.21e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.85e-1)"	11.3	11.1	11.8	14.0	25.7	14.6	12.5	19.5	15.5	8.3	0.7	13.2	18.0	8.4	5.8	6.9	5.5	5.7	9.4	9.9	19.4	3.7	7.7	6.6	19.9	25.1	19.5	7.2	14.1	4.3	3.0	4.4	8.6	26.2	7.3	13.9	11.3	6.1	5.3	13.0	7.0	21.5	10.3	23.8	10.2	11.7	4.1	21.4	10.5	5.9	11.9	28.7	9.0	4.4	41.7	4.1	5.6	5.8	2.9	11.1	16.7	6.8	9.8	9.1	19.0	7.9	8.7	1.8	55.7	10.0	14.9	4.9	4.8	8.3	6.4	11.3	57.6	1.6	12.6	16.4	5.1	2.6	2.0	2.5	9.5	4.4	8.5	6.5	7.2	14.0	5.0	1.9	15.0	9.8	7.9	2.1	0.6	7.7	5.5	10.0	4.8	15.2	23.7	9.5	3.4	6.7	4.6	22.6	5.3	2.7	8.6	12.4	0.2	17.9	8.1	19.1	8.0	2.7	24.0	14.3	164.6	3.1	1.4	5.7	1.4	0.7	1.0	4.9	0.3	3.6	54.4	4.8	4.8	2.0	55.0	11.2	10.0	0.9	2.3	0.8	5.8	9.5	6.2	11.8	25.7	19.5	15.5	9.9	19.4	25.1	19.5	7.2	26.2	23.8	21.4	41.7	15.2	9.6	3.3	87.8	80.5	24.9	10.7	9.9	73.4	8.3	11.7	13.0	14.5	0.0	2.7	3.7	16.7	7.0	6.8	5.4	1.9	2.4	0.7	3.3	6.1	10.5	10.1	3.2	60.7	4.0	30.8	23.5	5.1	4.2	0.0	0.9	18.2	6.4	1.9	11.8	78.2	1.5	8.2	1.6	15.2	1.3	14.3	6.4	42.7	67.5	24.8	13.9	3.1	80.4	243.1	4.3	3.5	18.0	260.9	8.9	9.3	4.6	2.3	10.5	6.6	20.3	13.5	0.7	2.2	11.0	11.5	2.9	12.9	24.0	1.8	2.0
RERG	MGC15754	ENSG00000134533	"RAS like estrogen regulated growth inhibitor"	Q96A58	12	15107783-15348675	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 105.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 202.7;Breast glandular cells: 80.1;Inhibitory neurons: 94.3;Sertoli cells: 92.1;Smooth muscle cells: 80.2"	"Cancer enhanced"	"Detected in all"		"breast cancer: 19.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 15.2;BEWO: 34.1;T-47d: 66.0;U-2 OS: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041387	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"HPA041387: AB_10796669"	"unprognostic (5.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.72e-2)"	"prognostic unfavorable (7.56e-4)"	"unprognostic (8.72e-2)"	"unprognostic (9.42e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.76e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.16e-3)"	"unprognostic (2.61e-3)"	"unprognostic (3.30e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.58e-2)"	29.4	45.9	9.8	6.9	20.5	0.0	43.0	6.5	16.4	29.3	4.5	27.5	4.1	105.5	50.8	15.2	73.3	11.3	10.7	10.2	11.8	37.4	2.5	16.6	4.3	19.5	12.3	8.6	29.3	9.9	4.8	1.4	33.6	22.5	17.2	9.4	0.8	10.3	78.2	5.5	9.1	18.1	84.6	7.5	31.7	20.3	9.0	11.2	2.6	5.8	5.9	2.8	17.5	20.2	18.8	0.0	1.6	0.3	15.2	6.0	0.3	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.9	0.0	0.1	0.0	0.2	0.2	0.0	0.0	4.3	0.1	5.9	0.0	4.7	0.0	1.9	0.8	1.0	0.0	2.3	0.0	0.0	0.0	0.6	0.0	1.4	0.7	0.2	0.3	1.7	0.0	0.9	0.1	0.0	0.2	5.8	0.3	0.1	2.2	2.5	2.6	0.0	1.0	66.0	0.0	0.0	0.9	21.5	0.4	0.0	0.1	5.7	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	20.5	6.5	16.4	10.2	11.8	19.5	12.3	8.6	22.5	7.5	11.2	18.8	10.7	0.0	2.2	202.7	0.4	3.8	8.6	0.9	6.2	1.3	80.1	36.2	1.0	5.7	4.0	7.3	0.0	12.0	0.7	0.0	15.6	9.8	20.9	6.5	9.8	6.0	1.8	0.0	20.2	9.8	14.6	28.7	2.6	1.0	0.0	0.1	2.2	0.0	2.1	3.3	94.3	0.0	18.3	0.0	2.3	16.1	22.1	1.1	7.2	41.2	0.0	5.0	0.0	3.0	1.1	2.2	0.0	32.0	0.0	3.5	0.0	33.7	0.1	0.5	92.1	8.2	80.2	8.3	15.0	12.6	5.5	14.0	1.2	16.1	0.0	5.8
RET	"CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51"	ENSG00000165731	"Ret proto-oncogene"	P07949	10	43077064-43130351	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Hirschsprung disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 21.0;brain: 25.0;parathyroid gland: 32.0"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 79.1;Ionocytes: 26.4;Skeletal myocytes: 23.1"	"Cancer enhanced"	"Detected in many"		"breast cancer: 11.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 74.6;NB-4: 42.2;SH-SY5Y: 329.3;THP-1: 95.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"midbrain: 53.3;spinal cord: 19.4"	"CAB002581, HPA008356, HPA008495"	Approved	Supported	Approved	"Golgi apparatus,Plasma membrane,Cytosol"		No	NA		2100000	"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: "	"unprognostic (7.94e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.49e-1)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.13e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (4.43e-1)"	"unprognostic (9.35e-5)"	"unprognostic (1.64e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.02e-2)"	1.8	21.0	3.1	1.4	1.8	0.4	1.1	4.8	6.0	0.9	0.2	2.9	1.5	0.6	0.3	0.4	0.6	0.6	1.3	1.1	5.0	0.9	3.0	0.4	0.6	12.8	25.0	1.3	0.4	1.4	32.0	5.3	0.5	12.7	1.8	1.5	4.8	5.1	2.1	5.9	0.9	1.4	1.0	5.7	0.2	2.3	2.7	7.6	1.6	0.8	3.1	0.2	0.6	1.4	15.4	0.1	0.4	0.1	1.7	0.0	0.0	0.1	0.7	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	5.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.6	0.0	42.2	7.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.7	329.3	0.1	0.0	0.1	0.5	4.1	95.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.1	0.0	3.1	1.8	4.8	6.0	1.1	5.0	12.8	25.0	1.3	12.7	5.7	7.6	15.4	0.4	0.0	0.5	1.6	0.0	0.3	0.8	0.0	0.0	1.7	6.0	0.5	2.1	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	1.5	0.0	0.3	1.1	0.0	0.0	4.2	0.2	2.3	6.8	0.0	0.0	1.3	0.5	0.0	1.2	0.1	79.1	8.6	1.9	26.4	0.0	0.6	1.5	0.3	0.5	0.0	1.0	0.0	0.8	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.8	1.7	0.0	23.1	1.2	1.1	4.7	0.0	0.6	0.0	0.2	0.3	0.2	0.1
RGS22	"CT145, DKFZP434I092, PRTD-NY2"	ENSG00000132554	"Regulator of G protein signaling 22"	Q8NE09	8	99960936-100131268	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 61.9"	"Group enriched"	"Detected in many"	8	"Early spermatids: 619.6;Late spermatids: 1623.3"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA053026			Supported	"Nucleoli fibrillar center,Actin filaments,Cytosol"		NA	NA			"Nucleoli fibrillar center"	"Actin filaments, Cytosol"	"HPA053026: "	"unprognostic (3.04e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.97e-1)"	"unprognostic (3.47e-5)"	"unprognostic (1.61e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.96e-3)"	"unprognostic (1.98e-5)"	"unprognostic (3.71e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.25e-3)"	"unprognostic (8.36e-4)"	2.7	0.9	4.9	0.0	2.4	0.0	0.6	2.0	1.6	1.4	8.7	0.3	0.0	2.9	1.1	0.3	10.7	1.2	0.3	0.8	7.4	0.2	0.1	1.7	0.3	5.3	5.6	0.7	7.4	0.5	0.0	1.1	0.5	3.3	1.3	0.1	1.0	0.1	2.3	0.1	0.6	0.1	1.5	4.0	0.0	0.1	61.9	3.1	0.1	0.3	0.1	0.3	0.4	0.5	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.9	0.6	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.1	0.0	0.3	1.3	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	2.4	2.0	1.6	0.8	7.4	5.3	5.6	0.7	3.3	4.0	3.1	2.9	0.1	0.0	0.0	14.4	0.0	2.2	0.0	1.6	0.6	1.2	1.2	0.8	0.8	0.0	12.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	619.6	58.1	14.2	0.7	0.0	0.0	2.3	0.0	0.2	8.6	0.5	0.8	0.0	1.3	0.0	0.0	0.2	0.0	1.6	0.0	4.1	0.0	2.9	1623.3	131.4	0.4	0.0	6.5	0.0	10.9	0.0	20.1	2.5	0.0	0.0	62.8	0.0	0.0	0.0	0.0	77.2	0.2	0.0	0.4	1.6	70.9	11.1	0.1	2.0	0.8	0.4	8.3	0.0	0.1
RHOH	"ARHH, TTF"	ENSG00000168421	"Ras homolog family member H"	Q15669	4	40191053-40246967	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 63.4;lymphoid tissue: 99.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 273.0;dendritic cells: 90.5;granulocytes: 141.8;NK-cells: 64.9;Plasma cells: 183.1;T-cells: 223.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 4.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 126.3;HMC-1: 92.5;JURKAT: 123.7;MOLT-4: 179.4;U-266/70: 65.5;U-266/84: 56.8;U-698: 116.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA030345, HPA061314"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA030345: AB_10601607, HPA061314: "	"unprognostic (4.00e-2)"	"unprognostic (1.83e-4)"	"unprognostic (1.24e-2)"	"unprognostic (2.22e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.30e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.31e-6)"	"unprognostic (2.96e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.44e-2)"	2.3	0.9	0.7	36.7	0.7	63.4	13.4	0.5	1.2	2.9	1.1	6.3	4.9	1.6	0.9	2.9	1.5	6.5	0.7	0.6	1.9	1.1	2.7	5.8	86.7	1.0	0.9	0.5	0.9	1.4	0.4	0.7	0.9	1.0	2.8	5.7	0.0	3.9	0.9	0.6	1.2	20.8	1.5	0.9	43.0	8.3	0.7	0.9	99.1	1.8	0.3	85.9	10.6	1.6	1.0	0.2	0.4	0.5	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	126.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	2.6	0.0	18.8	0.1	0.0	0.0	21.1	92.5	1.5	0.0	0.0	0.0	0.1	0.1	123.7	1.4	1.2	0.0	0.0	179.4	13.3	2.3	0.0	0.4	19.1	0.3	4.3	0.0	0.0	0.1	0.1	0.3	0.8	0.2	0.1	5.7	0.5	0.5	0.0	0.5	0.1	0.2	65.5	56.8	116.3	0.1	4.4	0.1	210.3	1.1	168.7	112.2	0.8	99.3	164.3	176.9	151.1	1.9	212.1	274.3	220.5	8.4	74.2	1.2	26.1	268.4	124.1	0.7	0.7	0.5	1.2	0.6	1.9	1.0	0.9	0.5	1.0	0.9	0.9	1.0	2.9	3.2	9.9	0.3	273.0	7.1	1.4	0.3	1.8	0.0	11.1	6.7	1.1	1.5	2.9	0.0	0.0	0.1	90.5	0.3	0.0	0.1	0.6	0.6	0.5	2.3	0.0	23.4	0.3	0.0	0.2	3.6	9.7	1.0	141.8	0.0	1.8	0.2	2.2	0.0	0.3	0.4	0.0	4.4	16.2	0.7	0.0	28.4	56.9	8.4	11.3	0.0	64.9	0.5	0.1	0.0	0.1	0.0	183.1	1.4	0.0	0.4	1.0	0.0	0.0	2.0	2.0	0.3	0.2	0.3	7.0	0.3	223.6	0.1	0.3	2.0
RIMS4	"C20orf190, dJ781B1.3"	ENSG00000101098	"Regulating synaptic membrane exocytosis 4"	Q9H426	20	44751808-44810546	"Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.0"	"Cell type enhanced"	"Detected in some"		"Granulosa cells: 110.3;Horizontal cells: 38.7;Inhibitory neurons: 14.4;Sertoli cells: 26.3"	"Cancer enhanced"	"Detected in many"		"breast cancer: 6.6;glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 19.3;MCF7: 13.4;SCLC-21H: 39.9;SH-SY5Y: 20.4;SiHa: 14.0;U-2 OS: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060928	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060928: AB_2684387"	"unprognostic (1.54e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.90e-2)"		"unprognostic (4.63e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.21e-3)"	"unprognostic (1.70e-1)"	"unprognostic (8.60e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-3)"	"unprognostic (2.94e-2)"	0.4	1.1	16.0	0.2	23.0	0.0	1.2	7.3	33.0	7.3	1.1	0.6	0.1	1.9	0.4	0.5	8.2	0.6	0.3	23.5	12.6	0.0	0.0	0.9	0.1	17.1	11.3	21.0	6.2	0.0	0.0	12.1	0.0	14.8	2.5	0.5	2.9	1.1	0.9	1.1	0.3	0.4	2.6	5.1	0.0	1.8	10.6	9.2	0.2	5.0	1.7	0.4	0.1	1.5	20.6	0.0	0.5	0.5	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.9	0.1	2.0	0.0	19.3	0.2	0.0	0.0	8.2	0.0	0.8	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	13.4	0.1	0.0	3.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	39.9	20.4	14.0	0.0	0.2	0.5	6.1	0.7	0.0	0.0	9.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	23.0	7.3	33.0	23.5	12.6	17.1	11.3	21.0	14.8	5.1	9.2	20.6	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	7.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.1	0.1	1.8	0.0	11.3	0.0	0.0	0.4	0.0	0.4	0.0	110.3	0.0	0.0	0.1	38.7	14.4	0.8	0.0	0.0	0.0	2.9	7.2	0.2	0.0	0.0	0.0	1.0	0.0	2.0	0.6	0.1	0.1	13.2	0.0	0.0	0.0	0.0	0.0	1.4	26.3	0.2	1.2	1.2	5.7	0.0	0.1	0.0	0.0	0.5	0.5	0.0
SCUBE2	"Cegb1, Cegf1, FLJ16792"	ENSG00000175356	"Signal peptide, CUB domain and EGF like domain containing 2"	Q9NQ36	11	9019476-9138114	"Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 49.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 30.3;Basal prostatic cells: 51.4;Breast glandular cells: 45.0;Breast myoepithelial cells: 31.5;Prostatic glandular cells: 39.8"	"Cancer enhanced"	"Detected in all"		"breast cancer: 54.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"non-classical monocyte: 1.0"	"Lineage enriched"	"Detected in single"	6	"monocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.7;SK-MEL-30: 8.1;T-47d: 28.4"	"Group enriched"	"Detected in some"	4	"olfactory bulb: 4.6;thalamus: 2.7"	"Low region specificity"	"Detected in all"			"HPA006353, HPA029871"	Uncertain				"Secreted to blood"	NA	NA		1100000			"HPA006353: AB_1856642, HPA029871: AB_10602299"	"prognostic favorable (2.41e-4)"	"unprognostic (5.72e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.12e-4)"	"unprognostic (3.11e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.12e-4)"	"unprognostic (4.35e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.88e-1)"	14.9	2.0	3.3	3.7	3.4	0.0	32.5	13.4	3.1	17.8	0.2	10.2	3.7	13.6	49.2	4.5	18.4	8.0	4.3	3.5	4.1	1.2	0.9	4.7	3.9	2.8	3.6	2.5	0.9	22.2	19.6	9.7	22.6	6.1	33.5	4.5	1.9	2.4	8.8	9.1	12.4	16.5	13.1	3.3	5.1	21.5	2.3	3.6	2.4	5.2	6.3	7.7	28.9	7.0	4.4	0.0	0.1	1.5	0.9	0.5	0.6	0.2	1.6	0.8	0.9	0.6	0.3	0.0	0.0	0.6	3.9	0.1	0.0	5.7	0.0	1.4	0.1	0.3	0.0	0.0	0.0	0.6	0.0	0.1	1.3	0.0	0.4	0.0	0.3	0.6	0.0	0.0	0.0	1.1	0.0	0.0	1.3	0.9	0.0	0.0	0.1	0.0	0.2	0.4	3.1	0.7	1.0	1.1	0.1	8.1	1.3	28.4	0.0	0.0	0.6	0.4	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.3	3.4	13.4	3.1	3.5	4.1	2.8	3.6	2.5	6.1	3.3	3.6	4.4	30.3	16.0	9.2	1.6	0.0	7.4	51.4	0.3	1.2	0.4	45.0	31.5	0.6	0.0	5.6	1.8	0.0	0.2	0.1	1.0	0.0	0.1	3.4	2.2	8.8	3.3	1.2	0.0	3.1	1.8	0.2	9.4	0.0	6.4	0.0	0.3	1.1	0.1	0.8	13.5	14.9	5.2	6.1	0.3	1.5	2.5	0.3	0.7	19.6	5.6	0.1	0.0	0.0	13.6	4.6	0.1	4.3	0.7	0.0	39.8	0.6	0.0	1.5	0.3	0.0	5.2	1.5	0.6	0.7	0.1	1.8	0.4	0.3	6.6	9.6	15.6
SERTAD4	DJ667H12.2	ENSG00000082497	"SERTA domain containing 4"	Q9NUC0	1	210232796-210246631	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 28.5;Breast glandular cells: 23.1;Extravillous trophoblasts: 54.9;Ionocytes: 24.4;Squamous epithelial cells: 27.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 10.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 7.5;BEWO: 7.4;SCLC-21H: 7.4;SK-BR-3: 8.5;T-47d: 10.5;U-2 OS: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027344, HPA028514"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027344: AB_10601770, HPA028514: AB_10611391"	"unprognostic (1.75e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.74e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.69e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.85e-2)"	"unprognostic (6.55e-2)"	"unprognostic (4.24e-1)"	1.0	0.3	0.7	0.3	1.7	0.0	3.7	1.0	1.2	2.0	0.4	3.6	0.4	3.8	0.6	4.3	1.7	0.7	2.4	0.7	1.3	1.0	0.0	1.5	0.1	0.9	1.4	0.6	1.0	0.1	0.6	1.0	1.0	1.1	1.8	1.4	0.1	5.9	1.4	0.2	3.2	0.8	2.7	1.1	0.1	1.4	0.2	1.1	0.6	1.4	0.7	0.7	0.6	1.9	1.2	7.5	0.1	1.6	0.0	0.8	0.7	7.4	1.8	1.8	1.4	2.4	0.3	0.8	0.0	0.2	0.4	1.1	3.6	0.2	0.6	0.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.2	1.7	0.2	0.0	0.0	0.0	0.3	1.8	0.0	0.0	5.2	6.0	0.3	0.0	2.4	0.0	1.2	1.3	7.4	6.3	1.2	8.5	0.1	2.9	10.5	0.0	2.3	2.0	8.7	0.1	5.6	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.7	1.0	1.2	0.7	1.3	0.9	1.4	0.6	1.1	1.1	1.1	1.2	5.0	6.4	3.9	1.6	0.0	16.7	9.6	16.0	28.5	2.5	23.1	9.3	0.7	1.5	10.9	9.2	0.0	14.2	0.0	1.5	7.9	2.1	0.5	4.8	1.2	5.2	1.2	0.0	10.1	3.9	54.9	7.5	2.6	5.8	0.0	9.3	2.5	0.0	1.4	0.0	3.7	5.6	24.4	0.0	5.0	0.6	0.6	0.3	10.6	3.7	0.0	0.5	0.0	1.0	9.4	8.1	1.3	1.5	0.0	2.5	0.0	0.4	13.9	0.3	0.0	1.8	3.7	0.1	1.7	27.4	4.7	4.4	0.3	0.1	6.5	3.4
SIDT1	"FLJ20174, SID-1"	ENSG00000072858	"SID1 transmembrane family member 1"	Q9NXL6	3	113532555-113629575	"Predicted membrane proteins, Transporters"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 10.3;salivary gland: 10.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 47.4;dendritic cells: 34.5;Excitatory neurons: 117.8;Inhibitory neurons: 86.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 33.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MCF7: 15.4;OE19: 16.2;PC-3: 21.0;RT4: 14.9;T-47d: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035862	Approved					NA	NA					"HPA035862: AB_10671110"	"unprognostic (4.23e-1)"	"prognostic favorable (3.78e-4)"	"unprognostic (3.43e-3)"	"unprognostic (1.33e-3)"	"unprognostic (2.28e-1)"	"unprognostic (6.64e-4)"	"unprognostic (2.93e-4)"	"unprognostic (1.50e-1)"	"unprognostic (4.02e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.02e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.32e-2)"	"prognostic favorable (4.09e-5)"	1.2	2.8	4.2	5.2	6.1	3.4	5.4	5.3	6.5	3.1	0.0	6.2	2.0	0.7	0.2	1.4	1.9	3.7	0.4	6.0	4.0	0.8	0.6	1.8	8.8	3.9	4.2	6.4	0.2	0.7	0.5	5.5	1.0	2.1	5.1	10.3	0.4	10.9	1.5	0.3	0.5	5.5	0.7	3.7	7.2	3.5	0.9	3.8	5.3	0.4	0.4	8.9	4.5	0.9	5.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.0	1.5	0.0	0.5	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.8	0.0	4.2	0.0	15.4	4.2	0.2	0.0	16.2	21.0	6.2	0.0	0.5	0.0	14.9	0.2	0.1	0.0	4.2	0.2	0.0	13.8	1.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.3	7.0	0.1	7.1	7.5	4.7	5.8	1.5	6.6	5.9	5.1	0.3	9.1	0.0	33.7	3.9	3.4	4.2	6.1	5.3	6.5	6.0	4.0	3.9	4.2	6.4	2.1	3.7	3.8	5.1	1.6	6.4	3.3	7.2	47.4	0.4	1.4	1.9	0.0	1.4	9.7	4.7	1.1	4.3	4.2	1.8	0.0	0.0	34.5	17.2	0.0	0.4	5.0	3.1	0.7	1.0	10.2	0.8	117.8	1.1	0.2	0.4	8.2	6.3	3.8	0.0	0.4	0.5	11.2	0.0	86.8	23.3	2.0	3.5	1.8	1.5	0.0	10.1	5.4	23.4	2.6	0.1	21.6	4.5	4.0	0.8	3.9	0.0	14.5	3.9	2.2	0.1	9.3	0.2	0.0	0.7	0.7	0.2	0.1	0.9	0.3	0.1	16.4	0.3	7.0	1.9
SLC6A4	"5-HTT, HTT, OCD1, SERT1"	ENSG00000108576	"Solute carrier family 6 member 4"	P31645	17	30194319-30236002	"FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 82.4;intestine: 40.7;lung: 29.1"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 125.4;Proximal enterocytes: 100.9;Syncytiotrophoblasts: 106.4"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Region enhanced"	"Detected in many"		"midbrain: 82.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.9;CACO-2: 3.9;Hep G2: 10.4"	"Region enriched"	"Detected in some"	4	"midbrain: 58.4"	"Group enriched"	"Detected in some"	7	"midbrain: 38.9;pons: 29.1"	"HPA054723, HPA071354, HPA074728"	Supported	Supported	Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA054723: , HPA071354: , HPA074728: AB_2686708"	"unprognostic (7.45e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.72e-4)"	"unprognostic (2.07e-1)"	"unprognostic (8.42e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.18e-2)"	0.1	0.1	0.3	0.0	0.1	0.2	0.2	0.2	3.0	0.1	0.0	0.5	10.4	0.0	0.0	2.8	1.7	0.0	0.9	0.1	0.3	0.2	0.0	29.1	0.1	14.4	82.4	0.1	0.1	1.4	0.2	0.0	18.6	31.8	0.1	0.1	0.1	0.7	0.2	0.1	0.6	40.7	0.0	0.0	0.1	0.9	0.3	21.6	0.0	0.5	0.0	0.2	0.1	0.3	20.8	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	10.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.4	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.2	3.0	0.1	0.3	14.4	82.4	0.1	31.8	0.0	21.6	20.8	1.1	16.0	5.0	0.3	0.0	0.1	0.4	0.1	17.1	1.2	0.1	0.0	1.0	0.0	1.9	1.8	0.0	125.4	1.5	0.2	0.0	0.0	2.8	0.2	0.6	3.2	0.0	0.0	0.9	0.0	8.6	1.3	0.0	0.5	2.5	0.2	2.2	0.3	9.5	0.0	0.6	2.3	0.0	1.0	1.2	2.2	0.3	5.9	0.0	0.0	0.1	0.5	2.1	0.5	0.5	0.4	0.0	0.4	0.1	0.3	100.9	0.4	0.7	0.8	0.0	1.3	0.5	0.5	0.9	4.8	0.3	106.4	0.5	0.2	4.1	0.3
SLITRK6	FLJ22774	ENSG00000184564	"SLIT and NTRK like family member 6"	Q9H5Y7	13	85792790-85806683	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Hearing, Sensory transduction, Vision"		Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 28.0;urinary bladder: 14.8"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 22.8;Bipolar cells: 41.7;Club cells: 27.4;Ionocytes: 16.2;Respiratory ciliated cells: 41.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 21.1;urothelial cancer: 18.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 28.8;OE19: 24.2;RT4: 101.4;WM-115: 23.7"	"Region enhanced"	"Detected in many"		"thalamus: 22.6"	"Low region specificity"	"Detected in many"			"HPA014491, HPA014513"	Uncertain		Supported	"Plasma membrane"		NA	NA		28000	"Plasma membrane"		"HPA014491: AB_10601603, HPA014513: AB_2669026"	"unprognostic (6.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.82e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.31e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.51e-2)"	0.1	0.2	1.0	0.9	3.0	0.0	3.2	1.9	1.4	1.2	0.1	5.6	3.5	1.0	2.5	1.9	0.5	1.4	1.5	0.1	1.8	0.1	0.9	3.4	0.0	0.9	2.3	0.3	0.0	0.2	0.0	0.1	0.9	1.4	7.7	6.9	4.8	28.0	2.2	0.0	5.6	5.8	0.4	0.3	0.1	1.5	0.3	4.4	0.2	0.3	0.1	0.1	14.8	1.4	0.9	0.0	2.9	0.1	0.5	0.0	0.0	0.0	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	4.9	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	28.8	0.0	3.3	2.7	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.0	24.2	1.9	0.2	0.0	0.0	0.0	101.4	1.0	1.2	0.5	0.1	0.1	1.7	0.5	0.0	0.0	0.3	1.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.0	1.9	1.4	0.1	1.8	0.9	2.3	0.3	1.4	0.3	4.4	0.9	0.1	0.0	1.8	0.0	0.0	3.8	5.0	22.8	0.0	41.7	5.3	1.5	0.4	0.0	27.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.2	4.3	0.3	0.0	0.0	0.1	0.0	0.0	2.0	0.0	2.7	0.0	2.2	2.2	0.0	0.2	0.0	0.4	1.7	16.2	0.0	0.6	0.0	9.6	0.1	0.0	1.0	0.0	0.6	0.0	0.0	0.0	1.8	0.0	0.4	0.0	1.5	0.0	0.1	41.6	2.0	0.0	0.0	0.8	0.0	0.1	3.8	2.4	0.0	0.2	0.1	0.5	4.5
SMR3A	"PBI, PRL5, PROL5"	ENSG00000109208	"Submaxillary gland androgen regulated protein 3A"	Q99954	4	70360760-70367158	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	59	"salivary gland: 60.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 0.7;liver cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044567	Enhanced				"Secreted to digestive system"	NA	NA					"HPA044567: AB_10796114"																"unprognostic (2.06e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	60.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPDYC	Ringo2	ENSG00000204710	"Speedy/RINGO cell cycle regulator family member C"	Q5MJ68	11	65170154-65173244	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"liver: 3.1;testis: 1.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.3;Extravillous trophoblasts: 4.6;Hepatocytes: 3.0;Late spermatids: 9.8;Macrophages: 1.8;Spermatogonia: 3.3;Syncytiotrophoblasts: 1.9"	"Cancer enhanced"	"Detected in many"		"breast cancer: 6.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.2;HEL: 7.1;Hep G2: 3.1;K-562: 17.2"					"Not detected"	"Not detected"			HPA039891	Uncertain					NA	NA					"HPA039891: AB_10795260"	"prognostic unfavorable (1.20e-5)"	"unprognostic (7.35e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.31e-3)"	"unprognostic (5.08e-2)"		"unprognostic (1.85e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.53e-1)"		"unprognostic (6.60e-4)"	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.0	3.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	7.1	0.0	3.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	17.2	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.3	0.1	0.0	0.2	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.1	0.0	0.0	0.0	0.0	0.0	3.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	9.8	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.3	0.0	0.0	1.9	0.0	0.0	0.1	0.0
ST8SIA6	SIAT8F	ENSG00000148488	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6"	P61647	10	17315421-17454595	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;lung: 5.9"	"Cell type enriched"	"Detected in some"	5	"Microglial cells: 137.7"	"Cancer enhanced"	"Detected in some"		"breast cancer: 5.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"HMC-1: 208.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011635, HPA072708"	Uncertain		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA011635: AB_2194921, HPA072708: "	"unprognostic (4.86e-3)"	"unprognostic (7.01e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.23e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.26e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.07e-3)"	0.7	0.3	5.6	0.4	3.6	1.8	5.2	2.9	3.8	0.3	2.7	0.6	0.3	0.4	4.6	0.5	0.3	0.5	3.4	2.7	2.8	0.8	1.0	5.9	0.2	5.0	9.7	2.3	0.4	0.2	0.0	0.3	1.1	4.2	1.5	0.4	0.5	0.6	0.2	0.2	1.1	0.4	0.3	3.2	0.6	0.3	0.3	7.8	0.3	0.4	0.8	0.4	0.2	0.4	4.0	0.2	0.2	0.1	1.7	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.6	0.6	0.0	0.1	0.3	0.3	0.5	0.1	0.0	0.0	0.4	0.2	25.9	0.4	0.5	0.0	0.0	208.0	0.1	0.0	0.2	0.1	1.8	0.0	0.3	4.6	0.4	2.5	1.9	1.1	0.4	2.1	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	9.3	0.2	1.1	0.0	3.6	0.1	0.3	0.0	0.1	0.1	0.2	0.1	0.1	0.4	0.1	1.7	0.5	0.5	0.5	0.1	0.2	0.1	0.3	0.3	0.2	0.3	0.3	0.4	1.0	0.7	0.3	0.2	0.8	0.2	5.6	3.6	2.9	3.8	2.7	2.8	5.0	9.7	2.3	4.2	3.2	7.8	4.0	0.6	0.0	0.0	2.6	0.1	0.6	0.1	0.2	0.0	0.0	10.0	3.9	0.8	0.0	0.2	0.0	0.0	0.0	5.5	1.2	0.0	0.0	0.5	0.1	0.0	10.9	0.0	25.5	3.0	0.0	0.0	0.3	0.0	0.8	10.2	2.8	26.7	0.0	0.1	0.0	4.4	0.0	0.0	0.9	0.0	0.6	0.0	0.2	8.8	137.7	0.2	0.0	8.2	1.5	1.1	0.1	0.1	0.0	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.8	0.3	0.0	0.0	0.0	2.4	0.1	0.0	0.1
STAC2	24b2	ENSG00000141750	"SH3 and cysteine rich domain 2"	Q6ZMT1	17	39210541-39225945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 57.3;breast: 56.7;retina: 122.0;skin 1: 44.3"	"Cell type enriched"	"Detected in many"	9	"Muller glia cells: 496.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 15.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"GAMG: 9.8;HeLa: 32.5;U-87 MG: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA076925			Approved	Cytosol		NA	NA			Cytosol		"HPA076925: "	"unprognostic (1.70e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (4.05e-5)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (1.42e-1)"	"unprognostic (8.66e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (1.12e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.17e-1)"	1.7	0.5	7.6	0.2	21.4	0.0	56.7	9.6	57.3	6.7	2.7	0.8	0.1	5.2	10.8	0.5	4.8	0.0	1.6	17.4	20.3	14.0	0.0	0.8	0.0	30.9	17.3	13.0	2.5	0.2	0.1	1.6	0.2	31.2	5.2	0.1	122.0	15.3	23.7	0.3	44.3	0.6	0.8	4.8	0.1	0.4	0.3	8.1	0.0	0.1	0.6	0.0	0.5	2.6	33.1	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	9.8	0.0	3.9	0.0	0.0	0.0	0.5	0.0	32.5	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.4	0.3	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	21.4	9.6	57.3	17.4	20.3	30.9	17.3	13.0	31.2	4.8	8.1	33.1	0.6	3.2	5.8	2.0	0.7	0.4	1.0	0.2	0.0	13.3	52.7	45.3	2.7	0.0	2.5	3.7	10.4	0.1	1.8	0.1	5.9	0.0	0.2	0.3	3.9	1.7	0.0	0.0	19.0	0.0	0.2	1.9	0.0	0.3	0.0	0.2	0.0	0.0	0.1	18.5	16.6	0.0	16.2	0.6	1.5	0.0	2.8	0.8	42.7	3.7	0.0	496.8	2.1	1.0	1.0	0.0	0.0	0.0	0.1	0.5	0.0	0.3	1.5	17.5	0.0	0.2	1.4	0.2	1.0	0.0	1.7	0.3	1.2	0.1	0.1	0.2
SUSD3	MGC26847	ENSG00000157303	"Sushi domain containing 3"	Q96L08	9	93058688-93085133	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 57.7;testis: 77.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 32.4;Granulosa cells: 30.8;Hepatocytes: 66.6;Hofbauer cells: 49.4;Proximal tubular cells: 59.4;T-cells: 37.5;Theca cells: 34.7"	"Cancer enhanced"	"Detected in all"		"breast cancer: 50.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 150.7;Karpas-707: 32.6;MCF7: 36.8;NB-4: 78.0;RPMI-8226: 82.5;THP-1: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042310	Uncertain					NA	NA					"HPA042310: AB_10796902"	"prognostic favorable (5.13e-4)"	"unprognostic (5.42e-2)"	"unprognostic (3.65e-1)"	"unprognostic (8.34e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.94e-2)"	"unprognostic (7.41e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.39e-3)"	"unprognostic (5.33e-2)"	3.5	1.9	4.0	17.8	4.3	41.6	15.6	4.6	4.3	14.3	4.4	3.8	4.9	20.0	10.1	4.3	35.7	4.3	1.0	4.0	6.3	21.4	28.0	4.2	57.7	6.2	5.9	2.8	40.5	1.1	1.3	5.5	2.0	6.1	2.4	2.2	6.5	11.5	3.2	1.2	3.7	18.9	6.2	8.1	36.6	4.5	77.8	6.1	32.1	4.2	0.6	30.8	4.4	6.1	6.2	7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.8	1.5	0.6	0.3	3.4	1.3	150.7	0.6	0.6	0.1	0.3	2.4	0.1	0.0	13.4	0.1	20.7	0.1	2.4	9.5	0.1	4.6	9.9	0.7	0.0	0.0	0.0	0.0	0.0	6.2	32.6	0.0	36.8	0.2	78.0	1.8	1.1	4.6	6.5	0.0	82.5	0.0	0.0	0.2	0.2	0.1	1.1	0.0	1.7	19.4	34.6	0.5	0.0	0.0	0.0	0.0	6.6	3.8	9.7	0.0	0.0	0.2	0.6	16.7	79.1	24.0	15.5	27.4	88.7	124.8	43.4	41.1	70.1	214.8	87.7	5.8	11.2	3.0	3.6	182.9	68.3	4.0	4.3	4.6	4.3	4.0	6.3	6.2	5.9	2.8	6.1	8.1	6.1	6.2	2.6	0.0	6.7	0.0	32.4	0.6	0.2	0.3	0.0	0.5	24.2	11.0	0.8	17.2	0.2	0.0	4.2	1.0	2.4	0.4	9.8	0.7	3.0	0.4	2.9	3.4	0.0	2.5	0.1	0.2	2.1	9.0	1.1	0.3	3.8	30.8	1.4	66.6	49.4	0.0	0.1	0.4	8.2	10.5	9.2	11.2	5.6	29.1	1.8	17.8	8.3	1.7	2.1	0.5	0.1	0.6	0.1	5.3	17.9	1.4	0.2	59.4	0.7	9.2	0.0	0.1	1.6	3.4	3.9	0.1	0.3	1.4	37.5	34.7	0.7	0.2
SYT9		ENSG00000170743	"Synaptotagmin 9"	Q86SS6	11	7238778-7469043	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.2;retina: 7.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 48.6;Late spermatids: 23.5;Oligodendrocyte precursor cells: 55.3;Oligodendrocytes: 139.2"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEK 293: 10.3;RT4: 17.9;SH-SY5Y: 13.2;TIME: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.47e-1)"	"unprognostic (9.41e-2)"		"unprognostic (1.39e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.31e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.92e-4)"	"unprognostic (1.22e-4)"	0.0	2.0	8.0	0.0	7.8	0.0	0.8	11.0	5.3	0.4	0.8	0.1	0.0	1.3	0.0	0.0	0.1	0.1	0.3	4.3	6.5	2.1	3.6	0.0	0.0	9.4	11.4	3.8	0.1	1.4	0.9	1.5	0.0	9.3	1.0	0.0	7.6	0.0	3.6	0.0	0.1	0.1	0.1	7.5	0.0	0.1	0.9	13.2	0.0	1.1	0.0	0.0	0.2	0.3	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	3.5	0.0	0.0	0.0	0.0	17.9	3.2	13.2	0.0	0.0	0.0	0.4	0.0	0.0	20.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	7.8	11.0	5.3	4.3	6.5	9.4	11.4	3.8	9.3	7.5	13.2	11.4	0.0	0.0	0.0	48.6	0.5	0.0	0.1	0.0	0.0	13.6	0.7	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	13.9	0.0	0.2	0.0	0.0	0.0	15.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	6.2	0.0	3.3	9.8	0.0	0.0	0.3	0.0	23.5	0.0	0.0	0.0	5.6	0.0	2.0	0.0	55.3	139.2	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.0	3.5	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TESMIN	"CXCDC2, MTL5"	ENSG00000132749	"Testis expressed metallothionein like protein"	Q9Y4I5	11	68707440-68751520	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 53.0"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 9.6;Breast myoepithelial cells: 7.4;Endometrial ciliated cells: 31.5;Glandular and luminal cells: 27.0;Proximal tubular cells: 11.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 6.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 11.9;T-47d: 23.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA018539			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA018539: "	"unprognostic (1.99e-1)"	"unprognostic (3.97e-3)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (3.22e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.76e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.47e-2)"	"unprognostic (5.27e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.99e-1)"	"unprognostic (9.85e-2)"	"unprognostic (3.17e-1)"	0.3	0.5	0.6	1.0	0.6	7.5	4.3	0.6	0.7	0.6	0.6	2.3	1.4	0.7	0.7	1.6	1.7	0.4	0.2	0.5	0.7	2.9	0.4	0.4	1.3	1.1	0.7	0.7	0.9	1.1	2.1	2.4	0.3	1.3	2.3	3.0	1.5	1.9	1.1	0.0	0.6	1.4	0.4	0.4	1.3	0.9	53.0	0.7	2.1	1.1	0.1	1.1	0.4	0.9	1.0	7.2	3.1	1.3	0.1	0.0	0.0	3.5	1.6	0.8	2.2	1.0	0.9	7.1	2.9	1.6	0.3	0.0	3.4	1.0	1.4	1.7	3.0	2.5	2.1	1.0	0.0	0.0	1.5	11.9	0.0	3.8	0.1	2.2	3.0	0.7	3.4	4.5	5.4	0.3	4.8	0.8	4.2	7.3	3.3	3.1	1.9	0.4	0.8	2.6	0.1	4.4	4.7	0.0	1.5	0.0	3.7	23.8	10.0	2.7	0.2	0.5	0.2	0.1	2.1	2.0	2.8	0.1	4.2	1.9	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.1	0.6	0.6	0.6	0.7	0.5	0.7	1.1	0.7	0.7	1.3	0.4	0.7	1.0	0.7	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	9.6	7.4	0.0	0.0	0.6	0.0	0.0	1.8	0.7	0.0	5.9	6.3	0.0	31.5	2.6	0.3	0.0	0.0	0.0	4.0	4.7	0.3	0.0	27.0	2.5	4.2	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.5	0.0	0.0	11.5	1.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	1.1	0.2	0.0	0.0
TEX14	CT113	ENSG00000121101	"Testis expressed 14, intercellular bridge forming factor"	Q8IWB6	17	58556678-58692055	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 27.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 23.3;Spermatocytes: 56.4;Spermatogonia: 16.2"	"Cancer enhanced"	"Detected in some"		"breast cancer: 0.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.3;Karpas-707: 7.9;MCF7: 3.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA030620, HPA077020"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Vesicles, Plasma membrane"	"HPA030620: AB_10601598, HPA077020: AB_2732327"	"unprognostic (1.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.67e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.76e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.00e-3)"	"unprognostic (5.88e-2)"	0.1	0.1	0.8	0.1	0.6	1.8	0.2	1.1	0.7	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.8	0.0	0.2	0.2	0.1	0.6	0.5	0.3	0.3	0.1	0.0	0.2	0.1	0.6	0.2	0.0	1.1	0.1	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.1	27.2	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.1	1.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.2	0.0	0.1	6.3	0.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	7.9	0.0	3.3	0.3	0.0	0.4	0.1	0.1	0.3	0.2	1.2	0.0	0.1	0.9	0.1	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.3	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	1.1	0.7	0.5	0.8	0.6	0.5	0.3	0.6	0.5	0.5	0.8	4.4	0.0	0.0	2.9	5.7	0.9	1.8	0.7	2.8	0.6	4.7	7.2	1.3	5.7	1.5	1.8	0.0	1.6	0.7	0.1	0.0	0.0	23.3	0.4	0.2	1.5	0.0	0.0	2.2	0.0	1.0	0.7	0.5	1.8	1.3	0.2	1.4	0.8	3.7	0.0	2.2	0.5	2.0	0.6	2.3	6.4	0.3	4.6	3.6	2.8	0.0	0.6	1.0	1.0	3.0	0.1	0.0	0.4	4.3	0.7	0.0	0.1	0.2	1.3	0.0	1.2	1.5	56.4	16.2	1.7	0.1	1.1	0.7	0.0	0.0	0.4
TMC3		ENSG00000188869	"Transmembrane channel like 3"	Q7Z5M5	15	81331088-81374213	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	34	"parathyroid gland: 84.2"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.7;Distal tubular cells: 1.9;Excitatory neurons: 1.0;Spermatocytes: 1.1"	"Cancer enhanced"	"Detected in single"		"breast cancer: 0.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040265, HPA040510"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA040265: AB_10795379, HPA040510: AB_10796123"	"unprognostic (1.17e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.14e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.20e-5)"	"unprognostic (2.32e-1)"	"unprognostic (1.97e-7)"	"unprognostic (1.60e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.96e-2)"	0.1	0.2	0.7	0.4	0.7	0.8	0.4	2.4	0.9	0.2	0.2	0.3	0.6	0.4	1.6	0.1	0.9	0.6	0.2	0.6	0.3	0.2	0.3	0.1	0.4	0.7	0.7	0.5	0.4	0.2	84.2	0.1	0.2	1.8	0.4	0.1	0.7	0.7	0.5	0.2	0.4	0.4	0.1	0.3	0.3	0.2	0.7	0.5	0.1	0.8	0.1	0.1	0.1	0.8	1.4	0.3	0.3	0.1	0.9	0.1	0.0	0.6	0.2	0.1	0.0	0.1	0.2	0.6	0.8	0.0	0.0	0.8	0.2	0.1	0.0	0.0	0.5	0.5	0.6	0.3	0.3	0.1	0.5	0.3	0.1	0.0	0.1	0.1	0.4	0.0	0.9	0.2	1.0	0.0	0.3	0.3	0.4	0.5	0.3	0.3	0.2	0.3	1.5	0.0	0.2	0.3	0.6	0.2	0.3	0.6	0.2	0.7	0.3	0.1	0.5	0.6	0.4	0.2	1.5	0.6	0.5	0.3	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.7	0.7	2.4	0.9	0.6	0.3	0.7	0.7	0.5	1.8	0.3	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.1	0.6	0.1	0.6	0.0	0.0	1.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM150C	"FLJ12993, TTN3"	ENSG00000249242	"Transmembrane protein 150C"	B9EJG8	4	82483170-82562357	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 136.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 88.6;Granulosa cells: 104.7;Syncytiotrophoblasts: 117.3"	"Cancer enhanced"	"Detected in all"		"breast cancer: 23.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 8.8;AN3-CA: 10.9;MCF7: 32.2;SCLC-21H: 20.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052921	Enhanced					NA	NA					"HPA052921: AB_2681988"	"unprognostic (2.99e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.71e-3)"	"prognostic favorable (7.87e-4)"	"unprognostic (2.94e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.94e-2)"	"prognostic favorable (5.68e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (4.59e-6)"	"unprognostic (4.18e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-3)"	12.4	43.4	12.8	4.7	15.5	1.9	22.2	10.4	17.0	15.2	7.1	7.1	7.4	5.0	136.1	3.7	7.4	6.5	12.8	15.4	12.8	17.4	14.0	6.3	14.8	13.2	13.5	15.1	31.8	3.5	5.4	8.4	9.9	12.9	12.7	4.3	4.6	17.1	7.7	6.9	4.3	7.0	7.0	12.0	14.5	5.1	3.3	11.8	9.2	11.5	9.8	12.9	5.0	5.2	13.4	0.1	1.0	8.8	10.9	0.1	0.1	0.4	1.9	4.7	1.3	1.2	0.0	0.6	0.3	0.9	0.3	3.6	0.2	5.0	0.0	1.4	0.4	2.3	0.7	1.2	0.1	0.0	0.0	1.0	4.5	0.6	0.0	0.0	0.8	2.7	5.3	0.0	0.0	0.2	32.2	0.6	0.8	3.9	0.0	0.5	1.0	0.2	1.2	0.2	4.8	20.1	3.5	0.5	0.4	2.8	4.1	0.5	0.2	0.8	0.5	0.3	0.1	1.1	0.1	0.5	0.4	0.6	0.1	2.2	2.6	0.3	0.5	0.2	0.2	0.1	1.0	0.3	0.2	0.1	1.1	0.2	0.2	1.4	0.5	0.3	0.6	0.1	0.1	12.8	15.5	10.4	17.0	15.4	12.8	13.2	13.5	15.1	12.9	12.0	11.8	13.4	30.7	0.0	1.1	36.6	0.2	2.4	3.5	1.9	0.6	1.1	19.3	13.6	10.1	5.7	6.1	14.7	2.1	88.6	1.4	0.2	0.0	7.2	5.5	2.6	11.2	24.8	1.2	3.0	35.6	2.5	1.3	13.1	0.5	10.5	6.3	104.7	25.4	20.4	5.7	1.7	24.2	1.1	0.0	1.0	3.6	2.9	14.3	1.8	1.8	7.5	7.8	14.8	0.0	17.6	13.1	1.4	0.2	9.8	1.2	4.9	0.4	2.6	7.1	2.2	0.0	3.9	7.8	1.1	4.1	1.6	1.1	117.3	0.6	1.8	4.3	0.9
TMEM63C	"C14orf171, CSC1, DKFZp434P0111, hsCSC1"	ENSG00000165548	"Transmembrane protein 63C"	Q9P1W3	14	77116568-77259495	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.0;pituitary gland: 42.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.5;Enteroendocrine cells: 19.2;Excitatory neurons: 25.8;Inhibitory neurons: 22.2;Oligodendrocyte precursor cells: 16.1"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 18.5;Karpas-707: 24.1;RPMI-8226: 12.7;SCLC-21H: 32.5;SK-BR-3: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030657	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA030657: AB_10601699"	"unprognostic (2.74e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.30e-8)"	"unprognostic (2.85e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.34e-7)"	"unprognostic (5.90e-3)"	0.2	9.7	7.0	0.6	5.6	0.8	3.4	28.0	11.1	1.4	0.0	4.2	1.2	0.1	4.6	6.5	0.2	0.2	0.5	5.6	19.7	0.5	0.1	0.5	0.3	4.5	10.1	6.7	0.1	4.8	1.6	42.3	0.7	13.3	0.2	3.1	2.4	2.7	0.0	0.5	8.6	2.7	0.6	1.4	3.3	2.0	11.4	14.4	0.1	2.2	0.4	0.3	0.0	7.2	5.3	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	18.5	3.4	0.0	3.0	2.5	3.8	1.5	0.0	1.2	1.4	0.3	1.8	0.0	0.0	3.2	0.1	0.0	7.5	0.0	0.2	0.0	0.0	8.7	0.0	24.1	0.0	9.3	2.6	0.1	0.8	0.0	0.0	0.0	1.2	12.7	0.3	0.0	32.5	4.9	0.4	29.1	0.0	0.6	2.8	1.6	0.0	0.0	5.9	0.0	0.0	1.9	0.1	0.7	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.3	0.3	0.0	0.0	0.1	7.0	5.6	28.0	11.1	5.6	19.7	4.5	10.1	6.7	13.3	1.4	14.4	5.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	3.3	2.2	0.8	0.7	0.0	1.7	0.0	2.1	0.0	1.5	3.8	1.9	0.0	9.5	0.3	0.4	0.1	19.2	0.0	25.8	0.2	0.1	0.3	0.0	2.4	0.0	0.2	0.0	0.0	2.7	3.3	22.2	3.0	4.1	0.0	0.0	6.2	0.0	0.2	0.0	3.7	0.6	0.3	0.0	16.1	1.1	0.2	7.0	0.4	0.1	0.0	0.5	0.2	0.1	0.6	0.0	0.0	0.3	0.6	0.1	2.4	0.0	0.0	0.2	0.7	0.7	0.1
TNN	TNW	ENSG00000120332	"Tenascin N"	Q9UQP3	1	175067833-175148075	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 12.1;breast: 4.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 6.1;Fibroblasts: 7.5;Hepatic stellate cells: 2.5;Langerhans cells: 2.5;Smooth muscle cells: 10.4"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.6;NB-4: 3.6;THP-1: 11.1;U-266/70: 2.7;U-937: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB010907, HPA026726, HPA026764"	Uncertain				"Secreted to extracellular matrix"	NA	NA		34000000			"CAB010907: AB_477565, HPA026726: AB_10601771, HPA026764: AB_10601859"	"unprognostic (1.16e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.69e-1)"	"unprognostic (5.07e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.76e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.02e-2)"	12.1	0.2	0.0	0.1	0.1	0.0	4.9	0.0	0.3	0.1	0.5	0.2	0.8	0.0	0.0	0.1	0.0	1.7	0.3	0.2	0.2	0.4	1.3	0.4	0.1	0.1	0.1	0.1	0.0	0.3	0.8	2.0	0.1	0.0	0.0	0.1	0.0	3.3	0.0	0.0	2.0	0.4	0.4	0.1	0.4	0.4	0.1	0.1	0.1	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	11.1	0.0	0.0	0.0	0.0	0.0	2.7	0.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	6.1	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.7	0.0	0.1	7.5	0.0	0.1	0.0	0.0	2.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	2.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	10.4	0.4	1.4	0.0	1.8	0.1	0.1	0.0	0.0	0.1
TRARG1	"BEC-1, DSPB1, IFITMD3, LOST1, TUSC5"	ENSG00000184811	"Trafficking regulator of GLUT4 (SLC2A4) 1"	Q8IXB3	17	1279662-1300978	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	34	"adipose tissue: 102.3;breast: 69.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 2.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	294	"ASC diff: 29.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050825	Approved					NA	NA					"HPA050825: AB_2681252"	"unprognostic (5.84e-2)"	"unprognostic (7.21e-2)"		"unprognostic (1.15e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.90e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (5.10e-1)"	102.3	1.1	0.0	1.2	0.0	0.0	69.2	0.0	0.4	0.3	0.0	1.0	0.0	0.2	0.0	0.1	0.1	0.6	1.5	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.4	0.0	1.2	1.7	2.3	0.0	0.0	0.0	0.6	0.6	0.0	0.1	1.0	0.6	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRPA1	ANKTM1	ENSG00000104321	"Transient receptor potential cation channel subfamily A member 1"	O75762	8	72019917-72075584	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 9.3;stomach 1: 10.4;urinary bladder: 28.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 10.9;Excitatory neurons: 5.0;Fibroblasts: 8.1;Intestinal goblet cells: 17.2;Skeletal myocytes: 4.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HHSteC: 25.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA						"unprognostic (2.14e-2)"	"unprognostic (2.50e-2)"	"prognostic favorable (6.57e-4)"	"unprognostic (1.28e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.11e-3)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.16e-4)"	"unprognostic (2.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.90e-1)"	0.4	0.4	0.1	3.8	0.0	0.0	0.0	0.0	0.6	0.1	0.0	8.0	6.3	0.3	0.0	1.0	0.2	7.0	0.8	0.7	0.0	0.1	0.0	0.2	0.8	0.2	0.0	0.0	0.8	0.1	0.0	0.0	0.7	0.1	0.1	9.3	0.0	0.2	0.0	0.1	0.1	7.5	0.3	0.0	0.5	10.4	0.5	0.0	0.2	0.1	0.0	0.2	28.0	0.3	0.2	0.0	2.8	0.8	0.0	0.0	0.1	0.0	0.3	2.5	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.0	0.4	1.5	0.1	0.0	0.5	0.0	25.9	0.0	0.2	1.7	0.0	1.2	0.2	5.5	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.6	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.5	0.0	2.6	0.2	0.0	0.4	0.0	0.1	4.0	1.2	0.0	0.3	0.3	0.0	1.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.6	0.7	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.9	0.0	0.1	0.0	0.0	0.0	5.0	0.0	0.0	8.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	17.2	0.0	0.0	0.0	0.8	0.3	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	4.5	0.8	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.5	0.0
UCP1	"SLC25A7, UCP"	ENSG00000109424	"Uncoupling protein 1"	P25874	4	140559431-140568961	"Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.7;brain: 1.0"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.2;Syncytiotrophoblasts: 2.3"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 4.7;HAP1: 3.3;JURKAT: 1.1"	"Not detected"	"Not detected"													NA	NA						"unprognostic (5.08e-3)"	"unprognostic (4.44e-1)"		"unprognostic (2.65e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.17e-2)"		"unprognostic (6.08e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.38e-1)"		"unprognostic (4.45e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.58e-2)"	0.4	2.7	0.1	0.0	0.1	0.0	0.6	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.2	0.1	0.1	0.2	0.4	0.0	0.4	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.8	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	2.3	0.0	0.0	0.1	0.0
VAV3		ENSG00000134215	"Vav guanine nucleotide exchange factor 3"	Q9UKW4	1	107571161-107965180	"Predicted intracellular proteins"	Angiogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 84.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 263.5;Basal squamous epithelial cells: 163.9;Syncytiotrophoblasts: 246.0"	"Cancer enhanced"	"Detected in all"		"breast cancer: 28.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 52.8;RH-30: 61.7;RPTEC TERT1: 86.2;T-47d: 107.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002012	Uncertain					NA	NA					"CAB002012: "	"unprognostic (4.80e-3)"	"unprognostic (7.99e-3)"	"unprognostic (5.31e-3)"	"unprognostic (3.78e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.67e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.34e-1)"	"prognostic favorable (4.60e-8)"	"unprognostic (1.89e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.23e-2)"	3.2	1.7	4.1	10.9	4.1	19.5	34.5	5.6	6.4	5.8	13.4	41.6	9.4	4.5	4.0	35.2	3.8	2.6	1.5	2.4	2.9	84.7	2.4	4.1	10.5	4.1	7.1	2.4	0.5	17.5	1.5	1.4	34.6	4.3	4.3	51.3	7.4	7.4	11.6	0.9	49.4	15.4	3.6	1.5	11.3	7.3	5.2	9.4	8.9	10.0	1.2	16.7	12.9	16.2	3.7	0.0	12.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	3.5	16.9	0.6	0.2	0.0	0.0	4.5	17.4	5.8	10.2	0.0	16.3	6.5	0.0	36.6	0.0	1.1	0.0	0.0	8.5	0.0	13.3	0.2	5.7	34.2	4.2	5.0	0.2	1.2	52.8	61.7	0.4	86.2	29.5	2.8	2.6	16.4	7.2	0.3	1.5	107.2	29.7	1.2	0.6	0.0	0.1	0.6	8.0	3.3	0.5	13.0	26.1	1.2	4.7	0.6	0.7	2.1	0.5	1.1	1.7	0.6	1.0	2.6	2.0	0.1	1.4	1.7	2.1	0.2	1.6	2.6	0.7	4.1	4.1	5.6	6.4	2.4	2.9	4.1	7.1	2.4	4.3	1.5	9.4	3.7	7.3	0.0	1.7	263.5	37.0	11.7	10.3	13.3	163.9	15.0	48.5	21.5	2.4	5.7	17.8	51.5	2.1	108.8	91.0	87.3	117.4	7.9	55.7	11.2	1.1	9.6	21.1	11.3	38.2	0.0	25.6	3.1	2.6	5.8	7.6	0.0	10.0	0.2	23.6	0.0	77.7	29.1	4.1	15.7	10.6	40.1	0.3	22.1	3.6	23.4	13.3	3.8	69.0	36.2	2.4	0.1	47.2	0.4	32.7	2.1	25.2	79.6	12.3	28.4	6.6	51.1	1.6	1.3	3.0	108.7	21.0	246.0	30.3	8.8	45.9	4.7
VSTM2A	"MGC33530, VSTM2"	ENSG00000170419	"V-set and transmembrane domain containing 2A"	Q8TAG5	7	54542325-54571080	"Plasma proteins, Predicted secreted proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 10.3;brain: 32.0;prostate: 9.8;retina: 14.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 42.0;Enteroendocrine cells: 7.3;Excitatory neurons: 12.5;Fibroblasts: 10.9;Inhibitory neurons: 30.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 4.6;glioma: 3.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 4.2;SH-SY5Y: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA		31000				"unprognostic (1.15e-1)"		"unprognostic (1.02e-1)"		"unprognostic (1.89e-1)"						"unprognostic (1.14e-2)"	"unprognostic (4.66e-1)"	"prognostic favorable (5.34e-4)"	"unprognostic (4.34e-2)"	"unprognostic (6.79e-2)"		"unprognostic (7.15e-2)"	0.0	10.3	3.5	0.0	10.3	0.0	0.3	0.0	32.0	0.0	0.0	4.4	1.4	0.0	0.0	0.0	0.0	0.1	0.0	11.9	10.5	0.0	0.0	0.0	0.0	2.1	2.4	11.7	0.0	0.6	0.0	0.3	0.0	7.9	9.8	4.1	14.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.7	0.4	8.4	0.0	0.2	0.2	0.0	0.6	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.2	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	10.3	0.0	32.0	11.9	10.5	2.1	2.4	11.7	7.9	0.0	8.4	4.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	42.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.2	7.3	0.0	12.5	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	2.2	0.0	2.5	0.5	0.0	1.1	0.0	0.0	0.2	0.0	0.1	0.7	4.1	0.0	0.2	2.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.3
ZNF552	FLJ21603	ENSG00000178935	"Zinc finger protein 552"	Q9H707	19	57803841-57814913	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"breast cancer: 23.6"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 25.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 25.3"	"Cell line enhanced"	"Detected in all"		"BEWO: 30.3;RT4: 42.5;T-47d: 69.6"					"Low region specificity"	"Detected in all"			"HPA043800, HPA053762, HPA072145"	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: "	"prognostic favorable (4.57e-4)"	"unprognostic (2.09e-1)"	"prognostic favorable (2.66e-4)"	"unprognostic (9.03e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (3.03e-2)"	"unprognostic (1.29e-3)"	"unprognostic (3.36e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.41e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.04e-3)"	3.0	2.3	2.7	4.8	2.8	8.2	26.3	12.8	6.6	9.9	7.3	9.5	7.2	5.1	5.4	5.5	5.6	8.8	2.9	3.1	1.9	7.2	4.7	6.1	5.3	2.3	1.6	1.4	4.2	4.3	6.1	2.5	6.5	5.6	12.5	12.2	4.0	17.7	6.9	4.9	9.7	7.4	3.1	0.4	6.1	14.0	3.0	2.7	5.1	4.1	2.7	5.5	14.9	5.9	3.1	5.6	3.2	3.7	5.9	3.0	1.5	30.3	2.0	2.4	4.5	2.5	9.6	8.8	7.6	3.8	3.6	1.0	4.8	7.6	5.0	5.4	3.4	15.1	2.6	8.4	7.1	7.1	8.5	3.4	3.3	10.9	3.1	3.2	2.8	6.0	8.0	5.5	2.5	3.0	5.0	3.7	2.5	5.2	6.9	7.3	7.6	4.7	8.0	13.4	42.5	4.9	3.5	10.2	22.6	5.1	10.4	69.6	3.5	4.5	3.8	4.2	2.5	3.5	11.0	8.1	6.1	3.1	6.4	2.2	2.1	3.3	7.4	2.7	3.3	2.5	3.7	3.4	4.3	1.7	3.7	4.5	3.8	25.3	2.4	1.4	2.3	3.0	2.4	2.7	2.8	12.8	6.6	3.1	1.9	2.3	1.6	1.4	5.6	0.4	2.7	3.1	2.9	12.8	3.1	4.2	7.8	2.5	14.8	9.7	8.0	6.2	19.4	9.8	3.1	18.6	15.0	20.2	2.1	22.1	5.3	9.4	25.4	6.9	5.7	20.2	4.9	3.7	8.4	6.1	7.7	1.8	5.2	3.8	19.4	15.0	8.8	14.2	7.1	4.2	5.2	3.3	8.1	14.5	14.2	2.4	3.1	1.5	2.8	3.6	1.8	1.9	3.1	2.3	2.1	4.5	5.1	3.1	13.4	2.2	4.8	8.3	15.6	4.8	20.5	12.7	6.6	2.9	3.5	3.8	4.6	7.0	2.7	21.3	7.1	5.4	9.3	14.2
